SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain and Structure information: based on WT protein Annotated databases Deep learning-based pathogenicity predictions Folding stability-based pathogenicity predictions Sequence/structure-based pathogenicity predictions Phase Separation Evolutionary/physical properties Molecular Dynamics-based analysis DOI
Domain IUPred2 ANCHOR2 AlphaFold MobiDB PhosphoSitePlus ClinVar gnomAD ESM1b AlphaMissense FoldX Rosetta Foldetta PremPS REVEL PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PSMutPred PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation
Score Prediction Score Prediction pLDDT disorder disorder LTP HTP KL PTM Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences IP RF SP RF Prediction PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.2122C>T
L708F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L708F is not reported in ClinVar and is present in gnomAD (ID 6‑33441587‑C‑T). Functional prediction tools that reach consensus classify the change as benign: REVEL, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Pathogenic predictions are limited to polyPhen‑2 HumDiv and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) return uncertain or no result. High‑accuracy assessments give AlphaMissense‑Optimized a benign score, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign, and Foldetta indicates no significant destabilization (uncertain). Overall, the preponderance of evidence supports a benign effect for L708F, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.250310Structured0.365875Uncertain0.9310.3780.0006-33441587-C-T21.24e-6-9.154Likely Pathogenic0.436AmbiguousLikely Benign1.48Ambiguous0.30.93Ambiguous1.21Ambiguous0.37Likely Benign0.110Likely Benign-2.46Neutral0.931Possibly Damaging0.326Benign3.29Benign0.07Tolerated3.5090.04970.236602-1.034.02
c.2137C>T
P713S
2D
AIThe SynGAP1 missense variant P713S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, Rosetta, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are provided by FoldX, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments further highlight this ambiguity: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus indicates a likely pathogenic effect, and Foldetta likewise yields an uncertain stability change. Overall, the majority of tools lean toward a pathogenic interpretation, and this aligns with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-8.496Likely Pathogenic0.846Likely PathogenicAmbiguous0.91Ambiguous0.70.19Likely Benign0.55Ambiguous0.62Ambiguous0.261Likely Benign-6.60Deleterious1.000Probably Damaging0.998Probably Damaging3.29Benign0.00Affected0.32340.36741-10.8-10.04
c.2138C>G
P713R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P713R has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The remaining tools, premPS and AlphaMissense‑Optimized, are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of predictions lean toward pathogenicity, while the most accurate methods give conflicting results. Thus, the variant is most likely pathogenic based on the current evidence, and this assessment does not contradict ClinVar status, which has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-12.101Likely Pathogenic0.930Likely PathogenicAmbiguous0.29Likely Benign0.00.21Likely Benign0.25Likely Benign0.86Ambiguous0.331Likely Benign-7.42Deleterious1.000Probably Damaging0.998Probably Damaging3.29Benign0.00Affected0.13660.23350-2-2.959.07
c.2150T>A
L717H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L717H occurs in the GAP domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overwhelming majority of computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.239899Structured0.429342Uncertain0.9690.3970.000-11.107Likely Pathogenic0.977Likely PathogenicLikely Pathogenic2.27Destabilizing0.12.04Destabilizing2.16Destabilizing1.05Destabilizing0.317Likely Benign-5.23Deleterious1.000Probably Damaging1.000Probably Damaging3.29Benign0.00Affected0.09180.0558-2-3-7.023.98
c.3901C>T
P1301S
2D
AIThe SynGAP1 missense variant P1301S is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify the substitution as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity. High‑accuracy assessments corroborate this benign prediction: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the computational evidence strongly supports a benign effect, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.728858Disordered0.885064Binding0.4470.8410.875-4.537Likely Benign0.071Likely BenignLikely Benign0.087Likely Benign1.84Neutral0.000Benign0.001Benign3.29Benign0.95Tolerated0.27990.34361-10.8-10.04
c.395T>G
F132C
2D
AIThe SynGAP1 missense variant F132C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Pathogenic” based on a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (derived from the four high‑accuracy predictors) also indicates likely pathogenic. Foldetta results are unavailable. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.450668Structured0.727897Binding0.3450.8920.250-10.013Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.331Likely Benign-4.55Deleterious0.938Possibly Damaging0.498Possibly Damaging3.29Benign0.00Affected0.26770.0925-4-2-0.3-44.04
c.3992T>A
I1331N
2D
AIThe SynGAP1 missense variant I1331N is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33451866‑T‑A). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the majority of evaluated tools predict a pathogenic impact, and there is no conflict with ClinVar status. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.921076Disordered0.941705Binding0.3590.7520.8756-33451866-T-A-3.788Likely Benign0.994Likely PathogenicLikely Pathogenic0.237Likely Benign-4.09Deleterious0.984Probably Damaging0.979Probably Damaging3.29Benign0.00Affected3.7750.10120.0666-3-2-8.00.94
c.1231A>T
I411F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I411F is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to FATHMM, while the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; premPS is uncertain. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.339366Uncertain0.9270.1980.000-13.377Likely Pathogenic0.977Likely PathogenicLikely Pathogenic5.71Destabilizing0.14.53Destabilizing5.12Destabilizing0.73Ambiguous0.503Likely Pathogenic-3.69Deleterious0.998Probably Damaging0.973Probably Damaging3.30Benign0.00Affected0.05380.285310-1.734.02
c.1232T>G
I411S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I411S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.339366Uncertain0.9270.1980.000-13.763Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.59Destabilizing0.23.83Destabilizing3.71Destabilizing1.91Destabilizing0.603Likely Pathogenic-5.50Deleterious1.000Probably Damaging1.000Probably Damaging3.30Benign0.00Affected0.22620.1487-1-2-5.3-26.08
c.1276A>T
N426Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two main groups: benign predictions come from REVEL, FoldX, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b. Two tools remain uncertain: Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on the current predictive landscape.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.042364Structured0.394941Uncertain0.9590.2870.000-8.510Likely Pathogenic0.541AmbiguousLikely Benign0.47Likely Benign0.0-0.50Ambiguous-0.02Likely Benign0.23Likely Benign0.341Likely Benign-5.48Deleterious0.999Probably Damaging0.993Probably Damaging3.30Benign0.25Tolerated0.05780.3338-2-22.249.07
c.1338G>C
E446D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E446D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a damaging effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports it as Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, yields an uncertain result. Taken together, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.271506Structured0.276479Uncertain0.9400.2160.000-5.668Likely Benign0.562AmbiguousLikely Benign1.65Ambiguous0.70.80Ambiguous1.23Ambiguous0.68Ambiguous0.171Likely Benign-2.40Neutral0.986Probably Damaging0.960Probably Damaging3.30Benign0.18Tolerated0.16570.4275320.0-14.03
c.1338G>T
E446D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change E446D lies in the GAP domain. ClinVar has no entry for this variant and it is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Two tools report a pathogenic signal: polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The remaining predictors (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus also benign, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Taken together, the majority of evidence points to a benign effect. Thus, the variant is most likely benign, and this is consistent with the lack of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.271506Structured0.276479Uncertain0.9400.2160.000-5.668Likely Benign0.562AmbiguousLikely Benign1.65Ambiguous0.70.80Ambiguous1.23Ambiguous0.68Ambiguous0.171Likely Benign-2.40Neutral0.986Probably Damaging0.960Probably Damaging3.30Benign0.18Tolerated0.16570.4275320.0-14.03
c.1340T>A
V447D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant V447D lies in the GAP domain. ClinVar has no entry for this change, and it is absent from gnomAD. Prediction tools that agree on benign impact are REVEL and FATHMM, whereas the remaining predictors—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently classify the variant as pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta also reports a pathogenic effect. Overall, the evidence points to a pathogenic effect for V447D, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.250310Structured0.283801Uncertain0.9700.2430.000-16.643Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.34Destabilizing0.13.59Destabilizing3.97Destabilizing2.29Destabilizing0.491Likely Benign-5.33Deleterious1.000Probably Damaging1.000Probably Damaging3.30Benign0.01Affected0.14240.0541-2-3-7.715.96
c.1369A>C
S457R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S457R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split opinion: benign calls come from REVEL, Rosetta, and FATHMM, while pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX, Foldetta, and premPS are inconclusive. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenic, whereas Foldetta’s stability analysis is uncertain. Overall, the majority of evidence points toward a pathogenic impact. This conclusion is not contradicted by ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.164327Structured0.297330Uncertain0.9090.1590.000-10.882Likely Pathogenic0.997Likely PathogenicLikely Pathogenic-1.04Ambiguous0.0-0.06Likely Benign-0.55Ambiguous0.74Ambiguous0.468Likely Benign-4.47Deleterious0.999Probably Damaging0.989Probably Damaging3.30Benign0.05Affected0.07810.34260-1-3.769.11
c.1369A>T
S457C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S457C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split assessment: benign predictions come from REVEL, FoldX, Foldetta, and FATHMM, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy methods give mixed results: AlphaMissense‑Optimized is inconclusive and therefore not used as evidence; the SGM‑Consensus majority vote (AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign effect. Overall, the majority of individual predictors lean toward pathogenicity, while the high‑accuracy Foldetta result suggests benign stability. Given the predominance of pathogenic calls and the lack of ClinVar evidence, the variant is most likely pathogenic, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.164327Structured0.297330Uncertain0.9090.1590.000-8.152Likely Pathogenic0.815Likely PathogenicAmbiguous-0.12Likely Benign0.0-0.79Ambiguous-0.46Likely Benign0.56Ambiguous0.497Likely Benign-4.81Deleterious0.999Probably Damaging0.987Probably Damaging3.30Benign0.01Affected0.08650.62840-13.316.06
c.1371T>A
S457R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S457R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, and FATHMM, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, SGM‑Consensus confirms a likely pathogenic status, and Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. No other high‑confidence stability predictions are available. Overall, the preponderance of evidence from multiple independent predictors indicates that S457R is most likely pathogenic, and this assessment does not contradict any existing ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.164327Structured0.297330Uncertain0.9090.1590.000-10.882Likely Pathogenic0.997Likely PathogenicLikely Pathogenic-1.04Ambiguous0.0-0.06Likely Benign-0.55Ambiguous0.74Ambiguous0.343Likely Benign-4.47Deleterious0.999Probably Damaging0.989Probably Damaging3.30Benign0.05Affected0.07810.34260-1-3.769.11
c.1371T>G
S457R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S457R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, and FATHMM, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, SGM‑Consensus confirms a likely pathogenic status, and Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. No other high‑confidence stability predictions are available. Overall, the preponderance of evidence from multiple independent predictors indicates that S457R is most likely pathogenic, and this assessment does not contradict any existing ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.164327Structured0.297330Uncertain0.9090.1590.000-10.882Likely Pathogenic0.997Likely PathogenicLikely Pathogenic-1.04Ambiguous0.0-0.06Likely Benign-0.55Ambiguous0.74Ambiguous0.343Likely Benign-4.47Deleterious0.999Probably Damaging0.989Probably Damaging3.30Benign0.05Affected0.07810.34260-1-3.769.11
c.1523A>G
D508G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D508G missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls are made by Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta. FoldX‑MD is inconclusive and is treated as unavailable. High‑accuracy assessments give a benign result from AlphaMissense‑Optimized, a likely pathogenic verdict from the SGM Consensus, and a pathogenic prediction from Foldetta. Overall, the majority of evidence, including the high‑accuracy tools, supports a pathogenic effect. This conclusion does not contradict ClinVar, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.019401Structured0.255890Uncertain0.8900.2280.000-8.478Likely Pathogenic0.622Likely PathogenicLikely Benign0.87Ambiguous0.23.20Destabilizing2.04Destabilizing0.13Likely Benign0.368Likely Benign-6.61Deleterious0.997Probably Damaging0.933Probably Damaging3.30Benign0.07Tolerated0.38210.45281-13.1-58.04
c.1535A>G
E512G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E512G is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. The remaining tools—FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized—return uncertain or inconclusive results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E512G, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.247079Uncertain0.9230.2730.000-11.996Likely Pathogenic0.817Likely PathogenicAmbiguous0.86Ambiguous0.11.84Ambiguous1.35Ambiguous0.17Likely Benign0.381Likely Benign-6.46Deleterious0.997Probably Damaging0.915Probably Damaging3.30Benign0.02Affected0.32620.41850-23.1-72.06
c.1561G>C
E521Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E521Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta predicts a benign stability change. Overall, the majority of evidence (9 benign vs. 4 pathogenic predictions) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.086953Structured0.062387Uncertain0.8650.3490.000-8.310Likely Pathogenic0.777Likely PathogenicLikely Benign-0.28Likely Benign0.20.19Likely Benign-0.05Likely Benign-0.06Likely Benign0.262Likely Benign-2.15Neutral0.992Probably Damaging0.993Probably Damaging3.30Benign0.11Tolerated0.15800.6552220.0-0.98
c.1613A>T
E538V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E538V missense change is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, Rosetta, Foldetta, premPS, and FATHMM. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized and FoldX give uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as benign. Overall, the majority of evidence points to a pathogenic effect. Based on the aggregate predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which has no entry for it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.122885Structured0.033501Uncertain0.9380.3590.000-11.537Likely Pathogenic0.885Likely PathogenicAmbiguous0.67Ambiguous0.0-0.49Likely Benign0.09Likely Benign0.23Likely Benign0.310Likely Benign-5.53Deleterious0.929Possibly Damaging0.641Possibly Damaging3.30Benign0.04Affected0.07220.4436-2-27.7-29.98
c.175C>A
L59M
2D
AIThe SynGAP1 missense variant L59M is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evaluated predictors lean toward a benign interpretation. Consequently, the variant is most likely benign based on current computational evidence, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.212910Structured0.484882Uncertain0.5100.6680.000-3.394Likely Benign0.618Likely PathogenicLikely Benign0.088Likely Benign-0.65Neutral0.824Possibly Damaging0.910Probably Damaging3.30Benign0.00Affected0.07720.331142-1.918.03
c.1846G>C
D616H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D616H missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM. Those that agree on a pathogenic effect comprise SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Two tools give uncertain results—Rosetta and AlphaMissense‑Optimized—so their outputs are treated as unavailable for inference. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is Pathogenic. Overall, the majority of evidence points to a pathogenic effect. The variant’s predicted pathogenicity does not contradict ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.129801Structured0.166689Uncertain0.8670.2520.000-9.815Likely Pathogenic0.904Likely PathogenicAmbiguous2.13Destabilizing0.21.89Ambiguous2.01Destabilizing0.45Likely Benign0.316Likely Benign-5.57Deleterious0.999Probably Damaging0.952Probably Damaging3.30Benign0.03Affected0.13300.42731-10.322.05
c.2011G>C
D671H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D671H is not reported in ClinVar and is absent from gnomAD. Benign predictions are provided by REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy tools give mixed results: AlphaMissense‑Optimized is uncertain, SGM Consensus predicts pathogenic, and Foldetta predicts benign. Overall, the balance of evidence leans toward pathogenicity, and this does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.194234Structured0.096749Uncertain0.6770.3700.000-11.501Likely Pathogenic0.940Likely PathogenicAmbiguous0.49Likely Benign0.00.29Likely Benign0.39Likely Benign0.09Likely Benign0.300Likely Benign-4.35Deleterious0.999Probably Damaging0.939Probably Damaging3.30Benign0.01Affected0.16270.65091-10.322.05
c.2029A>G
S677G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S677G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. No tool predicts pathogenicity. Predictions that are inconclusive—FoldX, Rosetta, Foldetta, and premPS—are treated as unavailable. High‑accuracy assessments reinforce the benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates benign; Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. Overall, the evidence supports a benign classification for S677G, and this conclusion does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.194234Structured0.115685Uncertain0.5550.3380.125-5.126Likely Benign0.060Likely BenignLikely Benign0.98Ambiguous0.11.20Ambiguous1.09Ambiguous0.64Ambiguous0.126Likely Benign-1.38Neutral0.002Benign0.001Benign3.30Benign0.26Tolerated0.28850.5325100.4-30.03
c.2049C>G
I683M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I683M variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of definitive predictions (five pathogenic vs. three benign) point to a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.200174Structured0.143268Uncertain0.8480.3140.000-9.010Likely Pathogenic0.424AmbiguousLikely Benign0.69Ambiguous0.10.68Ambiguous0.69Ambiguous0.74Ambiguous0.296Likely Benign-2.88Deleterious0.999Probably Damaging0.986Probably Damaging3.30Benign0.01Affected0.09330.266221-2.618.03
c.2099T>C
L700P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L700P is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while only FATHMM predicts it benign. The SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Pathogenic” verdict (3 pathogenic vs. 1 benign). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.416255Uncertain0.9270.3310.000-13.092Likely Pathogenic0.982Likely PathogenicLikely Pathogenic7.29Destabilizing0.512.85Destabilizing10.07Destabilizing1.84Destabilizing0.541Likely Pathogenic-4.31Deleterious0.999Probably Damaging0.966Probably Damaging3.30Benign0.01Affected0.36030.1025-3-3-5.4-16.04
c.3164G>A
G1055E
2D
AIThe SynGAP1 missense variant G1055E is catalogued in gnomAD (variant ID 6‑33443716‑G‑A) but has no ClinVar entry. In silico prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a benign effect. Foldetta, a protein‑folding stability predictor, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar classification (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.982235Disordered0.872113Binding0.3790.9350.8756-33443716-G-A16.21e-7-10.951Likely Pathogenic0.290Likely BenignLikely Benign0.320Likely Benign-0.03Neutral0.901Possibly Damaging0.456Possibly Damaging3.30Benign0.10Tolerated3.7750.15250.4459-20-3.172.06
c.3164G>C
G1055A
2D
AIThe SynGAP1 missense variant G1055A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while only polyPhen‑2 HumDiv indicates a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign and the SGM‑Consensus also reports Likely Benign; Foldetta results are unavailable. Overall, the consensus of the available predictions points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.982235Disordered0.872113Binding0.3790.9350.875-6.835Likely Benign0.083Likely BenignLikely Benign0.244Likely Benign0.15Neutral0.649Possibly Damaging0.148Benign3.30Benign1.00Tolerated0.33500.5144102.214.03
c.3992T>G
I1331S
2D
AIThe SynGAP1 I1331S variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta results are unavailable. Overall, the majority of evidence (six pathogenic vs. three benign predictions) indicates that the variant is most likely pathogenic. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.921076Disordered0.941705Binding0.3590.7520.875-3.014Likely Benign0.997Likely PathogenicLikely Pathogenic0.230Likely Benign-3.40Deleterious0.984Probably Damaging0.969Probably Damaging3.30Benign0.00Affected0.29290.0836-1-2-5.3-26.08
c.4008G>C
E1336D
2D
AIThe SynGAP1 missense variant E1336D is listed in ClinVar (ID 3323942.0) as benign and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. The SGM‑Consensus result is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yielding a benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, consistent with the ClinVar benign designation. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.865454Disordered0.973342Binding0.3360.7170.750Likely Benign 1-3.344Likely Benign0.596Likely PathogenicLikely Benign0.062Likely Benign-1.92Neutral0.001Benign0.003Benign3.30Benign0.00Affected3.7750.19950.5101230.0-14.03
c.4008G>T
E1336D
2D
AIThe SynGAP1 missense variant E1336D is catalogued in gnomAD (ID 6‑33451882‑G‑T) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a benign or likely benign outcome. Only two tools—SIFT and AlphaMissense‑Default—predict pathogenicity. High‑accuracy assessments further support benignity: AlphaMissense‑Optimized scores the variant as benign, and the SGM‑Consensus also reports it as likely benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a benign classification, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.865454Disordered0.973342Binding0.3360.7170.7506-33451882-G-T-3.344Likely Benign0.596Likely PathogenicLikely Benign0.065Likely Benign-1.92Neutral0.001Benign0.003Benign3.30Benign0.00Affected3.7750.19950.5101230.0-14.03
c.1232T>C
I411T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I411T missense variant is not reported in ClinVar (status: None) and has no entries in gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, while the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Rosetta’s assessment is uncertain. High‑accuracy methods give consistent pathogenic predictions: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is Pathogenic. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.339366Uncertain0.9270.1980.000-11.258Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.86Destabilizing0.01.75Ambiguous2.31Destabilizing1.86Destabilizing0.579Likely Pathogenic-4.54Deleterious1.000Probably Damaging0.999Probably Damaging3.31Benign0.00Affected0.09030.13890-1-5.2-12.05
c.1233C>G
I411M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I411M is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two consensus groups: benign predictions come from REVEL and FATHMM, while pathogenic predictions are supported by SGM‑Consensus, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. FoldX and AlphaMissense‑Optimized yield uncertain results. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized is inconclusive, the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta also predicts pathogenicity. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.339366Uncertain0.9270.1980.000-10.969Likely Pathogenic0.911Likely PathogenicAmbiguous1.30Ambiguous0.22.76Destabilizing2.03Destabilizing1.21Destabilizing0.344Likely Benign-2.73Deleterious1.000Probably Damaging0.999Probably Damaging3.31Benign0.00Affected0.06770.284821-2.618.03
c.1256A>G
E419G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E419G is listed in ClinVar with an uncertain significance (ClinVar ID 2004834.0) and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL and FATHMM, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as likely pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus confirms likely pathogenic, and the Foldetta stability analysis is inconclusive. No evidence from FoldX, Rosetta, or premPS is available. Overall, the preponderance of predictions indicates that E419G is most likely pathogenic, which contrasts with the current ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.371949Uncertain0.9610.2610.000Uncertain 1-10.589Likely Pathogenic0.956Likely PathogenicLikely Pathogenic1.41Ambiguous0.01.94Ambiguous1.68Ambiguous0.83Ambiguous0.469Likely Benign-6.42Deleterious1.000Probably Damaging0.997Probably Damaging3.31Benign0.02Affected3.37290.29920.57280-23.1-72.06165.3110.80.00.0-0.10.0XPotentially PathogenicThe carboxylate group of Glu419, located on an α helix (res. Met414-Glu436), forms a salt bridge with the side chain of either Arg716 or Lys418 from an opposing helix (res. Pro713-Arg726). The backbone amide group of Glu419 does not form H-bonds, resulting in a slight bend in the α helix. Thus, although glycine is known as an “α helix breaker,” the residue swap does not disrupt the continuity or integrity of the α helix. However, because Gly419 cannot form a salt bridge with the guanidinium group of the Arg716 side chain, the C2-GAP domain tertiary structure could be compromised during folding.
c.1265A>C
E422A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E422A missense variant is not reported in ClinVar and has no gnomAD entry. Prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM; pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized remains uncertain. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized is inconclusive; the SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates likely pathogenic; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts benign. Overall, the balance of evidence (seven pathogenic versus six benign predictions) points to a likely pathogenic effect for E422A, and this conclusion is not contradicted by the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.426709Uncertain0.9650.2550.000-12.088Likely Pathogenic0.952Likely PathogenicAmbiguous0.49Likely Benign0.00.25Likely Benign0.37Likely Benign0.26Likely Benign0.371Likely Benign-5.43Deleterious0.999Probably Damaging0.996Probably Damaging3.31Benign0.01Affected0.29490.44590-15.3-58.04
c.1265A>G
E422G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E422G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split assessment: benign predictions come from REVEL, premPS, and FATHMM, while pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are provided by FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy analyses indicate that the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts a likely pathogenic effect, whereas AlphaMissense‑Optimized remains inconclusive and Foldetta shows no definitive stability change. Overall, the majority of evidence points toward a pathogenic impact for E422G, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.426709Uncertain0.9650.2550.000-11.468Likely Pathogenic0.952Likely PathogenicAmbiguous1.13Ambiguous0.01.25Ambiguous1.19Ambiguous0.39Likely Benign0.488Likely Benign-6.38Deleterious1.000Probably Damaging0.997Probably Damaging3.31Benign0.01Affected0.24400.41840-23.1-72.06
c.1277A>T
N426I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N426I has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, AlphaMissense‑Optimized, and the protein‑folding stability method Foldetta. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicting pathogenicity, and Foldetta indicating a benign folding stability outcome. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.394941Uncertain0.9590.2870.000-10.158Likely Pathogenic0.570Likely PathogenicLikely Benign0.67Ambiguous0.00.14Likely Benign0.41Likely Benign0.23Likely Benign0.216Likely Benign-5.71Deleterious0.998Probably Damaging0.991Probably Damaging3.31Benign0.09Tolerated0.06560.3244-2-38.0-0.94
c.1340T>G
V447G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V447G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM, while the remaining tools—FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. No prediction or stability result is missing or inconclusive. Overall, the preponderance of evidence indicates that V447G is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.250310Structured0.283801Uncertain0.9700.2430.000-13.648Likely Pathogenic0.861Likely PathogenicAmbiguous3.81Destabilizing0.14.62Destabilizing4.22Destabilizing2.28Destabilizing0.499Likely Benign-5.43Deleterious1.000Probably Damaging1.000Probably Damaging3.31Benign0.01Affected0.18630.2240-1-3-4.6-42.08
c.1388A>T
D463V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D463V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, premPS, SIFT, and FATHMM, whereas those that agree on a pathogenic effect are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Uncertain predictions come from Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points toward a pathogenic impact for D463V, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-12.374Likely Pathogenic0.880Likely PathogenicAmbiguous0.23Likely Benign0.10.98Ambiguous0.61Ambiguous0.33Likely Benign0.521Likely Pathogenic-7.95Deleterious0.973Probably Damaging0.658Possibly Damaging3.31Benign0.09Tolerated0.07130.5526-2-37.7-15.96
c.1535A>C
E512A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E512A missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain results come from Foldetta, AlphaMissense‑Optimized, and Rosetta. High‑accuracy assessments show SGM‑Consensus as likely pathogenic, AlphaMissense‑Optimized as uncertain, and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not contradict any ClinVar annotation because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.247079Uncertain0.9230.2730.000-10.979Likely Pathogenic0.861Likely PathogenicAmbiguous0.45Likely Benign0.10.97Ambiguous0.71Ambiguous0.04Likely Benign0.309Likely Benign-5.71Deleterious0.987Probably Damaging0.937Probably Damaging3.31Benign0.12Tolerated0.42930.51620-15.3-58.04
c.1540A>C
I514L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I514L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Two tools (premPS and AlphaMissense‑Default) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta also predicts a benign outcome. No prediction or folding stability result is missing or inconclusive. Overall, the majority of evidence points to a benign impact, and this is consistent with the lack of ClinVar annotation—there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.049374Structured0.221408Uncertain0.9480.2660.000-10.239Likely Pathogenic0.490AmbiguousLikely Benign-0.05Likely Benign0.20.34Likely Benign0.15Likely Benign0.81Ambiguous0.310Likely Benign-1.99Neutral0.879Possibly Damaging0.985Probably Damaging3.31Benign0.12Tolerated0.07670.267822-0.70.00
c.1557A>C
E519D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E519D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments further show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. With seven benign predictions versus six pathogenic ones, the overall evidence slightly favors a benign classification. This conclusion does not contradict the ClinVar status, which contains no pathogenic assertion for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.078022Structured0.104514Uncertain0.8990.3280.000-8.009Likely Pathogenic0.723Likely PathogenicLikely Benign0.24Likely Benign0.00.40Likely Benign0.32Likely Benign0.05Likely Benign0.183Likely Benign-2.62Deleterious0.989Probably Damaging0.979Probably Damaging3.31Benign0.07Tolerated0.20880.1824320.0-14.03
c.1557A>T
E519D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E519D is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, and FATHMM, while those that predict a pathogenic outcome are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicating a likely pathogenic status, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a benign effect. Overall, the majority of tools, including the high‑accuracy methods, lean toward a benign interpretation. This consensus does not contradict ClinVar status, as the variant is currently unreported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.078022Structured0.104514Uncertain0.8990.3280.000-8.009Likely Pathogenic0.723Likely PathogenicLikely Benign0.24Likely Benign0.00.40Likely Benign0.32Likely Benign0.05Likely Benign0.182Likely Benign-2.62Deleterious0.989Probably Damaging0.979Probably Damaging3.31Benign0.07Tolerated0.20880.1824320.0-14.03
c.1562A>G
E521G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E521G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The high‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it is a 2‑vs‑2 split and is treated as unavailable. Overall, the majority of evidence points to a benign impact. The variant is most likely benign based on current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.086953Structured0.062387Uncertain0.8650.3490.000-6.636Likely Benign0.767Likely PathogenicLikely Benign0.18Likely Benign0.10.58Ambiguous0.38Likely Benign0.14Likely Benign0.289Likely Benign-3.64Deleterious1.000Probably Damaging0.999Probably Damaging3.31Benign0.07Tolerated0.29320.54550-23.1-72.06
c.1744G>A
E582K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E582K missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, premPS, PROVEAN, SIFT, and FATHMM, while pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta predicts a benign effect on protein stability. Taken together, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is available). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.102787Structured0.033838Uncertain0.8450.2350.000-11.826Likely Pathogenic0.814Likely PathogenicAmbiguous0.20Likely Benign0.10.07Likely Benign0.14Likely Benign0.02Likely Benign0.168Likely Benign-1.83Neutral0.994Probably Damaging0.994Probably Damaging3.31Benign0.33Tolerated0.20380.376201-0.4-0.94
c.1816A>T
S606C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S606C is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign, and the SGM‑Consensus as Likely Pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overall distribution of predictions, the variant is most likely benign, although the SGM‑Consensus suggests pathogenicity; this does not contradict any ClinVar status because the variant is not yet classified in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.191720Uncertain0.8750.2470.000-11.122Likely Pathogenic0.774Likely PathogenicLikely Benign-0.34Likely Benign0.0-0.31Likely Benign-0.33Likely Benign0.49Likely Benign0.348Likely Benign-4.98Deleterious0.999Probably Damaging0.997Probably Damaging3.31Benign0.00Affected0.09860.45800-13.316.06
c.1817G>T
S606I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S606I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL, Rosetta, Foldetta, premPS, and FATHMM, while those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points toward a pathogenic impact for S606I. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.191720Uncertain0.8750.2470.000-14.552Likely Pathogenic0.976Likely PathogenicLikely Pathogenic-0.60Ambiguous0.1-0.08Likely Benign-0.34Likely Benign0.41Likely Benign0.288Likely Benign-5.98Deleterious0.999Probably Damaging0.998Probably Damaging3.31Benign0.01Affected0.08910.4162-1-25.326.08
c.1952A>G
E651G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E651G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Predictions that are uncertain or unavailable are FoldX, Rosetta, ESM1b, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as unavailable. Overall, the majority of tools (five benign vs. four pathogenic) lean toward a benign interpretation, and this does not contradict the lack of ClinVar annotation. Thus, based on the available predictions, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.088832Structured0.365409Uncertain0.9550.3400.000-7.596In-Between0.591Likely PathogenicLikely Benign0.66Ambiguous0.11.61Ambiguous1.14Ambiguous0.32Likely Benign0.444Likely Benign-4.78Deleterious0.999Probably Damaging0.935Probably Damaging3.31Benign0.06Tolerated0.29080.44880-23.1-72.06
c.1961A>T
E654V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E654V missense variant is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include Rosetta, Foldetta, premPS, and FATHMM, while those that agree on a pathogenic effect are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. FoldX and AlphaMissense‑Optimized are inconclusive. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta predicts benign. Overall, the majority of tools (8 pathogenic vs. 4 benign) and the SGM‑Consensus result support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.026892Structured0.303029Uncertain0.9570.3110.000-12.306Likely Pathogenic0.950Likely PathogenicAmbiguous0.55Ambiguous0.0-0.33Likely Benign0.11Likely Benign0.21Likely Benign0.540Likely Pathogenic-6.66Deleterious0.988Probably Damaging0.734Possibly Damaging3.31Benign0.01Affected0.06860.4757-2-27.7-29.98
c.2012A>T
D671V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D671V missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM. Tools that predict a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus methods give a pathogenic signal: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain. Overall, the majority of predictions (seven pathogenic vs. three benign) support a pathogenic classification. There is no ClinVar entry to contradict this assessment, so the variant is most likely pathogenic based on the available computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.194234Structured0.096749Uncertain0.6770.3700.000-12.376Likely Pathogenic0.963Likely PathogenicLikely Pathogenic0.63Ambiguous0.10.51Ambiguous0.57Ambiguous0.14Likely Benign0.379Likely Benign-6.08Deleterious0.975Probably Damaging0.885Possibly Damaging3.31Benign0.01Affected0.08200.6651-2-37.7-15.96
c.2029A>C
S677R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S677R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Those that predict a pathogenic effect are FoldX, ESM1b, and AlphaMissense‑Default. Uncertain results come from Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta is also inconclusive. Overall, the majority of tools and the high‑accuracy benign prediction suggest the variant is most likely benign, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.194234Structured0.115685Uncertain0.5550.3380.125-9.388Likely Pathogenic0.714Likely PathogenicLikely Benign2.59Destabilizing0.10.73Ambiguous1.66Ambiguous0.71Ambiguous0.104Likely Benign-2.49Neutral0.385Benign0.037Benign3.31Benign0.12Tolerated0.11200.41950-1-3.769.11
c.2031T>A
S677R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S677R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Those that predict a pathogenic effect are FoldX, ESM1b, and AlphaMissense‑Default. Tools with uncertain or inconclusive results are Rosetta, Foldetta, and premPS. High‑accuracy methods give mixed signals: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta is uncertain. Overall, the majority of consensus tools (six benign vs. three pathogenic) lean toward a benign interpretation. This prediction does not contradict any ClinVar status, as none is available. Thus, the variant is most likely benign based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.194234Structured0.115685Uncertain0.5550.3380.125-9.388Likely Pathogenic0.714Likely PathogenicLikely Benign2.59Destabilizing0.10.73Ambiguous1.66Ambiguous0.71Ambiguous0.150Likely Benign-2.49Neutral0.385Benign0.037Benign3.31Benign0.12Tolerated0.11200.41950-1-3.769.11
c.2031T>G
S677R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S677R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Those that predict a pathogenic effect are FoldX, ESM1b, and AlphaMissense‑Default. Tools with uncertain or inconclusive results are Rosetta, Foldetta, and premPS. High‑accuracy methods give mixed signals: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta is uncertain. Overall, the majority of consensus tools (six benign vs. three pathogenic) lean toward a benign interpretation. This prediction does not contradict any ClinVar status, as none is available. Thus, the variant is most likely benign based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.194234Structured0.115685Uncertain0.5550.3380.125-9.388Likely Pathogenic0.714Likely PathogenicLikely Benign2.59Destabilizing0.10.73Ambiguous1.66Ambiguous0.71Ambiguous0.150Likely Benign-2.49Neutral0.385Benign0.037Benign3.31Benign0.12Tolerated0.11200.41950-1-3.769.11
c.2056G>T
G686C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G686C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from FoldX, Rosetta, FATHMM, and the protein‑folding stability method Foldetta; pathogenic predictions arise from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized, with the SGM‑Consensus score labeling the variant as Likely Pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as Pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.109221Structured0.177104Uncertain0.9190.2680.000-12.790Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.25Likely Benign0.20.41Likely Benign0.33Likely Benign0.93Ambiguous0.553Likely Pathogenic-8.14Deleterious1.000Probably Damaging0.988Probably Damaging3.31Benign0.02Affected0.12090.3246-3-32.946.09
c.2057G>T
G686V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G686V has no ClinVar entry and is not reported in gnomAD. Functional prediction tools that agree on benign impact are Rosetta and FATHMM, while the majority of other in silico predictors (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM‑Consensus score (Likely Pathogenic) indicate a pathogenic effect. Uncertain results come from FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for G686V, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.109221Structured0.177104Uncertain0.9190.2680.000-13.751Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.89Ambiguous0.50.21Likely Benign0.55Ambiguous0.74Ambiguous0.570Likely Pathogenic-8.08Deleterious1.000Probably Damaging0.979Probably Damaging3.31Benign0.01Affected0.10590.3646-1-34.642.08
c.2093A>G
E698G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E698G missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM. In contrast, a majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all indicate deleteriousness. FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are inconclusive, providing no definitive evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E698G. This prediction aligns with the absence of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-10.617Likely Pathogenic0.786Likely PathogenicAmbiguous0.57Ambiguous0.01.25Ambiguous0.91Ambiguous0.29Likely Benign0.439Likely Benign-6.37Deleterious1.000Probably Damaging0.993Probably Damaging3.31Benign0.01Affected0.25290.32860-23.1-72.06
c.2132T>A
L711Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711Q is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM. Tools that predict a pathogenic effect include FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, SGM Consensus, and Foldetta; Rosetta is uncertain. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts Pathogenic, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. No predictions are missing or inconclusive. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-11.792Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.93Destabilizing0.01.68Ambiguous2.31Destabilizing1.63Destabilizing0.388Likely Benign-5.67Deleterious1.000Probably Damaging1.000Probably Damaging3.31Benign0.00Affected0.10410.0488-2-2-7.314.97
c.2134G>T
G712C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G712C is catalogued in gnomAD (6‑33441599‑G‑T) but has no ClinVar entry. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the majority of algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.0006-33441599-G-T16.20e-7-11.376Likely Pathogenic0.829Likely PathogenicAmbiguous2.54Destabilizing0.05.72Destabilizing4.13Destabilizing0.56Ambiguous0.516Likely Pathogenic-7.75Deleterious1.000Probably Damaging1.000Probably Damaging3.31Benign0.00Affected3.5090.15130.3947-3-32.946.09
c.2854G>A
G952S
2D
AIThe SynGAP1 missense variant G952S is listed in ClinVar (ID 1325573.0) with an “Uncertain” clinical significance and is present in gnomAD (variant ID 6‑33443406‑G‑A). All evaluated in‑silico predictors agree on a benign effect: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all return benign scores. No tool predicts pathogenicity. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, did not provide a result for this variant, so its status is unavailable. Overall, the computational evidence strongly supports a benign classification, which is consistent with the ClinVar “Uncertain” status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.985964Disordered0.910621Binding0.3410.9260.750Conflicting 26-33443406-G-A21.24e-6-6.190Likely Benign0.077Likely BenignLikely Benign0.167Likely Benign0.19Neutral0.000Benign0.002Benign3.31Benign0.07Tolerated3.7750.25090.550210-0.430.03
c.3163G>A
G1055R
2D
AIThe SynGAP1 missense variant G1055R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, while Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.982235Disordered0.872113Binding0.3790.9350.875-8.778Likely Pathogenic0.375AmbiguousLikely Benign0.275Likely Benign-0.09Neutral0.970Probably Damaging0.728Possibly Damaging3.31Benign0.08Tolerated0.10130.4733-3-2-4.199.14
c.3163G>C
G1055R
2D
AIThe SynGAP1 missense variant G1055R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. AlphaMissense‑Default is uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign outcome (2 benign vs. 1 pathogenic, 1 uncertain). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence indicates the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.982235Disordered0.872113Binding0.3790.9350.875-8.778Likely Pathogenic0.375AmbiguousLikely Benign0.275Likely Benign-0.09Neutral0.970Probably Damaging0.728Possibly Damaging3.31Benign0.08Tolerated0.10130.4733-3-2-4.199.14
c.395T>C
F132S
2D
AIThe SynGAP1 missense variant F132S is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, ESM1b, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the balance of evidence (five pathogenic vs four benign predictions) indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.450668Structured0.727897Binding0.3450.8920.250-4.177Likely Benign0.996Likely PathogenicLikely Pathogenic0.329Likely Benign-4.54Deleterious0.567Possibly Damaging0.249Benign3.31Benign0.00Affected0.48690.0000-3-2-3.6-60.10
c.3991A>T
I1331F
2D
AIThe SynGAP1 missense variant I1331F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain” and the SGM‑Consensus as “Likely Benign”; Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign interpretation, with no ClinVar entry to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.921076Disordered0.941705Binding0.3590.7520.875-4.220Likely Benign0.946Likely PathogenicAmbiguous0.181Likely Benign-2.46Neutral0.984Probably Damaging0.969Probably Damaging3.31Benign0.00Affected0.05220.322510-1.734.02
c.1238C>G
P413R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P413R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The remaining methods, Foldetta and Rosetta, yield uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar annotation because no ClinVar status exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.332472Uncertain0.9270.2010.000-15.523Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.40Destabilizing0.21.34Ambiguous1.87Ambiguous1.07Destabilizing0.562Likely Pathogenic-8.29Deleterious1.000Probably Damaging0.998Probably Damaging3.32Benign0.01Affected0.15500.21990-2-2.959.07
c.1253A>T
K418I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K418I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM. In contrast, the majority of tools predict a pathogenic outcome: SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta as Uncertain. Overall, the preponderance of evidence points to a pathogenic effect for K418I, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.360134Uncertain0.9480.2630.000-14.895Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.51Ambiguous0.00.64Ambiguous0.58Ambiguous0.27Likely Benign0.428Likely Benign-7.27Deleterious1.000Probably Damaging1.000Probably Damaging3.32Benign0.01Affected0.12970.2432-2-38.4-15.01
c.1256A>C
E419A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, whereas a majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the balance of evidence favors a pathogenic classification; this conclusion does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.371949Uncertain0.9610.2610.000-10.951Likely Pathogenic0.944Likely PathogenicAmbiguous0.56Ambiguous0.10.94Ambiguous0.75Ambiguous0.28Likely Benign0.398Likely Benign-5.60Deleterious0.999Probably Damaging0.996Probably Damaging3.32Benign0.03Affected0.40510.67050-15.3-58.04
c.1345A>T
S449C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S449C is not reported in ClinVar and is absent from gnomAD. All evaluated in‑silico predictors classify the substitution as benign: REVEL, FoldX, Rosetta, premPS (uncertain), PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity. High‑accuracy assessments concur: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports a benign effect. Based on the unanimous benign predictions and lack of ClinVar evidence, the variant is most likely benign, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.254060Structured0.301437Uncertain0.9580.2510.000-2.207Likely Benign0.050Likely BenignLikely Benign0.48Likely Benign0.0-0.31Likely Benign0.09Likely Benign-0.57Ambiguous0.067Likely Benign0.48Neutral0.000Benign0.000Benign3.32Benign0.21Tolerated0.08640.50120-13.316.06
c.1381G>C
A461P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A461P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, and FATHMM, whereas the majority of tools predict a pathogenic outcome: SGM‑Consensus (Likely Pathogenic), Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS remains uncertain. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta is pathogenic. Based on the overall consensus of the available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.179055Structured0.292531Uncertain0.9360.1510.125-13.869Likely Pathogenic0.977Likely PathogenicLikely Pathogenic-0.35Likely Benign0.15.09Destabilizing2.37Destabilizing0.84Ambiguous0.451Likely Benign-4.52Deleterious0.999Probably Damaging0.849Possibly Damaging3.32Benign0.03Affected0.17480.39491-1-3.426.04
c.1382C>A
A461D
2D
AIThe SynGAP1 missense variant A461D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM. The majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta are inconclusive, providing no definitive evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that A461D is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.179055Structured0.292531Uncertain0.9360.1510.125-14.918Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.89Ambiguous1.12.18Destabilizing1.54Ambiguous1.09Destabilizing0.477Likely Benign-5.47Deleterious0.997Probably Damaging0.792Possibly Damaging3.32Benign0.01Affected0.15330.20160-2-5.344.01
c.1382C>G
A461G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A461G has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into three groups: benign predictions come from REVEL, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b; the remaining tools (FoldX, premPS, AlphaMissense‑Default, Foldetta) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic effect, with no ClinVar record to contradict this assessment. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.179055Structured0.292531Uncertain0.9360.1510.125-11.360Likely Pathogenic0.556AmbiguousLikely Benign1.46Ambiguous0.12.06Destabilizing1.76Ambiguous0.83Ambiguous0.276Likely Benign-3.79Deleterious0.991Probably Damaging0.628Possibly Damaging3.32Benign0.00Affected0.19880.331710-2.2-14.03
c.1388A>G
D463G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D463G missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. Five tools favor pathogenicity versus three favor benign, with the remaining five (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) yielding uncertain results. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is inconclusive; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, also remains inconclusive. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion is not contradicted by ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-10.713Likely Pathogenic0.921Likely PathogenicAmbiguous0.66Ambiguous0.11.93Ambiguous1.30Ambiguous0.54Ambiguous0.422Likely Benign-6.36Deleterious0.994Probably Damaging0.824Possibly Damaging3.32Benign0.09Tolerated0.37510.48981-13.1-58.04
c.1522G>A
D508N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D508N missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, FoldX, premPS, FATHMM, AlphaMissense‑Optimized) and pathogenic predictions (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b). Three tools remain uncertain (Rosetta, Foldetta, AlphaMissense‑Default). High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized classifies the change as benign; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—returns a pathogenic verdict; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an inconclusive result. Because the consensus of the high‑accuracy methods is split, the overall prediction is ambiguous, but the balance of evidence leans toward pathogenicity. This assessment does not contradict ClinVar, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.019401Structured0.255890Uncertain0.8900.2280.000-9.909Likely Pathogenic0.411AmbiguousLikely Benign0.11Likely Benign0.11.24Ambiguous0.68Ambiguous-0.12Likely Benign0.265Likely Benign-4.62Deleterious0.870Possibly Damaging0.615Possibly Damaging3.32Benign0.04Affected0.15770.4599210.0-0.98
c.1534G>A
E512K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E512K missense variant is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, FATHMM, premPS, and Foldetta, while those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; Rosetta is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as benign. Overall, seven tools predict pathogenicity versus six predicting benignity, with one uncertain result. Thus, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.247079Uncertain0.9230.2730.000-13.927Likely Pathogenic0.960Likely PathogenicLikely Pathogenic0.17Likely Benign0.10.63Ambiguous0.40Likely Benign-0.03Likely Benign0.344Likely Benign-3.85Deleterious0.962Probably Damaging0.658Possibly Damaging3.32Benign0.06Tolerated0.28440.477601-0.4-0.94
c.1534G>C
E512Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E512Q missense change is not reported in ClinVar and has no gnomAD entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign effect. Because the variant is absent from ClinVar and gnomAD, there is no external evidence to contradict the computational predictions. Overall, the balance of high‑confidence tools leans toward a pathogenic interpretation, though the presence of an equal number of benign predictions indicates that the evidence remains inconclusive.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.247079Uncertain0.9230.2730.000-9.964Likely Pathogenic0.847Likely PathogenicAmbiguous0.09Likely Benign0.10.42Likely Benign0.26Likely Benign0.00Likely Benign0.283Likely Benign-2.86Deleterious0.947Possibly Damaging0.706Possibly Damaging3.32Benign0.14Tolerated0.15230.4815220.0-0.98
c.1600T>A
S534T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S534T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate benign or likely benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Thus, the overall evidence strongly supports a benign classification, with no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.167087Structured0.032173Uncertain0.8600.3620.000-4.925Likely Benign0.104Likely BenignLikely Benign0.10Likely Benign0.10.46Likely Benign0.28Likely Benign0.19Likely Benign0.200Likely Benign-2.42Neutral0.676Possibly Damaging0.933Probably Damaging3.32Benign0.07Tolerated0.12380.5064110.114.03
c.1600T>C
S534P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S534P is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33438843‑T‑C). Functional prediction tools that report a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The high‑accuracy assessments are consistent with a benign outcome: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Based on the aggregate predictions, the variant is most likely benign, which does not contradict the ClinVar status of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.167087Structured0.032173Uncertain0.8600.3620.000Uncertain 16-33438843-T-C31.86e-6-5.056Likely Benign0.265Likely BenignLikely Benign-0.40Likely Benign0.20.35Likely Benign-0.03Likely Benign0.47Likely Benign0.203Likely Benign-3.81Deleterious0.993Probably Damaging0.993Probably Damaging3.32Benign0.05Affected3.37350.20710.4650-11-0.810.04
c.1643A>G
E548G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E548G missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SIFT and FATHMM, while the majority of other in silico predictors (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate a pathogenic impact; SGM‑Consensus also classifies the variant as likely pathogenic. Uncertain results are reported by FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized predicting pathogenicity, SGM‑Consensus confirming a likely pathogenic status, and Foldetta yielding an inconclusive stability change. Overall, the consensus of the available predictions points to a pathogenic effect for E548G, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.054297Structured0.008632Uncertain0.9650.2880.000-12.010Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.97Ambiguous0.11.66Ambiguous1.32Ambiguous0.59Ambiguous0.521Likely Pathogenic-6.73Deleterious1.000Probably Damaging0.999Probably Damaging3.32Benign0.06Tolerated0.26380.36540-23.1-72.06
c.1847A>C
D616A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D616A missense variant is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, SIFT, FATHMM, and polyPhen‑2 HumVar, while pathogenic predictions arise from SGM‑Consensus (Likely Pathogenic), Rosetta, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized model classifies the variant as benign, whereas the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates pathogenicity. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.129801Structured0.166689Uncertain0.8670.2520.000-11.386Likely Pathogenic0.664Likely PathogenicLikely Benign1.76Ambiguous0.22.07Destabilizing1.92Ambiguous0.41Likely Benign0.126Likely Benign-6.13Deleterious0.539Possibly Damaging0.122Benign3.32Benign0.10Tolerated0.35430.42070-25.3-44.01
c.1848T>A
D616E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D616E missense variant is catalogued in gnomAD (ID 6‑33440900‑T‑A) but has no ClinVar submission. Functional prediction tools show a split assessment: benign calls come from REVEL, both polyPhen‑2 HumDiv and HumVar, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls arise from PROVEAN, SIFT, and AlphaMissense‑Default. The remaining predictors (FoldX, Rosetta, Foldetta, premPS, ESM1b) are inconclusive. A high‑accuracy consensus (SGM) that aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN yields a pathogenic verdict. AlphaMissense‑Optimized remains benign, and Foldetta, which evaluates protein‑folding stability, is uncertain. Overall, the majority of evidence leans toward pathogenicity, and this conclusion does not conflict with ClinVar because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.166689Uncertain0.8670.2520.0006-33440900-T-A16.20e-7-7.250In-Between0.695Likely PathogenicLikely Benign0.96Ambiguous0.11.52Ambiguous1.24Ambiguous0.58Ambiguous0.092Likely Benign-2.85Deleterious0.421Benign0.232Benign3.32Benign0.03Affected3.37350.12250.4128230.014.03
c.1848T>G
D616E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D616E is not reported in ClinVar but is present in gnomAD (ID 6‑33440900‑T‑G). Functional prediction tools that agree on benign impact include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, SIFT, and AlphaMissense‑Default. The remaining tools (FoldX, Rosetta, Foldetta, premPS, ESM1b) are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of conventional predictors lean toward a benign effect, but the high‑accuracy consensus is split, leaving the variant’s clinical significance unresolved. Thus, the variant is most likely benign based on the bulk of predictions, and this does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.166689Uncertain0.8670.2520.0006-33440900-T-G31.86e-6-7.250In-Between0.695Likely PathogenicLikely Benign0.96Ambiguous0.11.52Ambiguous1.24Ambiguous0.58Ambiguous0.092Likely Benign-2.85Deleterious0.421Benign0.232Benign3.32Benign0.03Affected3.37350.12250.4128230.014.03
c.2018T>A
L673Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L673Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. FoldX and Foldetta, as well as AlphaMissense‑Default, are inconclusive and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta remains uncertain. Overall, the majority of available predictions (seven pathogenic vs. three benign) indicate that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar claim exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.060549Structured0.104692Uncertain0.5450.3690.000-11.963Likely Pathogenic0.445AmbiguousLikely Benign1.56Ambiguous0.22.32Destabilizing1.94Ambiguous1.02Destabilizing0.190Likely Benign-3.40Deleterious1.000Probably Damaging0.968Probably Damaging3.32Benign0.03Affected0.10450.1172-2-2-7.314.97
c.2030G>C
S677T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S677T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree that the substitution is benign: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, premPS, FoldX, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, and FATHMM all classify it as benign. No tool predicts pathogenicity. The only inconclusive results come from Rosetta (Uncertain) and Foldetta (Uncertain), which are treated as unavailable evidence. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta remains Uncertain. Overall, the consensus of available predictions indicates that S677T is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.194234Structured0.115685Uncertain0.5550.3380.125-4.760Likely Benign0.063Likely BenignLikely Benign-0.17Likely Benign0.3-0.85Ambiguous-0.51Ambiguous0.15Likely Benign0.070Likely Benign-0.97Neutral0.008Benign0.007Benign3.32Benign0.30Tolerated0.17750.6985110.114.03
c.2044T>C
Y682H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y682H is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL and FATHMM, whereas the majority of other in silico predictors (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict it to be pathogenic. The high‑accuracy consensus method SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. AlphaMissense‑Optimized and the protein‑folding stability predictor Foldetta both return uncertain results, and FoldX and Rosetta individually are inconclusive. Overall, the preponderance of pathogenic predictions outweighs the benign ones, indicating that Y682H is most likely pathogenic. This assessment does not contradict ClinVar status, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.141467Uncertain0.7580.3280.000-9.255Likely Pathogenic0.902Likely PathogenicAmbiguous1.78Ambiguous0.00.56Ambiguous1.17Ambiguous1.23Destabilizing0.399Likely Benign-4.58Deleterious1.000Probably Damaging0.999Probably Damaging3.32Benign0.03Affected0.24050.086802-1.9-26.03
c.2044T>G
Y682D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y682D is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, whereas SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. The high‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a pathogenic effect. With no ClinVar assertion to oppose these findings, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.141467Uncertain0.7580.3280.000-15.094Likely Pathogenic0.957Likely PathogenicLikely Pathogenic2.81Destabilizing0.43.06Destabilizing2.94Destabilizing0.96Ambiguous0.639Likely Pathogenic-9.60Deleterious1.000Probably Damaging0.999Probably Damaging3.32Benign0.01Affected0.41910.0760-4-3-2.2-48.09
c.2135G>T
G712V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G712V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, while the majority of tools (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.000-10.466Likely Pathogenic0.877Likely PathogenicAmbiguous3.79Destabilizing0.06.18Destabilizing4.99Destabilizing0.79Ambiguous0.410Likely Benign-7.55Deleterious1.000Probably Damaging0.999Probably Damaging3.32Benign0.00Affected0.13950.3712-1-34.642.08
c.2146C>T
R716W
2D
3DClick to see structure in 3D Viewer
AIClinVar has no entry for this SynGAP1 R716W variant, and it is present in the gnomAD database (ID 6‑33441611‑C‑T). Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, AlphaMissense‑Optimized, premPS, and Foldetta, while those that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic. With two high‑accuracy tools supporting benign and one supporting pathogenic, the overall prediction leans toward a benign effect. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.247041Structured0.419135Uncertain0.9620.3790.0006-33441611-C-T53.10e-6-11.543Likely Pathogenic0.766Likely PathogenicLikely Benign-0.11Likely Benign0.00.87Ambiguous0.38Likely Benign0.31Likely Benign0.339Likely Benign-6.72Deleterious1.000Probably Damaging0.995Probably Damaging3.32Benign0.00Affected3.5090.13030.3252-323.630.03
c.3992T>C
I1331T
2D
AIThe SynGAP1 missense variant I1331T is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic vs. two benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence (seven pathogenic vs. three benign predictions) indicates that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.921076Disordered0.941705Binding0.3590.7520.875-2.953Likely Benign0.999Likely PathogenicLikely Pathogenic0.170Likely Benign-2.69Deleterious0.947Possibly Damaging0.950Probably Damaging3.32Benign0.00Affected0.11150.15500-1-5.2-12.05
c.3993T>G
I1331M
2D
AIThe SynGAP1 I1331M missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on benign impact include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict pathogenicity are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, and Foldetta results are unavailable. Considering the majority of consensus‑based and individual predictors, the variant is most likely benign. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.921076Disordered0.941705Binding0.3590.7520.875-4.202Likely Benign0.883Likely PathogenicAmbiguous0.143Likely Benign-1.69Neutral0.984Probably Damaging0.979Probably Damaging3.32Benign0.00Affected0.06980.322021-2.618.03
c.1257G>C
E419D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, and FATHMM. Tools that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Uncertain or inconclusive predictions come from Foldetta, AlphaMissense‑Optimized, ESM1b, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain (treated as unavailable), the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta remains uncertain (unavailable). Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.102787Structured0.371949Uncertain0.9610.2610.000-7.036In-Between0.869Likely PathogenicAmbiguous0.17Likely Benign0.10.87Ambiguous0.52Ambiguous0.48Likely Benign0.170Likely Benign-2.40Neutral0.995Probably Damaging0.960Probably Damaging3.33Benign0.10Tolerated0.19660.4906320.0-14.03
c.1257G>T
E419D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, and FATHMM. Tools that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Uncertain or inconclusive predictions come from Foldetta, AlphaMissense‑Optimized, ESM1b, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain (treated as unavailable), the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta remains uncertain (unavailable). Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.102787Structured0.371949Uncertain0.9610.2610.000-7.036In-Between0.869Likely PathogenicAmbiguous0.17Likely Benign0.10.87Ambiguous0.52Ambiguous0.48Likely Benign0.170Likely Benign-2.40Neutral0.995Probably Damaging0.960Probably Damaging3.33Benign0.10Tolerated0.19660.4906320.0-14.03
c.1271T>A
V424D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V424D is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in silico predictors indicates a pathogenic effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, whereas only FATHMM predicts a benign outcome. High‑accuracy tools reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. No prediction is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.050641Structured0.411431Uncertain0.9730.2480.000-15.531Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.60Destabilizing0.13.50Destabilizing3.55Destabilizing2.13Destabilizing0.615Likely Pathogenic-5.87Deleterious1.000Probably Damaging0.992Probably Damaging3.33Benign0.00Affected0.15360.0845-2-3-7.715.96
c.1360A>T
I454F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I454F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM. All other evaluated algorithms—FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. premPS is uncertain and does not influence the overall assessment. Based on the preponderance of pathogenic predictions and the absence of benign evidence, the variant is most likely pathogenic, with no ClinVar status to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.312811Uncertain0.9650.1820.000-12.468Likely Pathogenic0.960Likely PathogenicLikely Pathogenic4.15Destabilizing0.72.96Destabilizing3.56Destabilizing0.70Ambiguous0.464Likely Benign-3.95Deleterious0.998Probably Damaging0.973Probably Damaging3.33Benign0.00Affected0.04220.256010-1.734.02
c.1387G>A
D463N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D463N missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Those that predict a pathogenic impact are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Predictions that are uncertain (Foldetta, AlphaMissense‑Optimized, Rosetta) are treated as unavailable and do not influence the overall assessment. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; Foldetta is uncertain. Overall, the majority of available predictions lean toward a benign effect, and this conclusion does not contradict any ClinVar status (none reported). Thus, the variant is most likely benign based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-11.428Likely Pathogenic0.812Likely PathogenicAmbiguous0.10Likely Benign0.11.19Ambiguous0.65Ambiguous0.40Likely Benign0.217Likely Benign-4.37Deleterious0.880Possibly Damaging0.430Benign3.33Benign0.10Tolerated0.11520.5531210.0-0.98
c.1388A>C
D463A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D463A missense variant has no ClinVar record and is not reported in gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, premPS, SIFT, FATHMM, and the folding‑stability method Foldetta. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as likely pathogenic, and Foldetta predicts a benign effect on protein stability. Overall, the majority of tools and the consensus high‑accuracy prediction lean toward pathogenicity, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-8.607Likely Pathogenic0.894Likely PathogenicAmbiguous-0.04Likely Benign0.10.96Ambiguous0.46Likely Benign0.43Likely Benign0.425Likely Benign-6.96Deleterious0.978Probably Damaging0.602Possibly Damaging3.33Benign0.29Tolerated0.35910.51690-25.3-44.01
c.1556A>C
E519A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E519A missense variant is listed in ClinVar as Pathogenic (ClinVar ID 1029087.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, SIFT, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, ESM1b, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Uncertain predictions from Rosetta and AlphaMissense‑Optimized are treated as unavailable. High‑accuracy results are: AlphaMissense‑Optimized – unavailable; SGM‑Consensus – Pathogenic; Foldetta – Benign. Overall, the predictions are balanced, but the high‑accuracy Foldetta result leans toward benign while the consensus leans toward pathogenic, leaving the assessment inconclusive. Based on the available predictions, the variant is most likely benign, contradicting the ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.078022Structured0.104514Uncertain0.8990.3280.000Likely Pathogenic 1-8.557Likely Pathogenic0.904Likely PathogenicAmbiguous-0.05Likely Benign0.00.55Ambiguous0.25Likely Benign0.00Likely Benign0.384Likely Benign-5.23Deleterious0.999Probably Damaging0.998Probably Damaging3.33Benign0.10Tolerated3.37350.35440.35450-15.3-58.04162.483.5-0.10.1-0.20.0XPotentially BenignGlu519 is located at the beginning of an α-α loop between the two α-helices (res. Gly502-Tyr518 and Ala533-Val560). In the WT simulations, the carboxylate side chain of Glu519 does not make any specific interactions. Accordingly, the Ala residue swap does not show any negative structural effects in the variant simulations. However, it should be noted that Glu519 faces the missing part of the N-terminal in the model, and thus its potential role in maintaining the tertiary structure might be de-emphasized in the current model.
c.1613A>G
E538G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E538G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No folding‑stability result is definitive. Overall, the balance of evidence, including the majority‑vote SGM Consensus and the higher number of pathogenic predictions, points to a pathogenic effect for E538G. This conclusion does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.122885Structured0.033501Uncertain0.9380.3590.000-9.258Likely Pathogenic0.701Likely PathogenicLikely Benign0.91Ambiguous0.01.07Ambiguous0.99Ambiguous0.31Likely Benign0.285Likely Benign-5.10Deleterious0.993Probably Damaging0.700Possibly Damaging3.33Benign0.03Affected0.31730.37130-23.1-72.06
c.1642G>A
E548K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E548K missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM, while those that predict a pathogenic impact are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicting likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) indicating a benign effect on protein stability. Overall, the balance of evidence leans toward a pathogenic interpretation, with no conflict with ClinVar status because the variant has not yet been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.054297Structured0.008632Uncertain0.9650.2880.000-13.734Likely Pathogenic0.992Likely PathogenicLikely Pathogenic-0.34Likely Benign0.0-0.19Likely Benign-0.27Likely Benign0.13Likely Benign0.348Likely Benign-3.85Deleterious0.999Probably Damaging0.994Probably Damaging3.33Benign0.09Tolerated0.19900.449101-0.4-0.94
c.1876A>G
I626V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I626V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are uncertain or unavailable are AlphaMissense‑Default, FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also indicates a likely benign outcome, while Foldetta’s stability analysis is inconclusive. Based on the overall consensus of the available predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.109221Structured0.040732Uncertain0.9700.2230.000-6.636Likely Benign0.398AmbiguousLikely Benign1.24Ambiguous0.01.06Ambiguous1.15Ambiguous0.80Ambiguous0.182Likely Benign-0.80Neutral0.969Probably Damaging0.960Probably Damaging3.33Benign0.13Tolerated0.10030.289143-0.3-14.03
c.1946T>G
M649R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M649R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also reports a pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.360413Uncertain0.9620.3450.000-14.827Likely Pathogenic0.996Likely PathogenicLikely Pathogenic5.02Destabilizing0.15.97Destabilizing5.50Destabilizing2.09Destabilizing0.595Likely Pathogenic-5.98Deleterious0.985Probably Damaging0.464Possibly Damaging3.33Benign0.00Affected0.16350.12280-1-6.424.99
c.1952A>C
E651A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E651A missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Rosetta is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicting it as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a benign impact. Overall, the balance of evidence leans toward a benign classification, and this conclusion does not contradict the absence of a ClinVar record.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.088832Structured0.365409Uncertain0.9550.3400.000-8.694Likely Pathogenic0.610Likely PathogenicLikely Benign0.38Likely Benign0.10.52Ambiguous0.45Likely Benign0.23Likely Benign0.396Likely Benign-4.54Deleterious0.986Probably Damaging0.875Possibly Damaging3.33Benign0.13Tolerated0.39260.55510-15.3-58.04
c.1960G>C
E654Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E654Q missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), and FATHMM, while those that predict a pathogenic outcome are SGM‑Consensus, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicating likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a benign effect. Overall, the majority of tools (nine benign vs. five pathogenic) suggest the variant is most likely benign. This conclusion does not contradict ClinVar status, as no ClinVar assertion is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.026892Structured0.303029Uncertain0.9570.3110.000-10.368Likely Pathogenic0.699Likely PathogenicLikely Benign0.00Likely Benign0.00.18Likely Benign0.09Likely Benign-0.12Likely Benign0.298Likely Benign-2.79Deleterious0.244Benign0.075Benign3.33Benign0.02Affected0.11400.3913220.0-0.98
c.2041G>T
G681C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681C is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all classify it as pathogenic, while only FATHMM predicts a benign outcome. Uncertain calls come from FoldX, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments reinforce the pathogenic signal: the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, Foldetta (combining FoldX‑MD and Rosetta) is pathogenic, and AlphaMissense‑Optimized remains inconclusive. Overall, the evidence strongly favors a pathogenic interpretation, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-12.374Likely Pathogenic0.941Likely PathogenicAmbiguous1.89Ambiguous1.32.63Destabilizing2.26Destabilizing0.66Ambiguous0.554Likely Pathogenic-8.98Deleterious1.000Probably Damaging0.959Probably Damaging3.33Benign0.00Affected0.11940.3886-3-32.946.09
c.2042G>T
G681V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the majority of algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—classify the change as pathogenic. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; SGM‑Consensus predicts a likely pathogenic effect; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a pathogenic outcome. No other high‑confidence predictions are available. Taken together, the consensus of pathogenic predictions outweighs the single benign call, indicating that G681V is most likely pathogenic. This assessment is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-14.043Likely Pathogenic0.953Likely PathogenicAmbiguous3.21Destabilizing2.06.12Destabilizing4.67Destabilizing0.64Ambiguous0.572Likely Pathogenic-8.98Deleterious0.999Probably Damaging0.928Probably Damaging3.33Benign0.01Affected0.13500.3840-1-34.642.08
c.2045A>G
Y682C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y682C is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all predict pathogenicity, while only FATHMM predicts a benign outcome. The remaining tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Optimized) are uncertain. High‑accuracy assessments reinforce this trend: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is pathogenic; AlphaMissense‑Optimized is uncertain; and Foldetta is uncertain. Overall, the preponderance of evidence points to a pathogenic impact for Y682C. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.141467Uncertain0.7580.3280.000-10.023Likely Pathogenic0.793Likely PathogenicAmbiguous1.79Ambiguous0.11.51Ambiguous1.65Ambiguous1.11Destabilizing0.559Likely Pathogenic-8.71Deleterious1.000Probably Damaging0.996Probably Damaging3.33Benign0.01Affected0.29490.23990-23.8-60.04
c.2053T>G
L685V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L685V is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No other folding‑stability methods provide definitive evidence. Overall, the preponderance of pathogenic predictions, including the SGM Consensus, suggests that the variant is most likely pathogenic; this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.162061Uncertain0.9130.2800.000-11.418Likely Pathogenic0.935Likely PathogenicAmbiguous1.87Ambiguous0.01.15Ambiguous1.51Ambiguous0.97Ambiguous0.214Likely Benign-2.99Deleterious0.993Probably Damaging0.694Possibly Damaging3.33Benign0.02Affected0.14140.3010210.4-14.03
c.2055G>C
L685F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L685F is not reported in ClinVar and has no gnomAD entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, and FATHMM, whereas pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized classifies the change as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic, while Foldetta’s stability analysis is inconclusive. FoldX and Rosetta predictions are uncertain and are treated as unavailable. Overall, the preponderance of evidence points to a pathogenic impact for the variant, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.162061Uncertain0.9130.2800.000-12.304Likely Pathogenic0.992Likely PathogenicLikely Pathogenic1.62Ambiguous0.21.80Ambiguous1.71Ambiguous0.50Likely Benign0.300Likely Benign-3.99Deleterious0.999Probably Damaging0.895Possibly Damaging3.33Benign0.01Affected0.07240.236720-1.034.02
c.2055G>T
L685F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L685F is not reported in ClinVar and has no gnomAD entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, and FATHMM, whereas pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized classifies the change as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic, while Foldetta’s stability analysis is inconclusive. FoldX and Rosetta predictions are uncertain and are treated as unavailable. Overall, the preponderance of evidence points to a pathogenic impact for the variant, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.162061Uncertain0.9130.2800.000-12.304Likely Pathogenic0.992Likely PathogenicLikely Pathogenic1.62Ambiguous0.21.80Ambiguous1.71Ambiguous0.50Likely Benign0.300Likely Benign-3.99Deleterious0.999Probably Damaging0.895Possibly Damaging3.33Benign0.01Affected0.07240.236720-1.034.02
c.2069C>G
S690C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S690C is not reported in ClinVar and has no gnomAD entry. Consensus predictions from high‑accuracy tools show a split: AlphaMissense‑Optimized rates it benign, whereas the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels it likely pathogenic. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, also predicts a benign effect. In contrast, the broader set of in silico predictors is divided: benign calls come from REVEL, FoldX, Rosetta, Foldetta, and FATHMM; pathogenic calls arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The premPS score is uncertain. Overall, the majority of tools (seven pathogenic vs. six benign) lean toward a pathogenic interpretation, but the presence of strong benign evidence from several high‑confidence methods tempers this conclusion. Thus, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.055536Structured0.247926Uncertain0.9440.2530.000-10.651Likely Pathogenic0.749Likely PathogenicLikely Benign0.26Likely Benign0.00.40Likely Benign0.33Likely Benign0.82Ambiguous0.358Likely Benign-4.69Deleterious0.999Probably Damaging0.944Probably Damaging3.33Benign0.00Affected0.07870.46120-13.316.06
c.2093A>T
E698V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E698V missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, and FATHMM, whereas those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. Tools with inconclusive results are FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, while the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts a likely pathogenic outcome. Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports an uncertain result. Overall, the majority of evidence points to a pathogenic impact for E698V, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-12.797Likely Pathogenic0.945Likely PathogenicAmbiguous0.76Ambiguous0.00.39Likely Benign0.58Ambiguous0.26Likely Benign0.480Likely Benign-6.51Deleterious0.992Probably Damaging0.967Probably Damaging3.33Benign0.00Affected0.05770.4546-2-27.7-29.98
c.2113A>G
K705E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K705E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, AlphaMissense‑Optimized, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta predicts a benign stability change. Overall, the majority of evidence (9 benign vs. 4 pathogenic) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.134866Structured0.379324Uncertain0.9220.3640.000-9.371Likely Pathogenic0.704Likely PathogenicLikely Benign0.10Likely Benign0.0-0.09Likely Benign0.01Likely Benign0.47Likely Benign0.075Likely Benign-1.53Neutral0.935Possibly Damaging0.537Possibly Damaging3.33Benign0.14Tolerated0.26010.0789010.40.94
c.2114A>G
K705R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K705R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate a benign or likely benign outcome. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic effect. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Thus, the variant is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.134866Structured0.379324Uncertain0.9220.3640.000-4.679Likely Benign0.126Likely BenignLikely Benign0.10Likely Benign0.00.35Likely Benign0.23Likely Benign0.18Likely Benign0.094Likely Benign-1.66Neutral0.960Probably Damaging0.545Possibly Damaging3.33Benign0.06Tolerated0.34560.078932-0.628.01
c.2147G>C
R716P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R716P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, premPS, and FATHMM; pathogenic predictions come from AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, Rosetta, Foldetta, and the SGM‑Consensus score. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or stability result is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.247041Structured0.419135Uncertain0.9620.3790.000-10.744Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.18Likely Benign0.15.67Destabilizing2.93Destabilizing0.49Likely Benign0.320Likely Benign-5.75Deleterious1.000Probably Damaging1.000Probably Damaging3.33Benign0.01Affected0.21400.35760-22.9-59.07
c.2186A>C
N729T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N729T is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID 6‑33441651‑A‑C). Consensus among the majority of in‑silico predictors is benign: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. No tool predicts pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign”; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, yields an uncertain result. Overall, the evidence strongly supports a benign effect, and this conclusion does not contradict ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.426547Uncertain0.6510.5830.6256-33441651-A-C16.20e-7-1.952Likely Benign0.103Likely BenignLikely Benign0.52Ambiguous0.31.73Ambiguous1.13Ambiguous-0.34Likely Benign0.052Likely Benign-0.52Neutral0.123Benign0.042Benign3.33Benign1.00Tolerated3.5970.12010.4805002.8-13.00
c.593T>A
L198H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L198H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict pathogenicity: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Predictions from FoldX, Rosetta, Foldetta, and premPS are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for L198H. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.444081Structured0.431715Uncertain0.5720.4850.125-15.650Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.09Ambiguous0.21.04Ambiguous1.07Ambiguous0.74Ambiguous0.419Likely Benign-5.91Deleterious0.999Probably Damaging0.936Probably Damaging3.33Benign0.00Affected0.10570.0519-2-3-7.023.98
c.593T>C
L198P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L198P has no ClinVar entry and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and FATHMM, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points toward a deleterious effect. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.444081Structured0.431715Uncertain0.5720.4850.125-12.250Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.55Ambiguous0.30.40Likely Benign0.98Ambiguous0.65Ambiguous0.491Likely Benign-5.87Deleterious0.997Probably Damaging0.916Probably Damaging3.33Benign0.00Affected0.38820.1582-3-3-5.4-16.04
c.1271T>G
V424G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V424G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM. All other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic consensus (3 pathogenic vs. 1 benign); and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. No predictions are missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.050641Structured0.411431Uncertain0.9730.2480.000-13.697Likely Pathogenic0.978Likely PathogenicLikely Pathogenic3.90Destabilizing0.14.84Destabilizing4.37Destabilizing2.44Destabilizing0.622Likely Pathogenic-6.26Deleterious0.994Probably Damaging1.000Probably Damaging3.34Benign0.00Affected0.13960.2029-1-3-4.6-42.08
c.1276A>G
N426D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Three tools (FoldX, premPS, AlphaMissense‑Default) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of predictions (six benign vs. four pathogenic) and the two high‑accuracy benign calls suggest the variant is most likely benign, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.042364Structured0.394941Uncertain0.9590.2870.000-11.159Likely Pathogenic0.554AmbiguousLikely Benign0.80Ambiguous0.00.18Likely Benign0.49Likely Benign0.64Ambiguous0.173Likely Benign-3.09Deleterious0.998Probably Damaging0.980Probably Damaging3.34Benign0.09Tolerated0.17300.1746210.00.98
c.1334A>C
E445A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E445A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and FATHMM. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as Benign. Overall, the majority of predictions lean toward pathogenicity, and the high‑accuracy consensus supports a likely pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.270205Uncertain0.9470.2280.000-12.659Likely Pathogenic0.849Likely PathogenicAmbiguous0.09Likely Benign0.0-0.34Likely Benign-0.13Likely Benign0.56Ambiguous0.476Likely Benign-5.73Deleterious0.997Probably Damaging0.991Probably Damaging3.34Benign0.01Affected0.28460.48760-15.3-58.04
c.1334A>T
E445V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E445V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Foldetta, premPS, and FATHMM, whereas a larger group predicts pathogenicity: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Two tools give uncertain results: Rosetta and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of evidence points toward a pathogenic effect. The variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.270205Uncertain0.9470.2280.000-14.830Likely Pathogenic0.946Likely PathogenicAmbiguous0.34Likely Benign0.1-0.67Ambiguous-0.17Likely Benign0.32Likely Benign0.572Likely Pathogenic-6.68Deleterious0.992Probably Damaging0.967Probably Damaging3.34Benign0.01Affected0.04140.5233-2-27.7-29.98
c.1367A>C
Q456P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q456P is listed in ClinVar with an uncertain significance (ClinVar ID 2697090.0) and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are made by FoldX, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta. High‑accuracy methods specifically report pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are inconclusive. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, which contradicts the current ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.170161Structured0.302348Uncertain0.9390.1640.000Uncertain 1-15.250Likely Pathogenic0.993Likely PathogenicLikely Pathogenic3.68Destabilizing0.28.43Destabilizing6.06Destabilizing0.82Ambiguous0.469Likely Benign-5.66Deleterious1.000Probably Damaging0.999Probably Damaging3.34Benign0.07Tolerated3.37340.22560.3631-101.9-31.01
c.1370G>C
S457T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S457T has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify the variant as benign include REVEL, Foldetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. FoldX and Rosetta provide uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicting likely pathogenic, and Foldetta predicting benign. Overall, the majority of high‑confidence tools lean toward a benign effect, and there is no conflict with the ClinVar status, which is currently unreported. Thus, the variant is most likely benign based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.164327Structured0.297330Uncertain0.9090.1590.000-8.772Likely Pathogenic0.723Likely PathogenicLikely Benign0.82Ambiguous0.1-0.57Ambiguous0.13Likely Benign0.38Likely Benign0.273Likely Benign-2.83Deleterious0.866Possibly Damaging0.780Possibly Damaging3.34Benign0.09Tolerated0.11540.6487110.114.03
c.1370G>T
S457I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S457I lies within the GAP domain. ClinVar has no entry for this change, and it is absent from gnomAD. Prediction tools that report a benign effect include FoldX and FATHMM, whereas the majority of other in silico predictors—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default and AlphaMissense‑Optimized—classify it as pathogenic. Uncertain results come from Rosetta, Foldetta and premPS. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM and PROVEAN) is Likely Pathogenic, and Foldetta remains inconclusive. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.164327Structured0.297330Uncertain0.9090.1590.000-13.170Likely Pathogenic0.976Likely PathogenicLikely Pathogenic-0.26Likely Benign0.3-0.96Ambiguous-0.61Ambiguous0.65Ambiguous0.557Likely Pathogenic-5.73Deleterious0.999Probably Damaging0.993Probably Damaging3.34Benign0.02Affected0.07790.6095-1-25.326.08
c.1378A>G
K460E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K460E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM. In contrast, a majority of tools predict a pathogenic impact: AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 (HumDiv and HumVar), Rosetta, and premPS all indicate pathogenicity, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No prediction or folding‑stability result is missing or inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for K460E, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.289547Uncertain0.9380.1500.125-13.304Likely Pathogenic0.982Likely PathogenicLikely Pathogenic1.68Ambiguous0.02.02Destabilizing1.85Ambiguous1.05Destabilizing0.398Likely Benign-3.40Deleterious0.999Probably Damaging0.991Probably Damaging3.34Benign0.09Tolerated0.39660.1022010.40.94
c.1536A>C
E512D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E512D is not reported in ClinVar or gnomAD. Across a broad panel of in silico predictors, the majority indicate a benign effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score. Only the ESM1b model assigns a pathogenic label, while Rosetta and Foldetta provide uncertain results. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta remains inconclusive. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.092881Structured0.247079Uncertain0.9230.2730.000-8.354Likely Pathogenic0.198Likely BenignLikely Benign0.12Likely Benign0.31.05Ambiguous0.59Ambiguous0.00Likely Benign0.259Likely Benign-2.10Neutral0.016Benign0.012Benign3.34Benign0.23Tolerated0.20550.3089320.0-14.03
c.1536A>T
E512D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change E512D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Across the broad panel of in‑silico predictors, the majority (REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all classify the variant as benign, whereas only ESM1b predicts it as pathogenic. The high‑accuracy tools give a consistent benign signal: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive. Overall, the evidence strongly supports a benign effect; this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.092881Structured0.247079Uncertain0.9230.2730.000-8.354Likely Pathogenic0.198Likely BenignLikely Benign0.12Likely Benign0.31.05Ambiguous0.59Ambiguous0.00Likely Benign0.259Likely Benign-2.10Neutral0.016Benign0.012Benign3.34Benign0.23Tolerated0.20550.3089320.0-14.03
c.1817G>C
S606T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S606T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, and AlphaMissense‑Optimized, whereas a pathogenic consensus is reached by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Uncertain results come from Rosetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools predict pathogenicity, and the SGM Consensus supports this view, while the high‑accuracy methods give mixed results. Thus, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.041405Structured0.191720Uncertain0.8750.2470.000-11.052Likely Pathogenic0.554AmbiguousLikely Benign0.06Likely Benign0.1-0.91Ambiguous-0.43Likely Benign0.57Ambiguous0.203Likely Benign-2.99Deleterious0.826Possibly Damaging0.933Probably Damaging3.34Benign0.03Affected0.12600.4513110.114.03
c.1910C>G
S637C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S637C is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that classify the variant as benign include REVEL, FoldX, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; Foldetta predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence supports a benign impact, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.076542Structured0.083482Uncertain0.9200.2530.000-10.040Likely Pathogenic0.138Likely BenignLikely Benign0.25Likely Benign0.00.54Ambiguous0.40Likely Benign0.22Likely Benign0.169Likely Benign-2.83Deleterious0.985Probably Damaging0.533Possibly Damaging3.34Benign0.01Affected0.13270.44390-13.316.06
c.1921T>C
S641P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S641P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN and SIFT. The remaining tools (FoldX, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) leaning toward benign, and Foldetta as uncertain. Overall, the majority of reliable predictions indicate a benign impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.125101Structured0.157322Uncertain0.7860.2700.000-6.907Likely Benign0.378AmbiguousLikely Benign1.73Ambiguous1.30.07Likely Benign0.90Ambiguous0.59Ambiguous0.205Likely Benign-3.05Deleterious0.000Benign0.000Benign3.34Benign0.04Affected0.22890.57911-1-0.810.04
c.1946T>A
M649K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M649K is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: pathogenic predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Benign calls are limited to polyPhen‑2 (HumVar) and FATHMM. High‑accuracy methods reinforce the pathogenic consensus: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.360413Uncertain0.9620.3450.000-14.533Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.42Destabilizing0.06.19Destabilizing4.81Destabilizing1.79Destabilizing0.614Likely Pathogenic-5.98Deleterious0.968Probably Damaging0.382Benign3.34Benign0.01Affected0.14380.10790-1-5.8-3.02
c.1951G>C
E651Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E651Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM—all classifying the change as benign. No tool predicts a pathogenic outcome. The high‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign effect; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports a benign result. Consequently, the variant is most likely benign based on the available predictions, and this assessment does not contradict any ClinVar status (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.088832Structured0.365409Uncertain0.9550.3400.000-6.308Likely Benign0.476AmbiguousLikely Benign0.13Likely Benign0.10.15Likely Benign0.14Likely Benign-0.13Likely Benign0.158Likely Benign-1.23Neutral0.244Benign0.075Benign3.34Benign0.58Tolerated0.14380.5893220.0-0.98
c.1961A>C
E654A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E654A has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into two groups: benign predictions come from FoldX, Rosetta, Foldetta, premPS, and FATHMM, while pathogenic predictions arise from REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Benign. Overall, the balance of evidence favors pathogenicity, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.026892Structured0.303029Uncertain0.9570.3110.000-10.797Likely Pathogenic0.873Likely PathogenicAmbiguous0.49Likely Benign0.10.20Likely Benign0.35Likely Benign0.25Likely Benign0.512Likely Pathogenic-5.70Deleterious0.986Probably Damaging0.875Possibly Damaging3.34Benign0.02Affected0.33670.39710-15.3-58.04
c.1979T>A
M660K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M660K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are polyPhen‑2 HumVar and FATHMM. All other evaluated predictors—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports a pathogenic effect. Based on the overwhelming consensus of pathogenic predictions and the corroborating high‑accuracy tools, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.047319Structured0.134270Uncertain0.9440.2890.000-14.123Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.13Destabilizing0.14.46Destabilizing3.80Destabilizing2.36Destabilizing0.604Likely Pathogenic-5.99Deleterious0.862Possibly Damaging0.216Benign3.34Benign0.00Affected0.13890.08560-1-5.8-3.02
c.1979T>G
M660R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M660R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, whereas only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction is inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.047319Structured0.134270Uncertain0.9440.2890.000-15.985Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.95Destabilizing0.23.52Destabilizing3.24Destabilizing1.96Destabilizing0.588Likely Pathogenic-5.99Deleterious0.976Probably Damaging0.464Possibly Damaging3.34Benign0.00Affected0.16120.09570-1-6.424.99
c.2005A>T
N669Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N669Y is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include FoldX, FATHMM, and premPS. Those that predict a pathogenic effect comprise SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. With eight pathogenic predictions versus three benign, the overall evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.142424Structured0.086615Uncertain0.8720.3800.000-13.548Likely Pathogenic0.802Likely PathogenicAmbiguous0.45Likely Benign0.41.29Ambiguous0.87Ambiguous0.21Likely Benign0.546Likely Pathogenic-7.01Deleterious1.000Probably Damaging0.997Probably Damaging3.34Benign0.00Affected0.06660.4151-2-22.249.07
c.2006A>T
N669I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N669I is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include premPS and FATHMM, whereas the remaining ten tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the majority‑vote SGM‑Consensus—predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain (treated as unavailable), SGM‑Consensus as likely pathogenic, and Foldetta as uncertain (also treated as unavailable). The overall consensus of the available predictions leans strongly toward pathogenicity, and this conclusion does not conflict with the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.142424Structured0.086615Uncertain0.8720.3800.000-13.324Likely Pathogenic0.862Likely PathogenicAmbiguous0.84Ambiguous0.01.09Ambiguous0.97Ambiguous0.31Likely Benign0.517Likely Pathogenic-8.18Deleterious0.999Probably Damaging0.996Probably Damaging3.34Benign0.00Affected0.07490.4697-2-38.0-0.94
c.2012A>C
D671A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D671A missense variant is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, premPS, and FATHMM. Those that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the balance of evidence favors a pathogenic interpretation, with seven tools supporting pathogenicity versus four supporting benignity. This conclusion does not conflict with ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.194234Structured0.096749Uncertain0.6770.3700.000-11.709Likely Pathogenic0.911Likely PathogenicAmbiguous0.25Likely Benign0.10.79Ambiguous0.52Ambiguous0.10Likely Benign0.245Likely Benign-5.08Deleterious0.980Probably Damaging0.804Possibly Damaging3.34Benign0.03Affected0.40560.58950-25.3-44.01
c.2030G>T
S677I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S677I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, premPS, polyPhen‑2 (HumDiv and HumVar), FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Pathogenicity is suggested only by PROVEAN and SIFT, while Foldetta and ESM1b give uncertain results. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign, and Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.194234Structured0.115685Uncertain0.5550.3380.125-7.942In-Between0.156Likely BenignLikely Benign-0.09Likely Benign0.0-2.25Stabilizing-1.17Ambiguous-0.01Likely Benign0.097Likely Benign-2.81Deleterious0.002Benign0.002Benign3.34Benign0.05Affected0.10400.6463-1-25.326.08
c.2044T>A
Y682N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 Y682N variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, while the majority of tools (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact; FoldX and AlphaMissense‑Optimized are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as pathogenic. Overall, the evidence strongly favors a pathogenic effect, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.141467Uncertain0.7580.3280.000-11.734Likely Pathogenic0.859Likely PathogenicAmbiguous1.86Ambiguous0.12.22Destabilizing2.04Destabilizing1.54Destabilizing0.564Likely Pathogenic-8.61Deleterious1.000Probably Damaging0.999Probably Damaging3.34Benign0.02Affected0.23540.0928-2-2-2.2-49.07
c.2099T>A
L700Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L700Q is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. All other evaluated tools—SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—predict a pathogenic impact. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized indicates a benign change, whereas the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both predict pathogenicity. No predictions are missing or inconclusive. Overall, the preponderance of evidence from the majority of tools points to a pathogenic effect, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.416255Uncertain0.9270.3310.000-10.522Likely Pathogenic0.783Likely PathogenicLikely Benign2.41Destabilizing0.14.02Destabilizing3.22Destabilizing1.35Destabilizing0.321Likely Benign-3.79Deleterious0.994Probably Damaging0.896Possibly Damaging3.34Benign0.01Affected0.10740.0488-2-2-7.314.97
c.2122C>A
L708I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L708I is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify the substitution as benign: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, premPS, FoldX, Rosetta, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, and FATHMM. No tool predicts pathogenicity. High‑accuracy assessments concur: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports a benign effect. Consequently, the variant is most likely benign based on current predictions, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.250310Structured0.365875Uncertain0.9310.3780.000-4.406Likely Benign0.116Likely BenignLikely Benign0.42Likely Benign0.0-0.21Likely Benign0.11Likely Benign-0.05Likely Benign0.108Likely Benign0.02Neutral0.022Benign0.021Benign3.34Benign0.20Tolerated0.07490.2729220.70.00
c.2131C>A
L711M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta reports an uncertain stability change, which is treated as unavailable evidence. Overall, the majority of individual predictors (six pathogenic vs. five benign) and the available high‑accuracy results lean toward a pathogenic interpretation. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.308712Structured0.377436Uncertain0.9500.3640.000-9.368Likely Pathogenic0.679Likely PathogenicLikely Benign0.39Likely Benign0.01.11Ambiguous0.75Ambiguous1.40Destabilizing0.216Likely Benign-1.86Neutral1.000Probably Damaging1.000Probably Damaging3.34Benign0.00Affected0.07550.275842-1.918.03
c.2131C>G
L711V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L711V is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33441596‑C‑G). Prediction tools that indicate a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. The majority of other in silico predictors—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—classify the change as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as likely pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence points to a pathogenic effect, which does not conflict with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000Uncertain16-33441596-C-G16.20e-7-10.045Likely Pathogenic0.709Likely PathogenicLikely Benign3.48Destabilizing0.12.22Destabilizing2.85Destabilizing1.40Destabilizing0.170Likely Benign-2.59Deleterious0.992Probably Damaging0.970Probably Damaging3.34Benign0.00Affected3.5090.13180.3010120.4-14.03
c.2137C>A
P713T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P713T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments further clarify the picture: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic, whereas AlphaMissense‑Optimized and Foldetta provide inconclusive results and are treated as unavailable. Taken together, the preponderance of evidence points to a pathogenic effect for P713T, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-9.915Likely Pathogenic0.819Likely PathogenicAmbiguous1.15Ambiguous0.00.46Likely Benign0.81Ambiguous0.65Ambiguous0.225Likely Benign-6.72Deleterious1.000Probably Damaging0.993Probably Damaging3.34Benign0.00Affected0.14170.38180-10.93.99
c.2137C>G
P713A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 P713A is not reported in ClinVar and is absent from gnomAD. Benign predictions are provided by REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default; the SGM‑Consensus score is labeled Likely Pathogenic. FoldX, Foldetta, and premPS give uncertain results. High‑accuracy tools: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic; Foldetta remains uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-8.535Likely Pathogenic0.689Likely PathogenicLikely Benign1.04Ambiguous0.10.15Likely Benign0.60Ambiguous0.75Ambiguous0.235Likely Benign-6.80Deleterious1.000Probably Damaging0.999Probably Damaging3.34Benign0.00Affected0.31590.34751-13.4-26.04
c.2138C>T
P713L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P713L is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact; AlphaMissense‑Optimized and premPS are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-11.323Likely Pathogenic0.850Likely PathogenicAmbiguous0.18Likely Benign0.1-0.03Likely Benign0.08Likely Benign0.55Ambiguous0.324Likely Benign-8.60Deleterious1.000Probably Damaging0.998Probably Damaging3.34Benign0.00Affected0.19930.5261-3-35.416.04
c.593T>G
L198R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L198R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Predictions from FoldX, Rosetta, Foldetta, and premPS are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence from multiple in‑silico predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.444081Structured0.431715Uncertain0.5720.4850.125-15.992Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.74Ambiguous0.21.56Ambiguous1.15Ambiguous0.69Ambiguous0.410Likely Benign-4.98Deleterious0.982Probably Damaging0.648Possibly Damaging3.34Benign0.00Affected0.11800.0719-3-2-8.343.03
c.1247T>C
L416P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L416P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from the remaining 13 tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen2_HumDiv, polyPhen2_HumVar, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, and the SGM Consensus). High‑accuracy methods specifically indicate pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No predictions are inconclusive. Based on the overall consensus of the majority of tools and the high‑accuracy methods, the variant is most likely pathogenic, which is consistent with the lack of ClinVar reporting and gnomAD absence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.336105Uncertain0.9350.2270.000-8.859Likely Pathogenic0.975Likely PathogenicLikely Pathogenic2.59Destabilizing0.16.23Destabilizing4.41Destabilizing1.27Destabilizing0.284Likely Benign-3.56Deleterious1.000Probably Damaging1.000Probably Damaging3.35Benign0.21Tolerated0.35890.1353-3-3-5.4-16.04
c.1247T>G
L416R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L416R missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also leans toward benign, while Foldetta remains uncertain. Overall, the majority of reliable predictors classify the variant as benign, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.104810Structured0.336105Uncertain0.9350.2270.000-8.600Likely Pathogenic0.511AmbiguousLikely Benign0.71Ambiguous0.00.97Ambiguous0.84Ambiguous0.84Ambiguous0.238Likely Benign-2.05Neutral0.999Probably Damaging0.992Probably Damaging3.35Benign0.43Tolerated0.14450.0702-3-2-8.343.03
c.1256A>T
E419V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419V missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, FoldX, FATHMM, and premPS, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, the SGM Consensus also indicates Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result. No evidence from the high‑accuracy tools contradicts the pathogenic prediction. Overall, the majority of computational evidence points to a pathogenic effect, which is consistent with the lack of ClinVar reporting and gnomAD absence, suggesting the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.371949Uncertain0.9610.2610.000-12.290Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.45Likely Benign0.01.41Ambiguous0.93Ambiguous0.27Likely Benign0.494Likely Benign-6.55Deleterious0.998Probably Damaging0.983Probably Damaging3.35Benign0.01Affected0.09530.6834-2-27.7-29.98
c.1333G>A
E445K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E445K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from FoldX, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic calls arise from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. When high‑accuracy methods are considered separately, AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of evidence—including the high‑accuracy tools—supports a pathogenic effect. This conclusion does not conflict with ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.270205Uncertain0.9470.2280.000-15.371Likely Pathogenic0.958Likely PathogenicLikely Pathogenic0.02Likely Benign0.00.02Likely Benign0.02Likely Benign0.46Likely Benign0.524Likely Pathogenic-3.82Deleterious0.991Probably Damaging0.951Probably Damaging3.35Benign0.02Affected0.17840.531101-0.4-0.94
c.1345A>G
S449G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S449G is listed in ClinVar with an “Uncertain” status and is present in the gnomAD database (variant ID 6‑33438250‑A‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while Rosetta, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as “Likely Benign,” and Foldetta as uncertain. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.254060Structured0.301437Uncertain0.9580.2510.000Uncertain 16-33438250-A-G31.86e-6-5.936Likely Benign0.071Likely BenignLikely Benign0.47Likely Benign0.00.55Ambiguous0.51Ambiguous0.85Ambiguous0.116Likely Benign-2.32Neutral0.948Possibly Damaging0.124Benign3.35Benign0.13Tolerated3.37320.26000.3718010.4-30.03
c.1369A>G
S457G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S457G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for S457G. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.164327Structured0.297330Uncertain0.9090.1590.000-9.154Likely Pathogenic0.811Likely PathogenicAmbiguous0.86Ambiguous0.00.87Ambiguous0.87Ambiguous0.65Ambiguous0.382Likely Benign-3.82Deleterious0.999Probably Damaging0.977Probably Damaging3.35Benign0.13Tolerated0.27350.4074100.4-30.03
c.1372A>C
T458P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T458P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are SIFT and FATHMM, while the remaining tools (REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, ESM1b, and the SGM‑Consensus) all predict a pathogenic impact; premPS is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a pathogenic effect. No prediction or folding stability result is missing or inconclusive. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.185198Structured0.294848Uncertain0.9150.1440.000-13.547Likely Pathogenic0.962Likely PathogenicLikely Pathogenic3.05Destabilizing0.25.36Destabilizing4.21Destabilizing0.78Ambiguous0.557Likely Pathogenic-5.33Deleterious1.000Probably Damaging0.999Probably Damaging3.35Benign0.06Tolerated0.20980.53950-1-0.9-3.99
c.1378A>C
K460Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K460Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, SIFT, and FATHMM, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. Predictions that are inconclusive include FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments give a pathogenic consensus from the SGM method (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) and an uncertain result from AlphaMissense‑Optimized; Foldetta likewise reports no definitive stability change. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.289547Uncertain0.9380.1500.125-9.404Likely Pathogenic0.793Likely PathogenicAmbiguous0.71Ambiguous0.00.86Ambiguous0.79Ambiguous0.86Ambiguous0.312Likely Benign-3.15Deleterious0.999Probably Damaging0.999Probably Damaging3.35Benign0.14Tolerated0.45230.1454110.4-0.04
c.1379A>C
K460T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K460T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two consensus groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Stability‑based methods (FoldX, Rosetta, premPS, Foldetta) yield uncertain or inconclusive results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus majority vote (AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta’s combined FoldX‑MD/Rosetta analysis remains inconclusive. Overall, the majority of evidence points to a pathogenic impact for K460T, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.289547Uncertain0.9380.1500.125-11.187Likely Pathogenic0.967Likely PathogenicLikely Pathogenic1.23Ambiguous0.11.16Ambiguous1.20Ambiguous0.77Ambiguous0.208Likely Benign-5.02Deleterious1.000Probably Damaging1.000Probably Damaging3.35Benign0.07Tolerated0.18580.38480-13.2-27.07
c.1387G>C
D463H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant D463H is not reported in ClinVar and is absent from gnomAD. Consensus from standard prediction algorithms shows a split: benign predictions come from REVEL, FoldX, SIFT, and FATHMM, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, SGM Consensus confirms Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, remains Uncertain. No evidence from ClinVar contradicts these findings. Overall, the preponderance of computational evidence indicates that D463H is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-13.151Likely Pathogenic0.970Likely PathogenicLikely Pathogenic0.20Likely Benign0.10.85Ambiguous0.53Ambiguous0.57Ambiguous0.356Likely Benign-5.96Deleterious0.996Probably Damaging0.852Possibly Damaging3.35Benign0.11Tolerated0.13410.61561-10.322.05
c.1387G>T
D463Y
2D
3DClick to see structure in 3D Viewer
AIClinVar reports no entry for this SynGAP1 D463Y variant, and it is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain results come from AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of conventional tools lean toward pathogenicity, while the high‑accuracy Foldetta suggests benign. Thus, the variant is most likely pathogenic based on the prevailing predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-14.387Likely Pathogenic0.904Likely PathogenicAmbiguous-0.14Likely Benign0.10.77Ambiguous0.32Likely Benign0.07Likely Benign0.399Likely Benign-7.95Deleterious0.998Probably Damaging0.904Possibly Damaging3.35Benign0.14Tolerated0.05400.6213-4-32.248.09
c.1433A>T
E478V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E478V missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, Rosetta, polyPhen‑2 (HumDiv and HumVar), FATHMM, and premPS; pathogenic predictions from SGM‑Consensus, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. Two tools give inconclusive results: FoldX (uncertain) and AlphaMissense‑Optimized (uncertain). High‑accuracy assessments further split the signal: the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts benign. With six benign versus five pathogenic calls and no ClinVar evidence, the overall evidence slightly favors a benign interpretation, and there is no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.414660Uncertain0.7870.2490.000-10.322Likely Pathogenic0.831Likely PathogenicAmbiguous0.55Ambiguous0.00.33Likely Benign0.44Likely Benign0.04Likely Benign0.385Likely Benign-5.84Deleterious0.434Benign0.199Benign3.35Benign0.01Affected0.05860.6604-2-27.7-29.98
c.1435C>T
R479W
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R479W is not reported in ClinVar and is present in gnomAD (ID 6‑33438467‑C‑T). Functional prediction tools show a split opinion: benign calls come from REVEL, premPS, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy assessments indicate that AlphaMissense‑Optimized predicts a benign effect, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels the variant as likely pathogenic; Foldetta remains inconclusive. Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.419256Uncertain0.8200.2490.0006-33438467-C-T63.72e-6-11.356Likely Pathogenic0.783Likely PathogenicLikely Benign0.60Ambiguous0.10.72Ambiguous0.66Ambiguous0.42Likely Benign0.249Likely Benign-4.75Deleterious1.000Probably Damaging0.995Probably Damaging3.35Benign0.02Affected3.39320.10460.2933-323.630.03
c.1614G>C
E538D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E538D is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as benign: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, premPS, FoldX, Rosetta, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, and FATHMM. No tool predicts pathogenicity. High‑accuracy assessments concur: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports benign. Consequently, the variant is most likely benign, and this prediction does not contradict the ClinVar status (no ClinVar entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.122885Structured0.033501Uncertain0.9380.3590.000-2.355Likely Benign0.112Likely BenignLikely Benign0.32Likely Benign0.00.09Likely Benign0.21Likely Benign0.16Likely Benign0.122Likely Benign-0.88Neutral0.002Benign0.005Benign3.35Benign0.30Tolerated0.18010.2352320.0-14.03
c.1614G>T
E538D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E538D is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as benign: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, premPS, FoldX, Rosetta, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, and FATHMM. No tool predicts pathogenicity. High‑accuracy assessments concur: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports benign. Consequently, the variant is most likely benign, and this prediction does not contradict the ClinVar status (no ClinVar entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.122885Structured0.033501Uncertain0.9380.3590.000-2.355Likely Benign0.112Likely BenignLikely Benign0.32Likely Benign0.00.09Likely Benign0.21Likely Benign0.16Likely Benign0.122Likely Benign-0.88Neutral0.002Benign0.005Benign3.35Benign0.30Tolerated0.18010.2352320.0-14.03
c.1771G>C
A591P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A591P is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools largely converge on a pathogenic effect: pathogenic predictions come from FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (Likely Pathogenic). Benign predictions are limited to REVEL and FATHMM. High‑accuracy assessments reinforce the pathogenic view: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenic. Consequently, the variant is most likely pathogenic, a conclusion that contrasts with its ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018787Structured0.093848Uncertain0.8820.1850.000Uncertain 1-14.479Likely Pathogenic0.991Likely PathogenicLikely Pathogenic3.78Destabilizing0.37.29Destabilizing5.54Destabilizing1.45Destabilizing0.404Likely Benign-4.41Deleterious0.995Probably Damaging0.853Possibly Damaging3.35Benign0.01Affected3.37350.18720.30871-1-3.426.04191.5-10.10.20.10.40.1XPotentially PathogenicThe methyl group of the Ala591 side chain, located in the middle of an α helix (res. Glu582-Met603), packs against hydrophobic residues (e.g., Ile483, Phe484) of an opposing partially helical loop (res. Phe476-Asn487).In the variant simulations, Pro591 lacks a free backbone amide group and, therefore, cannot form a hydrogen bond with the backbone carbonyl of Arg587 as Ala591 does in the WT. This notably weakens the α helix integrity and compromises the continuity of the helix. In reality, the effect on the structure during protein folding could be more severe.
c.1772C>T
A591V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A591V missense variant is not reported in ClinVar and is present in gnomAD (ID 6‑33440824‑C‑T). Functional prediction tools show discordant results: benign calls come from REVEL, polyPhen‑2 HumVar, and FATHMM, while pathogenic calls are made by PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain, Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain, and the SGM Consensus remains Likely Pathogenic. Overall, the majority of evidence points toward a pathogenic effect, and this assessment is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018787Structured0.093848Uncertain0.8820.1850.0006-33440824-C-T21.24e-6-12.282Likely Pathogenic0.926Likely PathogenicAmbiguous1.35Ambiguous0.40.98Ambiguous1.17Ambiguous0.86Ambiguous0.321Likely Benign-3.79Deleterious0.970Probably Damaging0.373Benign3.35Benign0.02Affected3.37350.11280.4228002.428.05
c.1816A>G
S606G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S606G is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions are made by SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result and is treated as unavailable. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.191720Uncertain0.8750.2470.000-12.281Likely Pathogenic0.603Likely PathogenicLikely Benign0.43Likely Benign0.11.42Ambiguous0.93Ambiguous0.84Ambiguous0.229Likely Benign-3.98Deleterious0.999Probably Damaging0.994Probably Damaging3.35Benign0.04Affected0.22860.3279100.4-30.03
c.1910C>A
S637Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S637Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, FoldX, premPS, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the majority of individual predictors (seven versus five) lean toward pathogenicity, and the consensus‑based SGM‑Consensus also supports a likely pathogenic classification. Therefore, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.076542Structured0.083482Uncertain0.9200.2530.000-12.633Likely Pathogenic0.770Likely PathogenicLikely Benign0.13Likely Benign0.11.52Ambiguous0.83Ambiguous0.50Likely Benign0.209Likely Benign-3.78Deleterious0.985Probably Damaging0.681Possibly Damaging3.35Benign0.00Affected0.09680.4071-3-2-0.576.10
c.1910C>T
S637F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S637F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, FoldX, Foldetta, premPS, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by Rosetta and AlphaMissense‑Optimized. The high‑accuracy consensus (SGM‑Consensus) aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN and yields a pathogenic verdict. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, predicts a benign effect. AlphaMissense‑Optimized remains inconclusive. Overall, the majority of evidence points toward a pathogenic impact, and this assessment does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.076542Structured0.083482Uncertain0.9200.2530.000-13.266Likely Pathogenic0.831Likely PathogenicAmbiguous0.01Likely Benign0.10.96Ambiguous0.49Likely Benign0.49Likely Benign0.222Likely Benign-3.92Deleterious0.985Probably Damaging0.681Possibly Damaging3.35Benign0.01Affected0.07800.4126-3-23.660.10
c.1934T>G
F645C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F645C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas the majority of tools predict a pathogenic outcome: FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is inconclusive. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized remains uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also pathogenic. Based on the preponderance of pathogenic predictions and the high‑accuracy consensus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.046336Structured0.276445Uncertain0.9210.3250.000-9.182Likely Pathogenic0.828Likely PathogenicAmbiguous2.25Destabilizing0.12.44Destabilizing2.35Destabilizing1.38Destabilizing0.286Likely Benign-5.41Deleterious0.967Probably Damaging0.389Benign3.35Benign0.01Affected0.24210.1372-4-2-0.3-44.04
c.1946T>C
M649T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M649T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.360413Uncertain0.9620.3450.000-11.916Likely Pathogenic0.988Likely PathogenicLikely Pathogenic3.19Destabilizing0.23.45Destabilizing3.32Destabilizing1.92Destabilizing0.531Likely Pathogenic-5.98Deleterious0.999Probably Damaging0.779Possibly Damaging3.35Benign0.00Affected0.17320.1615-1-1-2.6-30.09
c.1999A>G
I667V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I667V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Only ESM1b predicts a pathogenic outcome; all other tools (FoldX, Rosetta, premPS, AlphaMissense‑Default, Foldetta) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a benign majority vote. Foldetta’s stability prediction is uncertain. Overall, the preponderance of evidence points to a benign effect. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.142424Structured0.083597Uncertain0.9270.3790.000-8.482Likely Pathogenic0.406AmbiguousLikely Benign1.32Ambiguous0.01.06Ambiguous1.19Ambiguous0.85Ambiguous0.234Likely Benign-0.86Neutral0.341Benign0.052Benign3.35Benign0.15Tolerated0.11780.305943-0.3-14.03
c.2005A>C
N669H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N669H has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.142424Structured0.086615Uncertain0.8720.3800.000-10.364Likely Pathogenic0.421AmbiguousLikely Benign1.26Ambiguous0.21.69Ambiguous1.48Ambiguous0.80Ambiguous0.432Likely Benign-4.49Deleterious0.999Probably Damaging0.993Probably Damaging3.35Benign0.01Affected0.17320.4839210.323.04
c.2026A>T
S676C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S676C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, polyPhen2_HumVar, and the SGM‑Consensus (majority vote). Tools that predict a pathogenic effect are polyPhen2_HumDiv, SIFT, and ESM1b. Rosetta and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Based on the overall consensus of the available predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.209395Structured0.113632Uncertain0.5510.3380.125-9.230Likely Pathogenic0.132Likely BenignLikely Benign0.47Likely Benign0.10.77Ambiguous0.62Ambiguous0.15Likely Benign0.164Likely Benign-2.45Neutral0.959Probably Damaging0.431Benign3.35Benign0.01Affected0.11130.63520-13.316.06
c.2047A>G
I683V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I683V is listed in ClinVar with an uncertain significance and is present in gnomAD (6‑33441306‑A‑G). Across a panel of in silico predictors, the majority indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (derived from a majority of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Only polyPhen‑2 HumDiv classifies the change as pathogenic. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, the SGM‑Consensus (majority vote) is benign, and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is inconclusive and therefore not considered evidence. No other tool provides a pathogenic signal. Consequently, the variant is most likely benign, and this assessment does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.200174Structured0.143268Uncertain0.8480.3140.000Uncertain 16-33441306-A-G21.24e-6-7.588In-Between0.138Likely BenignLikely Benign0.90Ambiguous0.00.60Ambiguous0.75Ambiguous0.76Ambiguous0.112Likely Benign-0.78Neutral0.538Possibly Damaging0.080Benign3.35Benign0.14Tolerated3.42170.10210.289843-0.3-14.03215.629.10.00.0-0.70.1XPotentially BenignThe sec-butyl side chain of Ile683, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is sterically packed against His453 and Glu688. In the variant simulations, the iso-propyl side chain of Val683 has similar size and physicochemical properties as Ile630 in the WT, and thus, it is able to maintain similar interactions in the inter-helix space. Consequently, no negative structural effects are observed during the simulations due to the residue swap.
c.2092G>C
E698Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E698Q is not reported in ClinVar and has no entries in gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Tools that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No prediction or folding stability result is missing or inconclusive. Overall, the evidence is split, with an equal number of benign and pathogenic calls; the high‑accuracy tools lean toward benign but are not definitive. Thus, the variant’s pathogenicity remains uncertain and does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-8.369Likely Pathogenic0.714Likely PathogenicLikely Benign0.00Likely Benign0.10.35Likely Benign0.18Likely Benign-0.02Likely Benign0.326Likely Benign-2.86Deleterious0.987Probably Damaging0.946Probably Damaging3.35Benign0.01Affected0.10290.3702220.0-0.98
c.2093A>C
E698A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E698A missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM, while those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as benign. No prediction or folding result is missing. Overall, the majority of tools (seven versus six) favor a pathogenic interpretation, and this does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-10.962Likely Pathogenic0.822Likely PathogenicAmbiguous0.31Likely Benign0.00.26Likely Benign0.29Likely Benign0.25Likely Benign0.476Likely Benign-5.57Deleterious0.997Probably Damaging0.991Probably Damaging3.35Benign0.01Affected0.31470.41600-15.3-58.04
c.2094G>C
E698D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E698D is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. No predictions are missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.120615Structured0.417514Uncertain0.9220.3150.000-6.716Likely Benign0.207Likely BenignLikely Benign0.21Likely Benign0.10.35Likely Benign0.28Likely Benign0.16Likely Benign0.155Likely Benign-2.45Neutral0.977Probably Damaging0.921Probably Damaging3.35Benign0.03Affected0.16430.2597320.0-14.03
c.2094G>T
E698D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E698D is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. No predictions are missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.120615Structured0.417514Uncertain0.9220.3150.000-6.716Likely Benign0.207Likely BenignLikely Benign0.21Likely Benign0.10.35Likely Benign0.28Likely Benign0.16Likely Benign0.155Likely Benign-2.45Neutral0.977Probably Damaging0.921Probably Damaging3.35Benign0.03Affected0.16430.2597320.0-14.03
c.2099T>G
L700R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L700R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign calls come from REVEL, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic calls are made by Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is inconclusive, SGM Consensus remains Likely Pathogenic, and Foldetta predicts a destabilizing, pathogenic effect. Overall, the preponderance of evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.416255Uncertain0.9270.3310.000-12.389Likely Pathogenic0.938Likely PathogenicAmbiguous1.82Ambiguous0.14.19Destabilizing3.01Destabilizing1.89Destabilizing0.485Likely Benign-4.29Deleterious0.728Possibly Damaging0.249Benign3.35Benign0.01Affected0.12100.0488-3-2-8.343.03
c.2122C>G
L708V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L708V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results are from FoldX (uncertain) and Foldetta (uncertain). High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign, while Foldetta remains uncertain. Overall, the evidence strongly indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.250310Structured0.365875Uncertain0.9310.3780.000-4.361Likely Benign0.097Likely BenignLikely Benign1.59Ambiguous0.00.12Likely Benign0.86Ambiguous-0.02Likely Benign0.122Likely Benign-0.23Neutral0.158Benign0.035Benign3.35Benign0.94Tolerated0.10940.2460210.4-14.03
c.2132T>G
L711R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711R lies in the GAP domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overwhelming majority of computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-14.009Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.71Destabilizing0.03.98Destabilizing3.85Destabilizing2.13Destabilizing0.432Likely Benign-5.71Deleterious0.999Probably Damaging0.992Probably Damaging3.35Benign0.00Affected0.13450.0488-3-2-8.343.03
c.2134G>C
G712R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G712R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors—PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, SIFT, ESM1b, PROVEAN, AlphaMissense‑Default, AlphaMissense‑Optimized, Foldetta, Rosetta, and the SGM Consensus—classify it as pathogenic. Two tools, FoldX and premPS, return uncertain results. High‑accuracy methods all support pathogenicity: AlphaMissense‑Optimized, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta each predict a deleterious effect. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.000-11.776Likely Pathogenic0.963Likely PathogenicLikely Pathogenic1.75Ambiguous0.04.68Destabilizing3.22Destabilizing0.82Ambiguous0.458Likely Benign-6.58Deleterious1.000Probably Damaging0.999Probably Damaging3.35Benign0.01Affected0.12290.4482-3-2-4.199.14
c.2147G>A
R716Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R716Q is listed in ClinVar with an uncertain significance (ClinVar ID 411585.0) and is present in gnomAD (ID 6‑33441612‑G‑A). Functional prediction tools that report a benign effect include REVEL, FoldX, Rosetta, Foldetta, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b, while premPS is inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the balance of evidence leans toward a benign impact, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.247041Structured0.419135Uncertain0.9620.3790.000Conflicting 26-33441612-G-A42.48e-6-8.338Likely Pathogenic0.308Likely BenignLikely Benign-0.01Likely Benign0.00.47Likely Benign0.23Likely Benign0.58Ambiguous0.210Likely Benign-3.14Deleterious1.000Probably Damaging0.990Probably Damaging3.35Benign0.02Affected3.5090.28340.2180111.0-28.06250.048.90.00.0-0.50.0XUncertainThe guanidinium group of Arg716, located on the outer surface of an α-helix (res. Leu714-Arg726), forms a salt bridge with the carboxylate group of Asp720. In the variant simulations, the carboxamide group of Gln716 also forms a hydrogen bond with the carboxylate group of Asp720, although this bond is weaker than the Arg716 salt bridge in the WT. Overall, no adverse effects on the protein structure are observed in the simulations. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.1231A>C
I411L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I411L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, whereas a majority (premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. Tools with uncertain or mixed outputs are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, yielding no definitive call; and Foldetta also reports an uncertain stability change. Overall, the majority of standard predictors lean toward pathogenicity, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely pathogenic based on current computational evidence, though high‑accuracy tools remain inconclusive.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.116183Structured0.339366Uncertain0.9270.1980.000-10.723Likely Pathogenic0.819Likely PathogenicAmbiguous1.02Ambiguous0.31.89Ambiguous1.46Ambiguous1.17Destabilizing0.285Likely Benign-1.84Neutral0.908Possibly Damaging0.943Probably Damaging3.36Benign0.01Affected0.08760.353922-0.70.00
c.1255G>A
E419K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419K missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Tools that agree on a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Foldetta and Rosetta give uncertain results and are not counted in either group. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus predicts likely pathogenic, and Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic impact for E419K. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.371949Uncertain0.9610.2610.000-12.257Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.01Likely Benign0.11.30Ambiguous0.66Ambiguous-0.03Likely Benign0.399Likely Benign-3.75Deleterious0.998Probably Damaging0.975Probably Damaging3.36Benign0.07Tolerated0.27590.689901-0.4-0.94
c.1315C>G
L439V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L439V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). Tools that predict a pathogenic effect are FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar; premPS is inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of predictions (8 benign vs. 5 pathogenic) favor a benign classification, and this consensus does not contradict the absence of ClinVar evidence. Thus, based on current computational predictions, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.222385Structured0.281542Uncertain0.9420.2650.000-6.340Likely Benign0.279Likely BenignLikely Benign2.34Destabilizing0.22.40Destabilizing2.37Destabilizing0.91Ambiguous0.121Likely Benign-1.13Neutral0.976Probably Damaging0.941Probably Damaging3.36Benign0.12Tolerated0.12720.2628210.4-14.03
c.1328G>T
G443V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G443V is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN and polyPhen‑2 HumDiv. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Uncertain. Overall, the majority of evidence points to a benign impact for G443V, and this conclusion does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.250310Structured0.258623Uncertain0.9350.2060.000-4.130Likely Benign0.274Likely BenignLikely Benign0.17Likely Benign0.2-2.19Stabilizing-1.01Ambiguous0.21Likely Benign0.099Likely Benign-2.90Deleterious0.585Possibly Damaging0.195Benign3.36Benign0.12Tolerated0.10890.3375-1-34.642.08
c.1336G>A
E446K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E446K is not reported in ClinVar (ClinVar status: not present) and is found in gnomAD (ID 6‑33438241‑G‑A). Prediction tools that agree on a benign effect include only FATHMM. Tools that agree on a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote). Predictions that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy methods give the following: AlphaMissense‑Optimized is uncertain; SGM‑Consensus indicates likely pathogenic; Foldetta is uncertain. Overall, the majority of evidence points to a pathogenic impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.276479Uncertain0.9400.2160.0006-33438241-G-A16.19e-7-14.140Likely Pathogenic0.953Likely PathogenicAmbiguous0.80Ambiguous0.41.57Ambiguous1.19Ambiguous0.81Ambiguous0.518Likely Pathogenic-3.75Deleterious0.994Probably Damaging0.975Probably Damaging3.36Benign0.01Affected3.38310.21410.651110-0.4-0.94
c.1366C>A
Q456K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q456K is not reported in ClinVar and has no gnomAD entry. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and FATHMM, whereas those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; premPS and AlphaMissense‑Optimized are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of tools (six pathogenic vs five benign) and the SGM‑Consensus result point toward a pathogenic interpretation, while Foldetta suggests stability‑preserving benignity. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.170161Structured0.302348Uncertain0.9390.1640.000-13.768Likely Pathogenic0.806Likely PathogenicAmbiguous0.21Likely Benign0.10.23Likely Benign0.22Likely Benign0.78Ambiguous0.391Likely Benign-3.75Deleterious0.969Probably Damaging0.875Possibly Damaging3.36Benign0.13Tolerated0.13210.254711-0.40.04
c.1381G>T
A461S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A461S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, polyPhen‑2 (HumVar), FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv), SIFT, and ESM1b. Four tools (FoldX, Rosetta, Foldetta, premPS) give uncertain results and are not considered evidence for either side. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta’s stability analysis is also unavailable. Overall, the balance of evidence leans toward a benign effect, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.179055Structured0.292531Uncertain0.9360.1510.125-10.663Likely Pathogenic0.309Likely BenignLikely Benign0.87Ambiguous0.01.18Ambiguous1.03Ambiguous0.63Ambiguous0.236Likely Benign-2.74Deleterious0.600Possibly Damaging0.289Benign3.36Benign0.02Affected0.24010.455111-2.616.00
c.1390T>G
F464V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F464V variant is listed in ClinVar with an “Uncertain” status (ClinVar ID 1716596.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective predictions, the variant is most likely pathogenic, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000Uncertain 1-12.254Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.61Destabilizing0.12.89Destabilizing3.25Destabilizing1.40Destabilizing0.592Likely Pathogenic-6.96Deleterious0.998Probably Damaging0.996Probably Damaging3.36Benign0.04Affected3.37340.15870.2219-1-11.4-48.04210.140.5-0.10.0-0.90.3XPotentially PathogenicThe phenyl ring of Phe464, located in the middle of an α helix (res. Ala461–Phe476), packs against hydrophobic residues (e.g., Met468, Leu451, Leu455, and Tyr428) in the inter-helix space formed with two other α helices (res. Asn440-Lys460 and res. Pro413-Glu436). The iso-propyl side chain of Val464 is similarly hydrophobic but considerably smaller than the original phenyl ring of Phe464. To compensate for the size difference, neighboring residues need to fill in the gap in the variant simulations.The phenolic side chain of Tyr428, located at the middle bend of an α helix (res. Glu436-Pro413), assumes a new position in the inter-helix space or rotates inward next to the third α helix (res. Asn440-Lys460) when the stable H-bond between Tyr428 and Asp467 seen in the WT simulations breaks. The residue swap also leads to the loss of the methionine-aromatic interaction between the Met468 and Phe464 side chains, which could weaken the integrity of the parent α helix (res. Ala461-Phe476). Although the simulations likely underestimate the full adverse effect of the introduced mutation during folding, the two opposing α helices (res. Ala461–Phe476 and res. Glu436-Pro413) move substantially closer to each other in the variant simulations.
c.1503T>G
I501M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I501M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Predictions that are inconclusive or unavailable are FoldX, Foldetta, premPS, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as uncertain. Taken together, the majority of evidence points to a benign impact for I501M. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.079919Structured0.366596Uncertain0.8860.1530.000-7.452In-Between0.259Likely BenignLikely Benign1.32Ambiguous0.2-0.19Likely Benign0.57Ambiguous0.95Ambiguous0.294Likely Benign-2.32Neutral1.000Probably Damaging1.000Probably Damaging3.36Benign0.01Affected0.06800.158921-2.618.03
c.1600T>G
S534A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 S534A is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict pathogenicity. High‑accuracy methods reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. No evidence suggests a deleterious effect. Therefore, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.167087Structured0.032173Uncertain0.8600.3620.000-4.691Likely Benign0.082Likely BenignLikely Benign0.01Likely Benign0.0-0.01Likely Benign0.00Likely Benign0.11Likely Benign0.163Likely Benign-1.70Neutral0.880Possibly Damaging0.994Probably Damaging3.36Benign0.42Tolerated0.50420.3131Weaken112.6-16.00
c.1613A>C
E538A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E538A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote). High‑accuracy methods give mixed results: AlphaMissense‑Optimized predicts benign, SGM‑Consensus predicts likely pathogenic, and Foldetta predicts benign. No prediction or folding stability result is missing or inconclusive. Overall, the majority of tools (7 pathogenic vs 6 benign) lean toward a pathogenic interpretation, and this does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.122885Structured0.033501Uncertain0.9380.3590.000-9.888Likely Pathogenic0.770Likely PathogenicLikely Benign0.33Likely Benign0.0-0.06Likely Benign0.14Likely Benign0.16Likely Benign0.269Likely Benign-4.66Deleterious0.944Possibly Damaging0.761Possibly Damaging3.36Benign0.05Affected0.39950.41870-15.3-58.04
c.175C>G
L59V
2D
AIThe SynGAP1 missense variant L59V is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for this variant. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.212910Structured0.484882Uncertain0.5100.6680.000-4.465Likely Benign0.588Likely PathogenicLikely Benign0.049Likely Benign-1.15Neutral0.458Possibly Damaging0.745Possibly Damaging3.36Benign0.00Affected0.15080.3217210.4-14.03
c.1909T>C
S637P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S637P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, premPS, polyPhen‑2 HumVar, and FATHMM, while pathogenic calls arise from FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments give a pathogenic signal: the SGM Consensus predicts likely pathogenic, Foldetta predicts destabilizing pathogenic effects, whereas AlphaMissense‑Optimized remains uncertain. Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.076542Structured0.083482Uncertain0.9200.2530.000-11.455Likely Pathogenic0.793Likely PathogenicAmbiguous6.73Destabilizing0.16.36Destabilizing6.55Destabilizing0.44Likely Benign0.192Likely Benign-3.12Deleterious0.946Possibly Damaging0.360Benign3.36Benign0.03Affected0.23740.40941-1-0.810.04
c.1976C>G
S659C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S659C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, AlphaMissense‑Default, AlphaMissense‑Optimized, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and SIFT. Two tools (Rosetta and ESM1b) return uncertain results and are not counted as evidence for either side. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. Based on the collective predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.067594Structured0.154597Uncertain0.9540.2830.000-7.133In-Between0.161Likely BenignLikely Benign0.09Likely Benign0.00.69Ambiguous0.39Likely Benign0.36Likely Benign0.173Likely Benign-4.12Deleterious0.981Probably Damaging0.397Benign3.36Benign0.04Affected0.11300.53840-13.316.06
c.1979T>C
M660T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M660T is catalogued in gnomAD (ID 6‑33441238‑T‑C) but has no ClinVar entry, so its clinical status is currently unreported. In silico prediction tools largely agree that the substitution is deleterious: pathogenic predictions come from SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a benign effect. High‑accuracy assessments reinforce the pathogenic view: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding result is missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.047319Structured0.134270Uncertain0.9440.2890.0006-33441238-T-C16.20e-7-9.791Likely Pathogenic0.989Likely PathogenicLikely Pathogenic3.62Destabilizing0.12.05Destabilizing2.84Destabilizing1.91Destabilizing0.561Likely Pathogenic-5.99Deleterious0.967Probably Damaging0.633Possibly Damaging3.36Benign0.02Affected3.38280.18110.1630-1-1-2.6-30.09
c.1999A>C
I667L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I667L is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and ESM1b. The remaining tools—FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation and gnomAD presence, indicating no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.142424Structured0.083597Uncertain0.9270.3790.000-10.452Likely Pathogenic0.459AmbiguousLikely Benign0.93Ambiguous0.20.72Ambiguous0.83Ambiguous0.75Ambiguous0.300Likely Benign-1.97Neutral0.457Possibly Damaging0.392Benign3.36Benign0.13Tolerated0.09800.314522-0.70.00
c.2011G>A
D671N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant D671N is reported in gnomAD (6‑33441270‑G‑A) but has no ClinVar entry. Functional prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus remains pathogenic. Overall, the predictions are split, with a slight bias toward benign outcomes from the majority of tools, but the consensus pathogenic signal from SGM and several high‑confidence predictors suggests uncertainty. The variant is most likely benign based on the preponderance of benign predictions, and this does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.194234Structured0.096749Uncertain0.6770.3700.0006-33441270-G-A-10.347Likely Pathogenic0.685Likely PathogenicLikely Benign0.18Likely Benign0.10.39Likely Benign0.29Likely Benign0.19Likely Benign0.184Likely Benign-3.19Deleterious0.887Possibly Damaging0.592Possibly Damaging3.36Benign0.02Affected3.39270.12980.6463120.0-0.98
c.2017C>G
L673V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L673V is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are FoldX, Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Benign, and Foldetta as pathogenic, yielding one pathogenic versus two benign predictions. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.060549Structured0.104692Uncertain0.5450.3690.000-8.132Likely Pathogenic0.099Likely BenignLikely Benign2.18Destabilizing0.32.10Destabilizing2.14Destabilizing0.10Likely Benign0.017Likely Benign-0.58Neutral0.016Benign0.003Benign3.36Benign0.28Tolerated0.14480.3777210.4-14.03
c.2018T>G
L673R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L673R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized; pathogenic calls come from Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote). FoldX and Foldetta are inconclusive. High‑accuracy assessments give a benign result from AlphaMissense‑Optimized, a likely pathogenic verdict from the SGM Consensus, and an uncertain outcome from Foldetta. Overall, the majority of evidence points toward pathogenicity, and this conclusion does not conflict with the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.060549Structured0.104692Uncertain0.5450.3690.000-14.474Likely Pathogenic0.714Likely PathogenicLikely Benign1.10Ambiguous0.22.04Destabilizing1.57Ambiguous1.23Destabilizing0.178Likely Benign-3.81Deleterious0.991Probably Damaging0.433Benign3.36Benign0.03Affected0.13480.1015-3-2-8.343.03
c.2050G>C
D684H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D684H is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are inconclusive or missing. Based on the overwhelming majority of pathogenic predictions, the variant is most likely pathogenic, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.153798Uncertain0.8700.2820.000Uncertain 1-14.194Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.36Destabilizing1.02.95Destabilizing3.16Destabilizing0.55Ambiguous0.613Likely Pathogenic-6.98Deleterious1.000Probably Damaging0.972Probably Damaging3.36Benign0.00Affected3.42170.13440.6618-110.322.05
c.2146C>G
R716G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R716G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Uncertain. Other stability predictors (FoldX, Rosetta, premPS) are also Uncertain. Overall, the balance of evidence from the majority of tools and the SGM‑Consensus indicates a pathogenic effect, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.247041Structured0.419135Uncertain0.9620.3790.000-9.927Likely Pathogenic0.728Likely PathogenicLikely Benign1.32Ambiguous0.11.63Ambiguous1.48Ambiguous0.72Ambiguous0.359Likely Benign-5.70Deleterious1.000Probably Damaging1.000Probably Damaging3.36Benign0.01Affected0.34370.2466-3-24.1-99.14
c.2149C>T
L717F
2D
AIThe SynGAP1 missense variant L717F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL and FATHMM, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain; the SGM‑Consensus indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also uncertain. No folding‑stability metrics (FoldX, Rosetta, premPS) provide decisive evidence. Overall, the majority of predictions lean toward pathogenicity, and this is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.239899Structured0.429342Uncertain0.9690.3970.000-10.917Likely Pathogenic0.903Likely PathogenicAmbiguous0.74Ambiguous0.60.59Ambiguous0.67Ambiguous0.63Ambiguous0.157Likely Benign-2.56Deleterious0.999Probably Damaging0.988Probably Damaging3.36Benign0.02Affected0.04440.220720-1.034.02
c.394T>A
F132I
2D
AISynGAP1 missense variant F132I is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two pathogenic, two benign) and Foldetta results are unavailable. Because the majority of consensus tools predict benign and no ClinVar evidence contradicts this, the variant is most likely benign, although the pathogenic signal from AlphaMissense‑Optimized and the inconclusive SGM Consensus leave some uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.450668Structured0.727897Binding0.3450.8920.250-6.245Likely Benign0.974Likely PathogenicLikely Pathogenic0.211Likely Benign-3.23Deleterious0.084Benign0.020Benign3.36Benign0.00Affected0.23060.1698101.7-34.02
c.1253A>C
K418T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K418T variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, FATHMM, premPS, and Foldetta. Those that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of tools (10 pathogenic vs. 5 benign) support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar record exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.360134Uncertain0.9480.2630.000-11.994Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.39Likely Benign0.10.55Ambiguous0.47Likely Benign0.41Likely Benign0.392Likely Benign-5.36Deleterious1.000Probably Damaging1.000Probably Damaging3.37Benign0.04Affected0.19750.18940-13.2-27.07
c.1253A>G
K418R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K418R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, ESM1b, FATHMM, PROVEAN, and AlphaMissense‑Optimized. Tools that predict pathogenicity are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The high‑accuracy consensus methods give a benign verdict: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign (3 benign vs. 1 pathogenic); and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is benign. premPS is uncertain and therefore not considered evidence. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.104810Structured0.360134Uncertain0.9480.2630.000-6.809Likely Benign0.635Likely PathogenicLikely Benign-0.18Likely Benign0.10.12Likely Benign-0.03Likely Benign0.56Ambiguous0.229Likely Benign-2.46Neutral0.994Probably Damaging0.962Probably Damaging3.37Benign0.04Affected0.43840.115132-0.628.01
c.1273A>C
T425P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Consensus from multiple in silico predictors indicates a pathogenic effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as deleterious, while only FATHMM predicts a benign outcome; premPS is uncertain. High‑accuracy tools reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a pathogenic effect. Taken together, the overwhelming majority of evidence supports a pathogenic classification, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.401218Uncertain0.9640.2800.000-12.318Likely Pathogenic0.963Likely PathogenicLikely Pathogenic2.81Destabilizing0.36.49Destabilizing4.65Destabilizing0.77Ambiguous0.512Likely Pathogenic-5.16Deleterious1.000Probably Damaging0.999Probably Damaging3.37Benign0.03Affected0.18150.34690-1-0.9-3.99
c.1297G>C
A433P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 A433P is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, SIFT, and FATHMM. Those that predict pathogenicity comprise FoldX, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. The remaining tools, premPS and AlphaMissense‑Optimized, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (integrating FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of evidence points to a pathogenic effect, which is consistent with the lack of ClinVar annotation and gnomAD absence. Therefore, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.098513Structured0.352258Uncertain0.9380.3020.000-9.887Likely Pathogenic0.883Likely PathogenicAmbiguous2.48Destabilizing0.07.09Destabilizing4.79Destabilizing0.55Ambiguous0.217Likely Benign-2.64Deleterious0.998Probably Damaging0.820Possibly Damaging3.37Benign0.07Tolerated0.14710.41501-1-3.426.04
c.1321G>T
V441F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V441F missense variant is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic outcome are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools lean toward a benign interpretation, and the high‑accuracy predictions are split but favor benign. Thus, the variant is most likely benign based on current computational evidence, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.161087Structured0.259875Uncertain0.9180.2490.000-13.519Likely Pathogenic0.653Likely PathogenicLikely Benign-0.26Likely Benign0.00.32Likely Benign0.03Likely Benign0.54Ambiguous0.355Likely Benign-4.22Deleterious0.992Probably Damaging0.658Possibly Damaging3.37Benign0.08Tolerated0.06700.3269-1-1-1.448.04
c.1325A>T
K442I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K442I missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy assessments are: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of predictions, including the two high‑accuracy pathogenic calls, indicate a pathogenic impact. There is no ClinVar entry to contradict this assessment, so the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.170161Structured0.255766Uncertain0.9120.2250.000-14.921Likely Pathogenic0.965Likely PathogenicLikely Pathogenic0.16Likely Benign0.1-0.16Likely Benign0.00Likely Benign0.30Likely Benign0.350Likely Benign-6.91Deleterious1.000Probably Damaging0.999Probably Damaging3.37Benign0.02Affected0.09430.3073-2-38.4-15.01
c.1327G>T
G443C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G443C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, premPS, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. The remaining tools are inconclusive: Foldetta is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Benign.” High‑accuracy assessments confirm this trend: AlphaMissense‑Optimized is benign, SGM‑Consensus is likely benign, and Foldetta remains uncertain. Overall, the consensus of the majority of evidence points to a benign impact for G443C, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.250310Structured0.258623Uncertain0.9350.2060.000-4.308Likely Benign0.208Likely BenignLikely Benign-0.06Likely Benign0.0-0.95Ambiguous-0.51Ambiguous-0.10Likely Benign0.260Likely Benign-2.94Deleterious0.977Probably Damaging0.504Possibly Damaging3.37Benign0.16Tolerated0.12580.2782-3-32.946.09
c.1339G>A
V447I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V447I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate a benign or likely benign outcome. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic effect. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta) predicts benign stability. Thus, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.250310Structured0.283801Uncertain0.9700.2430.000-5.067Likely Benign0.167Likely BenignLikely Benign-0.33Likely Benign0.10.27Likely Benign-0.03Likely Benign-0.44Likely Benign0.117Likely Benign-0.06Neutral0.947Possibly Damaging0.851Possibly Damaging3.37Benign0.28Tolerated0.06250.3059430.314.03
c.1340T>C
V447A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V447A missense variant is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta both predict pathogenicity. No predictions are missing or inconclusive. Based on the overall distribution of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.250310Structured0.283801Uncertain0.9700.2430.000-9.852Likely Pathogenic0.692Likely PathogenicLikely Benign2.18Destabilizing0.02.72Destabilizing2.45Destabilizing1.56Destabilizing0.266Likely Benign-2.84Deleterious1.000Probably Damaging0.999Probably Damaging3.37Benign0.15Tolerated0.24560.212400-2.4-28.05
c.1346G>A
S449N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S449N is not reported in ClinVar (ClinVar status: not listed) but is present in the gnomAD database (gnomAD ID: 6‑33438251‑G‑A). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from premPS (uncertain) and ESM1b (uncertain). High‑accuracy assessments reinforce the benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is benign. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.254060Structured0.301437Uncertain0.9580.2510.0006-33438251-G-A16.19e-7-7.692In-Between0.210Likely BenignLikely Benign0.38Likely Benign0.1-0.03Likely Benign0.18Likely Benign0.81Ambiguous0.070Likely Benign-2.31Neutral0.372Benign0.026Benign3.37Benign0.18Tolerated3.37320.10850.376711-2.727.03
c.1367A>G
Q456R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q456R has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, and FATHMM. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain; the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, whereas Foldetta (a folding‑stability method combining FoldX‑MD and Rosetta outputs) predicts benign. No evidence from the data contradicts ClinVar status, which is currently unclassified. Based on the available predictions, the variant is most likely benign, though the evidence is conflicting and does not conflict with the lack of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.170161Structured0.302348Uncertain0.9390.1640.000-11.326Likely Pathogenic0.801Likely PathogenicAmbiguous0.21Likely Benign0.10.12Likely Benign0.17Likely Benign0.33Likely Benign0.295Likely Benign-3.69Deleterious0.980Probably Damaging0.943Probably Damaging3.37Benign0.20Tolerated0.12410.112411-1.028.06
c.1368G>C
Q456H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q456H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Tools with uncertain or inconclusive results are FoldX, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of predictions lean toward a benign impact, and this does not contradict the lack of ClinVar annotation. Thus, based on the available computational evidence, the variant is most likely benign, though a high‑accuracy consensus suggests a possible pathogenic effect that warrants further investigation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.170161Structured0.302348Uncertain0.9390.1640.000-7.993In-Between0.598Likely PathogenicLikely Benign0.74Ambiguous0.10.39Likely Benign0.57Ambiguous0.32Likely Benign0.214Likely Benign-4.07Deleterious0.996Probably Damaging0.974Probably Damaging3.37Benign0.19Tolerated0.09870.2358300.39.01
c.1368G>T
Q456H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q456H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Tools with uncertain or inconclusive results are FoldX, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of predictions lean toward a benign impact, and this does not contradict the lack of ClinVar annotation. Thus, based on the available computational evidence, the variant is most likely benign, though a high‑accuracy consensus suggests a possible pathogenic effect that warrants further investigation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.170161Structured0.302348Uncertain0.9390.1640.000-7.993In-Between0.598Likely PathogenicLikely Benign0.74Ambiguous0.10.39Likely Benign0.57Ambiguous0.32Likely Benign0.214Likely Benign-4.07Deleterious0.996Probably Damaging0.974Probably Damaging3.37Benign0.19Tolerated0.09870.2358300.39.01
c.1457A>T
E486V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E486V is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, SIFT, FATHMM, and Foldetta. Tools that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also pathogenic; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Uncertain results from FoldX and Rosetta are treated as unavailable. Overall, the majority of predictions support a pathogenic classification, and this conclusion does not contradict ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.196879Structured0.358545Uncertain0.8330.2450.125-15.115Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.54Ambiguous0.1-0.65Ambiguous-0.06Likely Benign0.31Likely Benign0.490Likely Benign-6.36Deleterious0.998Probably Damaging0.991Probably Damaging3.37Benign0.06Tolerated0.04930.6445-2-27.7-29.98
c.1502T>A
I501N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I501N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, while a majority of tools (SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. Uncertain results come from AlphaMissense‑Optimized, Foldetta, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as inconclusive, whereas the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta likewise remains inconclusive. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict any existing ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.079919Structured0.366596Uncertain0.8860.1530.000-11.105Likely Pathogenic0.854Likely PathogenicAmbiguous2.22Destabilizing0.01.70Ambiguous1.96Ambiguous1.90Destabilizing0.445Likely Benign-6.13Deleterious1.000Probably Damaging1.000Probably Damaging3.37Benign0.01Affected0.08250.0270-2-3-8.00.94
c.1523A>C
D508A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D508A is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The high‑accuracy methods give a split result: AlphaMissense‑Optimized predicts benign, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is uncertain. No prediction or stability result is missing; all available outputs are considered. Overall, the predictions are evenly divided between benign and pathogenic, with no clear consensus. Therefore, the variant is inconclusive; it is not contradictory to the ClinVar status, which has no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.019401Structured0.255890Uncertain0.8900.2280.000-11.434Likely Pathogenic0.704Likely PathogenicLikely Benign-0.18Likely Benign0.21.84Ambiguous0.83Ambiguous0.09Likely Benign0.339Likely Benign-7.37Deleterious0.988Probably Damaging0.762Possibly Damaging3.37Benign0.06Tolerated0.37580.42410-25.3-44.01
c.1612G>C
E538Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E538Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the majority of evidence supports a benign impact. This conclusion does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.122885Structured0.033501Uncertain0.9380.3590.000-10.380Likely Pathogenic0.733Likely PathogenicLikely Benign0.07Likely Benign0.00.07Likely Benign0.07Likely Benign-0.08Likely Benign0.188Likely Benign-2.14Neutral0.890Possibly Damaging0.436Benign3.37Benign0.11Tolerated0.11270.3952220.0-0.98
c.1642G>C
E548Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E548Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM, while those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Because the predictions are split evenly and the high‑accuracy tools give opposing results, the variant’s functional impact remains ambiguous. Thus, the variant is most likely benign based on the majority of evidence, and this does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.054297Structured0.008632Uncertain0.9650.2880.000-11.006Likely Pathogenic0.921Likely PathogenicAmbiguous-0.15Likely Benign0.00.16Likely Benign0.01Likely Benign0.05Likely Benign0.310Likely Benign-2.88Deleterious0.999Probably Damaging0.993Probably Damaging3.37Benign0.06Tolerated0.09570.4330220.0-0.98
c.1817G>A
S606N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S606N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, FoldX, Rosetta, SIFT, FATHMM) and pathogenic predictions (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default). Two tools give uncertain results: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show SGM‑Consensus as Likely Pathogenic, AlphaMissense‑Optimized as Uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Because the majority of individual predictors lean toward pathogenic and the SGM‑Consensus, a high‑confidence consensus, also indicates pathogenicity, the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.191720Uncertain0.8750.2470.000-11.352Likely Pathogenic0.919Likely PathogenicAmbiguous0.11Likely Benign0.10.20Likely Benign0.16Likely Benign0.76Ambiguous0.136Likely Benign-2.99Deleterious0.920Possibly Damaging0.955Probably Damaging3.37Benign0.10Tolerated0.11370.321811-2.727.03
c.1847A>G
D616G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D616G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Tools with uncertain or inconclusive results—FoldX, AlphaMissense‑Default, and Foldetta—are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the predictions are split evenly between benign and pathogenic, with no clear consensus. Thus, the variant is most likely of uncertain significance; it does not contradict any ClinVar status because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.166689Uncertain0.8670.2520.000-10.310Likely Pathogenic0.547AmbiguousLikely Benign1.48Ambiguous0.12.13Destabilizing1.81Ambiguous0.49Likely Benign0.144Likely Benign-5.60Deleterious0.985Probably Damaging0.800Possibly Damaging3.37Benign0.06Tolerated0.34960.43861-13.1-58.04
c.1934T>C
F645S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F645S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign calls come from REVEL, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic calls are made by FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, while both the SGM Consensus and Foldetta predict pathogenicity. No evidence from ClinVar contradicts these findings. Overall, the preponderance of predictions supports a pathogenic classification for F645S.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.046336Structured0.276445Uncertain0.9210.3250.000-9.748Likely Pathogenic0.947Likely PathogenicAmbiguous2.49Destabilizing0.22.30Destabilizing2.40Destabilizing1.57Destabilizing0.326Likely Benign-5.34Deleterious0.755Possibly Damaging0.112Benign3.37Benign0.03Affected0.38990.0547-3-2-3.6-60.10
c.1972G>T
G658C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G658C is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. One tool, ESM1b, yields an uncertain result. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also favors benign (2 benign vs. 1 pathogenic, 1 uncertain), and Foldetta predicts a benign impact on protein stability. Overall, the majority of evidence points to a benign effect. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.029376Structured0.180299Uncertain0.9420.2510.000-7.577In-Between0.170Likely BenignLikely Benign0.05Likely Benign0.00.04Likely Benign0.05Likely Benign0.46Likely Benign0.146Likely Benign-3.49Deleterious0.989Probably Damaging0.544Possibly Damaging3.37Benign0.04Affected0.15090.3141-3-32.946.09
c.1997A>G
E666G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E666G is listed in ClinVar as Benign (ClinVar ID 1115026.0) and is present in gnomAD (ID 6‑33441256‑A‑G). Functional prediction tools that agree on pathogenicity include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus. Only FATHMM predicts a benign effect. Predictions marked Uncertain (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as Uncertain. Overall, the majority of evidence points to a pathogenic impact, which contradicts the ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.086870Uncertain0.9250.3870.000Likely Benign 16-33441256-A-G106.20e-6-12.261Likely Pathogenic0.911Likely PathogenicAmbiguous1.57Ambiguous0.11.46Ambiguous1.52Ambiguous0.93Ambiguous0.522Likely Pathogenic-6.25Deleterious1.000Probably Damaging0.970Probably Damaging3.37Benign0.02Affected3.38280.30510.40150-23.1-72.06173.998.50.00.0-0.70.0XPotentially PathogenicIn the WT simulations, the carboxylate group of Glu666, located on the α-helix (res. Ser641-Glu666), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), such as Lys566, Thr672, and Asn669. In the variant simulations, the carbonyl group of Gly666 occasionally forms hydrogen bonds with Lys566 and Asn669. However, Gly666 lacks a side chain and thus cannot maintain as well-coordinated a hydrogen-bond network as Glu666 in the WT, which may affect the tertiary structure assembly.
c.2017C>A
L673I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L673I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome. The remaining tools (FoldX, Rosetta, Foldetta, ESM1b) return uncertain or inconclusive results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Taken together, the majority of reliable predictors indicate a benign effect, and there is no conflict with ClinVar status (which has no entry). Therefore, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.060549Structured0.104692Uncertain0.5450.3690.000-7.823In-Between0.099Likely BenignLikely Benign1.51Ambiguous0.21.89Ambiguous1.70Ambiguous-0.02Likely Benign0.036Likely Benign-0.14Neutral0.535Possibly Damaging0.112Benign3.37Benign0.47Tolerated0.09100.3689220.70.00
c.2018T>C
L673P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L673P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. All other evaluated tools—SGM‑Consensus, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized indicates benign, but the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts Pathogenic. Taken together, the overwhelming majority of predictions, including the high‑accuracy tools, classify the variant as pathogenic. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.060549Structured0.104692Uncertain0.5450.3690.000-12.160Likely Pathogenic0.622Likely PathogenicLikely Benign2.41Destabilizing0.31.63Ambiguous2.02Destabilizing1.17Destabilizing0.207Likely Benign-4.10Deleterious1.000Probably Damaging0.978Probably Damaging3.37Benign0.02Affected0.35520.1474-3-3-5.4-16.04
c.2024A>T
N675I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N675I is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools cluster into two groups: benign predictions come from REVEL, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. FoldX and Rosetta give uncertain results and are treated as unavailable. High‑accuracy methods give mixed outcomes: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta predicts benign. Overall, the majority of tools (7/12) indicate pathogenicity, while 5/12 indicate benign. Thus, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.129801Structured0.111024Uncertain0.5130.3330.000-13.254Likely Pathogenic0.574Likely PathogenicLikely Benign1.00Ambiguous0.1-0.97Ambiguous0.02Likely Benign0.41Likely Benign0.338Likely Benign-7.37Deleterious0.999Probably Damaging0.955Probably Damaging3.37Benign0.00Affected0.06200.7188-2-38.0-0.94
c.2032A>T
S678C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FoldX, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Tools with uncertain results are Rosetta and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign (2 benign vs. 1 pathogenic, 1 uncertain), and Foldetta also predicts benign. No prediction or folding stability result is missing or inconclusive. Overall, the preponderance of evidence indicates the variant is most likely benign, and this conclusion does not contradict any ClinVar status because the variant is not yet classified in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.301917Structured0.123585Uncertain0.6600.3210.000-7.879In-Between0.095Likely BenignLikely Benign0.21Likely Benign0.20.55Ambiguous0.38Likely Benign0.35Likely Benign0.094Likely Benign-3.31Deleterious0.947Possibly Damaging0.527Possibly Damaging3.37Benign0.01Affected0.10800.58750-13.316.06
c.2051A>G
D684G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D684G is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess the variant’s effect largely agree on a deleterious outcome. Benign predictions come from premPS and FATHMM, whereas the remaining 12 tools—including REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify it as pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. No prediction is inconclusive or missing. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.153798Uncertain0.8700.2820.000-14.238Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.34Destabilizing1.04.07Destabilizing3.71Destabilizing-0.30Likely Benign0.561Likely Pathogenic-6.98Deleterious0.999Probably Damaging0.935Probably Damaging3.37Benign0.01Affected0.36860.54031-13.1-58.04
c.2052C>A
D684E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D684E missense variant has no ClinVar entry and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM. In contrast, a majority of predictors (SGM‑Consensus, FoldX, Foldetta, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate a pathogenic impact; predictions from Rosetta and premPS are inconclusive and are treated as unavailable. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.153798Uncertain0.8700.2820.000-9.506Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.88Destabilizing0.91.48Ambiguous2.18Destabilizing0.66Ambiguous0.362Likely Benign-3.99Deleterious0.910Possibly Damaging0.210Benign3.37Benign0.01Affected0.13160.6187320.014.03
c.2052C>G
D684E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D684E is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas the majority of algorithms predict a deleterious effect: FoldX, Foldetta, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Two methods (Rosetta and premPS) returned uncertain results. High‑accuracy assessments further support a damaging impact: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. Overall, the computational evidence overwhelmingly indicates that D684E is pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.153798Uncertain0.8700.2820.000-9.506Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.88Destabilizing0.91.48Ambiguous2.18Destabilizing0.66Ambiguous0.362Likely Benign-3.99Deleterious0.910Possibly Damaging0.210Benign3.37Benign0.01Affected0.13160.6187320.014.03
c.2057G>C
G686A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G686A is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, Rosetta, SIFT, and FATHMM, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy methods give a pathogenic verdict from AlphaMissense‑Optimized and a Likely Pathogenic consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), while Foldetta predicts benign stability. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.109221Structured0.177104Uncertain0.9190.2680.000-9.975Likely Pathogenic0.983Likely PathogenicLikely Pathogenic-0.39Likely Benign0.2-0.46Likely Benign-0.43Likely Benign0.58Ambiguous0.321Likely Benign-5.19Deleterious0.993Probably Damaging0.732Possibly Damaging3.37Benign0.13Tolerated0.37440.4131102.214.03
c.2068T>A
S690T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S690T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, FATHMM, and polyPhen‑2 HumVar, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. Predictions that are inconclusive (FoldX, premPS, AlphaMissense‑Optimized) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the balance of evidence leans toward pathogenicity, and this conclusion does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.055536Structured0.247926Uncertain0.9440.2530.000-11.380Likely Pathogenic0.845Likely PathogenicAmbiguous0.99Ambiguous0.2-0.21Likely Benign0.39Likely Benign0.67Ambiguous0.311Likely Benign-2.84Deleterious0.943Possibly Damaging0.267Benign3.37Benign0.01Affected0.10590.4674110.114.03
c.2092G>A
E698K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E698K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) indicates a benign impact. Because the high‑accuracy predictions are split, the overall evidence is inconclusive, but the majority of tools lean toward pathogenicity. The variant is therefore most likely pathogenic based on the preponderance of predictions, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.417514Uncertain0.9220.3150.000-8.881Likely Pathogenic0.963Likely PathogenicLikely Pathogenic0.23Likely Benign0.10.38Likely Benign0.31Likely Benign-0.07Likely Benign0.466Likely Benign-3.79Deleterious0.991Probably Damaging0.951Probably Damaging3.37Benign0.01Affected0.22180.438301-0.4-0.94
c.2095G>A
V699M
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant V699M is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33441354‑G‑A). Across in silico predictors, benign calls are made by REVEL, Rosetta, Foldetta, PROVEAN, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. Predictions that are inconclusive (FoldX, premPS, AlphaMissense‑Default) are noted but not used as evidence. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) reports benign stability. Overall, the preponderance of evidence indicates the variant is most likely benign, which does not contradict the ClinVar uncertain status but provides a stronger leaning toward benignity.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.069024Structured0.432975Uncertain0.9350.3150.000Uncertain 26-33441354-G-A84.96e-6-8.869Likely Pathogenic0.484AmbiguousLikely Benign-0.58Ambiguous0.10.29Likely Benign-0.15Likely Benign0.96Ambiguous0.276Likely Benign-2.18Neutral0.994Probably Damaging0.806Possibly Damaging3.37Benign0.03Affected3.47100.07340.307121-2.332.06257.8-47.20.00.00.90.1XPotentially BenignThe isopropyl side chain of Val699, located on an α-helix (res. Leu685-Gln702), packs against hydrophobic residues (e.g., Leu703, Leu696, Leu435, Leu439) in the inter-helix space. In the variant simulations, the thioether side chain of Met699 has similar physicochemical properties to Val699 in the WT, and thus, it is able to maintain similar interactions. Consequently, the mutation causes no apparent changes in the structure.
c.2096T>G
V699G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V699G has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FATHMM and AlphaMissense‑Optimized, while the remaining tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b) uniformly predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic verdict; and Foldetta also predicts pathogenic. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.069024Structured0.432975Uncertain0.9350.3150.000-11.912Likely Pathogenic0.481AmbiguousLikely Benign2.22Destabilizing0.03.25Destabilizing2.74Destabilizing1.77Destabilizing0.514Likely Pathogenic-5.11Deleterious0.972Probably Damaging0.999Probably Damaging3.37Benign0.01Affected0.18300.2240-1-3-4.6-42.08
c.2115G>C
K705N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K705N is listed in ClinVar (ID 872011.0) as Pathogenic and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, Rosetta, premPS, FATHMM) and pathogenic predictions (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default). Uncertain results come from FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is inconclusive, but the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—classifies the variant as Likely Pathogenic, and Foldetta also yields an uncertain stability change. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, which aligns with its ClinVar classification and does not contradict the reported status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.379324Uncertain0.9220.3640.000Likely Pathogenic 1-9.767Likely Pathogenic0.925Likely PathogenicAmbiguous0.74Ambiguous0.00.37Likely Benign0.56Ambiguous0.44Likely Benign0.183Likely Benign-3.12Deleterious0.996Probably Damaging0.876Possibly Damaging3.37Benign0.02Affected3.47100.24800.1124100.4-14.07221.4-20.20.00.00.00.1XUncertainThe amino side chain of Lys705, located at the end and outer surface of an α-helix (res. Thr704-Gly712), does not form any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Asn705 briefly forms a salt bridge with Glu706. However, there is no apparent difference between the systems. Due to the model ending abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2115G>T
K705N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K705N is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, premPS, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Three tools (FoldX, Foldetta, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments further support a pathogenic interpretation: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic”; AlphaMissense‑Optimized remains uncertain, and Foldetta is also uncertain. Overall, the balance of evidence favors a pathogenic effect for K705N, and this conclusion does not contradict the current ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.379324Uncertain0.9220.3640.000-9.767Likely Pathogenic0.925Likely PathogenicAmbiguous0.74Ambiguous0.00.37Likely Benign0.56Ambiguous0.44Likely Benign0.183Likely Benign-3.12Deleterious0.996Probably Damaging0.876Possibly Damaging3.37Benign0.02Affected3.47100.24800.1124100.4-14.07221.4-20.20.00.00.00.1XUncertainThe amino side chain of Lys705, located at the end and outer surface of an α-helix (res. Thr704-Gly712), does not form any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Asn705 briefly forms a salt bridge with Glu706. However, there is no apparent difference between the systems. Due to the model ending abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2138C>A
P713Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P713Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, FoldX, Foldetta, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain calls are made by Rosetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments further highlight this discordance: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. Overall, the majority of evidence leans toward a benign interpretation, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-10.253Likely Pathogenic0.875Likely PathogenicAmbiguous0.26Likely Benign0.0-0.77Ambiguous-0.26Likely Benign0.95Ambiguous0.364Likely Benign-6.38Deleterious1.000Probably Damaging0.997Probably Damaging3.37Benign0.00Affected0.12250.33880-1-1.931.01
c.2143C>A
P715T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P715T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split assessment: benign predictions come from REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions arise from FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus. Two tools, Foldetta and premPS, returned uncertain results. High‑accuracy analyses further clarify the picture: AlphaMissense‑Optimized predicts a benign effect, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates pathogenicity; Foldetta remains inconclusive. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.243554Structured0.409757Uncertain0.9560.3620.000-10.501Likely Pathogenic0.744Likely PathogenicLikely Benign2.55Destabilizing0.10.29Likely Benign1.42Ambiguous0.72Ambiguous0.368Likely Benign-7.23Deleterious1.000Probably Damaging0.993Probably Damaging3.37Benign0.01Affected0.13570.40720-10.93.99
c.2144C>A
P715H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P715H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, and FATHMM, whereas a majority of predictors (FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) indicate a pathogenic impact. Tools with inconclusive results (Foldetta, premPS, AlphaMissense‑Optimized) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the consensus of the majority of evidence points to a pathogenic effect for P715H. Based on the aggregate predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.243554Structured0.409757Uncertain0.9560.3620.000-10.523Likely Pathogenic0.906Likely PathogenicAmbiguous2.80Destabilizing0.00.28Likely Benign1.54Ambiguous0.56Ambiguous0.271Likely Benign-7.73Deleterious1.000Probably Damaging0.998Probably Damaging3.37Benign0.00Affected0.14130.36840-2-1.640.02
c.1241T>G
M414R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M414R has no ClinVar entry and is not reported in gnomAD. Functional prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Pathogenic.” High‑accuracy assessments further support a damaging outcome: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus remains likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. Overall, the preponderance of evidence indicates that M414R is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.081712Structured0.329108Uncertain0.9140.2170.000-13.404Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.17Ambiguous0.12.58Destabilizing1.88Ambiguous1.45Destabilizing0.525Likely Pathogenic-5.20Deleterious0.972Probably Damaging0.895Possibly Damaging3.38Benign0.03Affected0.15090.10370-1-6.424.99
c.1246C>A
L416I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L416I missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, and FATHMM. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Predictions that remain inconclusive are FoldX, Rosetta, AlphaMissense‑Default, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a benign prediction. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain. Overall, the preponderance of evidence points to a benign effect. This conclusion is not contradicted by any ClinVar annotation, as the variant has no existing ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.104810Structured0.336105Uncertain0.9350.2270.000-8.613Likely Pathogenic0.396AmbiguousLikely Benign0.57Ambiguous0.00.69Ambiguous0.63Ambiguous0.50Likely Benign0.127Likely Benign-1.28Neutral0.997Probably Damaging0.989Probably Damaging3.38Benign0.37Tolerated0.10730.3480220.70.00
c.1264G>C
E422Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E422Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, and FATHMM, while those that predict a pathogenic effect are SIFT, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool rates the variant as uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.067594Structured0.426709Uncertain0.9650.2550.000-9.460Likely Pathogenic0.926Likely PathogenicAmbiguous0.32Likely Benign0.00.21Likely Benign0.27Likely Benign-0.15Likely Benign0.208Likely Benign-2.26Neutral0.997Probably Damaging0.973Probably Damaging3.38Benign0.03Affected0.10450.4913220.0-0.98
c.1266G>C
E422D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E422D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM; pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. ESM1b is uncertain. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors pathogenic; whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the majority of tools (six benign vs five pathogenic) lean toward a benign effect, but the two most accurate predictors and the consensus vote indicate a pathogenic tendency. Thus, the variant is most likely benign based on the broader tool set, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.067594Structured0.426709Uncertain0.9650.2550.000-7.092In-Between0.969Likely PathogenicLikely Pathogenic0.39Likely Benign0.0-0.03Likely Benign0.18Likely Benign0.21Likely Benign0.199Likely Benign-2.76Deleterious0.995Probably Damaging0.960Probably Damaging3.38Benign0.07Tolerated0.16860.2864320.0-14.03
c.1266G>T
E422D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E422D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM; pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. ESM1b is uncertain. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors pathogenic; whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the majority of tools (six benign vs five pathogenic) lean toward a benign effect, but the two most accurate predictors and the consensus vote indicate a pathogenic tendency. Thus, the variant is most likely benign based on the broader tool set, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.067594Structured0.426709Uncertain0.9650.2550.000-7.092In-Between0.969Likely PathogenicLikely Pathogenic0.39Likely Benign0.0-0.03Likely Benign0.18Likely Benign0.21Likely Benign0.199Likely Benign-2.76Deleterious0.995Probably Damaging0.960Probably Damaging3.38Benign0.07Tolerated0.16860.2864320.0-14.03
c.1267T>G
Y423D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y423D is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: benign predictions are limited to FATHMM, while the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.088832Structured0.421885Uncertain0.9750.2420.000-13.279Likely Pathogenic0.993Likely PathogenicLikely Pathogenic4.67Destabilizing0.14.79Destabilizing4.73Destabilizing1.78Destabilizing0.553Likely Pathogenic-8.28Deleterious1.000Probably Damaging1.000Probably Damaging3.38Benign0.04Affected0.32620.0412-4-3-2.2-48.09
c.1268A>G
Y423C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y423C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM. The remaining tools—SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain (treated as unavailable), SGM‑Consensus as Likely Pathogenic, and Foldetta as Pathogenic. With the majority of evidence pointing to deleterious effects, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.088832Structured0.421885Uncertain0.9750.2420.000-9.003Likely Pathogenic0.935Likely PathogenicAmbiguous4.01Destabilizing0.14.49Destabilizing4.25Destabilizing1.84Destabilizing0.286Likely Benign-7.51Deleterious1.000Probably Damaging0.999Probably Damaging3.38Benign0.03Affected0.23810.10960-23.8-60.04
c.1278C>A
N426K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426K resides in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools give inconclusive results: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show that AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which is currently unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.394941Uncertain0.9590.2870.000-11.659Likely Pathogenic0.867Likely PathogenicAmbiguous0.03Likely Benign0.00.00Likely Benign0.02Likely Benign0.54Ambiguous0.197Likely Benign-3.86Deleterious0.998Probably Damaging0.978Probably Damaging3.38Benign0.12Tolerated0.19060.282210-0.414.07
c.1278C>G
N426K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N426K is located in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, SIFT, and FATHMM, while those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools report uncertainty: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show that AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect on protein stability. Overall, the majority of predictions lean toward pathogenicity, with a split in the most reliable methods. Therefore, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.394941Uncertain0.9590.2870.000-11.659Likely Pathogenic0.867Likely PathogenicAmbiguous0.03Likely Benign0.00.00Likely Benign0.02Likely Benign0.54Ambiguous0.197Likely Benign-3.86Deleterious0.998Probably Damaging0.978Probably Damaging3.38Benign0.12Tolerated0.19060.282210-0.414.07
c.1298C>G
A433G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A433G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that reach a consensus all indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all score the substitution as tolerated. No tool predicts pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Benign. The protein‑folding stability method Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result and is therefore treated as unavailable evidence. Overall, the collective predictions strongly suggest that the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.098513Structured0.352258Uncertain0.9380.3020.000-5.044Likely Benign0.107Likely BenignLikely Benign0.59Ambiguous0.01.21Ambiguous0.90Ambiguous0.70Ambiguous0.038Likely Benign-1.54Neutral0.035Benign0.014Benign3.38Benign0.15Tolerated0.16290.291910-2.2-14.03
c.1301T>A
V434D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V434D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign are SIFT and FATHMM; all other evaluated algorithms—including REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), AlphaMissense‑Default, and ESM1b—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized returns a pathogenic score; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among pathogenic predictors and the corroborating high‑accuracy tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.158265Structured0.342846Uncertain0.9540.3060.000-14.765Likely Pathogenic0.983Likely PathogenicLikely Pathogenic3.26Destabilizing0.03.33Destabilizing3.30Destabilizing1.78Destabilizing0.592Likely Pathogenic-5.18Deleterious1.000Probably Damaging1.000Probably Damaging3.38Benign0.13Tolerated0.13070.0741-2-3-7.715.96
c.1322T>A
V441D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V441D is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and Foldetta, whereas a majority of tools (SGM Consensus, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. FoldX and Rosetta are inconclusive, and AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show that the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, while Foldetta predicts benign stability. Overall, the balance of evidence leans toward pathogenicity, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.161087Structured0.259875Uncertain0.9180.2490.000-15.392Likely Pathogenic0.934Likely PathogenicAmbiguous-0.57Ambiguous0.10.56Ambiguous-0.01Likely Benign1.15Destabilizing0.308Likely Benign-6.07Deleterious1.000Probably Damaging0.959Probably Damaging3.38Benign0.10Tolerated0.12320.0698-2-3-7.715.96
c.1349C>A
A450E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A450E is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that classify the variant as benign include SIFT and FATHMM, whereas the majority of tools predict it to be pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. No predictions are inconclusive. Overall, the evidence strongly favors a pathogenic impact for A450E, which does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.000Uncertain 1-16.578Likely Pathogenic0.989Likely PathogenicLikely Pathogenic3.86Destabilizing0.25.23Destabilizing4.55Destabilizing1.59Destabilizing0.653Likely Pathogenic-4.67Deleterious0.999Probably Damaging0.992Probably Damaging3.38Benign0.07Tolerated3.37320.08230.16950-1-5.358.04240.1-82.60.00.00.70.0XXPotentially PathogenicThe methyl group of Ala450, located in an α helix (res. Asn440-Thr458), packs against hydrophobic residues in the inter-helix space (e.g., Leu692). In the variant simulations, the carboxylate group of the Glu450 side chain rotates outward, away from the hydrophobic niche, where it does not form any lasting salt bridges or H-bonds. Although the residue swap does not negatively affect the protein structure based on the simulations, it is possible that the introduction of the negatively charged residue adversely affects the folding process or tertiary assembly.
c.1436G>T
R479L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R479L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, FoldX, Rosetta, premPS, SIFT, FATHMM) and pathogenic predictions (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default). AlphaMissense‑Optimized is uncertain. High‑accuracy assessments give mixed results: AlphaMissense‑Optimized remains uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. No single metric dominates, and the overall evidence is balanced. Therefore, the variant’s pathogenicity is inconclusive; it is not contradicted by ClinVar status, which has no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.419256Uncertain0.8200.2490.000-11.118Likely Pathogenic0.832Likely PathogenicAmbiguous0.45Likely Benign0.10.12Likely Benign0.29Likely Benign0.39Likely Benign0.265Likely Benign-4.21Deleterious1.000Probably Damaging0.999Probably Damaging3.38Benign0.15Tolerated0.13260.3624-3-28.3-43.03
c.1456G>C
E486Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E486Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM, while those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, Foldetta (combining FoldX‑MD and Rosetta outputs) as benign, and AlphaMissense‑Optimized as uncertain. No prediction or stability result is missing or inconclusive beyond the stated uncertainty. Overall, the evidence is balanced, with an equal number of benign and pathogenic calls, and the high‑accuracy tools provide opposing conclusions. Thus, the variant is most likely benign based on the preponderance of benign predictions, and this assessment does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.196879Structured0.358545Uncertain0.8330.2450.125-10.549Likely Pathogenic0.953Likely PathogenicAmbiguous0.12Likely Benign0.10.00Likely Benign0.06Likely Benign0.24Likely Benign0.334Likely Benign-2.68Deleterious0.999Probably Damaging0.992Probably Damaging3.38Benign0.09Tolerated0.08880.5880220.0-0.98
c.1726T>C
C576R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant C576R is listed in ClinVar with an uncertain significance (ClinVar ID 2780076.0) and is not reported in gnomAD. Prediction tools that classify the variant as benign include only FATHMM. All other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized scores it pathogenic, the SGM‑Consensus (derived from the majority of high‑confidence predictors) is pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Taken together, the overwhelming majority of computational evidence indicates that C576R is likely pathogenic, a conclusion that is consistent with, but not in conflict with, the current ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.017684Uncertain0.9130.2450.000Conflicting 2-14.886Likely Pathogenic1.000Likely PathogenicLikely Pathogenic7.20Destabilizing1.04.09Destabilizing5.65Destabilizing1.64Destabilizing0.579Likely Pathogenic-10.88Deleterious0.999Probably Damaging0.996Probably Damaging3.38Benign0.00Affected3.37350.18870.1279-3-4-7.053.05
c.1726T>G
C576G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C576G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic predictions come from REVEL, FoldX (uncertain), Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a benign outcome. When high‑accuracy methods are considered, AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labels it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) also predicts pathogenicity. No prediction is inconclusive or missing. Consequently, the variant is most likely pathogenic based on the consensus of available computational evidence, and this assessment does not contradict any ClinVar annotation (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.017684Uncertain0.9130.2450.000-14.809Likely Pathogenic0.976Likely PathogenicLikely Pathogenic1.66Ambiguous0.02.53Destabilizing2.10Destabilizing1.67Destabilizing0.586Likely Pathogenic-10.96Deleterious1.000Probably Damaging1.000Probably Damaging3.38Benign0.00Affected0.32690.2574-3-3-2.9-46.09
c.1727G>A
C576Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C576Y is not reported in ClinVar and has no gnomAD allele. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, whereas SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default and AlphaMissense‑Optimized all classify the change as pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also indicates pathogenicity. No tool yields an inconclusive result. Based on the consensus of available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.017684Uncertain0.9130.2450.000-13.891Likely Pathogenic0.999Likely PathogenicLikely Pathogenic8.77Destabilizing0.53.90Destabilizing6.34Destabilizing0.63Ambiguous0.612Likely Pathogenic-9.98Deleterious0.999Probably Damaging0.996Probably Damaging3.38Benign0.00Affected0.13980.30090-2-3.860.04
c.1728C>G
C576W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C576W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, while the majority of other in silico predictors (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate a pathogenic impact; premPS is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the preponderance of pathogenic predictions and the absence of benign consensus, the variant is most likely pathogenic, with no contradiction to ClinVar status (which has no entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.017684Uncertain0.9130.2450.000-14.796Likely Pathogenic1.000Likely PathogenicLikely Pathogenic13.87Destabilizing1.55.46Destabilizing9.67Destabilizing0.60Ambiguous0.473Likely Benign-10.01Deleterious1.000Probably Damaging0.999Probably Damaging3.38Benign0.00Affected0.18940.3017-8-2-3.483.07
c.1816A>C
S606R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S606R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, and FATHMM, whereas a separate group predicts pathogenicity: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Tools with uncertain outcomes are Foldetta, premPS, and Rosetta. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta remains inconclusive. Overall, the majority of high‑confidence predictions and the consensus vote indicate a pathogenic effect. Because ClinVar contains no entry for this variant, there is no contradiction between the computational evidence and clinical annotation. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.191720Uncertain0.8750.2470.000-12.900Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.15Likely Benign0.41.80Ambiguous0.98Ambiguous0.82Ambiguous0.252Likely Benign-4.98Deleterious0.999Probably Damaging0.997Probably Damaging3.38Benign0.08Tolerated0.08190.27500-1-3.769.11
c.1818T>A
S606R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S606R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, and FATHMM, whereas a separate group predicts pathogenicity: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Tools with uncertain outcomes are Foldetta, premPS, and Rosetta. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta remains inconclusive. Overall, the majority of high‑confidence predictions and the consensus vote indicate a pathogenic effect. Because ClinVar contains no entry for this variant, there is no contradiction between the computational evidence and clinical annotation. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.191720Uncertain0.8750.2470.000-12.900Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.15Likely Benign0.41.80Ambiguous0.98Ambiguous0.82Ambiguous0.246Likely Benign-4.98Deleterious0.999Probably Damaging0.997Probably Damaging3.38Benign0.08Tolerated0.08190.27500-1-3.769.11
c.1818T>G
S606R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S606R is not reported in ClinVar or gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, SIFT, and FATHMM, whereas a majority predict pathogenicity: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta outputs, is uncertain. High‑accuracy methods confirm the pathogenic trend: AlphaMissense‑Optimized is pathogenic, SGM Consensus is Likely Pathogenic, and Foldetta remains uncertain. Overall, the evidence points to the variant being most likely pathogenic, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.191720Uncertain0.8750.2470.000-12.900Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.15Likely Benign0.41.80Ambiguous0.98Ambiguous0.82Ambiguous0.246Likely Benign-4.98Deleterious0.999Probably Damaging0.997Probably Damaging3.38Benign0.08Tolerated0.08190.27500-1-3.769.11
c.1962G>C
E654D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E654D missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Two tools give uncertain results: Rosetta and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the predictions are mixed, with a slight majority leaning toward benign, but the high‑accuracy tools conflict. The variant is most likely benign based on the aggregate predictions, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.026892Structured0.303029Uncertain0.9570.3110.000-10.454Likely Pathogenic0.886Likely PathogenicAmbiguous0.44Likely Benign0.00.52Ambiguous0.48Likely Benign0.29Likely Benign0.166Likely Benign-2.87Deleterious0.906Possibly Damaging0.429Benign3.38Benign0.11Tolerated0.16780.2583320.0-14.03
c.1962G>T
E654D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E654D has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are SGM Consensus, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show that AlphaMissense‑Optimized is uncertain (treated as unavailable), SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. No other folding‑stability results are available. Overall, the balance of evidence leans toward a benign interpretation, and this assessment does not contradict ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.026892Structured0.303029Uncertain0.9570.3110.000-10.454Likely Pathogenic0.886Likely PathogenicAmbiguous0.44Likely Benign0.00.52Ambiguous0.48Likely Benign0.29Likely Benign0.166Likely Benign-2.87Deleterious0.906Possibly Damaging0.429Benign3.38Benign0.11Tolerated0.16780.2583320.0-14.03
c.1973G>T
G658V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G658V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, polyPhen‑2 HumVar, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are PROVEAN and polyPhen‑2 HumDiv; Rosetta’s output is uncertain and therefore not used as evidence. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta) as Benign. Taken together, the majority of reliable predictors indicate a benign impact. Thus, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.029376Structured0.180299Uncertain0.9420.2510.000-6.815Likely Benign0.166Likely BenignLikely Benign-0.07Likely Benign0.0-0.71Ambiguous-0.39Likely Benign0.34Likely Benign0.117Likely Benign-3.23Deleterious0.841Possibly Damaging0.264Benign3.38Benign0.13Tolerated0.13370.3330-1-34.642.08
c.1976C>A
S659Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S659Y is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default; FoldX is uncertain and therefore not considered evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of individual predictors lean toward a benign impact, and there is no ClinVar entry to contradict this assessment. Thus, based on the available predictions, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.154597Uncertain0.9540.2830.000-10.832Likely Pathogenic0.600Likely PathogenicLikely Benign-0.64Ambiguous0.10.00Likely Benign-0.32Likely Benign0.29Likely Benign0.173Likely Benign-4.24Deleterious0.084Benign0.014Benign3.38Benign0.04Affected0.09930.5962-3-2-0.576.10
c.2023A>T
N675Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N675Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Tools with uncertain or inconclusive results are Rosetta, Foldetta, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of available predictions (six pathogenic vs. four benign) indicate that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.111024Uncertain0.5130.3330.000-9.981Likely Pathogenic0.553AmbiguousLikely Benign3.02Destabilizing1.3-0.81Ambiguous1.11Ambiguous0.19Likely Benign0.439Likely Benign-5.86Deleterious1.000Probably Damaging0.955Probably Damaging3.38Benign0.01Affected0.06030.6417-2-22.249.07
c.2027G>T
S676I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S676I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and ESM1b. FoldX, Rosetta, Foldetta, and AlphaMissense‑Default are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction, while Foldetta remains uncertain. Overall, the balance of evidence (five benign versus three pathogenic predictions) indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.209395Structured0.113632Uncertain0.5510.3380.125-10.165Likely Pathogenic0.383AmbiguousLikely Benign1.25Ambiguous0.31.12Ambiguous1.19Ambiguous0.14Likely Benign0.170Likely Benign-2.46Neutral0.801Possibly Damaging0.063Benign3.38Benign0.02Affected0.08790.5720-1-25.326.08
c.2102C>A
P701H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P701H missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Predictions that are uncertain or inconclusive are FoldX, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the balance of evidence favors a benign classification, and this conclusion does not contradict the ClinVar status, which contains no pathogenic assertion for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.404318Uncertain0.9180.3450.000-8.786Likely Pathogenic0.553AmbiguousLikely Benign1.40Ambiguous0.0-0.41Likely Benign0.50Ambiguous0.62Ambiguous0.141Likely Benign-2.12Neutral0.936Possibly Damaging0.539Possibly Damaging3.38Benign0.03Affected0.14950.34950-2-1.640.02
c.2107C>A
L703I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L703I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized, while those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and Rosetta. Predictions that are uncertain or inconclusive (FoldX, Foldetta, premPS, AlphaMissense‑Default) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of high‑confidence tools predict a benign impact, and this conclusion does not contradict the ClinVar status, which has no pathogenic classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.144935Structured0.388282Uncertain0.9290.3530.000-9.332Likely Pathogenic0.345AmbiguousLikely Benign1.44Ambiguous0.12.21Destabilizing1.83Ambiguous0.61Ambiguous0.108Likely Benign-1.50Neutral0.982Probably Damaging0.758Possibly Damaging3.38Benign0.00Affected0.09090.3079220.70.00
c.2114A>C
K705T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K705T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain calls are made by FoldX and AlphaMissense‑Optimized. High‑accuracy assessments indicate that the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts a pathogenic effect, while Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign outcome. Overall, the balance of evidence leans toward a pathogenic interpretation, and this assessment does not conflict with ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.379324Uncertain0.9220.3640.000-8.617Likely Pathogenic0.826Likely PathogenicAmbiguous0.60Ambiguous0.00.04Likely Benign0.32Likely Benign0.17Likely Benign0.272Likely Benign-4.05Deleterious0.995Probably Damaging0.991Probably Damaging3.38Benign0.02Affected0.12990.26120-13.2-27.07
c.2129A>T
K710M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K710M missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM Consensus as Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of individual predictors (seven pathogenic vs. six benign) and the SGM Consensus lean toward a pathogenic interpretation, while the high‑accuracy Foldetta result is contradictory. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.370438Uncertain0.9490.3680.000-13.081Likely Pathogenic0.822Likely PathogenicAmbiguous-0.13Likely Benign0.00.28Likely Benign0.08Likely Benign0.20Likely Benign0.298Likely Benign-5.61Deleterious1.000Probably Damaging1.000Probably Damaging3.38Benign0.00Affected0.08350.34440-15.83.02
c.2149C>G
L717V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L717V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Two tools predict a damaging effect: polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Stability‑based methods (FoldX, Rosetta, Foldetta) return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta as inconclusive. Taken together, the majority of evidence points to a benign impact. This conclusion is consistent with the absence of a ClinVar assertion, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.239899Structured0.429342Uncertain0.9690.3970.000-6.164Likely Benign0.308Likely BenignLikely Benign1.53Ambiguous0.01.25Ambiguous1.39Ambiguous0.09Likely Benign0.119Likely Benign-0.25Neutral0.995Probably Damaging0.970Probably Damaging3.38Benign0.51Tolerated0.12260.2489210.4-14.03
c.2186A>G
N729S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N729S is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). No tool in the dataset predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus also as benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.426547Uncertain0.6510.5830.625Uncertain 1-1.578Likely Benign0.066Likely BenignLikely Benign0.14Likely Benign0.11.34Ambiguous0.74Ambiguous-0.36Likely Benign0.063Likely Benign-0.42Neutral0.221Benign0.027Benign3.38Benign0.93Tolerated3.5970.34110.4854112.7-27.03
c.394T>G
F132V
2D
AIThe SynGAP1 missense variant F132V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that agree on a pathogenic effect are PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized; ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of high‑confidence predictions indicate a pathogenic effect, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.450668Structured0.727897Binding0.3450.8920.250-7.637In-Between0.979Likely PathogenicLikely Pathogenic0.328Likely Benign-3.86Deleterious0.084Benign0.034Benign3.38Benign0.00Affected0.23490.1725-1-11.4-48.04
c.1247T>A
L416Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L416Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all predict benign. Only two tools, polyPhen‑2 (HumDiv and HumVar), predict a pathogenic outcome. Stability‑based methods (FoldX, Rosetta, Foldetta, premPS) are inconclusive. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, the SGM‑Consensus is benign, and Foldetta remains uncertain. Overall, the evidence strongly supports a benign classification for this variant, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.104810Structured0.336105Uncertain0.9350.2270.000-6.445Likely Benign0.234Likely BenignLikely Benign1.17Ambiguous0.10.54Ambiguous0.86Ambiguous0.88Ambiguous0.187Likely Benign-1.07Neutral1.000Probably Damaging1.000Probably Damaging3.39Benign0.46Tolerated0.12810.0860-2-2-7.314.97
c.1261G>C
A421P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A421P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL, FATHMM, and polyPhen‑2 HumVar, whereas pathogenic predictions are made by FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus also indicates Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, reports a pathogenic effect. Taken together, the overwhelming majority of evidence points to a pathogenic impact for A421P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-13.126Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.51Destabilizing0.28.77Destabilizing6.64Destabilizing1.17Destabilizing0.371Likely Benign-4.31Deleterious0.855Possibly Damaging0.420Benign3.39Benign0.04Affected0.19630.33431-1-3.426.04
c.1264G>A
E422K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E422K missense variant is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split opinion: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM, while pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus also indicates Likely Pathogenic, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign effect. Overall, the balance of evidence leans toward pathogenicity, and this assessment does not contradict any ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.426709Uncertain0.9650.2550.000-13.042Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.30Likely Benign0.00.10Likely Benign0.20Likely Benign0.32Likely Benign0.346Likely Benign-3.52Deleterious0.998Probably Damaging0.975Probably Damaging3.39Benign0.04Affected0.19950.512901-0.4-0.94
c.1267T>C
Y423H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 Y423H missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect comprise FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and AlphaMissense‑Default. AlphaMissense‑Optimized is reported as uncertain. High‑accuracy assessments show that AlphaMissense‑Optimized is inconclusive, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie and therefore inconclusive, while Foldetta predicts a pathogenic impact. Overall, the majority of evaluated tools (10 pathogenic vs. 4 benign) support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.088832Structured0.421885Uncertain0.9750.2420.000-6.638Likely Benign0.873Likely PathogenicAmbiguous3.09Destabilizing0.12.44Destabilizing2.77Destabilizing1.66Destabilizing0.257Likely Benign-3.88Deleterious1.000Probably Damaging1.000Probably Damaging3.39Benign0.61Tolerated0.16030.035202-1.9-26.03
c.1271T>C
V424A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 V424A is not reported in ClinVar (ClinVar status: not reported) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on benign impact are REVEL and FATHMM, whereas the remaining tools—SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as unavailable, SGM‑Consensus as likely pathogenic, and Foldetta as pathogenic. Based on the collective evidence, the variant is most likely pathogenic; this conclusion is not contradicted by the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.050641Structured0.411431Uncertain0.9730.2480.000-9.665Likely Pathogenic0.904Likely PathogenicAmbiguous2.31Destabilizing0.12.54Destabilizing2.43Destabilizing2.10Destabilizing0.245Likely Benign-3.45Deleterious0.997Probably Damaging0.961Probably Damaging3.39Benign0.01Affected0.21050.135500-2.4-28.05
c.1283A>G
Y428C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y428C is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM. The remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus—consistently predict a pathogenic impact. High‑accuracy assessments show the SGM‑Consensus result as “Likely Pathogenic,” Foldetta predicts a destabilizing, pathogenic effect, while AlphaMissense‑Optimized is uncertain. No prediction or stability result is missing; the only inconclusive outcome is the AlphaMissense‑Optimized score. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar status exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.000-11.312Likely Pathogenic0.852Likely PathogenicAmbiguous2.82Destabilizing0.02.99Destabilizing2.91Destabilizing2.02Destabilizing0.454Likely Benign-8.59Deleterious1.000Probably Damaging0.999Probably Damaging3.39Benign0.01Affected0.33220.22200-23.8-60.04
c.1301T>G
V434G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V434G has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are SIFT and FATHMM, while the remaining tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default) all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as pathogenic. Taken together, the overwhelming majority of evidence indicates a deleterious effect. Therefore, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.158265Structured0.342846Uncertain0.9540.3060.000-12.519Likely Pathogenic0.809Likely PathogenicAmbiguous3.08Destabilizing0.04.37Destabilizing3.73Destabilizing1.91Destabilizing0.564Likely Pathogenic-5.16Deleterious1.000Probably Damaging1.000Probably Damaging3.39Benign0.07Tolerated0.17580.2408-1-3-4.6-42.08
c.1324A>C
K442Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K442Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.170161Structured0.255766Uncertain0.9120.2250.000-10.410Likely Pathogenic0.562AmbiguousLikely Benign0.05Likely Benign0.10.03Likely Benign0.04Likely Benign0.25Likely Benign0.268Likely Benign-3.10Deleterious0.998Probably Damaging0.995Probably Damaging3.39Benign0.18Tolerated0.33530.1014110.4-0.04
c.1332G>C
K444N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K444N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the majority of tools (FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic impact. The high‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic; Foldetta’s stability assessment is uncertain and therefore not used as evidence. Overall, the preponderance of evidence points to a pathogenic effect for K444N. This conclusion is not contradicted by ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.262172Uncertain0.9550.2130.000-14.797Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.41Destabilizing0.01.52Ambiguous1.97Ambiguous1.18Destabilizing0.286Likely Benign-4.77Deleterious1.000Probably Damaging0.996Probably Damaging3.39Benign0.01Affected0.32820.1213100.4-14.07
c.1332G>T
K444N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K444N is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM. Tools that predict a pathogenic effect include FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain predictions come from Rosetta and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact. There is no ClinVar annotation to contradict this assessment, so the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.262172Uncertain0.9550.2130.000-14.797Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.41Destabilizing0.01.52Ambiguous1.97Ambiguous1.18Destabilizing0.286Likely Benign-4.77Deleterious1.000Probably Damaging0.996Probably Damaging3.39Benign0.01Affected0.32820.1213100.4-14.07
c.1334A>G
E445G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E445G missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, while the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. Predictions that are inconclusive or uncertain are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E445G, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.270205Uncertain0.9470.2280.000-12.294Likely Pathogenic0.823Likely PathogenicAmbiguous0.80Ambiguous0.10.79Ambiguous0.80Ambiguous0.69Ambiguous0.523Likely Pathogenic-6.68Deleterious1.000Probably Damaging0.993Probably Damaging3.39Benign0.01Affected0.24460.42020-23.1-72.06
c.1921T>A
S641T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S641T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all score the variant as benign. Rosetta also predicts a benign outcome, while FoldX and Foldetta are inconclusive (marked “Uncertain”). No tool predicts pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; Foldetta remains uncertain. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.125101Structured0.157322Uncertain0.7860.2700.000-6.637Likely Benign0.087Likely BenignLikely Benign0.83Ambiguous0.30.41Likely Benign0.62Ambiguous0.13Likely Benign0.043Likely Benign-1.50Neutral0.008Benign0.003Benign3.39Benign0.09Tolerated0.15050.5888110.114.03
c.1922C>T
S641L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S641L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields an equal split of benign and pathogenic calls. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict any ClinVar annotation, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.125101Structured0.157322Uncertain0.7860.2700.000-9.501Likely Pathogenic0.237Likely BenignLikely Benign0.33Likely Benign0.3-0.14Likely Benign0.10Likely Benign0.32Likely Benign0.103Likely Benign-4.33Deleterious0.115Benign0.014Benign3.39Benign0.07Tolerated0.12480.5376-3-24.626.08
c.1951G>A
E651K
2D
AIThe SynGAP1 E651K missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into two groups: benign calls (REVEL, FoldX, premPS, polyPhen‑2 HumVar, SIFT, FATHMM) and pathogenic calls (PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default). Three tools (Rosetta, Foldetta, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized is uncertain; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels the variant as likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, remains uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.088832Structured0.365409Uncertain0.9550.3400.000-8.714Likely Pathogenic0.818Likely PathogenicAmbiguous0.11Likely Benign0.41.15Ambiguous0.63Ambiguous0.08Likely Benign0.211Likely Benign-2.92Deleterious0.921Possibly Damaging0.303Benign3.39Benign0.17Tolerated0.27680.580301-0.4-0.94
c.1975T>C
S659P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S659P is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are SGM‑Consensus, Rosetta, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Tools with uncertain or inconclusive results—FoldX, premPS, and Foldetta—are treated as unavailable. High‑accuracy methods give mixed signals: AlphaMissense‑Optimized reports a benign change, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta’s stability assessment is uncertain. Overall, the balance of evidence leans toward a pathogenic effect, but the presence of a strong benign prediction from AlphaMissense‑Optimized and the lack of ClinVar annotation means the variant’s clinical significance remains uncertain and does not contradict existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.154597Uncertain0.9540.2830.000-10.461Likely Pathogenic0.609Likely PathogenicLikely Benign-0.73Ambiguous0.32.98Destabilizing1.13Ambiguous0.73Ambiguous0.224Likely Benign-3.26Deleterious0.932Possibly Damaging0.245Benign3.39Benign0.18Tolerated0.22070.55531-1-0.810.04
c.1976C>T
S659F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S659F is listed in ClinVar with an uncertain significance and is absent from gnomAD. Functional prediction tools that provide definitive calls cluster into two groups: benign predictions come from REVEL, Rosetta, premPS, polyPhen2_HumVar, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from PROVEAN, polyPhen2_HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, SGM Consensus predicts pathogenic, and Foldetta (which integrates FoldX‑MD and Rosetta outputs) yields an uncertain result and is therefore unavailable. Overall, the majority of reliable tools favor a pathogenic effect. Thus, the variant is most likely pathogenic, a conclusion that does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.154597Uncertain0.9540.2830.000Uncertain 1-10.925Likely Pathogenic0.662Likely PathogenicLikely Benign-0.81Ambiguous0.1-0.25Likely Benign-0.53Ambiguous0.32Likely Benign0.194Likely Benign-4.59Deleterious0.806Possibly Damaging0.171Benign3.39Benign0.05Affected3.38280.08970.5828-3-23.660.10221.3-61.20.00.00.60.4XPotentially BenignIn the WT simulations, the hydroxyl group of Ser659, located in a kink in the middle of the long α-helix (res. Ser641-Glu666), forms a hydrogen bond with the carboxylate group of Glu656. However, the phenol ring of the Phe659 side chain cannot form a similar hydrogen bond. Instead, it interacts with the hydrophobic isopropyl side chain of Val555 from the opposing α-helix (res. Ala533-Val560). This residue swap may therefore cause issues during protein folding.
c.2015C>T
T672M
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T672M is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33441274‑C‑T). Prediction tools that classify the variant as benign include REVEL, FoldX, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. Rosetta and Foldetta report uncertain results, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while SGM Consensus and Foldetta remain unavailable. Overall, the balance of evidence favors a benign effect, and this conclusion does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.116183Structured0.102069Uncertain0.5860.3620.000Conflicting 36-33441274-C-T191.18e-5-9.472Likely Pathogenic0.174Likely BenignLikely Benign0.31Likely Benign0.41.52Ambiguous0.92Ambiguous0.41Likely Benign0.127Likely Benign-4.34Deleterious0.993Probably Damaging0.520Possibly Damaging3.39Benign0.00Affected3.40250.13320.6677-1-12.630.09231.9-52.91.10.10.50.0XXPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. Met672 can only form a hydrogen bond with the amino group of the Lys566 side chain via its backbone carbonyl group. Nevertheless, the Lys566-Glu666 salt bridge forms intermittently. This is possible because Asn669 keeps the carboxylate group of Glu666 in the vicinity through hydrogen bonding, and the hydrophobic side chain of Met stays mostly rotated away from the salt bridge. Consequently, no drastic disruption of the hydrogen-bond network that keeps the loop close to the helices occurs in the variant simulations.
c.2023A>C
N675H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N675H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Predictions that are inconclusive are Foldetta and premPS. High‑accuracy methods give a benign result from AlphaMissense‑Optimized, a benign consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and an uncertain result from Foldetta. Taken together, the majority of evidence points to a benign impact, and this does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.129801Structured0.111024Uncertain0.5130.3330.000-5.593Likely Benign0.254Likely BenignLikely Benign3.06Destabilizing1.1-0.16Likely Benign1.45Ambiguous0.56Ambiguous0.186Likely Benign-2.62Deleterious0.999Probably Damaging0.929Probably Damaging3.39Benign0.04Affected0.14780.7478210.323.04
c.2026A>G
S676G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S676G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and SIFT. Two tools (ESM1b and premPS) returned uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, and Foldetta predicts a benign stability change. No prediction or folding result is missing or inconclusive. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, as the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.209395Structured0.113632Uncertain0.5510.3380.125-7.249In-Between0.117Likely BenignLikely Benign0.38Likely Benign0.10.25Likely Benign0.32Likely Benign0.67Ambiguous0.132Likely Benign-2.74Deleterious0.855Possibly Damaging0.100Benign3.39Benign0.02Affected0.27720.4342100.4-30.03
c.2050G>A
D684N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D684N is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM, whereas the majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM‑Consensus also reports it as likely pathogenic, and the Foldetta stability analysis is inconclusive. Protein‑stability predictors FoldX and Rosetta likewise return uncertain results. Overall, the preponderance of evidence points to a pathogenic effect, which contradicts the current ClinVar designation of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.153798Uncertain0.8700.2820.000Uncertain 1-13.155Likely Pathogenic0.985Likely PathogenicLikely Pathogenic1.47Ambiguous0.81.76Ambiguous1.62Ambiguous0.37Likely Benign0.382Likely Benign-4.99Deleterious0.999Probably Damaging0.746Possibly Damaging3.39Benign0.01Affected0.11570.6373210.0-0.98
c.2069C>A
S690Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S690Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM, whereas the majority of other in silico predictors (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the variant as pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus confirms a Likely Pathogenic status, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic effect. Based on the preponderance of pathogenic predictions and the absence of benign consensus, the variant is most likely pathogenic, with no contradiction to ClinVar status (which has no entry for this variant).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.055536Structured0.247926Uncertain0.9440.2530.000-14.051Likely Pathogenic0.989Likely PathogenicLikely Pathogenic11.45Destabilizing3.13.02Destabilizing7.24Destabilizing0.16Likely Benign0.381Likely Benign-5.76Deleterious0.999Probably Damaging0.935Probably Damaging3.39Benign0.00Affected0.05120.4643-3-2-0.576.10
c.2069C>T
S690F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S690F is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of algorithms predict a pathogenic outcome: FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). The high‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No predictions are inconclusive or missing. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.055536Structured0.247926Uncertain0.9440.2530.000-14.325Likely Pathogenic0.992Likely PathogenicLikely Pathogenic9.85Destabilizing2.42.17Destabilizing6.01Destabilizing0.51Ambiguous0.384Likely Benign-5.76Deleterious0.999Probably Damaging0.935Probably Damaging3.39Benign0.00Affected0.04980.4800-3-23.660.10
c.2111G>A
S704N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704N is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33441370‑G‑A). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while premPS and AlphaMissense‑Default are inconclusive. High‑accuracy assessments reinforce the benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”; and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Overall, the majority of evidence points to a benign effect, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.096677Structured0.383620Uncertain0.9280.3630.000Conflicting 46-33441370-G-A271.67e-5-5.917Likely Benign0.421AmbiguousLikely Benign0.48Likely Benign0.1-0.12Likely Benign0.18Likely Benign0.54Ambiguous0.058Likely Benign-0.49Neutral0.771Possibly Damaging0.275Benign3.39Benign0.08Tolerated3.47100.09110.375411-2.727.03233.2-29.1-0.10.0-0.10.1XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. However, in the variant simulations, the carboxamide side chain of Asn704 achieves more lasting and numerous hydrogen-bonding interactions with the residues at the helix end, such as Glu706, Ala707, and Leu708. Consequently, the residue swap could strengthen the α-helix secondary structure integrity at the helix end, which could have either positive or negative effects on its function.
c.2120C>A
A707D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A707D is not reported in ClinVar (status: None) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect are SGM‑Consensus, AlphaMissense‑Default, ESM1b, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Two tools give uncertain results: premPS and Rosetta. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta predicts benign. Overall, the majority of evidence points to a pathogenic impact, and this assessment does not contradict any ClinVar classification because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.371229Uncertain0.9270.3650.000-9.160Likely Pathogenic0.772Likely PathogenicLikely Benign0.29Likely Benign0.0-0.61Ambiguous-0.16Likely Benign0.89Ambiguous0.225Likely Benign-3.16Deleterious0.996Probably Damaging0.983Probably Damaging3.39Benign0.02Affected0.13760.17410-2-5.344.01
c.2123T>C
L708P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L708P is not reported in ClinVar and is absent from gnomAD. Consensus among most in‑silico predictors is strongly pathogenic: FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a deleterious effect. Only REVEL and FATHMM predict a benign outcome, while AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is inconclusive, SGM Consensus reports “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic change. Taken together, the preponderance of evidence points to a pathogenic impact for L708P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.250310Structured0.365875Uncertain0.9310.3780.000-10.268Likely Pathogenic0.932Likely PathogenicAmbiguous4.29Destabilizing0.16.43Destabilizing5.36Destabilizing1.62Destabilizing0.298Likely Benign-4.47Deleterious1.000Probably Damaging0.989Probably Damaging3.39Benign0.04Affected0.28000.0825-3-3-5.4-16.04
c.2128A>C
K710Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K710Q missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. The high‑accuracy AlphaMissense‑Optimized score classifies the variant as benign, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (uncertain), ESM1b (pathogenic), FATHMM (benign), and PROVEAN (pathogenic)—indicates pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, also predicts a benign effect. Overall, the majority of evidence points to a benign impact, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.321458Structured0.370438Uncertain0.9490.3680.000-8.920Likely Pathogenic0.372AmbiguousLikely Benign0.12Likely Benign0.00.02Likely Benign0.07Likely Benign0.49Likely Benign0.183Likely Benign-3.58Deleterious0.999Probably Damaging0.999Probably Damaging3.39Benign0.01Affected0.30430.1214110.4-0.04
c.2144C>T
P715L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P715L is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. FoldX and premPS give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Because the majority of consensus and individual predictors indicate pathogenicity, the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar, which contains no entry for P715L.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.243554Structured0.409757Uncertain0.9560.3620.000-12.207Likely Pathogenic0.764Likely PathogenicLikely Benign1.43Ambiguous0.10.06Likely Benign0.75Ambiguous0.58Ambiguous0.318Likely Benign-9.10Deleterious1.000Probably Damaging0.998Probably Damaging3.39Benign0.01Affected0.19440.5105-3-35.416.04
c.2168C>T
T723I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T723I is listed in ClinVar as Benign (ClinVar ID 436924.0) and is observed in gnomAD (variant ID 6‑33441633‑C‑T). Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only SIFT classifies the change as pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports “Likely Benign.” High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, the SGM Consensus is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates a benign impact. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion is consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.476583Structured0.458243Uncertain0.9450.4470.375Likely Benign 16-33441633-C-T21.24e-6-2.591Likely Benign0.120Likely BenignLikely Benign-0.39Likely Benign0.0-0.20Likely Benign-0.30Likely Benign0.26Likely Benign0.045Likely Benign-2.09Neutral0.088Benign0.030Benign3.39Benign0.03Affected3.5080.07080.58030-15.212.05252.3-31.60.00.0-0.20.2XUncertainThe hydroxyl group of Thr723, located on the outer surface of an α-helix (res. Leu714-Arg726), continuously forms hydrogen bonds with the backbone carbonyl of Asn719 in the WT simulations, potentially lowering the stability of the α-helix. In the variant simulations, the sec-butyl side chain of Ile723 cannot form any hydrogen bonds, which, in theory, could increase the helix stability. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2263A>C
M755L
2D
AIThe SynGAP1 missense variant M755L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of all available predictions is benign, and this conclusion does not contradict any ClinVar annotation (none present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.490133Structured0.783855Binding0.3360.8730.375-1.298Likely Benign0.084Likely BenignLikely Benign0.067Likely Benign0.03Neutral0.000Benign0.001Benign3.39Benign0.22Tolerated0.11670.3311421.9-18.03
c.2263A>T
M755L
2D
AIThe SynGAP1 missense variant M755L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify it as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a neutral effect. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign outcome. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized reports a benign effect, and the SGM‑Consensus (majority vote) yields a likely benign classification. Foldetta results are not available, so they do not influence the assessment. Overall, the computational evidence strongly supports a benign interpretation of M755L, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.490133Structured0.783855Binding0.3360.8730.375-1.298Likely Benign0.084Likely BenignLikely Benign0.067Likely Benign0.03Neutral0.000Benign0.001Benign3.39Benign0.22Tolerated0.11670.3311421.9-18.03
c.395T>A
F132Y
2D
AIThe SynGAP1 missense variant F132Y is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta results are unavailable. Overall, the majority of available predictions (five benign vs three pathogenic) suggest a benign impact. This consensus does not contradict any ClinVar annotation, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.450668Structured0.727897Binding0.3450.8920.250-8.220Likely Pathogenic0.839Likely PathogenicAmbiguous0.165Likely Benign-1.98Neutral0.272Benign0.126Benign3.39Benign0.00Affected0.16350.152673-4.116.00
c.592C>T
L198F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L198F has no ClinVar entry and is absent from gnomAD. Functional prediction tools split into two consensus groups: benign predictions come from REVEL, Rosetta, premPS, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments are mixed: AlphaMissense‑Optimized and Foldetta report uncertain results, whereas the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic effect. No evidence from ClinVar contradicts these findings. Overall, the preponderance of pathogenic predictions and the SGM‑Consensus designation suggest that the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.444081Structured0.431715Uncertain0.5720.4850.125-10.602Likely Pathogenic0.930Likely PathogenicAmbiguous1.03Ambiguous0.20.27Likely Benign0.65Ambiguous0.00Likely Benign0.282Likely Benign-3.33Deleterious0.997Probably Damaging0.916Probably Damaging3.39Benign0.00Affected0.05860.311220-1.034.02
c.1241T>A
M414K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M414K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. FoldX and Foldetta provide uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta is unavailable. Based on the overwhelming agreement among the majority of prediction tools and the high‑accuracy methods, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.081712Structured0.329108Uncertain0.9140.2170.000-13.537Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.18Ambiguous0.12.39Destabilizing1.79Ambiguous1.50Destabilizing0.503Likely Pathogenic-5.03Deleterious0.942Possibly Damaging0.860Possibly Damaging3.40Benign0.04Affected0.12990.08880-1-5.8-3.02
c.1267T>A
Y423N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y423N is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include SIFT and FATHMM, whereas the remaining tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Based on the overwhelming majority of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.088832Structured0.421885Uncertain0.9750.2420.000-10.937Likely Pathogenic0.963Likely PathogenicLikely Pathogenic3.97Destabilizing0.14.08Destabilizing4.03Destabilizing2.07Destabilizing0.501Likely Pathogenic-7.47Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.06Tolerated0.14050.0412-2-2-2.2-49.07
c.1268A>C
Y423S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y423S is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, SIFT, and FATHMM, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Taken together, the preponderance of evidence points to a pathogenic effect for Y423S. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.088832Structured0.421885Uncertain0.9750.2420.000-10.847Likely Pathogenic0.985Likely PathogenicLikely Pathogenic4.28Destabilizing0.14.78Destabilizing4.53Destabilizing1.95Destabilizing0.345Likely Benign-7.39Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.09Tolerated0.31520.1259-3-20.5-76.10
c.1270G>T
V424F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant V424F is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The remaining tools (FoldX, Foldetta, premPS, AlphaMissense‑Optimized) yield uncertain or unavailable results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.050641Structured0.411431Uncertain0.9730.2480.000-10.947Likely Pathogenic0.939Likely PathogenicAmbiguous1.99Ambiguous0.3-0.37Likely Benign0.81Ambiguous0.55Ambiguous0.275Likely Benign-3.66Deleterious0.995Probably Damaging0.775Possibly Damaging3.40Benign0.01Affected0.08160.2094-1-1-1.448.04
c.1282T>C
Y428H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y428H is not reported in ClinVar but is present in gnomAD (ID 6‑33438187‑T‑C). Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM Consensus score (Likely Pathogenic) all suggest a deleterious impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Consequently, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.0006-33438187-T-C16.19e-7-8.566Likely Pathogenic0.961Likely PathogenicLikely Pathogenic3.18Destabilizing0.12.20Destabilizing2.69Destabilizing1.80Destabilizing0.458Likely Benign-4.77Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.04Affected3.38250.26850.071120-1.9-26.03
c.1318A>C
N440H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N440H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Pathogenicity is suggested only by polyPhen‑2 HumDiv and ESM1b, while FoldX, Rosetta, and Foldetta provide uncertain or inconclusive results. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” and Foldetta’s stability prediction is unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.191378Structured0.267204Uncertain0.9290.2450.000-8.064Likely Pathogenic0.226Likely BenignLikely Benign1.12Ambiguous0.10.83Ambiguous0.98Ambiguous0.00Likely Benign0.140Likely Benign-2.48Neutral0.835Possibly Damaging0.217Benign3.40Benign0.19Tolerated0.09350.3270210.323.04
c.1327G>C
G443R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G443R has no ClinVar entry and is not reported in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM all classify it as benign. Only two tools predict pathogenicity: polyPhen‑2 HumDiv and AlphaMissense‑Default. Predictions that are inconclusive—FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized—are treated as unavailable. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign outcome. High‑accuracy assessments are: AlphaMissense‑Optimized (uncertain), SGM Consensus (likely benign), and Foldetta (uncertain). Overall, the preponderance of evidence points to a benign impact for G443R, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.250310Structured0.258623Uncertain0.9350.2060.000-6.954Likely Benign0.886Likely PathogenicAmbiguous-0.88Ambiguous0.3-1.19Ambiguous-1.04Ambiguous0.28Likely Benign0.132Likely Benign-1.49Neutral0.832Possibly Damaging0.286Benign3.40Benign0.21Tolerated0.09340.3197-3-2-4.199.14
c.1330A>G
K444E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K444E missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated predictors—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a pathogenic effect. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.262172Uncertain0.9550.2130.000-15.571Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.99Destabilizing0.13.75Destabilizing3.37Destabilizing1.10Destabilizing0.437Likely Benign-3.82Deleterious0.997Probably Damaging0.981Probably Damaging3.40Benign0.01Affected0.34860.0793010.40.94
c.1333G>C
E445Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E445Q is reported in gnomAD (ID 6‑33438238‑G‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions (REVEL, FoldX, Rosetta, SIFT, FATHMM) and pathogenic predictions (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, ESM1b). Two tools remain inconclusive (premPS, AlphaMissense‑Optimized). High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic effect; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign impact. Overall, the balance of evidence tilts toward pathogenicity, with the high‑accuracy consensus supporting this view, and there is no conflict with ClinVar status because the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.270205Uncertain0.9470.2280.0006-33438238-G-C16.19e-7-12.430Likely Pathogenic0.790Likely PathogenicAmbiguous-0.03Likely Benign0.00.20Likely Benign0.09Likely Benign0.70Ambiguous0.240Likely Benign-2.86Deleterious0.987Probably Damaging0.946Probably Damaging3.40Benign0.12Tolerated3.38310.07870.5018220.0-0.98
c.1345A>C
S449R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S449R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, AlphaMissense‑Optimized, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are SGM Consensus, PROVEAN, polyPhen‑2 HumDiv, AlphaMissense‑Default, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) classifying it as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) yielding an uncertain stability change. No folding‑stability prediction is definitive. Overall, the majority of tools predict a benign outcome, and this does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.301437Uncertain0.9580.2510.000-8.486Likely Pathogenic0.677Likely PathogenicLikely Benign-0.69Ambiguous0.2-1.33Ambiguous-1.01Ambiguous0.50Likely Benign0.145Likely Benign-3.36Deleterious0.950Possibly Damaging0.214Benign3.40Benign0.18Tolerated0.07620.32500-1-3.769.11
c.1346G>T
S449I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S449I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, and polyPhen2_HumVar. Those that predict a pathogenic effect are PROVEAN, polyPhen2_HumDiv, and ESM1b. Rosetta and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs. 2 pathogenic). Foldetta also remains uncertain. Overall, the majority of evidence (7 benign vs. 3 pathogenic) points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.254060Structured0.301437Uncertain0.9580.2510.000-9.549Likely Pathogenic0.310Likely BenignLikely Benign0.04Likely Benign0.1-1.39Ambiguous-0.68Ambiguous0.13Likely Benign0.105Likely Benign-3.23Deleterious0.559Possibly Damaging0.044Benign3.40Benign0.14Tolerated0.07560.5006-1-25.326.08
c.1347T>A
S449R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S449R is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, SIFT, FATHMM, and polyPhen‑2 HumVar, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments provide a mixed picture: AlphaMissense‑Optimized predicts a benign effect, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an inconclusive result. FoldX and Rosetta predictions are also uncertain and are treated as unavailable. Overall, the evidence is balanced, with an equal number of benign and pathogenic calls, and the high‑accuracy tools do not converge on a single conclusion. Consequently, the variant is most likely pathogenic based on the preponderance of pathogenic predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.301437Uncertain0.9580.2510.000-8.486Likely Pathogenic0.677Likely PathogenicLikely Benign-0.69Ambiguous0.2-1.33Ambiguous-1.01Ambiguous0.50Likely Benign0.168Likely Benign-3.36Deleterious0.950Possibly Damaging0.214Benign3.40Benign0.18Tolerated0.07620.32500-1-3.769.11
c.1347T>G
S449R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S449R is not reported in ClinVar (ClinVar status: None) and has no entry in gnomAD (gnomAD ID: None). Prediction tools that classify the variant as benign include REVEL, premPS, SIFT, FATHMM, and polyPhen‑2 HumVar. Those that predict pathogenicity are SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized predicting a benign effect, while the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta’s stability prediction is uncertain and therefore treated as unavailable. Overall, the predictions are split, with an equal number of benign and pathogenic calls and conflicting high‑accuracy results. Consequently, the variant’s impact remains inconclusive, and there is no contradiction with the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.301437Uncertain0.9580.2510.000-8.486Likely Pathogenic0.677Likely PathogenicLikely Benign-0.69Ambiguous0.2-1.33Ambiguous-1.01Ambiguous0.50Likely Benign0.167Likely Benign-3.36Deleterious0.950Possibly Damaging0.214Benign3.40Benign0.18Tolerated0.07620.32500-1-3.769.11
c.1348G>A
A450T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A450T missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Because the majority of conventional tools lean toward benign and no ClinVar evidence contradicts this, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.321458Structured0.306281Uncertain0.9630.2340.000-9.149Likely Pathogenic0.380AmbiguousLikely Benign0.50Ambiguous0.20.98Ambiguous0.74Ambiguous0.81Ambiguous0.233Likely Benign-3.35Deleterious0.996Probably Damaging0.973Probably Damaging3.40Benign0.06Tolerated0.09430.590210-2.530.03
c.1348G>C
A450P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A450P missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, SIFT, and FATHMM, whereas the majority of other in silico predictors (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM Consensus score all classify the change as pathogenic. The high‑accuracy predictors give consistent pathogenic results: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. premPS remains uncertain. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, which is consistent with the absence of a benign ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.000-15.378Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.75Destabilizing0.38.32Destabilizing5.54Destabilizing0.72Ambiguous0.459Likely Benign-4.67Deleterious0.999Probably Damaging0.992Probably Damaging3.40Benign0.08Tolerated0.14940.43091-1-3.426.04
c.1349C>G
A450G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A450G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. The majority of other in silico predictors (SGM‑Consensus, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) classify the variant as pathogenic; FoldX is inconclusive. High‑accuracy assessments further support a pathogenic interpretation: AlphaMissense‑Optimized predicts benign, but the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta) both predict pathogenic. Overall, the preponderance of evidence indicates that A450G is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.000-11.090Likely Pathogenic0.695Likely PathogenicLikely Benign1.79Ambiguous0.02.29Destabilizing2.04Destabilizing1.23Destabilizing0.355Likely Benign-3.82Deleterious0.998Probably Damaging0.980Probably Damaging3.40Benign0.04Affected0.16700.307810-2.2-14.03
c.1358A>C
H453P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H453P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM. The majority of tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, premPS (uncertain), PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No predictions are missing or inconclusive. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-15.704Likely Pathogenic0.987Likely PathogenicLikely Pathogenic3.29Destabilizing0.47.04Destabilizing5.17Destabilizing0.84Ambiguous0.488Likely Benign-9.88Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.04Affected0.21150.39380-21.6-40.02
c.1360A>G
I454V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I454V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus as likely benign, and Foldetta as uncertain. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.254060Structured0.312811Uncertain0.9650.1820.000-4.719Likely Benign0.657Likely PathogenicLikely Benign1.47Ambiguous0.01.36Ambiguous1.42Ambiguous0.69Ambiguous0.132Likely Benign-0.79Neutral0.935Possibly Damaging0.858Possibly Damaging3.40Benign0.18Tolerated0.08330.295943-0.3-14.03
c.1372A>G
T458A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T458A missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and FATHMM. Those that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools give uncertain results: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show that AlphaMissense‑Optimized is uncertain, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts benign. Overall, the majority of reliable predictors (six pathogenic vs. five benign) indicate a pathogenic effect. This conclusion does not contradict ClinVar status, as the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.185198Structured0.294848Uncertain0.9150.1440.000-10.734Likely Pathogenic0.924Likely PathogenicAmbiguous0.36Likely Benign0.00.31Likely Benign0.34Likely Benign0.56Ambiguous0.358Likely Benign-4.27Deleterious0.995Probably Damaging0.960Probably Damaging3.40Benign0.15Tolerated0.41370.4257102.5-30.03
c.1373C>A
T458K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T458K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, Rosetta, SIFT, and FATHMM. Tools that agree on a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results from FoldX and premPS are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized predicting pathogenicity, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicting pathogenicity, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting benign stability. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.185198Structured0.294848Uncertain0.9150.1440.000-13.734Likely Pathogenic0.990Likely PathogenicLikely Pathogenic-0.59Ambiguous0.1-0.26Likely Benign-0.43Likely Benign0.80Ambiguous0.373Likely Benign-5.23Deleterious0.999Probably Damaging0.973Probably Damaging3.40Benign0.14Tolerated0.11530.33260-1-3.227.07
c.1373C>T
T458I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T458I missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM. Those that predict a pathogenic impact are SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools (seven versus six) and the two high‑accuracy pathogenic predictions suggest the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar classification is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.185198Structured0.294848Uncertain0.9150.1440.000-9.436Likely Pathogenic0.994Likely PathogenicLikely Pathogenic-0.40Likely Benign0.10.29Likely Benign-0.06Likely Benign0.50Likely Benign0.337Likely Benign-4.76Deleterious0.999Probably Damaging0.989Probably Damaging3.40Benign0.09Tolerated0.07240.61280-15.212.05
c.1381G>A
A461T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A461T missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and ESM1b. Four tools (FoldX, Rosetta, Foldetta, premPS) returned uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta is also inconclusive. Overall, the balance of evidence favors a benign classification, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.179055Structured0.292531Uncertain0.9360.1510.125-10.885Likely Pathogenic0.323Likely BenignLikely Benign1.21Ambiguous0.20.51Ambiguous0.86Ambiguous0.65Ambiguous0.214Likely Benign-3.27Deleterious0.508Possibly Damaging0.042Benign3.40Benign0.13Tolerated0.10830.593010-2.530.03
c.1384A>C
K462Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K462Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as benign. Overall, the majority of tools and the protein‑stability analysis favor a benign effect, while the consensus pathogenic score introduces uncertainty. Thus, the variant is most likely benign; this assessment does not contradict ClinVar status, which has no entry for K462Q.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-12.144Likely Pathogenic0.809Likely PathogenicAmbiguous0.12Likely Benign0.10.34Likely Benign0.23Likely Benign0.48Likely Benign0.384Likely Benign-3.85Deleterious0.999Probably Damaging0.999Probably Damaging3.40Benign0.15Tolerated0.46390.1286110.4-0.04
c.1385A>T
K462M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K462M missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, FATHMM, premPS, and the protein‑folding stability method Foldetta; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score. Rosetta’s output is inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also pathogenic, while Foldetta indicates a benign effect on protein stability. No evidence from ClinVar contradicts these findings. Overall, the majority of predictive tools and the consensus score support a pathogenic classification, suggesting that K462M is most likely pathogenic rather than benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-12.837Likely Pathogenic0.970Likely PathogenicLikely Pathogenic-0.23Likely Benign0.10.86Ambiguous0.32Likely Benign0.17Likely Benign0.475Likely Benign-5.82Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.02Affected0.12820.39320-15.83.02
c.1432G>C
E478Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478Q is listed in gnomAD (ID 6‑33438464‑G‑C) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and Foldetta as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑vs‑2 split. Overall, the majority of evidence (nine benign vs three pathogenic) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.264545Structured0.414660Uncertain0.7870.2490.0006-33438464-G-C16.20e-7-9.881Likely Pathogenic0.603Likely PathogenicLikely Benign-0.04Likely Benign0.00.31Likely Benign0.14Likely Benign0.07Likely Benign0.222Likely Benign-2.49Neutral0.623Possibly Damaging0.199Benign3.40Benign0.14Tolerated3.37340.10270.5867220.0-0.98
c.1441C>T
H481Y
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant H481Y is listed in ClinVar as benign (ClinVar ID 1543764.0) and is present in the gnomAD database (gnomAD ID 6‑33438473‑C‑T). Prediction tools that classify the variant as benign include REVEL, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. FoldX and Foldetta report uncertain stability effects. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Taking all available evidence together, the variant is most likely benign, which is consistent with its ClinVar benign annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000Likely Benign 16-33438473-C-T169.91e-6-10.910Likely Pathogenic0.565Likely PathogenicLikely Benign-0.53Ambiguous0.1-0.46Likely Benign-0.50Ambiguous0.20Likely Benign0.256Likely Benign-3.32Deleterious0.988Probably Damaging0.979Probably Damaging3.40Benign0.59Tolerated3.37330.06100.3558021.926.03256.5-44.40.00.00.20.2XXUncertainThe imidazole ring of the His481 side chain is located in a short helical structure (res. Glu480-Leu482) within an α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. In the WT simulations, His481 alternately stacks against Arg485, Arg587, and Glu480 without a definite role. In the variant simulations, Tyr481 also alternately stacks with nearby arginine residues, including Arg485, Arg587, and Arg479. The interaction between Tyr481 and Arg479 affects the α-α loop, causing it to fold into a distorted helical structure, an effect that might be more pronounced during protein folding. Finally, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1456G>A
E486K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E486K is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, and FATHMM. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus as pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) indicates a benign effect. Because the predictions are split evenly and the high‑accuracy tools are contradictory, the variant’s impact remains uncertain; thus, the variant is most likely pathogenic based on the high‑accuracy predictions, a conclusion that contradicts its ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.196879Structured0.358545Uncertain0.8330.2450.125Uncertain 2-14.545Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.06Likely Benign0.10.37Likely Benign0.22Likely Benign0.41Likely Benign0.435Likely Benign-3.58Deleterious1.000Probably Damaging0.988Probably Damaging3.40Benign0.12Tolerated3.37350.19400.639201-0.4-0.94206.852.1-0.30.10.20.0XXUncertainGlu486 is located in an α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. It is adjacent to the arginine finger (Arg485) and is expected to closely interact with Ras. The residue swap could affect complex formation with the GTPase and its activation. In the WT simulations, the carboxylate group of Glu486 forms salt bridges with Arg485 and Arg475 on the preceding α-helix (res. Ala461-Phe476). In the variant simulations, Lys486 does not form any specific interactions. Although the amino group of the Lys486 side chain cannot form these salt bridges, no negative effects on the protein structure are observed. Nevertheless, the potential role of Glu486 in SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations, and no definite conclusions can be drawn.
c.1501A>T
I501F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I501F missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain (a stability method that integrates FoldX‑MD and Rosetta outputs). No predictions are missing or inconclusive. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.079919Structured0.366596Uncertain0.8860.1530.000-12.113Likely Pathogenic0.664Likely PathogenicLikely Benign3.06Destabilizing0.10.26Likely Benign1.66Ambiguous0.71Ambiguous0.385Likely Benign-3.88Deleterious0.998Probably Damaging0.993Probably Damaging3.40Benign0.03Affected0.05740.159410-1.734.02
c.1552T>C
Y518H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y518H is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), AlphaMissense‑Default, and ESM1b. Predictions that are inconclusive are Foldetta, AlphaMissense‑Optimized, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for Y518H, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.139895Structured0.126970Uncertain0.8970.3210.000Uncertain 1-9.797Likely Pathogenic0.943Likely PathogenicAmbiguous2.39Destabilizing0.40.82Ambiguous1.61Ambiguous1.31Destabilizing0.496Likely Benign-4.74Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.08Tolerated0.19270.021202-1.9-26.03
c.1552T>G
Y518D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y518D is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all predict pathogenicity, whereas only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. No predictions are missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.139895Structured0.126970Uncertain0.8970.3210.000-12.247Likely Pathogenic0.990Likely PathogenicLikely Pathogenic3.92Destabilizing0.92.68Destabilizing3.30Destabilizing1.36Destabilizing0.619Likely Pathogenic-9.41Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.03Affected0.36820.0212-4-3-2.2-48.09
c.1563G>C
E521D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change E521D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as Benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a Benign effect. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.086953Structured0.062387Uncertain0.8650.3490.000-4.963Likely Benign0.372AmbiguousLikely Benign0.13Likely Benign0.00.17Likely Benign0.15Likely Benign-0.29Likely Benign0.227Likely Benign1.07Neutral0.986Probably Damaging0.989Probably Damaging3.40Benign0.92Tolerated0.20260.3721320.0-14.03
c.1563G>T
E521D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E521D missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate benign or likely benign. Only two tools—polyPhen‑2 HumDiv and HumVar—predict a pathogenic outcome. The high‑accuracy methods give a consistent benign signal: AlphaMissense‑Optimized is benign, the SGM‑Consensus is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. No prediction or folding stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.086953Structured0.062387Uncertain0.8650.3490.000-4.963Likely Benign0.372AmbiguousLikely Benign0.13Likely Benign0.00.17Likely Benign0.15Likely Benign-0.29Likely Benign0.227Likely Benign1.07Neutral0.986Probably Damaging0.989Probably Damaging3.40Benign0.92Tolerated0.20260.3721320.0-14.03
c.1700A>G
E567G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E567G missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on benign impact include REVEL, SIFT, and FATHMM, whereas those that agree on pathogenic impact include AlphaMissense‑Default, ESM1b, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, Rosetta, and Foldetta. Predictions that are inconclusive are FoldX, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Taken together, the majority of evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.021816Structured0.051008Uncertain0.9160.2340.000-13.402Likely Pathogenic0.912Likely PathogenicAmbiguous1.47Ambiguous0.03.48Destabilizing2.48Destabilizing0.75Ambiguous0.456Likely Benign-6.67Deleterious1.000Probably Damaging0.999Probably Damaging3.40Benign0.07Tolerated0.25860.47150-23.1-72.06
c.1726T>A
C576S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C576S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions from REVEL and FATHMM, while the majority of other in silico methods (premPS, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict pathogenicity. FoldX and Rosetta give uncertain stability changes, and Foldetta likewise reports no definitive effect. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic. Foldetta remains inconclusive. Overall, the preponderance of evidence from multiple pathogenic‑oriented tools and the high‑accuracy predictions indicates that C576S is most likely pathogenic, which is consistent with the absence of a ClinVar entry and gnomAD data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.017684Uncertain0.9130.2450.000-10.474Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.77Ambiguous0.11.57Ambiguous1.17Ambiguous1.61Destabilizing0.414Likely Benign-8.91Deleterious1.000Probably Damaging0.999Probably Damaging3.40Benign0.02Affected0.49680.14640-1-3.3-16.06
c.1727G>C
C576S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C576S is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect are limited to FATHMM, whereas the remaining 11 tools (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict a pathogenic or likely pathogenic outcome. High‑accuracy methods reinforce this trend: AlphaMissense‑Optimized reports pathogenic; the SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also returns likely pathogenic; Foldetta, a protein‑folding stability predictor combining FoldX‑MD and Rosetta, is inconclusive. Folding‑stability tools FoldX and Rosetta individually yield uncertain results and are treated as unavailable. Taken together, the majority of evidence points to a pathogenic effect. This conclusion is consistent with the absence of ClinVar annotation and gnomAD data, so there is no contradiction with existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.017684Uncertain0.9130.2450.000-10.474Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.77Ambiguous0.11.57Ambiguous1.17Ambiguous1.61Destabilizing0.523Likely Pathogenic-8.91Deleterious1.000Probably Damaging0.999Probably Damaging3.40Benign0.02Affected0.49680.14640-1-3.3-16.06
c.1727G>T
C576F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C576F is not reported in ClinVar (ClinVar ID = None) and has no entries in gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect are limited to FATHMM, which scores the variant as benign. All other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta—consistently predict a pathogenic or likely pathogenic impact. Uncertain predictions from Rosetta and premPS are treated as unavailable. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized reports pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Based on the overwhelming agreement among high‑confidence tools, the variant is most likely pathogenic, and this assessment does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.017684Uncertain0.9130.2450.000-13.467Likely Pathogenic0.994Likely PathogenicLikely Pathogenic5.04Destabilizing0.51.81Ambiguous3.43Destabilizing0.58Ambiguous0.516Likely Pathogenic-9.93Deleterious0.999Probably Damaging0.996Probably Damaging3.40Benign0.02Affected0.16260.3527-4-20.344.04
c.1840T>G
Y614D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y614D is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM predicts it to be benign, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all classify it as pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.182134Uncertain0.8520.2540.000-15.073Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.14Destabilizing0.64.16Destabilizing3.15Destabilizing1.69Destabilizing0.597Likely Pathogenic-9.83Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.02Affected0.40130.0573-4-3-2.2-48.09
c.1907T>A
F636Y
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F636Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, favors a pathogenic outcome (3/4 votes). High‑accuracy assessments further reveal AlphaMissense‑Optimized as benign, SGM Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as inconclusive. Stability‑based tools FoldX, Rosetta, and premPS are uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.071525Uncertain0.9130.2640.000-9.638Likely Pathogenic0.695Likely PathogenicLikely Benign0.84Ambiguous0.10.51Ambiguous0.68Ambiguous0.90Ambiguous0.394Likely Benign-2.89Deleterious0.927Possibly Damaging0.836Possibly Damaging3.40Benign0.08Tolerated0.12970.186673-4.116.00
c.1907T>G
F636C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F636C is reported in gnomAD (ID 6‑33440959‑T‑G) but has no ClinVar entry. Prediction tools largely agree on a deleterious effect: pathogenic calls come from REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Only FATHMM predicts a benign outcome; FoldX is uncertain and therefore not counted as evidence. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming majority of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.071525Uncertain0.9130.2640.0006-33440959-T-G31.86e-6-13.287Likely Pathogenic0.972Likely PathogenicLikely Pathogenic1.74Ambiguous0.12.65Destabilizing2.20Destabilizing1.22Destabilizing0.612Likely Pathogenic-7.67Deleterious1.000Probably Damaging0.997Probably Damaging3.40Benign0.04Affected3.37340.23010.0830-2-4-0.3-44.04
c.1914G>C
K638N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K638N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the balance of evidence favors a pathogenic classification; this conclusion does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.098064Uncertain0.9370.2600.000-9.420Likely Pathogenic0.947Likely PathogenicAmbiguous0.74Ambiguous0.10.90Ambiguous0.82Ambiguous0.40Likely Benign0.256Likely Benign-4.59Deleterious1.000Probably Damaging0.989Probably Damaging3.40Benign0.02Affected0.28750.1126100.4-14.07
c.1914G>T
K638N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K638N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the balance of evidence favors a pathogenic classification; this conclusion does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.098064Uncertain0.9370.2600.000-9.420Likely Pathogenic0.947Likely PathogenicAmbiguous0.74Ambiguous0.10.90Ambiguous0.82Ambiguous0.40Likely Benign0.256Likely Benign-4.59Deleterious1.000Probably Damaging0.989Probably Damaging3.40Benign0.02Affected0.28750.1126100.4-14.07
c.1933T>G
F645V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F645V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that agree on a pathogenic effect are premPS, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessments give an uncertain result from AlphaMissense‑Optimized, a pathogenic outcome from the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and an uncertain outcome from Foldetta (combining FoldX‑MD and Rosetta). No definitive folding‑stability change is reported. Overall, the majority of evidence points to a pathogenic impact for F645V, and this conclusion does not contradict any ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.046336Structured0.276445Uncertain0.9210.3250.000-12.175Likely Pathogenic0.810Likely PathogenicAmbiguous1.98Ambiguous0.11.70Ambiguous1.84Ambiguous1.02Destabilizing0.316Likely Benign-4.41Deleterious0.036Benign0.018Benign3.40Benign0.02Affected0.21630.2919-1-11.4-48.04
c.1943T>G
F648C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F648C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools largely agree on a deleterious effect: all evaluated algorithms except FATHMM predict pathogenicity, while FATHMM alone predicts benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also reports a pathogenic effect. In summary, the overwhelming consensus from both general and high‑accuracy predictors is that F648C is pathogenic. This conclusion is consistent with the absence of any ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.346782Uncertain0.9430.3390.000-10.547Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.28Destabilizing0.13.35Destabilizing3.32Destabilizing1.22Destabilizing0.621Likely Pathogenic-7.98Deleterious1.000Probably Damaging0.998Probably Damaging3.40Benign0.03Affected0.22830.0783-4-2-0.3-44.04
c.1945A>G
M649V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M649V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. With 8 pathogenic versus 3 benign predictions, the overall evidence favors a deleterious effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.360413Uncertain0.9620.3450.000-9.907Likely Pathogenic0.887Likely PathogenicAmbiguous2.84Destabilizing0.32.55Destabilizing2.70Destabilizing1.05Destabilizing0.370Likely Benign-3.99Deleterious0.997Probably Damaging0.735Possibly Damaging3.40Benign0.06Tolerated0.23890.3121212.3-32.06
c.1947G>A
M649I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M649I has no ClinVar entry and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas the majority of tools (SGM‑Consensus, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact; Rosetta is inconclusive and is not counted. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Taken together, the preponderance of evidence supports a pathogenic classification for M649I, and this conclusion does not conflict with ClinVar status, which is currently unavailable.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.360413Uncertain0.9620.3450.000-9.361Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.42Destabilizing0.21.96Ambiguous2.19Destabilizing1.01Destabilizing0.449Likely Benign-3.99Deleterious0.672Possibly Damaging0.093Benign3.40Benign0.02Affected3.38270.12150.2980212.6-18.03243.721.50.00.10.00.1XPotentially BenignThe thioether side chain of Met649, located on an α helix (res. Ser641-Glu666), bridges Phe652, Phe648, and Phe639 in an inter-helix hydrophobic cavity in the WT simulations. In the variant simulations, the sec-butyl side chain of Ile649 maintains hydrophobic interactions with nearby residues, with no significant effects on the protein structure.However, methionine is known as a bridging motif for aromatic residues, and these Met-aromatic interactions are lost in the variant. Indeed, in the second variant simulation,the bridging of Phe652, Phe648 and Phe639 is completely lost. In reality, the effect could be more severe on the structure during the protein folding.
c.1947G>C
M649I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M649I is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas the majority of other in silico predictors (FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) report a pathogenic outcome; Rosetta is inconclusive. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. Overall, the preponderance of evidence points to a pathogenic effect for M649I, which is consistent with the ClinVar “Uncertain” classification rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.360413Uncertain0.9620.3450.000Uncertain 1-9.361Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.42Destabilizing0.21.96Ambiguous2.19Destabilizing1.01Destabilizing0.449Likely Benign-3.99Deleterious0.672Possibly Damaging0.093Benign3.40Benign0.02Affected3.38270.12150.2980212.6-18.03243.721.50.00.10.00.1XPotentially BenignThe thioether side chain of Met649, located on an α helix (res. Ser641-Glu666), bridges Phe652, Phe648, and Phe639 in an inter-helix hydrophobic cavity in the WT simulations. In the variant simulations, the sec-butyl side chain of Ile649 maintains hydrophobic interactions with nearby residues, with no significant effects on the protein structure.However, methionine is known as a bridging motif for aromatic residues, and these Met-aromatic interactions are lost in the variant. Indeed, in the second variant simulation,the bridging of Phe652, Phe648 and Phe639 is completely lost. In reality, the effect could be more severe on the structure during the protein folding.
c.1947G>T
M649I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M649I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic calls are made by FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, votes strongly for pathogenicity (3/4 pathogenic). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote) is likely pathogenic, and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, also predicts pathogenic. Rosetta alone is uncertain and is treated as unavailable. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.360413Uncertain0.9620.3450.000-9.361Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.42Destabilizing0.21.96Ambiguous2.19Destabilizing1.01Destabilizing0.449Likely Benign-3.99Deleterious0.672Possibly Damaging0.093Benign3.40Benign0.02Affected3.38270.12150.2980212.6-18.03243.721.50.00.10.00.1XPotentially BenignThe thioether side chain of Met649, located on an α helix (res. Ser641-Glu666), bridges Phe652, Phe648, and Phe639 in an inter-helix hydrophobic cavity in the WT simulations. In the variant simulations, the sec-butyl side chain of Ile649 maintains hydrophobic interactions with nearby residues, with no significant effects on the protein structure.However, methionine is known as a bridging motif for aromatic residues, and these Met-aromatic interactions are lost in the variant. Indeed, in the second variant simulation,the bridging of Phe652, Phe648 and Phe639 is completely lost. In reality, the effect could be more severe on the structure during the protein folding.
c.1972G>C
G658R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G658R is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, SIFT, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default. Four tools (FoldX, Foldetta, premPS, ESM1b) return uncertain results. High‑accuracy methods give a mixed signal: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta is uncertain. Because the majority of conventional predictors lean benign and no ClinVar evidence contradicts this, the variant is most likely benign, though the conflicting high‑accuracy predictions leave some uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.029376Structured0.180299Uncertain0.9420.2510.000-7.725In-Between0.618Likely PathogenicLikely Benign-1.17Ambiguous0.1-0.46Likely Benign-0.82Ambiguous0.64Ambiguous0.120Likely Benign-3.11Deleterious0.955Possibly Damaging0.591Possibly Damaging3.40Benign0.19Tolerated0.11570.3888-3-2-4.199.14
c.1985A>C
Q662P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q662P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, SIFT, and FATHMM, while pathogenic predictions are made by SGM‑Consensus, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy methods give a consistent pathogenic signal: the SGM‑Consensus score (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic,” and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a pathogenic effect. AlphaMissense‑Optimized returns an uncertain result, which is treated as unavailable. Overall, the majority of evidence points to a pathogenic impact for Q662P, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.046336Structured0.103446Uncertain0.9320.3230.000-13.174Likely Pathogenic0.922Likely PathogenicAmbiguous2.15Destabilizing0.09.37Destabilizing5.76Destabilizing0.36Likely Benign0.268Likely Benign-3.42Deleterious0.999Probably Damaging0.962Probably Damaging3.40Benign0.08Tolerated0.26210.43640-11.9-31.01
c.2008C>A
L670M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L670M occurs in the GAP domain. ClinVar contains no entry for this variant, but it is present in gnomAD (ID 6‑33441267‑C‑A). Prediction tools that classify the variant as benign include REVEL, FoldX, premPS, PROVEAN, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, FATHMM, Foldetta, and the SGM‑Consensus score (Likely Benign). Tools that predict pathogenicity are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b; Rosetta gives an uncertain result. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a benign effect, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.161087Structured0.090855Uncertain0.8120.3850.0006-33441267-C-A21.24e-6-9.438Likely Pathogenic0.125Likely BenignLikely Benign-0.11Likely Benign0.00.70Ambiguous0.30Likely Benign0.06Likely Benign0.038Likely Benign-0.16Neutral0.970Probably Damaging0.777Possibly Damaging3.40Benign0.25Tolerated3.39270.08260.384924-1.918.03
c.2009T>A
L670Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L670Q is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Predictions that are inconclusive (FoldX, Rosetta, Foldetta, premPS) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also as Likely Benign, while Foldetta remains uncertain. Overall, the majority of available evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.161087Structured0.090855Uncertain0.8120.3850.000-8.217Likely Pathogenic0.306Likely BenignLikely Benign1.02Ambiguous0.11.21Ambiguous1.12Ambiguous0.96Ambiguous0.152Likely Benign-1.12Neutral1.000Probably Damaging0.988Probably Damaging3.40Benign0.36Tolerated0.10880.1303-2-2-7.314.97
c.2014A>C
T672P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T672P missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Uncertain results come from premPS and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as pathogenic. No predictions are missing or inconclusive. Overall, the majority of evidence points to a pathogenic impact for T672P. This conclusion is not contradicted by ClinVar status, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.116183Structured0.102069Uncertain0.5860.3620.000-11.022Likely Pathogenic0.346AmbiguousLikely Benign2.22Destabilizing0.25.54Destabilizing3.88Destabilizing0.55Ambiguous0.087Likely Benign-4.20Deleterious0.968Probably Damaging0.824Possibly Damaging3.40Benign0.01Affected0.19880.55320-1-0.9-3.99
c.2015C>A
T672K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T672K is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Uncertain predictions come from Foldetta, premPS, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as inconclusive. Overall, the majority of tools lean toward a benign interpretation, but the high‑accuracy consensus is split, leaving the variant’s impact uncertain. Thus, the variant is most likely benign based on the bulk of predictions, and this does not contradict its ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.102069Uncertain0.5860.3620.000Uncertain 1-12.192Likely Pathogenic0.698Likely PathogenicLikely Benign0.20Likely Benign0.51.21Ambiguous0.71Ambiguous0.72Ambiguous0.065Likely Benign-4.31Deleterious0.745Possibly Damaging0.051Benign3.40Benign0.07Tolerated3.40250.11520.32500-1-3.227.07195.17.00.40.70.40.1XXPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. In the variant simulations, Lys672 can only form a hydrogen bond with the amino group of the Lys566 side chain via its backbone carbonyl group. Consequently, it cannot maintain the Lys566-Glu666 salt bridge through hydrogen bonding. However, the amino group of Lys periodically forms a salt bridge with the carboxylate group of Glu666, which prevents a drastic disruption of the hydrogen-bond network that keeps the loop close to the helices.
c.2026A>C
S676R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S676R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, FATHMM, and polyPhen‑2 HumVar, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction or folding stability result is missing; all available data are reported. Overall, the balance of evidence (six benign versus four pathogenic predictions, with the high‑accuracy Foldetta supporting benign) indicates that the variant is most likely benign. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.209395Structured0.113632Uncertain0.5510.3380.125-10.665Likely Pathogenic0.936Likely PathogenicAmbiguous0.22Likely Benign0.30.74Ambiguous0.48Likely Benign0.45Likely Benign0.136Likely Benign-2.34Neutral0.891Possibly Damaging0.278Benign3.40Benign0.02Affected0.09620.34540-1-3.769.11
c.2028C>A
S676R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S676R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, FATHMM, and polyPhen‑2 HumVar, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction or folding stability result is missing; all available data are included. Overall, the balance of evidence (six benign versus four pathogenic predictions, with the high‑accuracy Foldetta supporting benign) indicates that the variant is most likely benign. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.209395Structured0.113632Uncertain0.5510.3380.125-10.665Likely Pathogenic0.936Likely PathogenicAmbiguous0.22Likely Benign0.30.74Ambiguous0.48Likely Benign0.45Likely Benign0.157Likely Benign-2.34Neutral0.891Possibly Damaging0.278Benign3.40Benign0.02Affected0.09620.34540-1-3.769.11
c.2028C>G
S676R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S676R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, FATHMM, and polyPhen‑2 HumVar, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction or folding stability result is missing; all available data are included. Overall, the balance of evidence (six benign versus four pathogenic predictions, with the high‑accuracy Foldetta supporting benign) indicates that the variant is most likely benign. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.209395Structured0.113632Uncertain0.5510.3380.125-10.665Likely Pathogenic0.936Likely PathogenicAmbiguous0.22Likely Benign0.30.74Ambiguous0.48Likely Benign0.45Likely Benign0.156Likely Benign-2.34Neutral0.891Possibly Damaging0.278Benign3.40Benign0.02Affected0.09620.34540-1-3.769.11
c.2036T>G
F679C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F679C has no ClinVar entry and is not reported in gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, whereas SGM‑Consensus, REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. FoldX and Foldetta are uncertain and are treated as unavailable evidence. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta remains inconclusive. Overall, the preponderance of evidence points to a pathogenic impact for F679C. This prediction is not contradicted by ClinVar status, which currently lacks any classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.222385Structured0.129316Uncertain0.7000.3200.000-10.269Likely Pathogenic0.958Likely PathogenicLikely Pathogenic1.65Ambiguous0.32.02Destabilizing1.84Ambiguous1.17Destabilizing0.532Likely Pathogenic-7.86Deleterious0.999Probably Damaging0.993Probably Damaging3.40Benign0.00Affected0.23440.0949-4-2-0.3-44.04
c.2045A>T
Y682F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y682F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. The SGM Consensus, which is a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign vs. two pathogenic votes) and is treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta (combining FoldX‑MD and Rosetta outputs) as benign, and the SGM Consensus remains unavailable. Overall, the balance of evidence—both from general predictors and from the high‑accuracy tools—leans toward a benign classification. This conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.206376Structured0.141467Uncertain0.7580.3280.000-9.740Likely Pathogenic0.225Likely BenignLikely Benign0.21Likely Benign0.1-0.09Likely Benign0.06Likely Benign0.42Likely Benign0.278Likely Benign-3.72Deleterious0.997Probably Damaging0.947Probably Damaging3.40Benign0.04Affected0.24520.3662734.1-16.00
c.2057G>A
G686D
2D
AIThe SynGAP1 missense variant G686D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.109221Structured0.177104Uncertain0.9190.2680.000-14.109Likely Pathogenic1.000Likely PathogenicLikely Pathogenic2.00Destabilizing1.72.61Destabilizing2.31Destabilizing1.05Destabilizing0.563Likely Pathogenic-6.28Deleterious1.000Probably Damaging0.967Probably Damaging3.40Benign0.00Affected0.17200.21961-1-3.158.04
c.2110A>T
S704C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Other stability‑based tools such as FoldX, Rosetta, and premPS also return uncertain results. Overall, the majority of individual predictors lean toward pathogenicity, and the high‑accuracy consensus also supports a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.096677Structured0.383620Uncertain0.9280.3630.000-10.438Likely Pathogenic0.423AmbiguousLikely Benign1.56Ambiguous0.10.98Ambiguous1.27Ambiguous0.52Ambiguous0.251Likely Benign-3.52Deleterious0.997Probably Damaging0.789Possibly Damaging3.40Benign0.01Affected0.07890.46120-13.316.06
c.1241T>C
M414T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M414T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions arise from SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta; Rosetta remains uncertain. High‑accuracy methods all support a deleterious effect: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta predicts a destabilizing, pathogenic outcome. Consequently, the consensus of the most reliable predictors classifies M414T as pathogenic, with no conflict with the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.081712Structured0.329108Uncertain0.9140.2170.000-8.698Likely Pathogenic0.975Likely PathogenicLikely Pathogenic2.04Destabilizing0.11.96Ambiguous2.00Destabilizing1.27Destabilizing0.406Likely Benign-5.00Deleterious0.997Probably Damaging0.972Probably Damaging3.41Benign0.08Tolerated0.17710.1976-1-1-2.6-30.09
c.1255G>C
E419Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E419Q missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the predictions are split, with a slight majority leaning toward pathogenicity. The variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.371949Uncertain0.9610.2610.000-9.268Likely Pathogenic0.923Likely PathogenicAmbiguous0.01Likely Benign0.10.36Likely Benign0.19Likely Benign0.02Likely Benign0.280Likely Benign-2.80Deleterious0.997Probably Damaging0.973Probably Damaging3.41Benign0.04Affected0.14990.6938220.0-0.98
c.1262C>G
A421G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A421G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the majority of tools and the SGM Consensus favor a pathogenic interpretation, while a minority suggest benign. Because there is no ClinVar entry, the predictions do not contradict existing clinical classification. The variant is most likely pathogenic based on the collective computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-9.699Likely Pathogenic0.757Likely PathogenicLikely Benign1.47Ambiguous0.12.13Destabilizing1.80Ambiguous1.19Destabilizing0.137Likely Benign-3.59Deleterious0.536Possibly Damaging0.176Benign3.41Benign0.05Affected0.16920.249910-2.2-14.03
c.1283A>T
Y428F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y428F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized, whereas a majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b) predict a pathogenic impact. Uncertain or inconclusive results are reported for FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as unavailable. Overall, the balance of evidence—five pathogenic versus three benign predictions, with a pathogenic SGM Consensus and a benign AlphaMissense‑Optimized—suggests that the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.118441Structured0.389652Uncertain0.9650.2920.000-10.464Likely Pathogenic0.530AmbiguousLikely Benign0.82Ambiguous0.10.52Ambiguous0.67Ambiguous0.89Ambiguous0.366Likely Benign-3.82Deleterious0.999Probably Damaging0.985Probably Damaging3.41Benign0.04Affected0.27190.3146734.1-16.00
c.1285C>T
R429W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R429W is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33438190‑C‑T). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b; premPS and AlphaMissense‑Default are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of predictions lean toward a benign impact, and this does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.390504Uncertain0.9590.2900.000Conflicting 56-33438190-C-T654.03e-5-10.666Likely Pathogenic0.500AmbiguousLikely Benign0.31Likely Benign0.1-0.13Likely Benign0.09Likely Benign0.52Ambiguous0.282Likely Benign-3.19Deleterious1.000Probably Damaging0.990Probably Damaging3.41Benign0.03Affected3.38250.12320.34222-33.630.03252.345.50.00.00.20.1XPotentially PathogenicThe guanidinium group of Arg429, located in an α helix (res. Met414-Glu436), either forms a salt bridge with the carboxylate group of an acidic residue (Asp474, Asp467) or a H-bond with the hydroxyl group of Ser471 in an opposing α helix (res. Ala461-Phe476). In the variant simulations, the indole ring of the Trp429 side chain cannot form ionic interactions with the acidic residues. Although it forms a H-bond with Ser471, the bonding is not as strong as that of arginine. The residue swap could affect the tertiary structure assembly during folding; however, no large-scale negative effects were seen during the simulations.
c.1297G>A
A433T
2D
AIThe SynGAP1 A433T missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only two tools—polyPhen‑2 HumDiv and polyPhen‑2 HumVar—predict a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.098513Structured0.352258Uncertain0.9380.3020.000-5.499Likely Benign0.080Likely BenignLikely Benign0.35Likely Benign0.5-0.02Likely Benign0.17Likely Benign0.40Likely Benign0.088Likely Benign-1.41Neutral0.964Probably Damaging0.481Possibly Damaging3.41Benign0.08Tolerated0.08910.555410-2.530.03
c.1321G>A
V441I
2D
AIThe SynGAP1 missense variant V441I is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign, while only ESM1b predicts it as pathogenic. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized reports benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates benign stability. No contradictory evidence is present. Based on the collective predictions, the variant is most likely benign, and this conclusion does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.161087Structured0.259875Uncertain0.9180.2490.000-8.773Likely Pathogenic0.122Likely BenignLikely Benign-0.24Likely Benign0.30.11Likely Benign-0.07Likely Benign0.25Likely Benign0.135Likely Benign-0.82Neutral0.287Benign0.038Benign3.41Benign0.16Tolerated0.06940.3412430.314.03
c.1322T>G
V441G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant V441G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into three groups: benign predictions come from REVEL, FoldX, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b; the remaining tools (Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain results. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized remains benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) favors pathogenic, and Foldetta is inconclusive. Taken together, the majority of evidence points to a benign effect, but the SGM Consensus and several individual pathogenic predictors introduce uncertainty. Therefore, the variant is most likely benign based on the overall prediction landscape, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.161087Structured0.259875Uncertain0.9180.2490.000-12.380Likely Pathogenic0.478AmbiguousLikely Benign0.18Likely Benign0.01.25Ambiguous0.72Ambiguous0.95Ambiguous0.273Likely Benign-5.88Deleterious0.841Possibly Damaging0.997Probably Damaging3.41Benign0.24Tolerated0.16640.1715-1-3-4.6-42.08
c.1328G>C
G443A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G443A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that reach a consensus all indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all score the substitution as tolerated. No tool predicts pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Benign. The protein‑folding stability predictor Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result and is therefore treated as unavailable evidence. Overall, the collective predictions strongly suggest that the variant is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.250310Structured0.258623Uncertain0.9350.2060.000-0.332Likely Benign0.101Likely BenignLikely Benign-0.59Ambiguous0.1-1.61Ambiguous-1.10Ambiguous-0.52Ambiguous0.033Likely Benign-1.04Neutral0.022Benign0.011Benign3.41Benign0.54Tolerated0.35390.3192102.214.03
c.1331A>T
K444M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K444M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions are returned by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further highlight the discrepancy: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports a benign effect. Overall, the majority of tools lean toward a pathogenic interpretation, and this is not contradicted by any ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.262172Uncertain0.9550.2130.000-14.223Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.39Likely Benign0.1-0.47Likely Benign-0.04Likely Benign0.33Likely Benign0.442Likely Benign-5.73Deleterious1.000Probably Damaging0.999Probably Damaging3.41Benign0.00Affected0.09340.38900-15.83.02
c.1357C>T
H453Y
2D
AIThe SynGAP1 missense variant H453Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign calls come from REVEL, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic calls come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus. Predictions from FoldX, Rosetta, and Foldetta are uncertain. High‑accuracy methods provide a mixed picture: AlphaMissense‑Optimized predicts benign, SGM‑Consensus predicts likely pathogenic, and Foldetta is inconclusive. Overall, the majority of evidence points toward a pathogenic effect, aligning with the SGM‑Consensus but opposing the benign predictions from several tools. Because ClinVar contains no entry for this variant, there is no conflict with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-12.060Likely Pathogenic0.753Likely PathogenicLikely Benign-0.52Ambiguous0.7-0.68Ambiguous-0.60Ambiguous0.09Likely Benign0.320Likely Benign-5.93Deleterious0.995Probably Damaging0.961Probably Damaging3.41Benign0.04Affected0.08150.3843021.926.03
c.1366C>G
Q456E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q456E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) yield uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicting pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) remaining uncertain. Overall, the predictions are split, but the high‑accuracy consensus leans toward pathogenicity. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict ClinVar status, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.170161Structured0.302348Uncertain0.9390.1640.000-12.982Likely Pathogenic0.503AmbiguousLikely Benign0.71Ambiguous0.10.87Ambiguous0.79Ambiguous0.65Ambiguous0.233Likely Benign-2.76Deleterious0.998Probably Damaging0.964Probably Damaging3.41Benign0.15Tolerated0.11910.1276220.00.98
c.1433A>G
E478G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E478G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN and polyPhen‑2 HumDiv. Uncertain predictions come from Rosetta, ESM1b, AlphaMissense‑Default, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to equal benign and pathogenic signals and two uncertain calls; Foldetta likewise yields an uncertain result. Overall, the majority of evaluated tools (seven benign vs. two pathogenic) support a benign classification. This consensus does not contradict any ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.264545Structured0.414660Uncertain0.7870.2490.000-7.897In-Between0.418AmbiguousLikely Benign0.40Likely Benign0.00.73Ambiguous0.57Ambiguous0.02Likely Benign0.306Likely Benign-4.91Deleterious0.923Possibly Damaging0.427Benign3.41Benign0.15Tolerated0.27580.55720-23.1-72.06
c.1436G>C
R479P
2D
3DClick to see structure in 3D Viewer
AIClinVar lists the SynGAP1 R479P variant as Uncertain, and it is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM. Those that predict a pathogenic effect are FoldX, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. Predictions that are inconclusive are AlphaMissense‑Optimized and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as pathogenic. Overall, the majority of tools and the high‑accuracy methods support a pathogenic classification, which is in contrast to the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.419256Uncertain0.8200.2490.000Uncertain 1-11.795Likely Pathogenic0.938Likely PathogenicAmbiguous2.86Destabilizing0.23.88Destabilizing3.37Destabilizing0.81Ambiguous0.277Likely Benign-3.52Deleterious1.000Probably Damaging1.000Probably Damaging3.41Benign0.18Tolerated0.19930.37470-22.9-59.07
c.1442A>T
H481L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H481L missense variant is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; FoldX is uncertain and therefore not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction or stability result is missing or inconclusive. Overall, the majority of tools (seven benign vs five pathogenic) lean toward a benign interpretation, and this does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign, though a subset of high‑accuracy predictors suggest pathogenicity, indicating some uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-9.097Likely Pathogenic0.587Likely PathogenicLikely Benign-0.58Ambiguous0.10.15Likely Benign-0.22Likely Benign0.29Likely Benign0.349Likely Benign-5.91Deleterious0.995Probably Damaging0.986Probably Damaging3.41Benign0.48Tolerated0.06610.4678-2-37.0-23.98
c.1701G>C
E567D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E567D missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain or unavailable results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta’s stability prediction is uncertain. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.021816Structured0.051008Uncertain0.9160.2340.000-8.276Likely Pathogenic0.575Likely PathogenicLikely Benign0.87Ambiguous0.11.94Ambiguous1.41Ambiguous0.70Ambiguous0.184Likely Benign-2.72Deleterious0.996Probably Damaging0.989Probably Damaging3.41Benign0.21Tolerated0.16020.3426320.0-14.03
c.1701G>T
E567D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E567D missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Uncertain or unavailable results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta’s stability prediction is inconclusive. Overall, the majority of pathogenic predictions outweigh the benign ones, suggesting the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.021816Structured0.051008Uncertain0.9160.2340.000-8.276Likely Pathogenic0.575Likely PathogenicLikely Benign0.87Ambiguous0.11.94Ambiguous1.41Ambiguous0.70Ambiguous0.184Likely Benign-2.72Deleterious0.996Probably Damaging0.989Probably Damaging3.41Benign0.21Tolerated0.16020.3426320.0-14.03
c.1841A>G
Y614C
2D
AIThe SynGAP1 missense variant Y614C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.182134Uncertain0.8520.2540.000-11.716Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.56Ambiguous0.73.21Destabilizing2.39Destabilizing1.76Destabilizing0.539Likely Pathogenic-8.83Deleterious1.000Probably Damaging1.000Probably Damaging3.41Benign0.02Affected0.30810.16790-23.8-60.04
c.1846G>A
D616N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D616N missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into benign (REVEL, premPS, SIFT, FATHMM, AlphaMissense‑Optimized) and pathogenic (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b). Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) favors pathogenic, and Foldetta remains uncertain. Overall, the majority of conventional predictors lean toward a benign effect, whereas the SGM Consensus suggests pathogenicity, leaving the variant’s clinical significance ambiguous. Based on the prevailing evidence, the variant is most likely benign, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.166689Uncertain0.8670.2520.000-8.292Likely Pathogenic0.349AmbiguousLikely Benign0.54Ambiguous0.21.05Ambiguous0.80Ambiguous0.03Likely Benign0.149Likely Benign-3.74Deleterious0.875Possibly Damaging0.581Possibly Damaging3.41Benign0.11Tolerated0.10530.3976210.0-0.98
c.1907T>C
F636S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F636S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, while the remaining 13 tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) all predict a pathogenic impact. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No prediction or folding‑stability result is missing or inconclusive. Based on the overwhelming agreement among the majority of tools and the high‑accuracy methods, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.071525Uncertain0.9130.2640.000-14.290Likely Pathogenic0.989Likely PathogenicLikely Pathogenic2.08Destabilizing0.12.66Destabilizing2.37Destabilizing1.51Destabilizing0.559Likely Pathogenic-7.50Deleterious1.000Probably Damaging0.999Probably Damaging3.41Benign0.03Affected0.38770.0200-3-2-3.6-60.10
c.1909T>G
S637A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S637A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, PROVEAN, SIFT, polyPhen‑2 (HumDiv and HumVar), REVEL, FoldX, and premPS. No tool predicts a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is inconclusive (Uncertain). Taken together, the overwhelming majority of evidence indicates a benign effect. The variant’s status is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.076542Structured0.083482Uncertain0.9200.2530.000-4.186Likely Benign0.137Likely BenignLikely Benign0.31Likely Benign0.10.99Ambiguous0.65Ambiguous0.22Likely Benign0.078Likely Benign-0.64Neutral0.120Benign0.182Benign3.41Benign1.00Tolerated0.48530.2996112.6-16.00
c.1913A>G
K638R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K638R is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). In contrast, PROVEAN and polyPhen‑2 HumDiv predict a pathogenic impact, while premPS remains inconclusive. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is benign. Overall, the majority of evidence points to a benign effect, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.045352Structured0.098064Uncertain0.9370.2600.000Uncertain 1-2.700Likely Benign0.110Likely BenignLikely Benign0.09Likely Benign0.1-0.04Likely Benign0.03Likely Benign0.53Ambiguous0.216Likely Benign-2.55Deleterious0.649Possibly Damaging0.240Benign3.41Benign0.13Tolerated3.37310.40260.097523-0.628.01
c.1913A>T
K638M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K638M missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FoldX, FATHMM, premPS, and Foldetta. Those that predict a pathogenic effect comprise SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized and Rosetta give uncertain results, which are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of evidence points to a pathogenic impact, and this conclusion is not contradicted by the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.098064Uncertain0.9370.2600.000-9.702Likely Pathogenic0.882Likely PathogenicAmbiguous-0.21Likely Benign0.00.61Ambiguous0.20Likely Benign0.09Likely Benign0.526Likely Pathogenic-5.19Deleterious1.000Probably Damaging0.998Probably Damaging3.41Benign0.01Affected0.09290.28960-15.83.02
c.1942T>A
F648I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F648I resides in the GAP domain. ClinVar contains no entry for this change, and it is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—report a pathogenic or likely pathogenic outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) also yields a pathogenic prediction. Taken together, the evidence overwhelmingly supports a pathogenic classification for F648I, and this conclusion does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.346782Uncertain0.9430.3390.000-11.912Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.49Destabilizing0.12.49Destabilizing2.49Destabilizing1.05Destabilizing0.472Likely Benign-5.98Deleterious0.999Probably Damaging0.989Probably Damaging3.41Benign0.04Affected0.16730.1955101.7-34.02
c.1943T>A
F648Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F648Y is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID: 6‑33441202‑T‑A). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the balance of evidence favors a pathogenic classification for F648Y. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.346782Uncertain0.9430.3390.0006-33441202-T-A42.48e-6-8.632Likely Pathogenic0.889Likely PathogenicAmbiguous0.74Ambiguous0.10.94Ambiguous0.84Ambiguous1.11Destabilizing0.407Likely Benign-2.99Deleterious0.984Probably Damaging0.913Probably Damaging3.41Benign0.11Tolerated3.37300.13070.139637-4.116.00
c.1968A>C
E656D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E656D has no ClinVar entry and is not reported in gnomAD. Prediction tools show mixed results: benign predictions come from REVEL, FoldX, premPS, polyPhen‑2 HumVar, SIFT, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, SGM‑Consensus confirms Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is Uncertain. No evidence from Foldetta or Rosetta is available to refute pathogenicity. Overall, the majority of high‑confidence tools predict a pathogenic impact, and this is consistent with the absence of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.032017Structured0.242242Uncertain0.9630.2640.000-11.992Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.22Likely Benign0.11.02Ambiguous0.62Ambiguous0.39Likely Benign0.275Likely Benign-2.72Deleterious0.985Probably Damaging0.426Benign3.41Benign0.06Tolerated0.20520.4120320.0-14.03
c.1968A>T
E656D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E656D missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into two groups: benign calls (REVEL, FoldX, premPS, polyPhen‑2 HumVar, SIFT, FATHMM) and pathogenic calls (PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized). The SGM‑Consensus score is “Likely Pathogenic,” while Foldetta and Rosetta outputs are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates pathogenicity, and Foldetta remains inconclusive. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.032017Structured0.242242Uncertain0.9630.2640.000-11.992Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.22Likely Benign0.11.02Ambiguous0.62Ambiguous0.39Likely Benign0.273Likely Benign-2.72Deleterious0.985Probably Damaging0.426Benign3.41Benign0.06Tolerated0.20520.4120320.0-14.03
c.1975T>A
S659T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S659T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, premPS, FoldX, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify the change as benign. Only Rosetta reports an uncertain outcome, which is treated as unavailable evidence. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, the SGM Consensus is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. No tool predicts pathogenicity. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.067594Structured0.154597Uncertain0.9540.2830.000-5.693Likely Benign0.157Likely BenignLikely Benign-0.15Likely Benign0.0-0.74Ambiguous-0.45Likely Benign0.42Likely Benign0.106Likely Benign-2.04Neutral0.069Benign0.011Benign3.41Benign0.39Tolerated0.15050.5976110.114.03
c.1982A>C
Q661P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q661P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from premPS and FATHMM, whereas the remaining 12 tools (REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score) all classify the change as pathogenic or likely pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports a pathogenic effect. No prediction is inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.117089Uncertain0.9240.3090.000-17.549Likely Pathogenic0.992Likely PathogenicLikely Pathogenic4.11Destabilizing0.15.97Destabilizing5.04Destabilizing0.45Likely Benign0.531Likely Pathogenic-4.58Deleterious1.000Probably Damaging0.994Probably Damaging3.41Benign0.01Affected0.18110.38500-11.9-31.01
c.2007T>A
N669K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N669K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, FoldX, and FATHMM, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus confirms a Likely Pathogenic status, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.142424Structured0.086615Uncertain0.8720.3800.000-10.797Likely Pathogenic0.957Likely PathogenicLikely Pathogenic0.39Likely Benign0.31.50Ambiguous0.95Ambiguous0.94Ambiguous0.243Likely Benign-5.35Deleterious0.999Probably Damaging0.989Probably Damaging3.41Benign0.03Affected0.26470.331210-0.414.07
c.2007T>G
N669K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N669K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, FoldX, and FATHMM, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus concurs, and the Foldetta stability analysis is inconclusive and therefore not used as evidence. No other tools provide definitive support for benignity. Consequently, the preponderance of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.142424Structured0.086615Uncertain0.8720.3800.000-10.797Likely Pathogenic0.957Likely PathogenicLikely Pathogenic0.39Likely Benign0.31.50Ambiguous0.95Ambiguous0.94Ambiguous0.243Likely Benign-5.35Deleterious0.999Probably Damaging0.989Probably Damaging3.41Benign0.03Affected0.26470.331210-0.414.07
c.2009T>C
L670P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L670P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate benign. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact. Stability‑based methods are inconclusive: FoldX, Rosetta, and the combined Foldetta output are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence supports a benign classification, and this is consistent with the absence of a ClinVar assertion; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.161087Structured0.090855Uncertain0.8120.3850.000-4.916Likely Benign0.237Likely BenignLikely Benign0.56Ambiguous0.31.83Ambiguous1.20Ambiguous-0.25Likely Benign0.211Likely Benign2.42Neutral1.000Probably Damaging0.996Probably Damaging3.41Benign0.26Tolerated0.35900.1474-3-3-5.4-16.04
c.2033G>C
S678T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678T is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify the change as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts pathogenicity. High‑accuracy assessments likewise support a benign effect: AlphaMissense‑Optimized is benign, the SGM Consensus is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Based on the unanimous computational evidence, the variant is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.301917Structured0.123585Uncertain0.6600.3210.000-5.389Likely Benign0.083Likely BenignLikely Benign0.32Likely Benign0.10.41Likely Benign0.37Likely Benign0.14Likely Benign0.053Likely Benign-1.82Neutral0.255Benign0.053Benign3.41Benign0.11Tolerated0.14940.6351110.114.03
c.2042G>C
G681A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G681A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign calls come from REVEL, polyPhen‑2 HumVar, SIFT, and FATHMM, while pathogenic calls are made by PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Predictions labeled uncertain include FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized remains uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also uncertain. Overall, the preponderance of evidence points to a pathogenic effect for G681A. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-11.958Likely Pathogenic0.836Likely PathogenicAmbiguous1.77Ambiguous1.00.89Ambiguous1.33Ambiguous0.68Ambiguous0.354Likely Benign-5.99Deleterious0.968Probably Damaging0.427Benign3.41Benign0.07Tolerated0.38790.4401102.214.03
c.2102C>G
P701R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P701R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Two tools (FoldX and premPS) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta (combining FoldX‑MD and Rosetta outputs) as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.404318Uncertain0.9180.3450.000-11.060Likely Pathogenic0.779Likely PathogenicLikely Benign0.54Ambiguous0.0-0.19Likely Benign0.18Likely Benign0.65Ambiguous0.088Likely Benign-2.09Neutral0.784Possibly Damaging0.278Benign3.41Benign0.08Tolerated0.13650.25000-2-2.959.07
c.2119G>C
A707P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A707P is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, SIFT, and FATHMM, whereas pathogenic predictions come from Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as Pathogenic. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.371229Uncertain0.9270.3650.000-8.082Likely Pathogenic0.885Likely PathogenicAmbiguous0.28Likely Benign0.15.75Destabilizing3.02Destabilizing0.76Ambiguous0.228Likely Benign-2.92Deleterious0.996Probably Damaging0.983Probably Damaging3.41Benign0.09Tolerated0.13750.30951-1-3.426.04
c.2125C>A
L709M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L709M is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate benign or likely benign. Only polyPhen‑2 HumDiv predicts a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. No predictions are missing or inconclusive. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.243554Structured0.365830Uncertain0.9340.3790.000-5.242Likely Benign0.108Likely BenignLikely Benign0.18Likely Benign0.00.40Likely Benign0.29Likely Benign-0.10Likely Benign0.065Likely Benign0.03Neutral0.688Possibly Damaging0.235Benign3.41Benign0.17Tolerated0.06290.240942-1.918.03
c.2129A>C
K710T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K710T is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain (no definitive stability change). Other stability predictions (FoldX, Rosetta) are also uncertain and thus unavailable for interpretation. Overall, the majority of evidence points to a pathogenic impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.370438Uncertain0.9490.3680.000-10.454Likely Pathogenic0.759Likely PathogenicLikely Benign1.02Ambiguous0.01.57Ambiguous1.30Ambiguous0.21Likely Benign0.305Likely Benign-5.45Deleterious0.999Probably Damaging1.000Probably Damaging3.41Benign0.06Tolerated0.14870.30000-13.2-27.07
c.2185A>G
N729D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N729D is predicted to be benign by all available in‑silico tools. Consensus predictors (REVEL, SIFT, polyPhen‑2 HumDiv/HumVar, PROVEAN, premPS, FoldX, Rosetta, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly report a benign effect, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates “Likely Benign.” High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, SGM‑Consensus is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign impact on protein stability. ClinVar contains no entry for this variant, and it is not listed in gnomAD. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.426547Uncertain0.6510.5830.625-5.117Likely Benign0.270Likely BenignLikely Benign0.03Likely Benign0.20.10Likely Benign0.07Likely Benign0.14Likely Benign0.054Likely Benign-1.22Neutral0.390Benign0.144Benign3.41Benign0.55Tolerated0.19310.2250210.00.98
c.1246C>G
L416V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L416V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact for the variant. This conclusion is not contradicted by any ClinVar annotation, as the variant is not present in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.104810Structured0.336105Uncertain0.9350.2270.000-7.861In-Between0.310Likely BenignLikely Benign1.46Ambiguous0.01.78Ambiguous1.62Ambiguous0.45Likely Benign0.124Likely Benign-1.47Neutral0.995Probably Damaging0.970Probably Damaging3.42Benign0.53Tolerated0.15630.3550210.4-14.03
c.1254A>C
K418N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K418N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM. The majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Stability‑based methods (FoldX, Rosetta, premPS, Foldetta) are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence indicates that K418N is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.360134Uncertain0.9480.2630.000-13.310Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.57Ambiguous0.00.77Ambiguous0.67Ambiguous0.56Ambiguous0.132Likely Benign-4.41Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.04Affected0.34830.0606100.4-14.07
c.1254A>T
K418N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K418N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two consensus groups: benign predictions are provided by REVEL and FATHMM, whereas pathogenic predictions are given by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus score (Likely Pathogenic). Stability‑based methods FoldX, Rosetta, Foldetta, and premPS returned uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, and Foldetta’s stability analysis is inconclusive. Overall, the majority of reliable predictors classify K418N as pathogenic, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.360134Uncertain0.9480.2630.000-13.310Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.57Ambiguous0.00.77Ambiguous0.67Ambiguous0.56Ambiguous0.132Likely Benign-4.41Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.04Affected0.34830.0606100.4-14.07
c.1273A>G
T425A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. Two tools (premPS and AlphaMissense‑Optimized) give uncertain results and are treated as unavailable. High‑accuracy assessments show SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign, and AlphaMissense‑Optimized as uncertain. Overall, the balance of evidence leans toward pathogenicity, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.401218Uncertain0.9640.2800.000-8.945Likely Pathogenic0.799Likely PathogenicAmbiguous-0.31Likely Benign0.1-0.05Likely Benign-0.18Likely Benign0.70Ambiguous0.372Likely Benign-4.17Deleterious0.995Probably Damaging0.960Probably Damaging3.42Benign0.09Tolerated0.29710.2572102.5-30.03
c.1273A>T
T425S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Four tools (Foldetta, premPS, ESM1b, Rosetta) return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools (five benign vs. four pathogenic) lean toward a benign interpretation, and this assessment does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.041405Structured0.401218Uncertain0.9640.2800.000-7.420In-Between0.676Likely PathogenicLikely Benign0.22Likely Benign0.10.77Ambiguous0.50Ambiguous0.63Ambiguous0.275Likely Benign-3.05Deleterious0.998Probably Damaging0.994Probably Damaging3.42Benign0.07Tolerated0.25110.232411-0.1-14.03
c.1274C>G
T425S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Four tools (Foldetta, premPS, ESM1b, Rosetta) return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools (five benign vs. four pathogenic) lean toward a benign interpretation, and this assessment does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.041405Structured0.401218Uncertain0.9640.2800.000-7.420In-Between0.676Likely PathogenicLikely Benign0.22Likely Benign0.10.77Ambiguous0.50Ambiguous0.63Ambiguous0.184Likely Benign-3.05Deleterious0.998Probably Damaging0.994Probably Damaging3.42Benign0.07Tolerated0.25110.232411-0.1-14.03
c.1280A>T
H427L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H427L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: nine tools (REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Optimized) predict a benign effect, while five tools (SGM‑Consensus, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default) predict pathogenicity. High‑accuracy methods provide a more focused view: AlphaMissense‑Optimized indicates a benign outcome; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, remains pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. Taken together, the majority of evidence supports a benign impact for H427L, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.081712Structured0.394261Uncertain0.9620.2870.000-9.691Likely Pathogenic0.755Likely PathogenicLikely Benign-0.17Likely Benign0.00.05Likely Benign-0.06Likely Benign0.31Likely Benign0.272Likely Benign-5.38Deleterious0.299Benign0.033Benign3.42Benign0.01Affected0.09420.4953-2-37.0-23.98
c.1298C>A
A433E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A433E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Two tools (premPS and AlphaMissense‑Default) give uncertain results. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign prediction; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports benign. No prediction is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.098513Structured0.352258Uncertain0.9380.3020.000-8.210Likely Pathogenic0.506AmbiguousLikely Benign-0.20Likely Benign0.00.15Likely Benign-0.03Likely Benign0.58Ambiguous0.148Likely Benign-1.65Neutral0.998Probably Damaging0.824Possibly Damaging3.42Benign0.18Tolerated0.07830.16950-1-5.358.04
c.1346G>C
S449T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S449T is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts pathogenicity. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus predicts likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Based on these predictions, the variant is most likely benign, and this assessment does not contradict the ClinVar status (which has no entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.254060Structured0.301437Uncertain0.9580.2510.000-6.262Likely Benign0.115Likely BenignLikely Benign0.36Likely Benign0.1-0.46Likely Benign-0.05Likely Benign-0.15Likely Benign0.039Likely Benign-1.48Neutral0.038Benign0.008Benign3.42Benign0.33Tolerated0.12190.5077110.114.03
c.1386G>C
K462N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K462N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are returned by PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, and the SGM Consensus also indicates Likely Pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result, providing no definitive evidence. Overall, the majority of high‑confidence predictors lean toward pathogenicity, contradicting the absence of a ClinVar classification. Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-12.823Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.69Ambiguous0.11.67Ambiguous1.18Ambiguous0.90Ambiguous0.304Likely Benign-4.83Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.07Tolerated3.37340.39670.1242010.4-14.07
c.1386G>T
K462N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K462N is reported in gnomAD (ID 6‑33438291‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Stability‑based methods (FoldX, Rosetta, premPS) and Foldetta are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM Consensus as likely pathogenic, while Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for K462N. This conclusion is not contradicted by ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.1256-33438291-G-T16.20e-7-12.823Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.69Ambiguous0.11.67Ambiguous1.18Ambiguous0.90Ambiguous0.303Likely Benign-4.83Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.07Tolerated3.37340.39670.1242010.4-14.07
c.1433A>C
E478A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E478A missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No predictions are missing or inconclusive. Overall, the majority of high‑confidence tools lean toward a benign classification, and this does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.414660Uncertain0.7870.2490.000-8.499Likely Pathogenic0.612Likely PathogenicLikely Benign0.46Likely Benign0.00.45Likely Benign0.46Likely Benign0.02Likely Benign0.342Likely Benign-4.74Deleterious0.585Possibly Damaging0.505Possibly Damaging3.42Benign0.05Affected0.35160.58470-15.3-58.04
c.1436G>A
R479Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R479Q is listed in ClinVar with an “Uncertain” significance and is present in gnomAD (variant ID 6‑33438468‑G‑A). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 HumDiv and HumVar both predict a pathogenic impact. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also as likely benign, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign effect, and this consensus does not contradict the ClinVar “Uncertain” status; thus the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.216401Structured0.419256Uncertain0.8200.2490.000Uncertain 16-33438468-G-A74.34e-6-7.109In-Between0.259Likely BenignLikely Benign0.54Ambiguous0.10.57Ambiguous0.56Ambiguous0.49Likely Benign0.191Likely Benign-1.16Neutral1.000Probably Damaging0.991Probably Damaging3.42Benign0.31Tolerated3.39320.24480.1812111.0-28.06
c.1677C>G
C559W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change C559W is not listed in ClinVar and has no entries in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM; pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is Uncertain, SGM Consensus is Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is Benign. Overall, seven of the twelve evaluated tools predict pathogenicity versus six benign, giving a slight majority toward a deleterious effect. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.016021Structured0.010460Uncertain0.8420.2040.000-12.765Likely Pathogenic0.921Likely PathogenicAmbiguous-0.19Likely Benign0.00.01Likely Benign-0.09Likely Benign0.44Likely Benign0.274Likely Benign-8.54Deleterious1.000Probably Damaging0.997Probably Damaging3.42Benign0.03Affected0.24920.2135-8-2-3.483.07
c.1687A>G
R563G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R563G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a predominance of pathogenic calls: Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default all predict deleterious effects, while the consensus SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenicity. Benign predictions come from REVEL, SIFT, and FATHMM. High‑accuracy assessments give an uncertain result from AlphaMissense‑Optimized, a pathogenic outcome from the SGM‑Consensus, and an uncertain outcome from Foldetta (which integrates FoldX‑MD and Rosetta stability scores). Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.039760Structured0.031987Uncertain0.8760.2090.000-9.549Likely Pathogenic0.848Likely PathogenicAmbiguous1.41Ambiguous0.02.01Destabilizing1.71Ambiguous0.89Ambiguous0.253Likely Benign-5.68Deleterious1.000Probably Damaging1.000Probably Damaging3.42Benign0.13Tolerated0.30820.1969-3-24.1-99.14
c.1687A>T
R563W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R563W is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments show that AlphaMissense‑Optimized is inconclusive, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also inconclusive. No evidence from the uncertain tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Optimized) supports either outcome. Overall, the balance of evidence favors a pathogenic classification for R563W, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.039760Structured0.031987Uncertain0.8760.2090.000-12.454Likely Pathogenic0.854Likely PathogenicAmbiguous1.25Ambiguous0.10.79Ambiguous1.02Ambiguous0.34Likely Benign0.302Likely Benign-6.75Deleterious1.000Probably Damaging0.997Probably Damaging3.42Benign0.01Affected0.13780.20882-33.630.03
c.1768A>G
S590G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S590G is listed in ClinVar (ID 1721675.0) with an uncertain significance status and is present in gnomAD (6‑33440820‑A‑G). Functional prediction tools that report a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. The high‑accuracy consensus (SGM Consensus) derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN yields a pathogenic majority. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive, as are FoldX, Rosetta, and premPS. Overall, the majority of evidence points toward a pathogenic impact, which does not contradict the ClinVar uncertain status but suggests a higher likelihood of pathogenicity.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.022667Structured0.088943Uncertain0.9180.1990.000Conflicting 26-33440820-A-G148.67e-6-14.277Likely Pathogenic0.574Likely PathogenicLikely Benign0.67Ambiguous0.11.28Ambiguous0.98Ambiguous0.71Ambiguous0.379Likely Benign-3.92Deleterious1.000Probably Damaging0.922Probably Damaging3.42Benign0.06Tolerated3.37350.26270.4118100.4-30.03186.749.40.00.00.10.0XPotentially PathogenicIn the WT simulations, the hydroxyl group of Ser590, located on an α helix (res. Glu582-Met603), forms hydrogen bonds with the backbone carbonyl of Ala634 and/or the carboxamide group of the Asn635 side chain at the end of the opposing α helix (res. Thr619-Ala634).The residue swap could weaken the integrity of the α helix, as glycine is known as an “α helix breaker.” However, no discernible difference was observed between the WT and variant simulations in this regard. Importantly, Gly590 cannot form hydrogen bonds with the opposing helix in the same way that serine can, which could weaken the tertiary structure assembly between the two helices.
c.1772C>A
A591D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A591D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining evaluated algorithms (AlphaMissense‑Default, ESM1b, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, premPS, FoldX‑MD, Rosetta, Foldetta, and the SGM Consensus) uniformly predict a pathogenic or likely pathogenic outcome; FoldX‑MD is uncertain but does not counter the overall trend. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Based on the preponderance of pathogenic predictions and the absence of benign evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018787Structured0.093848Uncertain0.8820.1850.000-14.747Likely Pathogenic0.990Likely PathogenicLikely Pathogenic1.55Ambiguous0.22.77Destabilizing2.16Destabilizing1.40Destabilizing0.414Likely Benign-5.02Deleterious0.919Possibly Damaging0.495Possibly Damaging3.42Benign0.00Affected0.15500.17410-2-5.344.01
c.1840T>A
Y614N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y614N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas the majority of other in silico predictors (Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate a pathogenic impact; FoldX is inconclusive and is treated as unavailable. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Taken together, the preponderance of evidence points to a pathogenic effect for Y614N, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.182134Uncertain0.8520.2540.000-13.004Likely Pathogenic0.982Likely PathogenicLikely Pathogenic1.32Ambiguous0.53.16Destabilizing2.24Destabilizing1.58Destabilizing0.471Likely Benign-8.86Deleterious1.000Probably Damaging1.000Probably Damaging3.42Benign0.06Tolerated0.19440.0573-2-2-2.2-49.07
c.1841A>T
Y614F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y614F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Uncertain or unavailable results come from Foldetta, premPS, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is unavailable. Overall, the majority of reliable predictors indicate a benign impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.314870Structured0.182134Uncertain0.8520.2540.000-5.584Likely Benign0.630Likely PathogenicLikely Benign0.09Likely Benign0.20.98Ambiguous0.54Ambiguous0.78Ambiguous0.364Likely Benign-3.75Deleterious1.000Probably Damaging0.996Probably Damaging3.42Benign0.07Tolerated0.19090.2762734.1-16.00
c.1912A>C
K638Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K638Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b; AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.045352Structured0.098064Uncertain0.9370.2600.000-9.561Likely Pathogenic0.556AmbiguousLikely Benign0.45Likely Benign0.00.37Likely Benign0.41Likely Benign0.22Likely Benign0.421Likely Benign-3.60Deleterious0.997Probably Damaging0.991Probably Damaging3.42Benign0.12Tolerated0.36230.0920110.4-0.04
c.1981C>G
Q661E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q661E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Four tools (FoldX, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of available predictions lean toward a benign impact. This conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.048328Structured0.117089Uncertain0.9240.3090.000-12.121Likely Pathogenic0.370AmbiguousLikely Benign0.64Ambiguous0.10.35Likely Benign0.50Ambiguous0.61Ambiguous0.141Likely Benign-2.15Neutral0.988Probably Damaging0.619Possibly Damaging3.42Benign0.03Affected0.11990.2439220.00.98
c.1983G>C
Q661H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q661H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain calls are made by FoldX and AlphaMissense‑Optimized. High‑accuracy assessments indicate that the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts a pathogenic effect, while Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign outcome. Overall, the balance of evidence leans toward a pathogenic interpretation, and this assessment does not conflict with ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.117089Uncertain0.9240.3090.000-9.938Likely Pathogenic0.886Likely PathogenicAmbiguous0.78Ambiguous0.10.07Likely Benign0.43Likely Benign0.09Likely Benign0.282Likely Benign-3.78Deleterious0.993Probably Damaging0.819Possibly Damaging3.42Benign0.02Affected0.12760.3424300.39.01
c.1983G>T
Q661H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q661H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, Foldetta, premPS, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain calls are made by FoldX and AlphaMissense‑Optimized. High‑accuracy assessments indicate that the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts a pathogenic effect, while Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign outcome. Overall, the balance of evidence leans toward a pathogenic interpretation, and this assessment does not conflict with ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.117089Uncertain0.9240.3090.000-9.938Likely Pathogenic0.886Likely PathogenicAmbiguous0.78Ambiguous0.10.07Likely Benign0.43Likely Benign0.09Likely Benign0.282Likely Benign-3.78Deleterious0.993Probably Damaging0.819Possibly Damaging3.42Benign0.02Affected0.12760.3424300.39.01
c.1985A>T
Q662L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q662L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, polyPhen2_HumVar, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen2_HumDiv, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign and Foldetta as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic). Overall, the majority of evidence supports a benign impact. This conclusion is consistent with the lack of ClinVar annotation and gnomAD presence, so there is no contradiction with existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.046336Structured0.103446Uncertain0.9320.3230.000-10.291Likely Pathogenic0.300Likely BenignLikely Benign0.04Likely Benign0.00.12Likely Benign0.08Likely Benign0.17Likely Benign0.186Likely Benign-4.09Deleterious0.699Possibly Damaging0.057Benign3.42Benign0.10Tolerated0.10700.5255-2-27.3-14.97
c.1986G>C
Q662H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q662H is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in‑silico tools overwhelmingly indicate a benign effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while the single pathogenic call comes from polyPhen‑2 HumDiv. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” status. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote) predicts likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. FoldX alone is uncertain, but this does not alter the overall consensus. Based on the collective predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.046336Structured0.103446Uncertain0.9320.3230.000-6.357Likely Benign0.331Likely BenignLikely Benign0.53Ambiguous0.00.18Likely Benign0.36Likely Benign-0.11Likely Benign0.159Likely Benign-2.00Neutral0.891Possibly Damaging0.243Benign3.42Benign0.15Tolerated0.16740.3186300.39.01
c.1986G>T
Q662H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q662H is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in‑silico tools overwhelmingly indicate a benign effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign, while the single pathogenic call comes from polyPhen‑2 HumDiv. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” status, and FoldX is inconclusive. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.046336Structured0.103446Uncertain0.9320.3230.000-6.357Likely Benign0.331Likely BenignLikely Benign0.53Ambiguous0.00.18Likely Benign0.36Likely Benign-0.11Likely Benign0.159Likely Benign-2.00Neutral0.891Possibly Damaging0.243Benign3.42Benign0.15Tolerated0.16740.3186300.39.01
c.2027G>A
S676N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S676N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote). Only SIFT predicts a pathogenic outcome. Predictions that are inconclusive (FoldX, premPS, ESM1b) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus, derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates benign. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is unavailable because one component (FoldX) is uncertain. Overall, the majority of evidence points to a benign effect, and this is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.209395Structured0.113632Uncertain0.5510.3380.125-7.486In-Between0.282Likely BenignLikely Benign0.60Ambiguous0.3-0.21Likely Benign0.20Likely Benign0.55Ambiguous0.099Likely Benign-1.63Neutral0.438Benign0.036Benign3.42Benign0.05Affected0.14540.459911-2.727.03
c.2041G>C
G681R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681R is listed in gnomAD (6-33441300-G-C) but has no ClinVar entry. In silico predictors largely converge on a deleterious effect: benign calls are limited to FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—report pathogenicity. premPS is inconclusive. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) indicates pathogenic folding instability. No prediction tool suggests a benign outcome, and the variant’s presence in gnomAD does not alter the consensus. Thus, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.0006-33441300-G-C16.20e-7-12.170Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.25Destabilizing1.75.46Destabilizing3.86Destabilizing0.99Ambiguous0.556Likely Pathogenic-7.98Deleterious0.999Probably Damaging0.928Probably Damaging3.42Benign0.00Affected3.43140.10220.3879-2-3-4.199.14
c.2045A>C
Y682S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y682S has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are SIFT and FATHMM, whereas the majority of tools predict a pathogenic impact: REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for Y682S, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.141467Uncertain0.7580.3280.000-11.058Likely Pathogenic0.894Likely PathogenicAmbiguous2.12Destabilizing0.11.12Ambiguous1.62Ambiguous0.88Ambiguous0.552Likely Pathogenic-8.64Deleterious1.000Probably Damaging0.999Probably Damaging3.42Benign0.12Tolerated0.44870.2343-3-20.5-76.10
c.2051A>C
D684A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D684A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: pathogenic calls are made by REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized, while only premPS and FATHMM predict a benign outcome. High‑accuracy assessments reinforce the pathogenic interpretation: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No evidence is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.153798Uncertain0.8700.2820.000-14.873Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.34Destabilizing1.12.85Destabilizing3.10Destabilizing0.28Likely Benign0.547Likely Pathogenic-7.98Deleterious0.994Probably Damaging0.758Possibly Damaging3.42Benign0.01Affected0.34770.54230-25.3-44.01
c.2072C>A
T691K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T691K missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify it as benign include REVEL, Rosetta, Foldetta, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX returned an uncertain result and is not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus indicates pathogenic. Overall, the majority of tools and the consensus high‑accuracy prediction lean toward pathogenicity. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.060549Structured0.271308Uncertain0.9410.2320.000-12.104Likely Pathogenic0.715Likely PathogenicLikely Benign-0.50Ambiguous0.1-0.31Likely Benign-0.41Likely Benign1.27Destabilizing0.147Likely Benign-3.20Deleterious0.937Possibly Damaging0.120Benign3.42Benign0.04Affected0.08510.26280-1-3.227.07
c.2081C>T
A694V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A694V is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, and polyPhen2_HumVar. Tools that predict a pathogenic effect are PROVEAN and polyPhen2_HumDiv, while Rosetta and ESM1b give uncertain results. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is benign; and Foldetta is benign. No prediction or stability result is missing or inconclusive. Overall, the majority of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.127496Structured0.352199Uncertain0.9380.2690.000-7.099In-Between0.221Likely BenignLikely Benign0.46Likely Benign0.1-0.76Ambiguous-0.15Likely Benign0.24Likely Benign0.149Likely Benign-2.66Deleterious0.970Probably Damaging0.207Benign3.42Benign0.08Tolerated0.12380.4771002.428.05
c.2096T>A
V699E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V699E missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL and FATHMM, whereas the majority of other in‑silico predictors (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score) indicate a pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Pathogenic. Based on the preponderance of pathogenic predictions and the high‑accuracy tools’ results, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.069024Structured0.432975Uncertain0.9350.3150.000-12.647Likely Pathogenic0.813Likely PathogenicAmbiguous2.41Destabilizing0.12.08Destabilizing2.25Destabilizing1.82Destabilizing0.468Likely Benign-4.56Deleterious1.000Probably Damaging0.986Probably Damaging3.42Benign0.02Affected0.10920.1326-2-2-7.729.98
c.2096T>C
V699A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V699A has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized, while premPS, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar predict a pathogenic impact. Tools with inconclusive results are FoldX, Rosetta, Foldetta, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is Benign, and the high‑accuracy AlphaMissense‑Optimized also reports Benign. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is Uncertain. Overall, the majority of evidence points to a benign effect, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.069024Structured0.432975Uncertain0.9350.3150.000-6.017Likely Benign0.426AmbiguousLikely Benign1.37Ambiguous0.01.30Ambiguous1.34Ambiguous1.21Destabilizing0.236Likely Benign-2.39Neutral0.861Possibly Damaging0.625Possibly Damaging3.42Benign0.54Tolerated0.24500.212400-2.4-28.05
c.2105A>C
Q702P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b; FoldX is uncertain and therefore not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, more tools predict pathogenicity (7) than benignity (5), and the high‑accuracy pathogenic prediction from Foldetta further supports this. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000-10.361Likely Pathogenic0.324Likely BenignLikely Benign1.76Ambiguous0.17.05Destabilizing4.41Destabilizing-0.04Likely Benign0.369Likely Benign-4.71Deleterious1.000Probably Damaging0.999Probably Damaging3.42Benign0.05Affected0.18770.33710-11.9-31.01
c.2105A>T
Q702L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the balance of evidence leans toward a benign effect. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000-9.954Likely Pathogenic0.149Likely BenignLikely Benign-0.13Likely Benign0.00.09Likely Benign-0.02Likely Benign0.16Likely Benign0.392Likely Benign-5.66Deleterious0.939Possibly Damaging0.838Possibly Damaging3.42Benign0.00Affected0.05840.3628-2-27.3-14.97
c.2110A>G
S704G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, premPS, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Taken together, the majority of reliable predictors indicate a benign impact, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.096677Structured0.383620Uncertain0.9280.3630.000-7.827In-Between0.169Likely BenignLikely Benign1.05Ambiguous0.11.33Ambiguous1.19Ambiguous0.53Ambiguous0.091Likely Benign-2.25Neutral0.981Probably Damaging0.514Possibly Damaging3.42Benign0.07Tolerated0.22240.3378100.4-30.03
c.2113A>C
K705Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K705Q missense variant (ClinVar ID 3699560.0) is listed as “Uncertain” in ClinVar and is present in gnomAD (variant ID 6‑33441372‑A‑C). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (uncertain), ESM1b (benign), FATHMM (benign), and PROVEAN (benign)—also yields a benign classification; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the preponderance of evidence supports a benign impact for K705Q, and this conclusion does not contradict the ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.134866Structured0.379324Uncertain0.9220.3640.000Uncertain 16-33441372-A-C16.20e-7-5.787Likely Benign0.436AmbiguousLikely Benign-0.10Likely Benign0.00.33Likely Benign0.12Likely Benign-0.02Likely Benign0.142Likely Benign-0.24Neutral0.997Probably Damaging0.969Probably Damaging3.42Benign0.78Tolerated3.47100.30630.1014110.4-0.04
c.2120C>G
A707G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A707G missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. The remaining tools (FoldX, Rosetta, Foldetta, premPS, ESM1b) give uncertain or inconclusive results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign, while Foldetta remains uncertain. Overall, the majority of definitive predictions lean toward a benign effect, and there is no ClinVar status to contradict this assessment. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.203355Structured0.371229Uncertain0.9270.3650.000-7.480In-Between0.224Likely BenignLikely Benign1.45Ambiguous0.01.52Ambiguous1.49Ambiguous0.62Ambiguous0.198Likely Benign-2.60Deleterious0.991Probably Damaging0.960Probably Damaging3.42Benign0.01Affected0.16780.238810-2.2-14.03
c.2125C>G
L709V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L709V is not reported in ClinVar and is absent from gnomAD. Across the available in‑silico predictors, every tool that produced a definitive call classifies the variant as benign: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all return benign scores. No tool predicts pathogenicity. The only inconclusive results are FoldX (uncertain) and Foldetta (uncertain), which are treated as unavailable evidence. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign; the SGM‑Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also benign; Foldetta remains uncertain. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.243554Structured0.365830Uncertain0.9340.3790.000-4.406Likely Benign0.101Likely BenignLikely Benign0.75Ambiguous0.00.42Likely Benign0.59Ambiguous0.03Likely Benign0.063Likely Benign-0.36Neutral0.062Benign0.016Benign3.42Benign0.45Tolerated0.11620.2460210.4-14.03
c.2130G>C
K710N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K710N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, premPS, and FATHMM, while pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain or unavailable results are reported for FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is inconclusive, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic impact for K710N, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.370438Uncertain0.9490.3680.000-9.330Likely Pathogenic0.943Likely PathogenicAmbiguous0.85Ambiguous0.00.50Ambiguous0.68Ambiguous0.33Likely Benign0.201Likely Benign-4.39Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.04Affected0.24850.1124100.4-14.07
c.2130G>T
K710N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K710N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM. In contrast, a majority of algorithms predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessment shows AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion does not conflict with the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.370438Uncertain0.9490.3680.000-9.330Likely Pathogenic0.943Likely PathogenicAmbiguous0.85Ambiguous0.00.50Ambiguous0.68Ambiguous0.33Likely Benign0.201Likely Benign-4.39Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.04Affected0.24850.1124100.4-14.07
c.2134G>A
G712S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G712S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact comprise FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Uncertain results come from premPS, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive and therefore unavailable. Overall, the majority of evidence points to a pathogenic effect for G712S. This conclusion does not contradict ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.278302Structured0.384858Uncertain0.9470.3650.000-7.942In-Between0.422AmbiguousLikely Benign2.30Destabilizing0.14.79Destabilizing3.55Destabilizing0.62Ambiguous0.282Likely Benign-4.84Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.02Affected0.28620.450110-0.430.03
c.1240A>G
M414V
2D
AISynGAP1 M414V is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools show a split: benign calls come from REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic calls come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b; the remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) are inconclusive. The SGM consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a pathogenic majority. High‑accuracy assessments give AlphaMissense‑Optimized benign, SGM consensus pathogenic, and Foldetta uncertain. Because the high‑accuracy predictions are divided and the overall tool set is evenly split, there is no definitive evidence for pathogenicity or benignity. Thus, the variant is most likely inconclusive, and this lack of consensus does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.081712Structured0.329108Uncertain0.9140.2170.000Uncertain 1-8.003Likely Pathogenic0.541AmbiguousLikely Benign1.81Ambiguous0.41.73Ambiguous1.77Ambiguous0.95Ambiguous0.261Likely Benign-2.95Deleterious0.999Probably Damaging0.987Probably Damaging3.43Benign0.24Tolerated0.25850.3482212.3-32.06
c.1261G>A
A421T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A421T is not reported in ClinVar and is present in gnomAD (ID 6‑33438166‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; the SGM‑Consensus score is “Likely Pathogenic.” Uncertain results from FoldX and premPS are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as benign. Overall, the majority of consensus predictions lean toward a benign impact, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.0006-33438166-G-A16.19e-7-9.217Likely Pathogenic0.975Likely PathogenicLikely Pathogenic0.75Ambiguous0.20.18Likely Benign0.47Likely Benign0.99Ambiguous0.179Likely Benign-3.12Deleterious0.353Benign0.136Benign3.43Benign0.09Tolerated3.37290.13460.443901-2.530.03
c.1285C>G
R429G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 R429G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta’s stability analysis is uncertain. No evidence from FoldX or Rosetta is available. Overall, the predictions are evenly split, with no clear consensus. The variant is most likely of uncertain significance; it is not contradicted by ClinVar status, which has no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.390504Uncertain0.9590.2900.000-9.157Likely Pathogenic0.333Likely BenignLikely Benign1.58Ambiguous0.01.68Ambiguous1.63Ambiguous1.21Destabilizing0.257Likely Benign-3.37Deleterious1.000Probably Damaging0.999Probably Damaging3.43Benign0.34Tolerated0.28880.2717-3-24.1-99.14
c.1286G>C
R429P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R429P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b; AlphaMissense‑Default and FoldX are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of tools and the high‑accuracy methods favor a pathogenic interpretation. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.390504Uncertain0.9590.2900.000-9.771Likely Pathogenic0.556AmbiguousLikely Benign1.53Ambiguous0.25.13Destabilizing3.33Destabilizing1.01Destabilizing0.265Likely Benign-2.89Deleterious1.000Probably Damaging1.000Probably Damaging3.43Benign0.25Tolerated0.18810.37900-22.9-59.07
c.1296T>G
C432W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C432W is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments reinforce this: AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM‑Consensus indicates a likely pathogenic status, and Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result, providing no counter‑evidence. Overall, the preponderance of evidence from both general and high‑accuracy predictors points to a pathogenic effect. This conclusion is consistent with the absence of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.111485Structured0.362533Uncertain0.9600.2850.000-13.936Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.17Ambiguous0.40.72Ambiguous0.95Ambiguous0.58Ambiguous0.433Likely Benign-10.50Deleterious1.000Probably Damaging0.995Probably Damaging3.43Benign0.00Affected0.12170.3246-8-2-3.483.07
c.1298C>T
A433V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A433V missense variant is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438203‑C‑T). Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign and Foldetta as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive and therefore unavailable as evidence. Overall, the majority of predictions support a benign impact, and this is consistent with the lack of ClinVar pathogenic classification. Thus, the variant is most likely benign based on current computational evidence, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.098513Structured0.352258Uncertain0.9380.3020.0006-33438203-C-T2401.49e-4-8.200Likely Pathogenic0.129Likely BenignLikely Benign0.48Likely Benign0.1-0.07Likely Benign0.21Likely Benign0.48Likely Benign0.096Likely Benign-2.91Deleterious0.994Probably Damaging0.527Possibly Damaging3.43Benign0.04Affected3.37290.07530.5104002.428.05214.5-45.80.00.00.00.2XPotentially BenignThe methyl group of Ala433, located on the outer surface of an α helix (res. Met414-Glu436), does not interact with any nearby residues in the WT simulations. In the variant simulations, the iso-propyl side chain of Val433, which has a similarly hydrophobic profile as alanine, also does not form any lasting interactions at the helix surface. Accordingly, the residue swap does not negatively affect the protein structure based on the simulations.
c.1318A>G
N440D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N440D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Only ESM1b predicts a pathogenic outcome, while FoldX, Foldetta, and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.191378Structured0.267204Uncertain0.9290.2450.000-9.335Likely Pathogenic0.407AmbiguousLikely Benign-0.62Ambiguous0.0-0.41Likely Benign-0.52Ambiguous0.47Likely Benign0.074Likely Benign-1.71Neutral0.229Benign0.045Benign3.43Benign0.43Tolerated0.15440.2025210.00.98
c.1318A>T
N440Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N440Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, AlphaMissense‑Optimized, and polyPhen2_HumVar. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen2_HumDiv, AlphaMissense‑Default, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicating pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, yielding an uncertain stability change. Overall, the majority of predictions lean toward a benign interpretation, and this is consistent with the lack of ClinVar annotation. Therefore, the variant is most likely benign, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.267204Uncertain0.9290.2450.000-10.586Likely Pathogenic0.674Likely PathogenicLikely Benign0.81Ambiguous0.11.25Ambiguous1.03Ambiguous0.20Likely Benign0.135Likely Benign-3.81Deleterious0.931Possibly Damaging0.230Benign3.43Benign0.07Tolerated0.05350.3624-2-22.249.07
c.1321G>C
V441L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V441L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Only ESM1b predicts a pathogenic outcome, while Rosetta and AlphaMissense‑Default are uncertain. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. No prediction or folding result is missing or inconclusive. Overall, the variant is most likely benign based on the preponderance of evidence, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.161087Structured0.259875Uncertain0.9180.2490.000-9.546Likely Pathogenic0.395AmbiguousLikely Benign-0.43Likely Benign0.00.59Ambiguous0.08Likely Benign0.45Likely Benign0.135Likely Benign-2.27Neutral0.165Benign0.028Benign3.43Benign0.11Tolerated0.09610.388121-0.414.03
c.1325A>C
K442T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K442T missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) indicates a benign stability change; AlphaMissense‑Optimized remains inconclusive. Overall, the predictions are evenly split, with no single consensus. Thus, the variant is most likely benign based on the majority of evidence, and this assessment does not contradict any ClinVar record (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.170161Structured0.255766Uncertain0.9120.2250.000-11.273Likely Pathogenic0.865Likely PathogenicAmbiguous0.30Likely Benign0.20.21Likely Benign0.26Likely Benign0.22Likely Benign0.330Likely Benign-5.01Deleterious0.999Probably Damaging0.999Probably Damaging3.43Benign0.07Tolerated0.15100.28590-13.2-27.07
c.1330A>C
K444Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 K444Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (majority vote) is pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for K444Q, and this conclusion does not conflict with any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.262172Uncertain0.9550.2130.000-12.876Likely Pathogenic0.992Likely PathogenicLikely Pathogenic1.34Ambiguous0.01.36Ambiguous1.35Ambiguous1.04Destabilizing0.382Likely Benign-3.82Deleterious0.998Probably Damaging0.997Probably Damaging3.43Benign0.07Tolerated0.41120.1057110.4-0.04
c.1382C>T
A461V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A461V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, FATHMM, AlphaMissense‑Optimized, and polyPhen2_HumVar. Tools that predict a pathogenic effect are PROVEAN, polyPhen2_HumDiv, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Because the majority of standard predictors (nine benign vs. three pathogenic) favor a benign outcome, the variant is most likely benign, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.179055Structured0.292531Uncertain0.9360.1510.125-9.968Likely Pathogenic0.436AmbiguousLikely Benign-0.08Likely Benign0.30.34Likely Benign0.13Likely Benign0.02Likely Benign0.141Likely Benign-3.05Deleterious0.983Probably Damaging0.273Benign3.43Benign0.66Tolerated0.08190.5078002.428.05
c.1385A>G
K462R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K462R is catalogued in gnomAD (ID 6‑33438290‑A‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Three tools (Rosetta, Foldetta, premPS) yield uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic) and Foldetta is uncertain, so neither provides decisive evidence. Overall, the majority of reliable predictors lean toward a benign effect. This consensus does not contradict ClinVar status, which is currently absent. Thus, based on available predictions, K462R is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.264545Structured0.297737Uncertain0.9210.1590.1256-33438290-A-G16.20e-7-9.980Likely Pathogenic0.184Likely BenignLikely Benign0.13Likely Benign0.10.90Ambiguous0.52Ambiguous0.84Ambiguous0.246Likely Benign-2.75Deleterious0.983Probably Damaging0.962Probably Damaging3.43Benign0.09Tolerated3.37340.49950.120123-0.628.01
c.1417G>C
V473L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V473L is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, and Foldetta, while those that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; Rosetta is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as benign. Overall, the majority of tools (seven pathogenic vs. six benign) indicate a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.362529Uncertain0.8840.2390.000-9.073Likely Pathogenic0.966Likely PathogenicLikely Pathogenic-0.29Likely Benign0.1-0.52Ambiguous-0.41Likely Benign0.35Likely Benign0.336Likely Benign-2.85Deleterious0.929Possibly Damaging0.917Probably Damaging3.43Benign0.21Tolerated0.07080.392121-0.414.03
c.1417G>T
V473L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V473L is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, and Foldetta, while those that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; Rosetta is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as benign. Overall, the majority of tools (seven pathogenic vs. six benign) indicate a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.362529Uncertain0.8840.2390.000-9.073Likely Pathogenic0.966Likely PathogenicLikely Pathogenic-0.29Likely Benign0.1-0.52Ambiguous-0.41Likely Benign0.35Likely Benign0.335Likely Benign-2.85Deleterious0.929Possibly Damaging0.917Probably Damaging3.43Benign0.21Tolerated0.07080.392121-0.414.03
c.1435C>G
R479G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R479G is reported in gnomAD (ID 6-33438467-C-G) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise AlphaMissense‑Default, ESM1b, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, Rosetta, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta, which assess protein‑folding stability, returned uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as pathogenic, and Foldetta as inconclusive. Overall, the majority of computational evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation. Therefore, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.216401Structured0.419256Uncertain0.8200.2490.0006-33438467-C-G16.20e-7-8.600Likely Pathogenic0.624Likely PathogenicLikely Benign0.97Ambiguous0.02.51Destabilizing1.74Ambiguous0.71Ambiguous0.228Likely Benign-2.82Deleterious1.000Probably Damaging1.000Probably Damaging3.43Benign0.42Tolerated3.39320.29110.2707-2-34.1-99.14
c.1442A>C
H481P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H481P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, and FATHMM. Those that predict a pathogenic effect comprise SGM Consensus (Likely Pathogenic), PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and PROVEAN. Tools with inconclusive results are Foldetta (Uncertain) and premPS (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta remains uncertain. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-10.205Likely Pathogenic0.630Likely PathogenicLikely Benign-0.48Likely Benign0.33.69Destabilizing1.61Ambiguous0.67Ambiguous0.385Likely Benign-5.84Deleterious1.000Probably Damaging1.000Probably Damaging3.43Benign0.26Tolerated0.19790.35530-21.6-40.02
c.1458G>C
E486D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E486D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign calls (REVEL, FoldX, Rosetta, SIFT, FATHMM) and pathogenic calls (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default). Two tools are uncertain (premPS, AlphaMissense‑Optimized). High‑accuracy assessments give mixed results: AlphaMissense‑Optimized is inconclusive; the SGM‑Consensus majority vote (AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Because the majority of standard predictors lean toward pathogenic and the SGM‑Consensus also indicates pathogenic, the variant is most likely pathogenic, although the Foldetta benign prediction and the presence of uncertain calls leave room for ambiguity. This assessment does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.196879Structured0.358545Uncertain0.8330.2450.125-10.363Likely Pathogenic0.914Likely PathogenicAmbiguous0.19Likely Benign0.00.38Likely Benign0.29Likely Benign0.54Ambiguous0.166Likely Benign-2.58Deleterious0.994Probably Damaging0.979Probably Damaging3.43Benign0.16Tolerated0.14530.4115320.0-14.03
c.1458G>T
E486D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E486D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign calls (REVEL, FoldX, Rosetta, SIFT, FATHMM) and pathogenic calls (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default). Two tools are uncertain (premPS, AlphaMissense‑Optimized). High‑accuracy assessments give mixed results: AlphaMissense‑Optimized is inconclusive; the SGM‑Consensus majority vote (AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Because the majority of standard predictors lean toward pathogenic and the SGM‑Consensus also indicates pathogenic, the variant is most likely pathogenic, although the Foldetta benign prediction and the presence of uncertain calls leave room for ambiguity. This assessment does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.196879Structured0.358545Uncertain0.8330.2450.125-10.363Likely Pathogenic0.914Likely PathogenicAmbiguous0.19Likely Benign0.00.38Likely Benign0.29Likely Benign0.54Ambiguous0.166Likely Benign-2.58Deleterious0.994Probably Damaging0.979Probably Damaging3.43Benign0.16Tolerated0.14530.4115320.0-14.03
c.1502T>G
I501S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I501S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are FATHMM and AlphaMissense‑Optimized; all other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized indicates a benign change, whereas the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both predict pathogenicity. Overall, the preponderance of evidence points to a pathogenic effect for I501S. This conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.079919Structured0.366596Uncertain0.8860.1530.000-9.914Likely Pathogenic0.677Likely PathogenicLikely Benign3.23Destabilizing0.22.40Destabilizing2.82Destabilizing1.79Destabilizing0.511Likely Pathogenic-5.14Deleterious1.000Probably Damaging1.000Probably Damaging3.43Benign0.04Affected0.23700.0858-1-2-5.3-26.08
c.1524T>A
D508E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D508E is reported in gnomAD (ID 6‑33438556‑T‑A) and has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the protein‑stability method Foldetta. Only PROVEAN predicts a pathogenic outcome, while Rosetta and premPS are inconclusive. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates benign. Overall, the majority of evidence points to a benign effect, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.019401Structured0.255890Uncertain0.8900.2280.0006-33438556-T-A16.20e-7-5.959Likely Benign0.242Likely BenignLikely Benign-0.39Likely Benign0.10.99Ambiguous0.30Likely Benign0.59Ambiguous0.118Likely Benign-3.16Deleterious0.005Benign0.006Benign3.43Benign0.20Tolerated3.37350.17660.4304230.014.03
c.1524T>G
D508E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D508E missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Foldetta, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign) all classify the change as benign. Only PROVEAN predicts a pathogenic outcome, while Rosetta and premPS are inconclusive. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized reports benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates benign stability. Based on the preponderance of evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.019401Structured0.255890Uncertain0.8900.2280.000-5.959Likely Benign0.242Likely BenignLikely Benign-0.39Likely Benign0.10.99Ambiguous0.30Likely Benign0.59Ambiguous0.118Likely Benign-3.16Deleterious0.005Benign0.006Benign3.43Benign0.20Tolerated3.37350.17660.4304230.014.03
c.1553A>C
Y518S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y518S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SIFT and FATHMM, whereas the remaining tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic”; AlphaMissense‑Optimized is uncertain; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic effect. Taken together, the preponderance of evidence points to a pathogenic effect for Y518S, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.139895Structured0.126970Uncertain0.8970.3210.000-12.453Likely Pathogenic0.912Likely PathogenicAmbiguous2.76Destabilizing0.82.45Destabilizing2.61Destabilizing1.61Destabilizing0.551Likely Pathogenic-8.38Deleterious1.000Probably Damaging1.000Probably Damaging3.43Benign0.06Tolerated0.39480.1059-3-20.5-76.10
c.1676G>T
C559F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C559F is not reported in ClinVar (ClinVar ID = None) and has no entry in gnomAD (gnomAD ID = None). Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the predictions are split evenly, but the two most reliable tools (AlphaMissense‑Optimized and Foldetta) both indicate a benign effect, whereas the consensus pathogenic tool is a single outlier. Thus, the variant is most likely benign based on the current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.016021Structured0.010460Uncertain0.8420.2040.000-13.194Likely Pathogenic0.779Likely PathogenicLikely Benign-0.43Likely Benign0.0-0.04Likely Benign-0.24Likely Benign0.29Likely Benign0.576Likely Pathogenic-8.48Deleterious0.999Probably Damaging0.996Probably Damaging3.43Benign0.09Tolerated0.22340.2653-4-20.344.04
c.1688G>T
R563M
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R563M is reported in gnomAD (ID 6‑33440740‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, FATHMM, premPS, and Foldetta; pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (integrating FoldX‑MD and Rosetta outputs) as benign. No prediction or stability result is missing; all available data are considered. Overall, the balance of evidence leans toward a pathogenic effect, with a single high‑accuracy tool (Foldetta) suggesting benign stability. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.039760Structured0.031987Uncertain0.8760.2090.0006-33440740-G-T-8.910Likely Pathogenic0.934Likely PathogenicAmbiguous-0.18Likely Benign0.10.70Ambiguous0.26Likely Benign0.17Likely Benign0.311Likely Benign-4.91Deleterious1.000Probably Damaging0.998Probably Damaging3.43Benign0.04Affected3.37350.16360.2230-106.4-24.99
c.1700A>C
E567A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E567A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, SIFT, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Four tools (Foldetta, premPS, Rosetta, AlphaMissense‑Optimized) yield uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic effect. This conclusion is not contradicted by ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.021816Structured0.051008Uncertain0.9160.2340.000-12.854Likely Pathogenic0.902Likely PathogenicAmbiguous0.43Likely Benign0.11.79Ambiguous1.11Ambiguous0.63Ambiguous0.418Likely Benign-5.74Deleterious1.000Probably Damaging0.999Probably Damaging3.43Benign0.17Tolerated0.31700.51890-15.3-58.04
c.1921T>G
S641A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S641A is not reported in ClinVar and is absent from gnomAD. Across the available in‑silico predictors, every tool examined (REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly classifies the substitution as benign. No pathogenic predictions are present. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports a benign effect. Consequently, the variant is most likely benign based on current predictions, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.125101Structured0.157322Uncertain0.7860.2700.000-6.103Likely Benign0.092Likely BenignLikely Benign0.37Likely Benign0.2-0.28Likely Benign0.05Likely Benign0.27Likely Benign0.067Likely Benign-2.07Neutral0.000Benign0.001Benign3.43Benign0.17Tolerated0.48730.4680112.6-16.00
c.1930G>C
D644H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D644H missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and polyPhen2_HumVar. Tools that predict a pathogenic effect are PROVEAN, polyPhen2_HumDiv, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and Foldetta as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. No other high‑accuracy predictions are available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.066181Structured0.248888Uncertain0.8830.3200.000-6.786Likely Benign0.771Likely PathogenicLikely Benign0.34Likely Benign0.1-0.83Ambiguous-0.25Likely Benign0.09Likely Benign0.284Likely Benign-2.93Deleterious0.789Possibly Damaging0.158Benign3.43Benign0.07Tolerated0.16560.63061-10.322.05
c.1963C>A
L655M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L655M is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify the change as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts pathogenicity. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign; the SGM Consensus indicates “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Based on the unanimous benign predictions and the absence of any pathogenic calls, the variant is most likely benign, and this conclusion does not contradict the ClinVar status (which has no entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.015344Structured0.268808Uncertain0.9610.2740.000-3.077Likely Benign0.083Likely BenignLikely Benign0.21Likely Benign0.00.25Likely Benign0.23Likely Benign-0.22Likely Benign0.076Likely Benign0.58Neutral0.048Benign0.037Benign3.43Benign0.18Tolerated0.09790.325242-1.918.03
c.1971G>C
W657C
2D
AISynGAP1 missense variant W657C is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that classify the variant as benign include REVEL and FATHMM. Those that predict a deleterious effect are FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; Rosetta reports an uncertain outcome. High‑accuracy assessments further support a damaging interpretation: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Overall, the preponderance of evidence indicates that W657C is most likely pathogenic, which does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.030611Structured0.208729Uncertain0.9410.2450.000Uncertain 1-12.035Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.74Destabilizing0.31.69Ambiguous2.22Destabilizing1.30Destabilizing0.463Likely Benign-11.06Deleterious1.000Probably Damaging0.982Probably Damaging3.43Benign0.03Affected0.38340.0766-8-23.4-83.07
c.1971G>T
W657C
2D
AIThe SynGAP1 W657C missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the majority of tools (SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact; Foldetta also supports pathogenicity, while Rosetta remains uncertain. High‑accuracy assessments further reinforce a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a pathogenic effect. Overall, the preponderance of evidence points to the variant being most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.030611Structured0.208729Uncertain0.9410.2450.000-12.035Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.74Destabilizing0.31.69Ambiguous2.22Destabilizing1.30Destabilizing0.463Likely Benign-11.06Deleterious1.000Probably Damaging0.982Probably Damaging3.43Benign0.03Affected0.38340.0766-8-23.4-83.07
c.1998G>C
E666D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E666D is listed in ClinVar with an uncertain significance (ID 587483.0) and is not reported in gnomAD. Functional prediction tools show a mixed signal: benign calls come from REVEL, SIFT, FATHMM, AlphaMissense‑Optimized, and Rosetta; pathogenic calls come from premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as likely pathogenic. High‑accuracy assessments give AlphaMissense‑Optimized a benign prediction, while the SGM Consensus remains pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the balance of evidence slightly favors a pathogenic interpretation, but the predictions are not unequivocal. Thus, the variant is most likely pathogenic according to the current computational data, and this does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.086870Uncertain0.9250.3870.000Uncertain 1-8.820Likely Pathogenic0.704Likely PathogenicLikely Benign0.88Ambiguous0.00.37Likely Benign0.63Ambiguous1.05Destabilizing0.197Likely Benign-2.69Deleterious0.992Probably Damaging0.603Possibly Damaging3.43Benign0.06Tolerated3.38280.19260.3092320.0-14.03237.216.50.00.0-0.30.1XPotentially PathogenicThe carboxylate group of Glu666, located on the α-helix (res. Ser641-Glu666), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), such as Lys566, Thr672, and Asn669, in the WT simulations. In the variant simulations, the shorter side chain of Asp666 cannot maintain these interactions as efficiently as Glu666 in the WT, resulting in a less coordinated hydrogen-bond network.
c.1998G>T
E666D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E666D missense variant is not reported in ClinVar (ClinVar ID: None) and has no entry in gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, Rosetta, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are SGM Consensus, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus (a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. FoldX alone is also uncertain, so these results are treated as unavailable. Overall, the balance of evidence leans toward a pathogenic impact for E666D, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.086870Uncertain0.9250.3870.000-8.820Likely Pathogenic0.704Likely PathogenicLikely Benign0.88Ambiguous0.00.37Likely Benign0.63Ambiguous1.05Destabilizing0.197Likely Benign-2.69Deleterious0.992Probably Damaging0.603Possibly Damaging3.43Benign0.06Tolerated3.38280.19260.3092320.0-14.03237.216.50.00.0-0.30.1XPotentially PathogenicThe carboxylate group of Glu666, located on the α-helix (res. Ser641-Glu666), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), such as Lys566, Thr672, and Asn669, in the WT simulations. In the variant simulations, the shorter side chain of Asp666 cannot maintain these interactions as efficiently as Glu666 in the WT, resulting in a less coordinated hydrogen-bond network.
c.2009T>G
L670R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L670R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining tools—FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of reliable predictions indicate a benign effect. There is no ClinVar annotation to contradict this assessment, so the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.161087Structured0.090855Uncertain0.8120.3850.000-9.801Likely Pathogenic0.552AmbiguousLikely Benign0.64Ambiguous0.11.42Ambiguous1.03Ambiguous0.67Ambiguous0.193Likely Benign-1.74Neutral0.993Probably Damaging0.755Possibly Damaging3.43Benign0.41Tolerated0.13270.1145-3-2-8.343.03
c.2014A>T
T672S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T672S is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS (uncertain), PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign or likely benign. No tool predicts pathogenicity. High‑accuracy methods corroborate this: AlphaMissense‑Optimized reports benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields “Likely Benign”; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.116183Structured0.102069Uncertain0.5860.3620.000-4.932Likely Benign0.097Likely BenignLikely Benign-0.13Likely Benign0.10.29Likely Benign0.08Likely Benign0.61Ambiguous0.044Likely Benign-2.32Neutral0.006Benign0.010Benign3.43Benign0.09Tolerated0.30050.428211-0.1-14.03
c.2015C>G
T672R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T672R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, Foldetta, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Uncertain results from Rosetta and premPS are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus indicates a likely pathogenic outcome. Overall, the majority of individual predictors lean toward pathogenicity, but the high‑accuracy tools provide conflicting benign signals. Therefore, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.102069Uncertain0.5860.3620.000-12.454Likely Pathogenic0.626Likely PathogenicLikely Benign-0.48Likely Benign0.41.19Ambiguous0.36Likely Benign0.60Ambiguous0.084Likely Benign-4.47Deleterious0.886Possibly Damaging0.377Benign3.43Benign0.02Affected0.09960.2919-1-1-3.855.08
c.2032A>G
S678G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, PROVEAN, PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, SIFT, REVEL, FoldX, premPS, and Foldetta. No tool predicts a pathogenic outcome; the only inconclusive result is from Rosetta, which is listed as “Uncertain.” High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.301917Structured0.123585Uncertain0.6600.3210.000-4.379Likely Benign0.069Likely BenignLikely Benign0.24Likely Benign0.20.55Ambiguous0.40Likely Benign-0.24Likely Benign0.082Likely Benign1.90Neutral0.000Benign0.001Benign3.43Benign1.00Tolerated0.28070.4961100.4-30.03
c.2033G>A
S678N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678N is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID 6‑33441292‑G‑A). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Overall, the variant is most likely benign, and this conclusion does not contradict ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.301917Structured0.123585Uncertain0.6600.3210.0006-33441292-G-A16.20e-7-3.355Likely Benign0.139Likely BenignLikely Benign-0.10Likely Benign0.1-0.47Likely Benign-0.29Likely Benign0.38Likely Benign0.067Likely Benign-0.63Neutral0.001Benign0.002Benign3.43Benign0.14Tolerated3.43190.14350.486311-2.727.03
c.2047A>C
I683L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I683L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and ESM1b. Remaining methods (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction, while Foldetta remains uncertain. Overall, the balance of evidence favors a benign impact for I683L, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.200174Structured0.143268Uncertain0.8480.3140.000-9.988Likely Pathogenic0.488AmbiguousLikely Benign0.63Ambiguous0.10.76Ambiguous0.70Ambiguous0.69Ambiguous0.286Likely Benign-2.00Neutral0.011Benign0.056Benign3.43Benign0.04Affected0.09570.318522-0.70.00
c.2071A>C
T691P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T691P is listed in ClinVar (ID 648126.0) as Pathogenic and is not reported in gnomAD. Across the broad panel of in‑silico predictors, three tools (REVEL, SIFT, FATHMM) classify the change as benign, whereas the remaining 11 predictors (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score) report it as pathogenic. High‑accuracy assessments further support a deleterious effect: the AlphaMissense‑Optimized model is inconclusive, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and the Foldetta stability analysis (combining FoldX‑MD and Rosetta outputs) is pathogenic. Taken together, the preponderance of evidence indicates that T691P is most likely pathogenic, which is consistent with its ClinVar classification and does not contradict the database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.060549Structured0.271308Uncertain0.9410.2320.000Likely Pathogenic 1-13.801Likely Pathogenic0.905Likely PathogenicAmbiguous5.04Destabilizing0.46.09Destabilizing5.57Destabilizing1.27Destabilizing0.214Likely Benign-3.43Deleterious1.000Probably Damaging0.952Probably Damaging3.43Benign0.06Tolerated3.43140.14660.42360-1-0.9-3.99188.933.00.10.0-0.60.0XXPotentially PathogenicThe hydroxyl side chain of Thr691, located in an α-helix (res. Leu696-Leu685), can form hydrogen bonds with the backbone carbonyl and the side chain guanidinium group of Arg687. This interaction facilitates the simultaneous formation of salt bridges between Arg687 and Glu688 on the same α-helix. Additionally, Thr691 occasionally interacts with the thioether side chain of Met409 in an anti-parallel β-sheet of the C2 domain (res. Ile411-Ala399), although this interaction is not consistently maintained throughout the WT simulations. In the variant simulations, the pyrrolidine side chain of Pro691 lacks hydrogen bond donors, making a similar setup impossible. Moreover, proline lacks a free amide group necessary for hydrogen bonding with the carbonyl group of Arg687, introducing a slight bend in the α-helix and compromising its integrity.
c.2105A>G
Q702R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q702R is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Predictions that remain inconclusive are Rosetta, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to equal benign and pathogenic signals. Overall, the majority of available predictions lean toward a benign impact, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000Uncertain 1-7.894In-Between0.348AmbiguousLikely Benign-0.31Likely Benign0.10.63Ambiguous0.16Likely Benign0.13Likely Benign0.294Likely Benign-3.14Deleterious0.909Possibly Damaging0.889Possibly Damaging3.43Benign0.02Affected3.47100.12250.060511-1.028.06270.3-52.90.00.00.00.1XPotentially PathogenicThe carboxamide side chain of Gln702 is located at the end and outer surface of an α-helix (res. Leu685-Gln702), where it does not directly form hydrogen bonds with any residues in the WT simulations. In the variant simulations, the positively charged guanidinium group of Arg702 forms a salt bridge with the negatively charged carboxylate group of Glu698 on the same helix and/or hydrogen bonds with the backbone carbonyl group of Ala438 on an opposite α-helix (res. Tyr428-Glu436). Consequently, the residue swap could strengthen the tertiary structure assembly, which could have either positive or negative effects on its function.
c.2119G>T
A707S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A707S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate benign. In contrast, polyPhen‑2 HumDiv and HumVar classify the variant as pathogenic. Stability‑based methods (FoldX, Rosetta, Foldetta) are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence supports a benign impact, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.203355Structured0.371229Uncertain0.9270.3650.000-4.432Likely Benign0.113Likely BenignLikely Benign0.70Ambiguous0.10.63Ambiguous0.67Ambiguous0.28Likely Benign0.150Likely Benign-1.07Neutral0.848Possibly Damaging0.945Probably Damaging3.43Benign0.08Tolerated0.18250.292411-2.616.00
c.2143C>T
P715S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P715S is listed in ClinVar as pathogenic (ClinVar ID 1804065.0) and is present in gnomAD (ID 6‑33441608‑C‑T). Functional prediction tools that agree on a benign effect are REVEL and FATHMM. Those that predict a pathogenic effect include FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. Predictions that are inconclusive are Rosetta, premPS, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of evidence points to a pathogenic impact, which is consistent with the ClinVar classification and does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.243554Structured0.409757Uncertain0.9560.3620.000Likely Pathogenic 16-33441608-C-T16.20e-7-7.635In-Between0.787Likely PathogenicAmbiguous3.54Destabilizing0.00.81Ambiguous2.18Destabilizing0.94Ambiguous0.277Likely Benign-7.17Deleterious1.000Probably Damaging0.998Probably Damaging3.43Benign0.01Affected3.5090.29770.37551-10.8-10.04231.8-14.0-0.10.0-0.80.1XUncertainPro715, along with Gly712 and Pro713, are located in a hinge region of an α-helix making a ~90-degree turn (res. Lys705-Leu725). In the WT simulations, the pyrrolidine side chain of Pro715, lacking the backbone amide groups altogether, forces the tight helix turn to take place while also hydrophobically packing with nearby residues (e.g., Leu700, Leu708, Leu714, and Leu718). Leu715, with a normal amide backbone, could potentially affect protein folding and turn formation, although this was not observed in the variant simulations. Additionally, the hydroxyl group of the Ser715 side chain can form hydrogen bonds with the backbone carbonyl group of Gly712 and disrupt the hydrophobic packing arrangement of the leucine residues from the neighboring α-helices, impacting the GAP domain tertiary assembly.
c.2149C>A
L717I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L717I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only two tools—polyPhen‑2 HumDiv and HumVar—predict a pathogenic outcome, while premPS is inconclusive. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts Benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) reports Benign. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.239899Structured0.429342Uncertain0.9690.3970.000-4.836Likely Benign0.168Likely BenignLikely Benign0.27Likely Benign0.00.33Likely Benign0.30Likely Benign-0.73Ambiguous0.182Likely Benign0.60Neutral0.997Probably Damaging0.989Probably Damaging3.43Benign1.00Tolerated0.07120.2570220.70.00
c.2190C>G
I730M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730M is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta outputs)—all uniformly indicate a benign impact. No prediction or folding‑stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-3.149Likely Benign0.110Likely BenignLikely Benign-0.15Likely Benign0.10.31Likely Benign0.08Likely Benign-0.15Likely Benign0.042Likely Benign-0.77Neutral0.993Probably Damaging0.914Probably Damaging3.43Benign0.09Tolerated0.06980.215921-2.618.03
c.592C>A
L198I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L198I is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Uncertain or inconclusive results come from AlphaMissense‑Default, FoldX, Rosetta, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.444081Structured0.431715Uncertain0.5720.4850.125-10.411Likely Pathogenic0.563AmbiguousLikely Benign0.59Ambiguous0.10.70Ambiguous0.65Ambiguous0.10Likely Benign0.234Likely Benign-1.72Neutral0.990Probably Damaging0.760Possibly Damaging3.43Benign0.00Affected0.09210.3307220.70.00
c.1242G>A
M414I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 M414I missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta is also inconclusive. Overall, more tools (five) predict pathogenicity than benign (four), and no ClinVar evidence contradicts this assessment. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.081712Structured0.329108Uncertain0.9140.2170.000-6.203Likely Benign0.972Likely PathogenicLikely Pathogenic0.83Ambiguous0.00.86Ambiguous0.85Ambiguous0.84Ambiguous0.265Likely Benign-3.00Deleterious0.870Possibly Damaging0.801Possibly Damaging3.44Benign0.36Tolerated0.11680.3161212.6-18.03
c.1242G>C
M414I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M414I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 vs 2), and Foldetta is uncertain, so these results are treated as unavailable. Overall, the majority of evaluated tools (5 pathogenic vs 4 benign) and the single high‑accuracy pathogenic prediction support a likely pathogenic classification. This assessment does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.081712Structured0.329108Uncertain0.9140.2170.000-6.203Likely Benign0.972Likely PathogenicLikely Pathogenic0.83Ambiguous0.00.86Ambiguous0.85Ambiguous0.84Ambiguous0.265Likely Benign-3.00Deleterious0.870Possibly Damaging0.801Possibly Damaging3.44Benign0.36Tolerated0.11680.3161212.6-18.03
c.1242G>T
M414I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M414I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 vs 2), and Foldetta is uncertain, so these results are treated as unavailable. Overall, the majority of evaluated tools (5 pathogenic vs 4 benign) and the single high‑accuracy pathogenic prediction support a likely pathogenic classification. This assessment does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.081712Structured0.329108Uncertain0.9140.2170.000-6.203Likely Benign0.972Likely PathogenicLikely Pathogenic0.83Ambiguous0.00.86Ambiguous0.85Ambiguous0.84Ambiguous0.265Likely Benign-3.00Deleterious0.870Possibly Damaging0.801Possibly Damaging3.44Benign0.36Tolerated0.11680.3161212.6-18.03
c.1262C>A
A421E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A421E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM, whereas pathogenic calls are made by ESM1b, PROVEAN, AlphaMissense‑Default, AlphaMissense‑Optimized, Rosetta, premPS, and the SGM‑Consensus score (Likely Pathogenic). Stability‑based methods give mixed results: FoldX is uncertain, Foldetta is uncertain, and Rosetta alone predicts pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Overall, the majority of evidence, including the high‑accuracy tools, points to a pathogenic impact for A421E, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-11.993Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.63Ambiguous0.22.07Destabilizing1.35Ambiguous1.30Destabilizing0.233Likely Benign-4.24Deleterious0.368Benign0.144Benign3.44Benign0.14Tolerated0.12880.18300-1-5.358.04
c.1274C>A
T425N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, FoldX, and FATHMM, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Predictions labeled uncertain (Foldetta, premPS, AlphaMissense‑Optimized, Rosetta) are treated as unavailable. High‑accuracy assessments further indicate a likely pathogenic outcome from the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and an uncertain result from AlphaMissense‑Optimized and Foldetta. Overall, the majority of definitive predictions support a pathogenic effect, and this conclusion does not contradict any ClinVar annotation because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.401218Uncertain0.9640.2800.000-10.709Likely Pathogenic0.925Likely PathogenicAmbiguous0.19Likely Benign0.10.81Ambiguous0.50Ambiguous0.82Ambiguous0.185Likely Benign-3.87Deleterious1.000Probably Damaging0.999Probably Damaging3.44Benign0.04Affected0.11690.284300-2.813.00
c.1274C>T
T425I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T425I is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic, whereas Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the balance of evidence slightly favors a pathogenic interpretation, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.401218Uncertain0.9640.2800.000-10.443Likely Pathogenic0.982Likely PathogenicLikely Pathogenic-0.04Likely Benign0.20.07Likely Benign0.02Likely Benign0.30Likely Benign0.268Likely Benign-5.30Deleterious0.999Probably Damaging0.989Probably Damaging3.44Benign0.06Tolerated0.08270.40230-15.212.05
c.1279C>T
H427Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H427Y missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and polyPhen‑2 HumVar, as well as the SGM‑Consensus “Likely Benign” call. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, and SIFT. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta)—all uniformly indicate a benign effect. No prediction or folding‑stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.081712Structured0.394261Uncertain0.9620.2870.000-6.824Likely Benign0.328Likely BenignLikely Benign-0.08Likely Benign0.0-0.37Likely Benign-0.23Likely Benign0.18Likely Benign0.180Likely Benign-3.47Deleterious0.815Possibly Damaging0.073Benign3.44Benign0.01Affected0.09580.4029021.926.03
c.1300G>T
V434F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V434F is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that indicate a benign effect include REVEL, premPS, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; SGM‑Consensus predicts pathogenic; Foldetta predicts pathogenic. All predictions are available and none are inconclusive. Based on the overall distribution of predictions, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.158265Structured0.342846Uncertain0.9540.3060.000-12.553Likely Pathogenic0.672Likely PathogenicLikely Benign3.64Destabilizing0.13.27Destabilizing3.46Destabilizing0.27Likely Benign0.417Likely Benign-3.93Deleterious0.999Probably Damaging0.993Probably Damaging3.44Benign0.04Affected0.05960.3391-1-1-1.448.04
c.1310C>A
P437H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P437H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, and FATHMM, whereas those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Predictions that are inconclusive or unavailable are FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts a likely pathogenic outcome, while AlphaMissense‑Optimized and Foldetta remain uncertain. Overall, the balance of evidence favors a pathogenic classification for P437H, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.306196Uncertain0.9210.2980.000-13.496Likely Pathogenic0.826Likely PathogenicAmbiguous1.19Ambiguous0.0-3.28Stabilizing-1.05Ambiguous0.31Likely Benign0.343Likely Benign-7.75Deleterious1.000Probably Damaging0.995Probably Damaging3.44Benign0.01Affected0.18190.43280-2-1.640.02
c.1322T>C
V441A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant V441A is listed in ClinVar as uncertain and is present in gnomAD (ID 6‑33438227‑T‑C). Consensus from most in silico predictors favors a benign effect: REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized all report benign. Pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, and ESM1b, while premPS and AlphaMissense‑Default remain uncertain. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports benign. Overall, the preponderance of evidence points to a benign impact, aligning with the ClinVar uncertain designation rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.161087Structured0.259875Uncertain0.9180.2490.000Conflicting 26-33438227-T-C31.86e-6-9.439Likely Pathogenic0.359AmbiguousLikely Benign-0.14Likely Benign0.00.33Likely Benign0.10Likely Benign0.95Ambiguous0.053Likely Benign-2.92Deleterious0.513Possibly Damaging0.214Benign3.44Benign0.93Tolerated3.37290.23900.180000-2.4-28.05195.044.60.00.10.50.0XXUncertainThe iso-propyl side chain of Val441, located on the outer surface of an α helix (res. Asn440-Thr458), does not interact with other residues in the WT simulations. In the variant simulations, the methyl side chain of Ala441 is similarly hydrophobic and does not form any interactions on the outer helix surface. Although the residue swap does not negatively affect the protein structure based on the simulations, it is noteworthy that the residue faces the RasGTPase interface. Thus, the effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1339G>T
V447F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant V447F is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that classify the variant as benign include REVEL, premPS, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized labeling the variant benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports an uncertain effect on protein folding. Overall, the majority of predictions lean toward pathogenicity, suggesting the variant is most likely pathogenic, a conclusion that does not conflict with the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.250310Structured0.283801Uncertain0.9700.2430.000Uncertain 1-8.673Likely Pathogenic0.701Likely PathogenicLikely Benign1.40Ambiguous0.30.61Ambiguous1.01Ambiguous0.20Likely Benign0.206Likely Benign-2.62Deleterious0.999Probably Damaging0.993Probably Damaging3.44Benign0.03Affected0.05510.3055-1-1-1.448.04
c.1390T>A
F464I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are limited to FATHMM, while all other evaluated algorithms—including SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-11.210Likely Pathogenic0.996Likely PathogenicLikely Pathogenic4.77Destabilizing0.24.35Destabilizing4.56Destabilizing1.23Destabilizing0.539Likely Pathogenic-5.97Deleterious0.998Probably Damaging0.994Probably Damaging3.44Benign0.03Affected0.14390.2002101.7-34.02
c.1457A>C
E486A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E486A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, premPS, SIFT, and FATHMM, whereas pathogenic predictions are made by SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive and therefore unavailable. Overall, the majority of evidence supports a pathogenic effect. The prediction aligns with the lack of ClinVar annotation, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.196879Structured0.358545Uncertain0.8330.2450.125-11.902Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.63Ambiguous0.00.32Likely Benign0.48Likely Benign-0.03Likely Benign0.398Likely Benign-5.17Deleterious0.999Probably Damaging0.998Probably Damaging3.44Benign0.39Tolerated0.35610.58590-15.3-58.04
c.1502T>C
I501T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I501T is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and premPS, while Rosetta remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of predictions lean toward a benign effect, and this does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.079919Structured0.366596Uncertain0.8860.1530.000Uncertain 1-5.996Likely Benign0.252Likely BenignLikely Benign2.40Destabilizing0.11.81Ambiguous2.11Destabilizing1.57Destabilizing0.362Likely Benign-3.48Deleterious1.000Probably Damaging1.000Probably Damaging3.44Benign0.16Tolerated3.37350.09720.06400-1-5.2-12.05214.526.90.00.00.50.0XPotentially PathogenicIle501 is located near a hinge in the middle of an α-helix (res. Leu489-Glu519). The sec-butyl side chain of Ile501 is hydrophobically packed with other residues in the inter-helix space (e.g., Leu500, Tyr497, Phe679) in the WT simulations. In the variant simulations, the hydroxyl group of Thr501 forms a hydrogen bond with the backbone atoms of Tyr497 on the same α-helix, which may weaken the α-helix integrity. Additionally, the polar hydroxyl group of Thr501 is not suitable for the hydrophobic inter-helix space, and thus, the residue swap could affect protein folding. However, Ile501 is followed by Gly502, which facilitates a hinge in the middle of the α-helix, making further weakening caused by Thr501 unlikely to be harmful to the α-helix integrity.
c.1906T>A
F636I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F636I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) reports pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among both general and high‑accuracy tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.071525Uncertain0.9130.2640.000-14.031Likely Pathogenic0.983Likely PathogenicLikely Pathogenic2.96Destabilizing0.24.57Destabilizing3.77Destabilizing1.10Destabilizing0.501Likely Pathogenic-5.78Deleterious0.994Probably Damaging0.977Probably Damaging3.44Benign0.03Affected0.16600.2153101.7-34.02
c.1906T>G
F636V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F636V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.041405Structured0.071525Uncertain0.9130.2640.000-14.603Likely Pathogenic0.975Likely PathogenicLikely Pathogenic3.06Destabilizing0.15.13Destabilizing4.10Destabilizing1.07Destabilizing0.533Likely Pathogenic-6.74Deleterious0.991Probably Damaging0.985Probably Damaging3.44Benign0.04Affected0.18410.2030-1-11.4-48.04
c.1930G>T
D644Y
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D644Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, premPS, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default; the SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports it as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Uncertain. The remaining tools, FoldX, REVEL, premPS, polyPhen‑2 HumVar, and FATHMM, support a benign effect, while PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default support a pathogenic effect. Overall, the majority of evidence leans toward pathogenicity, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.066181Structured0.248888Uncertain0.8830.3200.000-10.143Likely Pathogenic0.721Likely PathogenicLikely Benign0.03Likely Benign0.1-1.18Ambiguous-0.58Ambiguous-0.04Likely Benign0.318Likely Benign-4.93Deleterious0.968Probably Damaging0.311Benign3.44Benign0.02Affected0.06790.6094-4-32.248.09
c.1933T>A
F645I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F645I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM, while pathogenic predictions are given by premPS, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Optimized) report uncertain or inconclusive outcomes. High‑accuracy assessments indicate that AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta is uncertain. Overall, the majority of evaluated predictors (five pathogenic vs four benign) lean toward a pathogenic effect. Therefore, the variant is most likely pathogenic, and this assessment does not contradict ClinVar status, which currently has no entry for F645I.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.046336Structured0.276445Uncertain0.9210.3250.000-13.055Likely Pathogenic0.878Likely PathogenicAmbiguous1.12Ambiguous0.21.68Ambiguous1.40Ambiguous1.01Destabilizing0.299Likely Benign-4.24Deleterious0.190Benign0.019Benign3.44Benign0.04Affected0.19200.2891101.7-34.02
c.1933T>C
F645L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F645L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; pathogenic predictions arise from SGM‑Consensus (Likely Pathogenic), PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. No evidence from FoldX, Rosetta, or premPS is available to alter this view. Overall, the majority of computational evidence points to a pathogenic impact for F645L, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.046336Structured0.276445Uncertain0.9210.3250.000-10.624Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.98Ambiguous0.11.25Ambiguous1.12Ambiguous0.99Ambiguous0.264Likely Benign-4.24Deleterious0.116Benign0.008Benign3.44Benign0.03Affected0.22140.3873201.0-34.02
c.1935T>A
F645L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F645L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; pathogenic predictions arise from SGM‑Consensus (Likely Pathogenic), PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. No evidence from FoldX, Rosetta, or premPS is available to alter this view. Overall, the majority of computational evidence points to a pathogenic impact for F645L, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.046336Structured0.276445Uncertain0.9210.3250.000-10.624Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.98Ambiguous0.11.25Ambiguous1.12Ambiguous0.99Ambiguous0.159Likely Benign-4.24Deleterious0.116Benign0.008Benign3.44Benign0.03Affected0.22140.3873201.0-34.02
c.1935T>G
F645L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F645L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that assess sequence conservation and structural impact fall into two groups: benign predictions are made by REVEL, polyPhen‑2 (HumDiv and HumVar), and FATHMM; pathogenic predictions are made by SGM‑Consensus (Likely Pathogenic), PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. No evidence from FoldX‑MD, Rosetta, or premPS is available to alter this conclusion. Overall, the majority of computational evidence points to a pathogenic impact for F645L, and this assessment is consistent with the absence of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.046336Structured0.276445Uncertain0.9210.3250.000-10.624Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.98Ambiguous0.11.25Ambiguous1.12Ambiguous0.99Ambiguous0.159Likely Benign-4.24Deleterious0.116Benign0.008Benign3.44Benign0.03Affected0.22140.3873201.0-34.02
c.1939G>T
G647C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G647C is not reported in ClinVar and is absent from gnomAD. Across the available in‑silico predictors, the majority (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus “Likely Benign”) uniformly predict a benign effect, whereas only SIFT classifies the change as pathogenic. High‑accuracy tools give consistent benign results: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) reports a benign stability change. No prediction or folding‑stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.048328Structured0.325524Uncertain0.9360.3560.000-2.955Likely Benign0.112Likely BenignLikely Benign0.41Likely Benign0.0-0.20Likely Benign0.11Likely Benign0.05Likely Benign0.112Likely Benign-1.63Neutral0.003Benign0.004Benign3.44Benign0.02Affected0.11940.3250-3-32.946.09
c.1960G>A
E654K
2D
AIThe SynGAP1 missense variant E654K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, polyPhen‑2 HumVar, SIFT, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). The high‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts pathogenic, Foldetta predicts benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic. Overall, the majority of high‑confidence predictions lean toward pathogenicity, and the variant is not contradicted by any ClinVar annotation. Thus, based on the available computational evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.026892Structured0.303029Uncertain0.9570.3110.000-12.587Likely Pathogenic0.968Likely PathogenicLikely Pathogenic0.12Likely Benign0.30.53Ambiguous0.33Likely Benign-0.17Likely Benign0.435Likely Benign-3.80Deleterious0.921Possibly Damaging0.303Benign3.44Benign0.11Tolerated0.23650.422401-0.4-0.94
c.1966G>A
E656K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E656K has no ClinVar entry and is absent from gnomAD. Prediction tools that classify it as benign include Rosetta, premPS, and FATHMM. Those that predict pathogenicity are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; the SGM‑Consensus score is “Likely Pathogenic.” FoldX and Foldetta return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, while Foldetta’s stability prediction is inconclusive. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not conflict with the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.032017Structured0.242242Uncertain0.9630.2640.000-13.833Likely Pathogenic0.992Likely PathogenicLikely Pathogenic-1.06Ambiguous0.00.02Likely Benign-0.52Ambiguous0.16Likely Benign0.502Likely Pathogenic-3.49Deleterious0.985Probably Damaging0.553Possibly Damaging3.44Benign0.03Affected0.30010.640601-0.4-0.94
c.1967A>G
E656G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E656G missense variant has no ClinVar entry and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic calls come from REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Only premPS and FATHMM predict a benign outcome, while FoldX and Foldetta are inconclusive. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenicity; Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E656G, and this conclusion is not contradicted by ClinVar status, which currently lacks an entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.032017Structured0.242242Uncertain0.9630.2640.000-14.112Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.96Ambiguous0.12.02Destabilizing1.49Ambiguous0.22Likely Benign0.534Likely Pathogenic-6.28Deleterious1.000Probably Damaging0.941Probably Damaging3.44Benign0.05Affected0.32160.52080-23.1-72.06
c.1997A>T
E666V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E666V missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools show mixed results: benign calls come from REVEL, Rosetta, Foldetta, premPS, polyPhen‑2 HumVar, and FATHMM, while pathogenic calls come from PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports a benign effect. FoldX alone is uncertain. Overall, the majority of tools and the high‑accuracy consensus favor a pathogenic interpretation, with no conflict from ClinVar status because no classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.086870Uncertain0.9250.3870.000-10.870Likely Pathogenic0.981Likely PathogenicLikely Pathogenic0.61Ambiguous0.10.08Likely Benign0.35Likely Benign0.31Likely Benign0.476Likely Benign-5.95Deleterious0.575Possibly Damaging0.214Benign3.44Benign0.03Affected0.08180.5613-2-27.7-29.98
c.2014A>G
T672A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T672A is listed in ClinVar as Benign (ClinVar ID 2154412.0) and is present in gnomAD (variant ID 6‑33441273‑A‑G). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only PROVEAN predicts a pathogenic outcome. Uncertain results are reported for FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Benign, and Foldetta as Uncertain. Overall, the preponderance of evidence points to a benign effect, and this conclusion is consistent with the ClinVar designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.116183Structured0.102069Uncertain0.5860.3620.000Benign 16-33441273-A-G31.86e-6-6.524Likely Benign0.109Likely BenignLikely Benign0.51Ambiguous0.31.15Ambiguous0.83Ambiguous0.65Ambiguous0.046Likely Benign-3.20Deleterious0.006Benign0.002Benign3.44Benign0.12Tolerated3.40250.36870.4380102.5-30.03188.542.5-0.10.30.20.0XPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. In the variant simulations, Ala672 can only form a hydrogen bond with Lys566 via its backbone carbonyl group. Consequently, it cannot maintain the Lys566-Glu666 salt bridge through hydrogen bonding, leading to a significant disruption of the intricate and stable hydrogen-bond network between the loop and the helices.
c.2021C>A
T674N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T674N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome; ESM1b is uncertain and does not influence the consensus. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized reports Benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. No contradictory evidence is present. **Based on the aggregate predictions, the variant is most likely benign, and this conclusion does not conflict with the ClinVar status.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.129801Structured0.109297Uncertain0.5210.3490.000-7.839In-Between0.135Likely BenignLikely Benign-0.21Likely Benign0.00.15Likely Benign-0.03Likely Benign0.19Likely Benign0.119Likely Benign-0.71Neutral0.958Probably Damaging0.671Possibly Damaging3.44Benign0.17Tolerated0.12630.497900-2.813.00
c.2025C>A
N675K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N675K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, Rosetta, and FATHMM, whereas pathogenic calls are made by FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported for Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized is inconclusive, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta remains uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not conflict with ClinVar, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.129801Structured0.111024Uncertain0.5130.3330.000-12.851Likely Pathogenic0.898Likely PathogenicAmbiguous2.88Destabilizing1.20.06Likely Benign1.47Ambiguous0.74Ambiguous0.177Likely Benign-4.75Deleterious0.993Probably Damaging0.688Possibly Damaging3.44Benign0.02Affected0.24240.604010-0.414.07
c.2025C>G
N675K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N675K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, and FATHMM, whereas a majority (FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. Tools with inconclusive results are Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the balance of evidence favors a pathogenic classification for N675K, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.129801Structured0.111024Uncertain0.5130.3330.000-12.851Likely Pathogenic0.898Likely PathogenicAmbiguous2.88Destabilizing1.20.06Likely Benign1.47Ambiguous0.74Ambiguous0.177Likely Benign-4.75Deleterious0.993Probably Damaging0.688Possibly Damaging3.44Benign0.02Affected0.24240.604010-0.414.07
c.2032A>C
S678R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign), and Foldetta predicts a benign effect. Overall, the majority of tools (8 benign vs. 4 pathogenic) support a benign classification. Thus, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.301917Structured0.123585Uncertain0.6600.3210.000-9.708Likely Pathogenic0.878Likely PathogenicAmbiguous-0.37Likely Benign0.20.48Likely Benign0.06Likely Benign0.32Likely Benign0.106Likely Benign-2.07Neutral0.454Possibly Damaging0.057Benign3.44Benign0.02Affected0.09500.35190-1-3.769.11
c.2034C>A
S678R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SIFT, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is classified as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign), and Foldetta predicts a benign effect. Overall, the majority of evidence (8 benign vs. 4 pathogenic) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.301917Structured0.123585Uncertain0.6600.3210.000-9.708Likely Pathogenic0.878Likely PathogenicAmbiguous-0.37Likely Benign0.20.48Likely Benign0.06Likely Benign0.32Likely Benign0.158Likely Benign-2.07Neutral0.454Possibly Damaging0.057Benign3.44Benign0.02Affected0.09500.35190-1-3.769.11
c.2034C>G
S678R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is classified as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta predicts a benign stability change. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.301917Structured0.123585Uncertain0.6600.3210.000-9.708Likely Pathogenic0.878Likely PathogenicAmbiguous-0.37Likely Benign0.20.48Likely Benign0.06Likely Benign0.32Likely Benign0.157Likely Benign-2.07Neutral0.454Possibly Damaging0.057Benign3.44Benign0.02Affected0.09500.35190-1-3.769.11
c.2050G>T
D684Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D684Y is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess the variant’s effect largely agree on a deleterious outcome: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. Only premPS and FATHMM predict a benign effect. High‑accuracy methods reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict the absence of ClinVar reporting.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.153798Uncertain0.8700.2820.000-15.224Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.65Destabilizing1.52.12Destabilizing2.89Destabilizing-0.06Likely Benign0.600Likely Pathogenic-8.98Deleterious1.000Probably Damaging0.963Probably Damaging3.44Benign0.00Affected0.05750.6564-4-32.248.09
c.2051A>T
D684V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D684V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic calls come from REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized, while only premPS and FATHMM predict a benign outcome. High‑accuracy assessments reinforce the pathogenic interpretation: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No evidence suggests a benign effect, and the lack of ClinVar annotation means there is no conflicting clinical classification. Therefore, the variant is most likely pathogenic, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.153798Uncertain0.8700.2820.000-16.128Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.86Destabilizing1.12.06Destabilizing2.96Destabilizing0.07Likely Benign0.601Likely Pathogenic-8.98Deleterious0.901Possibly Damaging0.480Possibly Damaging3.44Benign0.00Affected0.07750.6209-2-37.7-15.96
c.2065C>A
L689I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L689I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, AlphaMissense‑Optimized, and polyPhen2_HumVar, while those that predict a pathogenic effect are polyPhen2_HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also unavailable. No folding‑stability evidence supports a deleterious change. Overall, the balance of evidence slightly favors a benign interpretation, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.042364Structured0.227227Uncertain0.9630.2480.000-11.196Likely Pathogenic0.677Likely PathogenicLikely Benign1.71Ambiguous0.11.12Ambiguous1.42Ambiguous0.85Ambiguous0.180Likely Benign-1.97Neutral0.822Possibly Damaging0.381Benign3.44Benign0.00Affected0.09210.3479220.70.00
c.2068T>C
S690P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S690P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that indicate a benign effect are REVEL and FATHMM, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all predict a pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Overall, the preponderance of evidence from multiple independent predictors indicates that the variant is most likely pathogenic, a conclusion that does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.055536Structured0.247926Uncertain0.9440.2530.000Uncertain 1-14.568Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.84Destabilizing0.34.40Destabilizing4.62Destabilizing1.42Destabilizing0.431Likely Benign-4.77Deleterious0.998Probably Damaging0.790Possibly Damaging3.44Benign0.01Affected3.42170.17870.40501-1-0.810.04207.515.10.10.0-0.10.2XXPotentially PathogenicThe hydroxyl side chain of Ser690, located in an α-helix (res. Leu696-Leu685), forms a hydrogen bond with the backbone carbonyl group of Ser410 in an anti-parallel β-sheet of the C2 domain (res. Ile411-Ala399). In the variant simulations, the pyrrolidine side chain of Pro690 cannot form hydrogen bonds with the C2 domain residue, resulting in the loss of this inter-domain connection. Additionally, prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Gly686, introducing a slight bend in the α-helix and compromising its integrity.
c.2080G>C
A694P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A694P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, while the majority of other in silico predictors (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate a pathogenic impact; premPS is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves as Likely Pathogenic, with three of four votes pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. Taken together, the preponderance of evidence points to a pathogenic effect for A694P. This conclusion is consistent with the absence of ClinVar annotation and gnomAD data, and there is no contradiction with existing clinical databases.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.127496Structured0.352199Uncertain0.9380.2690.000-10.569Likely Pathogenic0.987Likely PathogenicLikely Pathogenic3.39Destabilizing0.25.59Destabilizing4.49Destabilizing0.82Ambiguous0.209Likely Benign-2.77Deleterious0.988Probably Damaging0.578Possibly Damaging3.44Benign0.03Affected0.22650.38291-1-3.426.04
c.2089T>G
W697G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 W697G missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. In contrast, a majority of tools predict a pathogenic outcome: FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar). AlphaMissense‑Default and ESM1b are uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it receives one benign, one pathogenic, and two uncertain calls. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus remains unavailable. Overall, the preponderance of evidence from multiple independent pathogenicity predictors and the protein‑stability assessment by Foldetta indicates that W697G is most likely pathogenic. This conclusion is not contradicted by ClinVar, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.175930Structured0.400169Uncertain0.9450.2970.000-7.429In-Between0.480AmbiguousLikely Benign2.57Destabilizing0.12.38Destabilizing2.48Destabilizing1.21Destabilizing0.485Likely Benign-8.93Deleterious1.000Probably Damaging0.987Probably Damaging3.44Benign0.06Tolerated0.39650.1482-7-20.5-129.16
c.2101C>A
P701T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P701T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify the substitution as benign: REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a tolerated change. No tool predicts pathogenicity. The high‑accuracy consensus methods corroborate this: AlphaMissense‑Optimized is benign; the SGM Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports benign. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive, and FoldX alone is uncertain, so these results are treated as unavailable. Overall, the evidence strongly supports a benign effect for P701T, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.074921Structured0.404318Uncertain0.9180.3450.000-6.920Likely Benign0.272Likely BenignLikely Benign1.61Ambiguous0.00.11Likely Benign0.86Ambiguous-0.18Likely Benign0.144Likely Benign-0.43Neutral0.084Benign0.050Benign3.44Benign0.70Tolerated0.13980.41600-10.93.99
c.2129A>G
K710R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K710R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments—all of which are available—show benign predictions: AlphaMissense‑Optimized is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.321458Structured0.370438Uncertain0.9490.3680.000-6.295Likely Benign0.141Likely BenignLikely Benign0.04Likely Benign0.0-0.14Likely Benign-0.05Likely Benign0.29Likely Benign0.209Likely Benign-2.78Deleterious0.983Probably Damaging0.962Probably Damaging3.44Benign0.02Affected0.33510.078932-0.628.01
c.2135G>C
G712A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 G712A missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Two tools report uncertainty: premPS and AlphaMissense‑Default. High‑accuracy assessments further refine the picture. AlphaMissense‑Optimized classifies the variant as benign. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also yields a benign verdict (2 benign vs. 1 pathogenic vote). Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic effect. Because the majority of conventional predictors (7/11) indicate pathogenicity, the overall consensus leans toward a pathogenic impact, despite the mixed high‑accuracy results. This conclusion does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.278302Structured0.384858Uncertain0.9470.3650.000-6.444Likely Benign0.553AmbiguousLikely Benign2.89Destabilizing0.14.98Destabilizing3.94Destabilizing0.70Ambiguous0.281Likely Benign-4.99Deleterious0.999Probably Damaging0.991Probably Damaging3.44Benign0.02Affected0.39930.4105102.214.03
c.425A>T
K142I
2D
AIThe SynGAP1 missense variant K142I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas those that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts Pathogenic, and the SGM‑Consensus also indicates Likely Pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of computational evidence points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.461924Structured0.558796Binding0.3740.8590.500-14.597Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.296Likely Benign-4.81Deleterious0.700Possibly Damaging0.403Benign3.44Benign0.00Affected0.10050.3173-2-38.4-15.01
c.551A>T
E184V
2D
AIThe SynGAP1 missense variant E184V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic calls come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized, while benign calls are made only by REVEL and FATHMM. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized scores the variant as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability analysis is available for this variant. Overall, the preponderance of evidence indicates that E184V is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.557691Disordered0.431514Uncertain0.3480.6220.625-13.119Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.371Likely Benign-5.72Deleterious0.997Probably Damaging0.879Possibly Damaging3.44Benign0.00Affected0.09950.8511-2-27.7-29.98
c.592C>G
L198V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L198V variant has no ClinVar record and is not listed in gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled Likely Pathogenic. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (3 pathogenic vs. 1 benign) indicates pathogenicity; Foldetta remains uncertain. Overall, the majority of evaluated tools predict a pathogenic impact, and this is not contradicted by any ClinVar annotation (none exists). Thus, the variant is most likely pathogenic based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.444081Structured0.431715Uncertain0.5720.4850.125-9.343Likely Pathogenic0.747Likely PathogenicLikely Benign1.10Ambiguous0.21.24Ambiguous1.17Ambiguous0.34Likely Benign0.265Likely Benign-2.54Deleterious0.990Probably Damaging0.675Possibly Damaging3.44Benign0.00Affected0.15200.3017210.4-14.03
c.1268A>T
Y423F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y423F is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess sequence conservation and functional impact uniformly classify the substitution as benign: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic effect, while premPS is inconclusive. High‑accuracy methods give consistent benign results: AlphaMissense‑Optimized is benign, the SGM‑Consensus is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta) predicts benign stability. Overall, the overwhelming majority of evidence supports a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.088832Structured0.421885Uncertain0.9750.2420.000-5.533Likely Benign0.181Likely BenignLikely Benign0.03Likely Benign0.1-0.05Likely Benign-0.01Likely Benign0.76Ambiguous0.149Likely Benign-2.30Neutral0.999Probably Damaging0.985Probably Damaging3.45Benign0.60Tolerated0.19340.2337734.1-16.00
c.1283A>C
Y428S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y428S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM. All other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact, while AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus indicates “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic effect. Based on the overwhelming majority of predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.000-10.936Likely Pathogenic0.928Likely PathogenicAmbiguous3.00Destabilizing0.03.42Destabilizing3.21Destabilizing2.00Destabilizing0.505Likely Pathogenic-8.59Deleterious1.000Probably Damaging1.000Probably Damaging3.45Benign0.03Affected0.46230.2352-3-20.5-76.10
c.1294T>C
C432R
2D
3DClick to see structure in 3D Viewer
AIClinVar has no entry for this SynGAP1 missense variant, and it is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM. The majority of algorithms predict a pathogenic impact: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). FoldX and Foldetta report uncertain results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, while Foldetta remains inconclusive. Overall, the consensus of the available predictions indicates that the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.111485Structured0.362533Uncertain0.9600.2850.000-13.858Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.03Ambiguous0.22.05Destabilizing1.54Ambiguous1.73Destabilizing0.690Likely Pathogenic-11.46Deleterious0.999Probably Damaging0.993Probably Damaging3.45Benign0.01Affected0.13590.1766-4-3-7.053.05
c.1294T>G
C432G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C432G has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM. Those that predict a pathogenic effect comprise SGM‑Consensus, REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Predictions that are inconclusive or uncertain are FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points to a pathogenic impact. This conclusion is consistent with the absence of a ClinVar classification; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.111485Structured0.362533Uncertain0.9600.2850.000-10.247Likely Pathogenic0.831Likely PathogenicAmbiguous1.37Ambiguous0.02.25Destabilizing1.81Ambiguous1.60Destabilizing0.631Likely Pathogenic-11.46Deleterious1.000Probably Damaging1.000Probably Damaging3.45Benign0.03Affected0.27960.2130-3-3-2.9-46.09
c.1295G>A
C432Y
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant C432Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized, while benign predictions are reported by REVEL, Rosetta, FATHMM, and Foldetta. Tools with uncertain or missing results (FoldX, premPS) are not considered evidence. High‑accuracy methods give mixed signals: AlphaMissense‑Optimized and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predict pathogenicity, whereas Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. Overall, the majority of predictions support a pathogenic impact, and this conclusion does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.111485Structured0.362533Uncertain0.9600.2850.000-13.720Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.62Ambiguous0.30.31Likely Benign0.47Likely Benign0.71Ambiguous0.441Likely Benign-10.50Deleterious0.999Probably Damaging0.993Probably Damaging3.45Benign0.02Affected0.08570.34380-2-3.860.04
c.1309C>A
P437T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P437T missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. The remaining tools—FoldX, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicting pathogenic, and Foldetta yielding an uncertain stability change. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.175930Structured0.306196Uncertain0.9210.2980.000-13.011Likely Pathogenic0.484AmbiguousLikely Benign1.35Ambiguous0.0-3.46Stabilizing-1.06Ambiguous0.54Ambiguous0.305Likely Benign-6.67Deleterious0.999Probably Damaging0.985Probably Damaging3.45Benign0.01Affected0.16590.57820-10.93.99
c.1331A>C
K444T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K444T is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM. Those that predict a pathogenic effect include FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools with uncertain or inconclusive results are Foldetta, Rosetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain (treated as unavailable for pathogenicity inference). Overall, the majority of reliable predictions indicate a pathogenic impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.262172Uncertain0.9550.2130.000-15.557Likely Pathogenic0.991Likely PathogenicLikely Pathogenic2.12Destabilizing0.11.17Ambiguous1.65Ambiguous0.96Ambiguous0.442Likely Benign-5.73Deleterious0.999Probably Damaging1.000Probably Damaging3.45Benign0.01Affected0.16430.34160-13.2-27.07
c.1331A>G
K444R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K444R is not reported in ClinVar and has no gnomAD allele. Prediction tools cluster into benign (REVEL, FoldX, SIFT, FATHMM, AlphaMissense‑Optimized) and pathogenic (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default). Two tools (Rosetta, premPS) give uncertain results. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta predicts benign. No prediction or folding stability result is missing. Overall, six tools favor pathogenicity while five favor benignity, and the high‑accuracy consensus leans toward benign. Thus the variant is most likely pathogenic based on the broader set of predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.262172Uncertain0.9550.2130.000-10.753Likely Pathogenic0.693Likely PathogenicLikely Benign-0.12Likely Benign0.1-0.61Ambiguous-0.37Likely Benign0.77Ambiguous0.213Likely Benign-2.86Deleterious0.972Probably Damaging0.926Probably Damaging3.45Benign0.12Tolerated0.45970.097232-0.628.01
c.1358A>T
H453L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H453L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, premPS, SIFT, FATHMM, and the protein‑folding stability method Foldetta; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments indicate that AlphaMissense‑Optimized is uncertain, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta predicts benign. Overall, the predictions are split, with a slight edge toward pathogenicity from the consensus and high‑accuracy tools, but the presence of several benign calls and the uncertainty of AlphaMissense‑Optimized temper this conclusion. Thus, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-10.438Likely Pathogenic0.834Likely PathogenicAmbiguous-0.59Ambiguous0.10.04Likely Benign-0.28Likely Benign0.31Likely Benign0.413Likely Benign-10.87Deleterious0.998Probably Damaging0.973Probably Damaging3.45Benign0.11Tolerated0.08410.4964-2-37.0-23.98
c.1359C>A
H453Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H453Q is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic outcome: SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Tools with uncertain or inconclusive results—FoldX, Rosetta, premPS, AlphaMissense‑Optimized, and Foldetta—are treated as unavailable for pathogenicity assessment. High‑accuracy methods specifically show SGM‑Consensus as Likely Pathogenic, AlphaMissense‑Optimized as uncertain, and Foldetta as uncertain. Overall, the preponderance of evidence from consensus and high‑accuracy predictors indicates that H453Q is most likely pathogenic, and this assessment does not contradict the current ClinVar status, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-10.894Likely Pathogenic0.893Likely PathogenicAmbiguous0.90Ambiguous0.11.55Ambiguous1.23Ambiguous0.92Ambiguous0.259Likely Benign-7.91Deleterious1.000Probably Damaging0.993Probably Damaging3.45Benign0.09Tolerated0.12230.311230-0.3-9.01
c.1359C>G
H453Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H453Q is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic outcome: SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Tools with uncertain or inconclusive results—FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized—are treated as unavailable for pathogenicity assessment. High‑accuracy methods specifically show SGM‑Consensus as Likely Pathogenic, AlphaMissense‑Optimized as Uncertain, and Foldetta as Uncertain. Overall, the preponderance of evidence points to a pathogenic effect for H453Q. This prediction does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-10.894Likely Pathogenic0.893Likely PathogenicAmbiguous0.90Ambiguous0.11.55Ambiguous1.23Ambiguous0.92Ambiguous0.258Likely Benign-7.91Deleterious1.000Probably Damaging0.993Probably Damaging3.45Benign0.09Tolerated0.12230.311230-0.3-9.01
c.1553A>G
Y518C
2D
AIThe SynGAP1 missense variant Y518C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into three groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default; and uncertain results from Rosetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus indicates likely pathogenic, and Foldetta predicts pathogenic folding instability. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.139895Structured0.126970Uncertain0.8970.3210.000-9.813Likely Pathogenic0.794Likely PathogenicAmbiguous2.99Destabilizing0.91.70Ambiguous2.35Destabilizing0.69Ambiguous0.415Likely Benign-8.35Deleterious1.000Probably Damaging1.000Probably Damaging3.45Benign0.16Tolerated0.29050.11280-23.8-60.04
c.1676G>A
C559Y
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant C559Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, premPS, SIFT, and FATHMM. Those that predict pathogenicity are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Because the evidence is split evenly between benign and pathogenic predictions and the high‑accuracy tools disagree, the variant is best classified as of uncertain significance. This assessment does not contradict ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.016021Structured0.010460Uncertain0.8420.2040.000-11.767Likely Pathogenic0.868Likely PathogenicAmbiguous-0.37Likely Benign0.0-0.19Likely Benign-0.28Likely Benign0.36Likely Benign0.561Likely Pathogenic-8.39Deleterious0.999Probably Damaging0.996Probably Damaging3.45Benign0.10Tolerated0.20940.21350-2-3.860.04
c.1699G>A
E567K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E567K is not reported in ClinVar (no entry) and is absent from gnomAD. Prediction tools cluster into two groups: benign calls come from REVEL, FoldX, SIFT, and FATHMM, while pathogenic calls arise from Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (likely pathogenic). High‑accuracy methods reinforce the pathogenic assessment: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, remains uncertain. PremPS is likewise inconclusive. Overall, the majority of evidence points to a pathogenic effect, and this conclusion is not contradicted by ClinVar status or gnomAD presence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.021816Structured0.051008Uncertain0.9160.2340.000-15.568Likely Pathogenic0.984Likely PathogenicLikely Pathogenic-0.18Likely Benign0.02.61Destabilizing1.22Ambiguous0.65Ambiguous0.380Likely Benign-3.75Deleterious0.999Probably Damaging0.994Probably Damaging3.45Benign0.16Tolerated0.21150.555201-0.4-0.94
c.1909T>A
S637T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S637T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive result is from Rosetta, which is treated as unavailable. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.076542Structured0.083482Uncertain0.9200.2530.000-4.116Likely Benign0.092Likely BenignLikely Benign0.36Likely Benign0.1-0.91Ambiguous-0.28Likely Benign-0.39Likely Benign0.067Likely Benign-0.19Neutral0.086Benign0.019Benign3.45Benign0.19Tolerated0.16750.4572110.114.03
c.1919C>A
T640N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T640N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as tolerated or benign. Only the protein‑stability predictors FoldX and Rosetta returned uncertain results, which are treated as unavailable evidence. High‑accuracy assessments corroborate the benign prediction: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also reports a benign effect. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.066181Structured0.137043Uncertain0.8930.2840.000-4.258Likely Benign0.107Likely BenignLikely Benign-0.50Ambiguous0.20.53Ambiguous0.02Likely Benign0.03Likely Benign0.097Likely Benign0.51Neutral0.229Benign0.084Benign3.45Benign0.25Tolerated0.15180.407900-2.813.00
c.1930G>A
D644N
2D
AIThe SynGAP1 missense variant D644N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM—all classifying the substitution as benign. No tool predicts pathogenicity. The only inconclusive result is AlphaMissense‑Default, which is listed as uncertain and therefore does not influence the overall assessment. High‑accuracy methods further support a benign outcome: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports benign. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.066181Structured0.248888Uncertain0.8830.3200.000-4.389Likely Benign0.360AmbiguousLikely Benign0.06Likely Benign0.3-0.28Likely Benign-0.11Likely Benign0.02Likely Benign0.124Likely Benign-2.28Neutral0.007Benign0.001Benign3.45Benign0.25Tolerated0.13680.6261210.0-0.98
c.1940G>A
G647D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G647D is reported in ClinVar as having no entry and is present in gnomAD (6‑33441199‑G‑A). Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized all predict benign. Only AlphaMissense‑Default predicts pathogenic, while FoldX, Foldetta, premPS, and ESM1b are uncertain. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields benign; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain. Overall, the consensus of most tools and the high‑accuracy predictions indicate that G647D is most likely benign, and this is consistent with the absence of a pathogenic ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.048328Structured0.325524Uncertain0.9360.3560.0006-33441199-G-A16.20e-7-7.643In-Between0.582Likely PathogenicLikely Benign0.68Ambiguous0.10.33Likely Benign0.51Ambiguous0.56Ambiguous0.098Likely Benign-1.63Neutral0.282Benign0.128Benign3.45Benign0.24Tolerated3.37300.16300.1372-11-3.158.04
c.1942T>C
F648L
2D
AISynGAP1 missense variant F648L is listed in ClinVar with an uncertain significance (ClinVar ID 3383902.0) and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas the remaining tools—FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, AlphaMissense‑Optimized, and ESM1b—consistently predict pathogenicity. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates likely pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized scores pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic change. Taken together, the preponderance of evidence points to a pathogenic impact for F648L, which contradicts the current ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.346782Uncertain0.9430.3390.000Uncertain 1-9.296Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.71Destabilizing0.82.08Destabilizing2.40Destabilizing1.04Destabilizing0.468Likely Benign-5.98Deleterious0.999Probably Damaging0.976Probably Damaging3.45Benign0.08Tolerated0.19610.3126201.0-34.02
c.1944C>A
F648L
2D
AIThe SynGAP1 missense variant F648L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, while the remaining 12 tools—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic effect. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized is pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic; and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic. Because the majority of evidence points to a deleterious impact and there is no ClinVar annotation to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.346782Uncertain0.9430.3390.000-9.296Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.71Destabilizing0.82.08Destabilizing2.40Destabilizing1.04Destabilizing0.319Likely Benign-5.98Deleterious0.999Probably Damaging0.976Probably Damaging3.45Benign0.08Tolerated0.19610.3126201.0-34.02
c.1944C>G
F648L
2D
AIThe SynGAP1 missense variant F648L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM. In contrast, the majority of tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), AlphaMissense‑Default, AlphaMissense‑Optimized, and ESM1b all indicate pathogenicity, and the SGM Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are missing or inconclusive. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion is consistent with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.346782Uncertain0.9430.3390.000-9.296Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.71Destabilizing0.82.08Destabilizing2.40Destabilizing1.04Destabilizing0.319Likely Benign-5.98Deleterious0.999Probably Damaging0.976Probably Damaging3.45Benign0.08Tolerated0.19610.3126201.0-34.02
c.1963C>G
L655V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L655V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, SGM‑Consensus indicates likely benign, while Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. No tools predict pathogenicity, and the uncertain stability assessment does not alter the overall benign inference. Therefore, based on the available predictions, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.015344Structured0.268808Uncertain0.9610.2740.000-6.743Likely Benign0.127Likely BenignLikely Benign0.78Ambiguous0.00.58Ambiguous0.68Ambiguous0.38Likely Benign0.058Likely Benign-0.62Neutral0.008Benign0.003Benign3.45Benign0.44Tolerated0.15510.3190210.4-14.03
c.1993T>C
Y665H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y665H is not reported in ClinVar (ClinVar status: not reported) but is present in gnomAD (gnomAD ID: 6‑33441252‑T‑C). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Tools with uncertain or inconclusive results are FoldX, Foldetta, and AlphaMissense‑Default. High‑accuracy methods give a benign consensus: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta remains uncertain. Overall, the majority of predictions (7 benign vs. 4 pathogenic) and the high‑accuracy consensus support a benign classification. This conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.098513Structured0.086641Uncertain0.9220.3610.0006-33441252-T-C21.24e-6-9.303Likely Pathogenic0.389AmbiguousLikely Benign0.85Ambiguous0.00.28Likely Benign0.57Ambiguous1.12Destabilizing0.129Likely Benign-2.00Neutral1.000Probably Damaging0.996Probably Damaging3.45Benign0.48Tolerated3.38280.21220.051320-1.9-26.03
c.1994A>G
Y665C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y665C is listed in ClinVar with no assertion (status: None) and is present in gnomAD (ID 6‑33441253‑A‑G). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. FoldX, Rosetta, and Foldetta give uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is also unavailable. Overall, the evidence is mixed, but the majority of high‑confidence tools lean toward a benign interpretation. Thus, the variant is most likely benign based on current predictions, and this does not contradict the ClinVar status, which remains unclassified.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.098513Structured0.086641Uncertain0.9220.3610.0006-33441253-A-G16.20e-7-9.007Likely Pathogenic0.261Likely BenignLikely Benign1.05Ambiguous0.11.60Ambiguous1.33Ambiguous1.12Destabilizing0.210Likely Benign-3.22Deleterious1.000Probably Damaging0.981Probably Damaging3.45Benign0.14Tolerated3.38280.25620.2019-203.8-60.04
c.1994A>T
Y665F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y665F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only ESM1b predicts a pathogenic outcome, while Rosetta and Foldetta are uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” status. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the preponderance of evidence points to a benign impact. This conclusion is consistent with the absence of a ClinVar claim; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.098513Structured0.086641Uncertain0.9220.3610.000-8.460Likely Pathogenic0.100Likely BenignLikely Benign0.07Likely Benign0.11.03Ambiguous0.55Ambiguous0.38Likely Benign0.106Likely Benign-1.23Neutral0.159Benign0.036Benign3.45Benign0.47Tolerated0.22770.3076734.1-16.00
c.1997A>C
E666A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E666A missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, and FATHMM, while those that agree on a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools give inconclusive results: FoldX (Uncertain) and AlphaMissense‑Optimized (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts Pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive because FoldX is Uncertain while Rosetta is Benign. Overall, the majority of available predictions (six pathogenic vs. five benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.086870Uncertain0.9250.3870.000-11.122Likely Pathogenic0.921Likely PathogenicAmbiguous0.57Ambiguous0.10.18Likely Benign0.38Likely Benign0.50Likely Benign0.407Likely Benign-5.15Deleterious0.992Probably Damaging0.863Possibly Damaging3.45Benign0.07Tolerated0.39500.48780-15.3-58.04
c.2012A>G
D671G
2D
AIThe SynGAP1 D671G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, whereas a majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. No evidence from these tools contradicts the pathogenic prediction. Overall, the balance of evidence favors a pathogenic classification for D671G, and this conclusion is consistent with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.194234Structured0.096749Uncertain0.6770.3700.000-10.346Likely Pathogenic0.857Likely PathogenicAmbiguous0.50Ambiguous0.51.53Ambiguous1.02Ambiguous0.00Likely Benign0.279Likely Benign-4.78Deleterious0.995Probably Damaging0.946Probably Damaging3.45Benign0.01Affected0.40320.58231-13.1-58.04
c.2020A>G
T674A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T674A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly favor a benign effect: AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, PROVEAN, SIFT, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, REVEL, FoldX, premPS, Foldetta, and the SGM‑Consensus score all indicate benign or likely benign. No tool predicts pathogenicity; the only inconclusive result comes from Rosetta, which is listed as uncertain. High‑accuracy methods corroborate the benign assessment: AlphaMissense‑Optimized is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Based on the aggregate predictions, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.129801Structured0.109297Uncertain0.5210.3490.000-5.915Likely Benign0.099Likely BenignLikely Benign-0.13Likely Benign0.00.89Ambiguous0.38Likely Benign0.29Likely Benign0.052Likely Benign-1.48Neutral0.398Benign0.045Benign3.45Benign0.28Tolerated0.40420.4845102.5-30.03
c.2033G>T
S678I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the majority of evidence (10 benign vs. 3 pathogenic) supports a benign classification. This consensus does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.301917Structured0.123585Uncertain0.6600.3210.000-9.735Likely Pathogenic0.253Likely BenignLikely Benign0.36Likely Benign0.3-0.01Likely Benign0.18Likely Benign-0.11Likely Benign0.119Likely Benign-3.99Deleterious0.294Benign0.057Benign3.45Benign0.01Affected0.09410.5954-1-25.326.08
c.2041G>A
G681S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, and FATHMM, while those that predict a pathogenic outcome are SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) yielding an uncertain result. Overall, the majority of tools lean toward pathogenicity, but the presence of a benign prediction from AlphaMissense‑Optimized and an uncertain Foldetta score leaves the assessment inconclusive. No ClinVar entry exists, so there is no contradiction with clinical database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-9.913Likely Pathogenic0.716Likely PathogenicLikely Benign2.11Destabilizing1.3-0.23Likely Benign0.94Ambiguous0.41Likely Benign0.483Likely Benign-5.99Deleterious0.997Probably Damaging0.780Possibly Damaging3.45Benign0.08Tolerated0.25910.458410-0.430.03
c.2042G>A
G681D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL and FATHMM, whereas the remaining 11 tools (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM‑Consensus score all predict pathogenicity. The high‑accuracy methods reinforce this view: AlphaMissense‑Optimized returns a pathogenic classification; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts a pathogenic effect. premPS is inconclusive and is treated as unavailable. Taken together, the overwhelming majority of evidence points to a pathogenic impact for G681D. This conclusion is consistent with the absence of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-12.451Likely Pathogenic0.966Likely PathogenicLikely Pathogenic2.62Destabilizing1.54.54Destabilizing3.58Destabilizing0.96Ambiguous0.471Likely Benign-6.98Deleterious0.999Probably Damaging0.840Possibly Damaging3.45Benign0.00Affected0.16970.16951-1-3.158.04
c.2068T>G
S690A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S690A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta reports an uncertain stability change, so these results are treated as unavailable. Overall, the balance of evidence favors a benign interpretation, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.055536Structured0.247926Uncertain0.9440.2530.000-8.763Likely Pathogenic0.318Likely BenignLikely Benign-0.82Ambiguous0.0-2.17Stabilizing-1.50Ambiguous0.45Likely Benign0.217Likely Benign-2.55Deleterious0.887Possibly Damaging0.738Possibly Damaging3.45Benign0.21Tolerated0.46190.3131112.6-16.00
c.2089T>A
W697R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W697R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict a pathogenic effect: SGM‑Consensus, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, PROVEAN, AlphaMissense‑Default, and premPS. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence from multiple pathogenic‑predicting tools indicates that W697R is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.400169Uncertain0.9450.2970.000-10.020Likely Pathogenic0.941Likely PathogenicAmbiguous1.14Ambiguous0.11.18Ambiguous1.16Ambiguous1.25Destabilizing0.401Likely Benign-9.50Deleterious1.000Probably Damaging0.994Probably Damaging3.45Benign0.02Affected3.46130.39440.06122-3-3.6-30.03254.4-41.20.00.0-0.70.0XPotentially BenignThe indole ring of Trp697, located on the outer surface of an α-helix (res. Leu685-Val699), is not involved in any long-lasting interactions in the WT simulations. In the variant simulations, the positively charged guanidinium side chain of Arg697 occasionally forms hydrogen bonds with nearby residues, such as Ser722 and Asn719. However, similar to Trp697 in the WT, Arg697 does not form any long-lasting interactions and thus does not induce any negative structural effects in the simulations.
c.2089T>C
W697R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W697R is listed in ClinVar as Benign (ClinVar ID 703213.0) and is present in the gnomAD database (gnomAD ID 6‑33441348‑T‑C). Functional prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence from multiple pathogenic‑predicting tools suggests that the variant is most likely pathogenic, which contradicts its current ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.400169Uncertain0.9450.2970.000Likely Benign 16-33441348-T-C16.20e-7-10.020Likely Pathogenic0.941Likely PathogenicAmbiguous1.14Ambiguous0.11.18Ambiguous1.16Ambiguous1.25Destabilizing0.401Likely Benign-9.50Deleterious1.000Probably Damaging0.994Probably Damaging3.45Benign0.02Affected3.46130.39440.06122-3-3.6-30.03254.4-41.20.00.0-0.70.0XPotentially BenignThe indole ring of Trp697, located on the outer surface of an α-helix (res. Leu685-Val699), is not involved in any long-lasting interactions in the WT simulations. In the variant simulations, the positively charged guanidinium side chain of Arg697 occasionally forms hydrogen bonds with nearby residues, such as Ser722 and Asn719. However, similar to Trp697 in the WT, Arg697 does not form any long-lasting interactions and thus does not induce any negative structural effects in the simulations.
c.2106G>C
Q702H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, Rosetta, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Uncertain results come from FoldX and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign outcome (2 benign vs. 1 pathogenic vote), and Foldetta predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000-7.966In-Between0.211Likely BenignLikely Benign0.55Ambiguous0.00.13Likely Benign0.34Likely Benign0.12Likely Benign0.233Likely Benign-4.11Deleterious0.982Probably Damaging0.947Probably Damaging3.45Benign0.00Affected0.08110.2555300.39.01
c.2106G>T
Q702H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, Rosetta, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Uncertain results come from FoldX and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign outcome (2 benign vs. 1 pathogenic vote), and Foldetta predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000-7.966In-Between0.211Likely BenignLikely Benign0.55Ambiguous0.00.13Likely Benign0.34Likely Benign0.12Likely Benign0.233Likely Benign-4.11Deleterious0.982Probably Damaging0.947Probably Damaging3.45Benign0.00Affected0.08110.2555300.39.01
c.2111G>C
S704T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704T is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Consensus from multiple in‑silico predictors shows a predominance of benign calls: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus. Only polyPhen‑2 HumDiv predicts a pathogenic effect, while FoldX remains inconclusive. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. Overall, the aggregate evidence indicates that S704T is most likely benign, which is consistent with its ClinVar uncertain status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.096677Structured0.383620Uncertain0.9280.3630.000Uncertain 1-4.930Likely Benign0.265Likely BenignLikely Benign0.80Ambiguous0.00.15Likely Benign0.48Likely Benign0.29Likely Benign0.071Likely Benign-1.72Neutral0.525Possibly Damaging0.107Benign3.45Benign0.07Tolerated3.47100.10360.4674110.114.03201.7-18.00.00.0-0.20.7XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. Similarly, in the variant simulations, the hydroxyl side chain of Thr704 forms hydrogen bonds with the amide groups of Ala707 and Leu708. Thus, the residue swap does not cause any apparent structural change.
c.2120C>T
A707V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A707V variant is not reported in ClinVar (no ClinVar ID) but is present in gnomAD (variant ID 6‑33441585‑C‑T). Functional prediction tools largely agree on a benign effect: REVEL, FoldX, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign classification. Only three tools—Rosetta, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar—predict pathogenicity, while Foldetta reports an uncertain stability change. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, the SGM‑Consensus is benign, and Foldetta remains uncertain. Overall, the majority of evidence supports a benign impact for A707V, and this conclusion does not contradict any ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.203355Structured0.371229Uncertain0.9270.3650.0006-33441585-C-T16.20e-7-6.479Likely Benign0.277Likely BenignLikely Benign0.05Likely Benign0.02.17Destabilizing1.11Ambiguous-0.30Likely Benign0.212Likely Benign-1.62Neutral0.991Probably Damaging0.912Probably Damaging3.45Benign1.00Tolerated3.5090.07940.4048002.428.05
c.2128A>G
K710E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K710E missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, SIFT, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.370438Uncertain0.9490.3680.000-11.405Likely Pathogenic0.885Likely PathogenicAmbiguous0.56Ambiguous0.00.94Ambiguous0.75Ambiguous0.39Likely Benign0.178Likely Benign-3.53Deleterious0.998Probably Damaging0.991Probably Damaging3.45Benign0.08Tolerated0.26550.0789010.40.94
c.2143C>G
P715A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P715A has no ClinVar entry and is not reported in gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions are reported by FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments further indicate AlphaMissense‑Optimized predicts Benign, whereas the SGM‑Consensus remains Likely Pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is Uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.243554Structured0.409757Uncertain0.9560.3620.000-9.261Likely Pathogenic0.597Likely PathogenicLikely Benign2.69Destabilizing0.00.28Likely Benign1.49Ambiguous0.77Ambiguous0.229Likely Benign-7.13Deleterious1.000Probably Damaging0.999Probably Damaging3.45Benign0.02Affected0.29930.35601-13.4-26.04
c.2188A>T
I730F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730F has no ClinVar entry and is not reported in gnomAD. Prediction tools largely agree on a benign effect: SGM‑Consensus (Likely Benign), REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen2_HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign or tolerated. Only polyPhen2_HumDiv classifies the change as pathogenic. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores the variant as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, reports a benign effect. No prediction tool or stability analysis is inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-4.953Likely Benign0.173Likely BenignLikely Benign-0.54Ambiguous0.1-0.01Likely Benign-0.28Likely Benign-0.01Likely Benign0.055Likely Benign-1.86Neutral0.699Possibly Damaging0.152Benign3.45Benign0.08Tolerated0.05090.208210-1.734.02
c.3991A>C
I1331L
2D
AIThe SynGAP1 missense variant I1331L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), which collectively classify the variant as likely benign. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized result is uncertain, and Foldetta stability analysis is unavailable. Overall, the balance of evidence leans toward a benign interpretation, with no conflict with ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.921076Disordered0.941705Binding0.3590.7520.875-2.450Likely Benign0.892Likely PathogenicAmbiguous0.180Likely Benign-1.04Neutral0.762Possibly Damaging0.785Possibly Damaging3.45Benign0.00Affected0.07520.361622-0.70.00
c.406C>T
R136W
2D
AIThe SynGAP1 missense variant R136W is listed in ClinVar (ID 1479441.0) with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a deleterious effect, and the SGM‑Consensus also indicates Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of computational evidence points to a pathogenic impact, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.433034Structured0.657394Binding0.3510.8940.250Uncertain 2-10.453Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.237Likely Benign-4.71Deleterious0.965Probably Damaging0.416Benign3.45Benign0.00Affected3.6150.11890.38272-33.630.03
c.551A>G
E184G
2D
AIThe SynGAP1 missense variant E184G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that E184G is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.557691Disordered0.431514Uncertain0.3480.6220.625-10.725Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.353Likely Benign-5.52Deleterious0.970Probably Damaging0.607Possibly Damaging3.45Benign0.00Affected0.32810.65340-23.1-72.06
c.1261G>T
A421S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A421S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split assessment: benign predictions come from REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions arise from PROVEAN, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves as Likely Pathogenic. High‑accuracy assessments indicate that AlphaMissense‑Optimized predicts a benign effect, the SGM‑Consensus predicts pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive. Stability calculations from FoldX and Rosetta are uncertain, and premPS is unavailable. Overall, the majority of tools lean toward a pathogenic interpretation, and this aligns with the SGM‑Consensus result; there is no conflict with ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-9.220Likely Pathogenic0.715Likely PathogenicLikely Benign0.66Ambiguous0.11.12Ambiguous0.89Ambiguous0.70Ambiguous0.155Likely Benign-2.50Deleterious0.058Benign0.072Benign3.46Benign0.08Tolerated0.22470.362111-2.616.00
c.1295G>T
C432F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C432F is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact; AlphaMissense‑Optimized and premPS are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.111485Structured0.362533Uncertain0.9600.2850.000-12.862Likely Pathogenic0.943Likely PathogenicAmbiguous-0.44Likely Benign0.2-0.34Likely Benign-0.39Likely Benign0.57Ambiguous0.434Likely Benign-10.50Deleterious0.999Probably Damaging0.993Probably Damaging3.46Benign0.01Affected0.10900.3956-4-20.344.04
c.1297G>T
A433S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A433S is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate benign or likely benign. Only polyPhen‑2 (HumDiv) predicts a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized reports benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a likely benign classification; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Overall, the preponderance of evidence points to a benign impact for A433S, and this conclusion is consistent with the lack of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.098513Structured0.352258Uncertain0.9380.3020.000-3.861Likely Benign0.077Likely BenignLikely Benign-0.04Likely Benign0.00.41Likely Benign0.19Likely Benign-0.21Likely Benign0.077Likely Benign0.35Neutral0.597Possibly Damaging0.391Benign3.46Benign0.28Tolerated0.19380.397511-2.616.00
c.1325A>G
K442R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K442R is catalogued in gnomAD (ID 6‑33438230‑A‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the only tools predicting a pathogenic outcome are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) classifies the variant as benign. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.170161Structured0.255766Uncertain0.9120.2250.0006-33438230-A-G16.20e-7-5.761Likely Benign0.093Likely BenignLikely Benign0.13Likely Benign0.10.29Likely Benign0.21Likely Benign0.51Ambiguous0.098Likely Benign-1.42Neutral0.972Probably Damaging0.875Possibly Damaging3.46Benign0.35Tolerated3.37290.38850.077823-0.628.01
c.1326A>C
K442N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K442N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, and the folding‑stability method Foldetta (which integrates FoldX‑MD and Rosetta outputs). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM Consensus as likely pathogenic, and Foldetta as benign. Overall, the majority of predictions lean toward pathogenicity, but the presence of several strong benign predictions and a benign folding‑stability result introduces uncertainty. Based on the current computational evidence, the variant is most likely pathogenic, and this does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.170161Structured0.255766Uncertain0.9120.2250.000-11.039Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.37Likely Benign0.10.53Ambiguous0.45Likely Benign0.31Likely Benign0.161Likely Benign-4.05Deleterious1.000Probably Damaging0.993Probably Damaging3.46Benign0.10Tolerated0.26860.1314100.4-14.07
c.1326A>T
K442N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K442N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, and the folding‑stability method Foldetta (which integrates FoldX‑MD and Rosetta outputs). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM Consensus as likely pathogenic, and Foldetta as benign. Overall, the majority of predictions lean toward pathogenicity, but the presence of several strong benign predictions and a benign folding‑stability result introduces uncertainty. Based on the current computational evidence, the variant is most likely pathogenic, and this does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.170161Structured0.255766Uncertain0.9120.2250.000-11.039Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.37Likely Benign0.10.53Ambiguous0.45Likely Benign0.31Likely Benign0.161Likely Benign-4.05Deleterious1.000Probably Damaging0.993Probably Damaging3.46Benign0.10Tolerated0.26860.1314100.4-14.07
c.1379A>G
K460R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K460R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate benign or likely benign. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict pathogenicity, while Rosetta and premPS are inconclusive. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Taken together, the overwhelming majority of evidence supports a benign classification, and this is consistent with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.155435Structured0.289547Uncertain0.9380.1500.125-5.349Likely Benign0.175Likely BenignLikely Benign-0.41Likely Benign0.00.63Ambiguous0.11Likely Benign0.55Ambiguous0.103Likely Benign-1.52Neutral0.991Probably Damaging0.962Probably Damaging3.46Benign0.63Tolerated0.50930.1169Weaken32-0.628.01
c.1427T>A
F476Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; FoldX is uncertain and therefore not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta predicts a benign outcome. Overall, the balance of evidence leans toward a benign impact for F476Y, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-9.707Likely Pathogenic0.576Likely PathogenicLikely Benign0.50Ambiguous0.20.30Likely Benign0.40Likely Benign1.10Destabilizing0.169Likely Benign-1.10Neutral0.965Probably Damaging0.919Probably Damaging3.46Benign0.90Tolerated0.11090.156873-4.116.00
c.1427T>G
F476C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476C is catalogued in gnomAD (ID 6‑33438459‑T‑G) but has no ClinVar entry. Functional prediction tools split in two groups: benign predictions come from REVEL, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from FoldX, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, seven tools predict pathogenicity versus six predicting benign, with no ClinVar evidence to contradict this assessment. Thus, the variant is most likely pathogenic based on the current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.0006-33438459-T-G-9.270Likely Pathogenic0.745Likely PathogenicLikely Benign2.05Destabilizing0.12.62Destabilizing2.34Destabilizing-0.30Likely Benign0.280Likely Benign2.69Neutral1.000Probably Damaging0.999Probably Damaging3.46Benign0.83Tolerated3.40220.20510.1251-2-4-0.3-44.04
c.1612G>A
E538K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E538K has no ClinVar entry and is not reported in gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumVar, SIFT, and FATHMM, whereas pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessment indicates that AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) supports a pathogenic outcome, and Foldetta (combining FoldX‑MD and Rosetta) predicts benign stability. Overall, the majority of tools lean toward a benign effect, but the consensus of high‑accuracy predictors and several individual pathogenic scores suggest uncertainty. The variant is most likely benign based on the bulk of evidence, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.122885Structured0.033501Uncertain0.9380.3590.000-11.345Likely Pathogenic0.922Likely PathogenicAmbiguous-0.03Likely Benign0.0-0.16Likely Benign-0.10Likely Benign-0.22Likely Benign0.215Likely Benign-2.97Deleterious0.848Possibly Damaging0.294Benign3.46Benign0.16Tolerated0.22570.381801-0.4-0.94
c.1688G>A
R563K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 R563K missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Predictions that are inconclusive are Rosetta and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta as benign. Based on the overall consensus of the available predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.039760Structured0.031987Uncertain0.8760.2090.000-10.948Likely Pathogenic0.335Likely BenignLikely Benign0.25Likely Benign0.00.66Ambiguous0.46Likely Benign0.70Ambiguous0.198Likely Benign-2.37Neutral0.990Probably Damaging0.998Probably Damaging3.46Benign0.35Tolerated0.44340.2379320.6-28.01
c.1919C>T
T640I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T640I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Only PROVEAN predicts a pathogenic outcome. The remaining tools (FoldX, Rosetta, ESM1b, AlphaMissense‑Default, and Foldetta) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is unavailable due to a tie, and Foldetta also yields an uncertain stability change. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar status, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.066181Structured0.137043Uncertain0.8930.2840.000-7.256In-Between0.358AmbiguousLikely Benign0.70Ambiguous0.10.66Ambiguous0.68Ambiguous0.28Likely Benign0.193Likely Benign-2.75Deleterious0.322Benign0.022Benign3.46Benign0.12Tolerated0.10300.47930-15.212.05
c.1931A>G
D644G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D644G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and AlphaMissense‑Default (polyPhen‑2 HumVar is benign). High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.066181Structured0.248888Uncertain0.8830.3200.000-4.496Likely Benign0.602Likely PathogenicLikely Benign0.13Likely Benign0.0-0.18Likely Benign-0.03Likely Benign0.04Likely Benign0.271Likely Benign-4.38Deleterious0.456Possibly Damaging0.069Benign3.46Benign0.14Tolerated0.40350.56101-13.1-58.04
c.1966G>C
E656Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E656Q is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33441225‑G‑C). Functional prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default; Rosetta reports an uncertain result. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑2 split. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.032017Structured0.242242Uncertain0.9630.2640.000Uncertain 16-33441225-G-C16.20e-7-9.145Likely Pathogenic0.766Likely PathogenicLikely Benign-0.14Likely Benign0.0-0.81Ambiguous-0.48Likely Benign0.25Likely Benign0.249Likely Benign-2.29Neutral0.980Probably Damaging0.528Possibly Damaging3.46Benign0.02Affected3.39240.17390.6645220.0-0.98224.31.70.00.10.10.0XPotentially BenignThe carboxylate side chain of Glu656, located on an α helix (res. Ser641-Glu666), frequently forms a hydrogen bond with the nearby residue Ser659 on the same α helix. In the variant simulations, the carboxamide side chain of Gln656 alternatively forms a hydrogen bond with either Ser659 or Glu548 on an opposing helix (res. Ala533-Val560).Although the frequent interaction between Gln656 and Glu548 may strengthen or stabilize the tertiary structure assembly, the effect is likely to be marginal.
c.1967A>C
E656A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E656A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM; pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely pathogenic. High‑accuracy assessments further reveal that AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus also indicates likely pathogenic, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. No prediction or stability result is missing or inconclusive. Based on the overall evidence, the variant is most likely pathogenic; this assessment does not contradict ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.032017Structured0.242242Uncertain0.9630.2640.000-14.373Likely Pathogenic0.974Likely PathogenicLikely Pathogenic0.12Likely Benign0.00.10Likely Benign0.11Likely Benign-0.13Likely Benign0.499Likely Benign-5.38Deleterious0.985Probably Damaging0.755Possibly Damaging3.46Benign0.03Affected0.42440.62710-15.3-58.04
c.1967A>T
E656V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E656V has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the majority of tools (8 of 13) indicate a pathogenic impact, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.032017Structured0.242242Uncertain0.9630.2640.000-15.252Likely Pathogenic0.992Likely PathogenicLikely Pathogenic-0.26Likely Benign0.0-0.10Likely Benign-0.18Likely Benign-0.77Ambiguous0.509Likely Pathogenic-6.38Deleterious0.784Possibly Damaging0.223Benign3.46Benign0.02Affected0.09900.7057-2-27.7-29.98
c.1969T>G
W657G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W657G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM. In contrast, the majority of other in silico predictors (AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FoldX, Rosetta, premPS, Foldetta) all classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. No predictions are missing or inconclusive. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.030611Structured0.208729Uncertain0.9410.2450.000-12.559Likely Pathogenic0.968Likely PathogenicLikely Pathogenic3.04Destabilizing0.22.80Destabilizing2.92Destabilizing1.28Destabilizing0.389Likely Benign-11.16Deleterious0.999Probably Damaging0.941Probably Damaging3.46Benign0.15Tolerated0.44700.0885-7-20.5-129.16
c.1996G>A
E666K
2D
AIThe SynGAP1 missense variant E666K is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy methods give mixed results: AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of predictions lean toward pathogenicity, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.086870Uncertain0.9250.3870.000-11.367Likely Pathogenic0.946Likely PathogenicAmbiguous0.20Likely Benign0.60.30Likely Benign0.25Likely Benign0.43Likely Benign0.401Likely Benign-3.26Deleterious0.992Probably Damaging0.717Possibly Damaging3.46Benign0.05Affected0.29530.530001-0.4-0.94
c.1996G>C
E666Q
2D
AIThe SynGAP1 E666Q missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; FoldX is uncertain and therefore not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split and is treated as unavailable. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the majority of reliable predictions indicate a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.155435Structured0.086870Uncertain0.9250.3870.000-10.963Likely Pathogenic0.737Likely PathogenicLikely Benign0.54Ambiguous0.50.20Likely Benign0.37Likely Benign0.46Likely Benign0.268Likely Benign-2.29Neutral0.997Probably Damaging0.696Possibly Damaging3.46Benign0.13Tolerated0.14370.4788220.0-0.98
c.2021C>T
T674I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T674I is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (ID 6‑33441280‑C‑T). Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, and ESM1b (polyPhen‑2 HumVar is benign). AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.109297Uncertain0.5210.3490.0006-33441280-C-T21.24e-6-8.951Likely Pathogenic0.522AmbiguousLikely Benign-0.05Likely Benign0.10.28Likely Benign0.12Likely Benign-0.04Likely Benign0.289Likely Benign-3.18Deleterious0.981Probably Damaging0.444Benign3.46Benign0.11Tolerated3.40240.08980.6945-105.212.05
c.2056G>A
G686S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G686S is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX, Foldetta, SIFT, and FATHMM. Those that predict pathogenicity are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; the SGM‑Consensus score is also “Likely Pathogenic.” Uncertain predictions from Rosetta and premPS are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta (a combined FoldX‑MD and Rosetta stability method) as benign. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.109221Structured0.177104Uncertain0.9190.2680.000-10.884Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.30Likely Benign0.30.50Ambiguous0.40Likely Benign0.69Ambiguous0.537Likely Pathogenic-5.29Deleterious0.998Probably Damaging0.929Probably Damaging3.46Benign0.06Tolerated0.25580.435510-0.430.03
c.2056G>C
G686R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G686R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include Rosetta, Foldetta, and FATHMM, whereas the remaining tools (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized) all predict a pathogenic impact; FoldX is listed as uncertain and is treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.109221Structured0.177104Uncertain0.9190.2680.000-14.801Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.79Ambiguous0.30.15Likely Benign0.47Likely Benign1.10Destabilizing0.503Likely Pathogenic-7.21Deleterious0.974Probably Damaging0.449Possibly Damaging3.46Benign0.00Affected0.09510.3580-3-2-4.199.14
c.2080G>A
A694T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A694T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while FoldX is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Taken together, the overwhelming majority of evidence indicates a benign effect for A694T, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.127496Structured0.352199Uncertain0.9380.2690.000-3.565Likely Benign0.102Likely BenignLikely Benign0.55Ambiguous0.10.11Likely Benign0.33Likely Benign-0.26Likely Benign0.095Likely Benign-0.71Neutral0.787Possibly Damaging0.098Benign3.46Benign0.17Tolerated0.16180.544010-2.530.03
c.2098C>G
L700V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L700V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates a likely benign outcome. In contrast, protein‑stability methods predict a deleterious impact: FoldX and Rosetta both score the variant as pathogenic, and the combined Foldetta analysis (FoldX‑MD + Rosetta) also reports a pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, while Foldetta remains pathogenic. Overall, the majority of predictions support a benign classification, and this is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.113710Structured0.416255Uncertain0.9270.3310.000-3.703Likely Benign0.192Likely BenignLikely Benign2.52Destabilizing0.03.16Destabilizing2.84Destabilizing0.13Likely Benign0.056Likely Benign0.37Neutral0.003Benign0.005Benign3.46Benign0.76Tolerated0.14240.2460210.4-14.03
c.2104C>A
Q702K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q702K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign and Foldetta as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.397258Uncertain0.9070.3450.000-8.750Likely Pathogenic0.338Likely BenignLikely Benign-0.23Likely Benign0.00.26Likely Benign0.02Likely Benign0.08Likely Benign0.224Likely Benign-2.86Deleterious0.863Possibly Damaging0.773Possibly Damaging3.46Benign0.08Tolerated0.13460.252411-0.40.04
c.2147G>T
R716L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R716L is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, premPS, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as benign. Overall, the majority of predictions (7/13) lean toward pathogenicity, with a near‑even split and a slight edge for pathogenic. The variant is therefore most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists for R716L.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.247041Structured0.419135Uncertain0.9620.3790.000-10.690Likely Pathogenic0.713Likely PathogenicLikely Benign0.31Likely Benign0.00.51Ambiguous0.41Likely Benign0.37Likely Benign0.289Likely Benign-5.70Deleterious1.000Probably Damaging0.999Probably Damaging3.46Benign0.01Affected0.17010.3775-3-28.3-43.03
c.2168C>A
T723K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T723K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv indicates a pathogenic outcome, while FoldX and AlphaMissense‑Default are uncertain. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, the SGM Consensus is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the preponderance of evidence supports a benign classification for T723K, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.476583Structured0.458243Uncertain0.9450.4470.375-4.624Likely Benign0.482AmbiguousLikely Benign-0.77Ambiguous0.1-0.04Likely Benign-0.41Likely Benign0.25Likely Benign0.121Likely Benign-1.40Neutral0.674Possibly Damaging0.118Benign3.46Benign0.51Tolerated0.09240.27980-1-3.227.07
c.2189T>A
I730N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730N is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar) and SIFT. The remaining tools—premPS, ESM1b, and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.733139Disordered0.420109Uncertain0.5910.6190.750-7.987In-Between0.369AmbiguousLikely Benign0.09Likely Benign0.20.04Likely Benign0.07Likely Benign0.70Ambiguous0.080Likely Benign-1.60Neutral1.000Probably Damaging0.986Probably Damaging3.46Benign0.02Affected0.09690.0533-2-3-8.00.94
c.325A>T
S109C
2D
AIThe SynGAP1 missense variant S109C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus (majority vote) also as Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.622677Disordered0.669335Binding0.3280.8640.750-6.268Likely Benign0.761Likely PathogenicLikely Benign0.217Likely Benign-2.19Neutral0.983Probably Damaging0.431Benign3.46Benign0.00Affected0.10840.53540-13.316.06
c.394T>C
F132L
2D
AIThe SynGAP1 missense variant F132L is not reported in ClinVar (status: none) but is present in gnomAD (ID 6‑33432691‑T‑C). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 pathogenic vs 2 benign), and Foldetta (combining FoldX‑MD and Rosetta) has no available output. Overall, the majority of consensus tools lean toward a benign interpretation, and the single high‑accuracy pathogenic prediction is counterbalanced by inconclusive consensus and missing folding‑stability data. Thus, the variant is most likely benign based on current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.450668Structured0.727897Binding0.3450.8920.2506-33432691-T-C-5.401Likely Benign0.998Likely PathogenicLikely Pathogenic0.165Likely Benign-2.99Deleterious0.000Benign0.002Benign3.46Benign0.00Affected3.6150.25640.2669021.0-34.02
c.396C>A
F132L
2D
AIThe SynGAP1 missense variant F132L is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which takes a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign, two pathogenic). Foldetta, a protein‑folding‑stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy tools (AlphaMissense‑Optimized and AlphaMissense‑Default) both predict pathogenicity, while the consensus and stability analyses are inconclusive or missing. Overall, the majority of individual predictors and the high‑accuracy tools lean toward a pathogenic effect, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.450668Structured0.727897Binding0.3450.8920.250-5.401Likely Benign0.998Likely PathogenicLikely Pathogenic0.137Likely Benign-2.99Deleterious0.000Benign0.002Benign3.46Benign0.00Affected3.6150.25640.2669021.0-34.02
c.396C>G
F132L
2D
AIThe SynGAP1 missense variant F132L is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which takes a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign, two pathogenic). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy tools (AlphaMissense‑Optimized and AlphaMissense‑Default) both predict pathogenicity, whereas the consensus and stability analyses are inconclusive or missing. Overall, the majority of individual predictors and the two high‑accuracy tools suggest a pathogenic effect, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.450668Structured0.727897Binding0.3450.8920.250-5.401Likely Benign0.998Likely PathogenicLikely Pathogenic0.137Likely Benign-2.99Deleterious0.000Benign0.002Benign3.46Benign0.00Affected3.6150.25640.2669021.0-34.02
c.557T>G
L186W
2D
AIThe SynGAP1 missense variant L186W has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence from both general and high‑accuracy tools indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.458154Structured0.428613Uncertain0.3970.6170.500-16.177Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.274Likely Benign-4.78Deleterious0.996Probably Damaging0.819Possibly Damaging3.46Benign0.00Affected0.05390.3138-2-2-4.773.05
c.67G>T
D23Y
2D
AIThe SynGAP1 D23Y missense variant is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33420331‑G‑T). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward a pathogenic impact. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.557691Disordered0.440341Uncertain0.3690.8920.3756-33420331-G-T-4.191Likely Benign0.729Likely PathogenicLikely Benign0.142Likely Benign-2.87Deleterious0.972Probably Damaging0.861Possibly Damaging3.46Benign0.00Affected4.3210.10130.7951-3-42.248.09
c.1277A>C
N426T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change N426T lies in the GAP domain. It is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. Predictions that are uncertain or inconclusive are FoldX, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, while Foldetta remains uncertain and is not taken as evidence. Overall, the majority of tools, including the high‑accuracy methods, predict a benign effect. This consensus does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.042364Structured0.394941Uncertain0.9590.2870.000-7.389In-Between0.194Likely BenignLikely Benign0.84Ambiguous0.00.38Likely Benign0.61Ambiguous0.12Likely Benign0.126Likely Benign-3.14Deleterious0.983Probably Damaging0.926Probably Damaging3.47Benign0.10Tolerated0.10900.3002002.8-13.00
c.1277A>G
N426S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N426S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The high‑accuracy AlphaMissense‑Optimized score is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and the Foldetta stability assessment is inconclusive. No evidence from FoldX or Rosetta is available. Overall, the majority of predictions support a benign impact, and this is consistent with the absence of a ClinVar assertion. Therefore, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.042364Structured0.394941Uncertain0.9590.2870.000-5.215Likely Benign0.081Likely BenignLikely Benign0.81Ambiguous0.00.52Ambiguous0.67Ambiguous0.03Likely Benign0.131Likely Benign-2.37Neutral0.998Probably Damaging0.921Probably Damaging3.47Benign0.33Tolerated0.22240.3188112.7-27.03
c.1286G>A
R429Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R429Q is listed in ClinVar with an “Uncertain” status and is present in gnomAD (variant ID 6‑33438191‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b, while premPS is inconclusive. The high‑accuracy consensus (SGM Consensus) – a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN – yields a “Likely Benign” result. AlphaMissense‑Optimized itself predicts benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Taken together, the preponderance of evidence points to a benign impact for R429Q, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.074921Structured0.390504Uncertain0.9590.2900.000Uncertain 26-33438191-G-A106.20e-6-8.227Likely Pathogenic0.143Likely BenignLikely Benign0.45Likely Benign0.10.36Likely Benign0.41Likely Benign0.98Ambiguous0.156Likely Benign-1.25Neutral1.000Probably Damaging0.979Probably Damaging3.47Benign0.58Tolerated3.38250.25180.1985111.0-28.06235.859.50.00.0-0.30.4XPotentially PathogenicThe guanidinium group of the Arg429 side chain, located in an α helix (res. Met414-Glu436), either forms a salt bridge with the carboxylate group of an acidic residue (Asp474, Asp467) or an H-bond with the hydroxyl group of Ser471 in an opposing α helix (res. Ala461-Phe476). In the variant simulations, Gln429 cannot form ionic interactions with the acidic residues; however, the carboxamide group can form multiple H-bonds. The H-bonding coordination of the Asn429 side chain varied between the replica simulations. In one simulation, three H-bonds were formed simultaneously with the Asp467 side chain, the backbone carbonyl group of Asn426, and the amide group of Met430 at the end of the same α helix. The residue swap could affect the tertiary structure assembly during folding due to weaker bond formation, but no large-scale negative effects were seen during the simulations.
c.1289T>A
M430K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN and ESM1b. The remaining tools—FoldX, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized classifies the variant as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) favors a pathogenic outcome; Foldetta remains uncertain. Overall, the majority of individual predictors lean toward a benign interpretation, whereas the SGM Consensus suggests pathogenicity. Given the lack of ClinVar evidence, there is no contradiction with existing clinical annotations. Based on the aggregate predictions, the variant is most likely benign, and this assessment does not conflict with the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.071867Structured0.385298Uncertain0.9520.3060.000-10.816Likely Pathogenic0.494AmbiguousLikely Benign0.78Ambiguous0.10.44Likely Benign0.61Ambiguous0.86Ambiguous0.149Likely Benign-2.66Deleterious0.134Benign0.033Benign3.47Benign0.32Tolerated0.16600.12710-1-5.8-3.02
c.1319A>T
N440I
2D
AISynGAP1 missense variant N440I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Optimized, while pathogenic calls come from PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy assessments indicate that AlphaMissense‑Optimized predicts a benign effect, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels the variant as likely pathogenic; Foldetta remains inconclusive. Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.267204Uncertain0.9290.2450.000-10.365Likely Pathogenic0.778Likely PathogenicLikely Benign0.97Ambiguous0.91.10Ambiguous1.04Ambiguous0.10Likely Benign0.100Likely Benign-4.07Deleterious0.322Benign0.109Benign3.47Benign0.03Affected0.05540.3772-2-38.0-0.94
c.1324A>G
K442E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K442E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split consensus: benign predictions come from REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments give mixed results: AlphaMissense‑Optimized remains uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. No single evidence decisively outweighs the others. Therefore, the variant’s pathogenicity remains uncertain; the predictions do not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.170161Structured0.255766Uncertain0.9120.2250.000-12.813Likely Pathogenic0.939Likely PathogenicAmbiguous-0.05Likely Benign0.1-0.21Likely Benign-0.13Likely Benign0.24Likely Benign0.324Likely Benign-3.34Deleterious0.997Probably Damaging0.966Probably Damaging3.47Benign0.16Tolerated0.29430.0789010.40.94
c.1348G>T
A450S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A450S missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining methods—FoldX, Rosetta, Foldetta, and premPS—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie and thus unavailable; Foldetta is uncertain. Overall, the balance of evidence (five benign versus four pathogenic predictions, with three uncertain) suggests the variant is most likely benign. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.321458Structured0.306281Uncertain0.9630.2340.000-9.257Likely Pathogenic0.274Likely BenignLikely Benign0.81Ambiguous0.01.35Ambiguous1.08Ambiguous0.69Ambiguous0.268Likely Benign-2.70Deleterious0.965Probably Damaging0.972Probably Damaging3.47Benign0.10Tolerated0.20030.432211-2.616.00
c.1385A>C
K462T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K462T missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, SIFT, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic effect. This conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-11.586Likely Pathogenic0.948Likely PathogenicAmbiguous0.55Ambiguous0.01.08Ambiguous0.82Ambiguous0.30Likely Benign0.414Likely Benign-5.82Deleterious0.999Probably Damaging1.000Probably Damaging3.47Benign0.08Tolerated0.20950.32570-13.2-27.07
c.1389C>A
D463E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D463E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and premPS. Only PROVEAN predicts a pathogenic outcome, while Rosetta and AlphaMissense‑Default are uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. No prediction or stability result is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.260850Structured0.305622Uncertain0.9400.1760.000-5.170Likely Benign0.527AmbiguousLikely Benign-0.42Likely Benign0.10.50Ambiguous0.04Likely Benign0.47Likely Benign0.162Likely Benign-2.58Deleterious0.012Benign0.003Benign3.47Benign0.29Tolerated0.13300.5177320.014.03
c.1389C>G
D463E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D463E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and premPS. Only PROVEAN predicts a pathogenic outcome, while Rosetta and AlphaMissense‑Default are uncertain. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) resolves to benign, and Foldetta also indicates benign stability. No prediction or stability result is missing or inconclusive. Overall, the variant is most likely benign based on the collective evidence, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.260850Structured0.305622Uncertain0.9400.1760.000-5.170Likely Benign0.527AmbiguousLikely Benign-0.42Likely Benign0.10.50Ambiguous0.04Likely Benign0.47Likely Benign0.162Likely Benign-2.58Deleterious0.012Benign0.003Benign3.47Benign0.29Tolerated0.13300.5177320.014.03
c.1442A>G
H481R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H481R is not listed in ClinVar and has no reported allele in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, SIFT, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by AlphaMissense‑Optimized, premPS, and Rosetta. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized is inconclusive; the SGM‑Consensus majority vote (AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect; and Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, predicts a benign impact. Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion is not contradicted by the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-11.753Likely Pathogenic0.823Likely PathogenicAmbiguous-0.45Likely Benign0.10.68Ambiguous0.12Likely Benign0.59Ambiguous0.252Likely Benign-4.48Deleterious0.983Probably Damaging0.977Probably Damaging3.47Benign0.53Tolerated0.15150.169020-1.319.05
c.1699G>C
E567Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E567Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Those that agree on a pathogenic effect are SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain results come from AlphaMissense‑Optimized, Foldetta, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta’s stability prediction is also uncertain. Overall, more tools (7) predict pathogenicity than benign (5), with three inconclusive. Thus, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.021816Structured0.051008Uncertain0.9160.2340.000-11.302Likely Pathogenic0.897Likely PathogenicAmbiguous0.03Likely Benign0.11.50Ambiguous0.77Ambiguous0.33Likely Benign0.345Likely Benign-2.82Deleterious0.998Probably Damaging0.993Probably Damaging3.47Benign0.14Tolerated0.10290.5391220.0-0.98
c.1792C>A
L598I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L598I is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar) and ESM1b. The remaining tools (FoldX, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of reliable predictions indicate a benign impact. This conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.007259Structured0.147872Uncertain0.9530.1540.000-9.396Likely Pathogenic0.512AmbiguousLikely Benign0.80Ambiguous0.00.38Likely Benign0.59Ambiguous0.78Ambiguous0.246Likely Benign-1.96Neutral0.988Probably Damaging0.910Probably Damaging3.47Benign0.10Tolerated0.07920.2000220.70.00
c.1918A>C
T640P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T640P is not reported in ClinVar and is absent from gnomAD. In silico predictors uniformly favor a benign effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen2_HumDiv, polyPhen2_HumVar, SIFT, FATHMM, AlphaMissense-Default, and AlphaMissense-Optimized all indicate benign. No tool predicts pathogenicity. FoldX and ESM1b were inconclusive. High‑accuracy methods corroborate this: AlphaMissense-Optimized is benign, the SGM Consensus (majority vote of AlphaMissense-Default, ESM1b, FATHMM, PROVEAN) is benign, and Foldetta (combining FoldX‑MD and Rosetta) also predicts benign. Consequently, the variant is most likely benign, and this assessment does not contradict the ClinVar status, which currently has no entry for T640P.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.066181Structured0.137043Uncertain0.8930.2840.000-7.594In-Between0.077Likely BenignLikely Benign0.98Ambiguous0.3-0.38Likely Benign0.30Likely Benign0.31Likely Benign0.313Likely Benign-0.91Neutral0.004Benign0.002Benign3.47Benign0.14Tolerated0.21790.47220-1-0.9-3.99
c.1964T>C
L655P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L655P is catalogued in gnomAD (ID 6‑33441223‑T‑C) but has no ClinVar entry. Functional prediction tools show a split: benign calls come from REVEL, PROVEAN, SIFT, and FATHMM, whereas pathogenic calls are made by Rosetta, Foldetta, both polyPhen‑2 versions, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX and premPS are uncertain. High‑accuracy assessments give AlphaMissense‑Optimized as pathogenic, Foldetta as pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive. Overall, the majority of evidence points to a pathogenic effect. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.015344Structured0.268808Uncertain0.9610.2740.0006-33441223-T-C16.20e-7-9.771Likely Pathogenic0.982Likely PathogenicLikely Pathogenic1.33Ambiguous0.56.52Destabilizing3.93Destabilizing0.57Ambiguous0.126Likely Benign-1.36Neutral0.981Probably Damaging0.772Possibly Damaging3.47Benign0.32Tolerated3.39240.35980.1274-3-3-5.4-16.04
c.1973G>C
G658A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G658A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify the substitution as benign: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a neutral effect, and the SGM‑Consensus score indicates a likely benign outcome. No tool predicts pathogenicity. High‑accuracy assessments corroborate this view: AlphaMissense‑Optimized returns a benign prediction, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports a likely benign result, while Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain outcome. Taken together, the evidence overwhelmingly supports a benign impact for G658A, and this conclusion does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.029376Structured0.180299Uncertain0.9420.2510.000-4.303Likely Benign0.083Likely BenignLikely Benign-0.34Likely Benign0.0-0.75Ambiguous-0.55Ambiguous-0.18Likely Benign0.072Likely Benign-0.93Neutral0.002Benign0.001Benign3.47Benign0.36Tolerated0.39370.3352102.214.03
c.2013C>A
D671E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D671E is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in‑silico tools uniformly indicate a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM all classify the substitution as benign. The only inconclusive result is AlphaMissense‑Default, which is listed as uncertain; all other high‑accuracy predictors support a benign outcome. In particular, AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports benign. No pathogenic predictions are present. Therefore, based on the available computational evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.194234Structured0.096749Uncertain0.6770.3700.000-3.657Likely Benign0.371AmbiguousLikely Benign-0.17Likely Benign0.10.22Likely Benign0.03Likely Benign0.03Likely Benign0.066Likely Benign-0.83Neutral0.013Benign0.009Benign3.47Benign0.53Tolerated0.15200.6388320.014.03
c.2013C>G
D671E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D671E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome. The high‑accuracy assessments are consistent: AlphaMissense‑Optimized indicates Benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. With all available evidence pointing to a benign effect and no ClinVar record to contradict this, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.194234Structured0.096749Uncertain0.6770.3700.000-3.657Likely Benign0.371AmbiguousLikely Benign-0.17Likely Benign0.10.22Likely Benign0.03Likely Benign0.03Likely Benign0.066Likely Benign-0.83Neutral0.013Benign0.009Benign3.47Benign0.53Tolerated0.15200.6388320.014.03
c.2020A>T
T674S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T674S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools uniformly indicate a benign effect: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, premPS, FoldX, Rosetta, and AlphaMissense‑Default all classify the change as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports a benign effect. With all available evidence pointing to a benign outcome and no conflicting ClinVar annotation, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.129801Structured0.109297Uncertain0.5210.3490.000-5.320Likely Benign0.082Likely BenignLikely Benign-0.23Likely Benign0.00.44Likely Benign0.11Likely Benign-0.14Likely Benign0.084Likely Benign0.47Neutral0.107Benign0.033Benign3.47Benign1.00Tolerated0.33290.493811-0.1-14.03
c.2021C>G
T674S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T674S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools uniformly indicate a benign effect: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, premPS, FoldX, Rosetta, and AlphaMissense‑Default all classify the change as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports a benign effect. With all available evidence pointing to a benign outcome and no conflicting ClinVar annotation, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.129801Structured0.109297Uncertain0.5210.3490.000-5.320Likely Benign0.082Likely BenignLikely Benign-0.23Likely Benign0.00.44Likely Benign0.11Likely Benign-0.14Likely Benign0.088Likely Benign0.47Neutral0.107Benign0.033Benign3.47Benign1.00Tolerated0.33290.493811-0.1-14.03
c.2036T>A
F679Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F679Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. Two tools give uncertain results: premPS and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) resolves to benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. Overall, the majority of evidence indicates that F679Y is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.222385Structured0.129316Uncertain0.7000.3200.000-5.842Likely Benign0.462AmbiguousLikely Benign0.48Likely Benign0.20.13Likely Benign0.31Likely Benign0.71Ambiguous0.315Likely Benign-2.71Deleterious0.993Probably Damaging0.952Probably Damaging3.47Benign0.14Tolerated0.13060.195473-4.116.00
c.2038G>C
E680Q
2D
AIThe SynGAP1 missense variant E680Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, premPS, SIFT, FATHMM, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points toward a benign impact for E680Q. This conclusion is not contradicted by ClinVar, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.209395Structured0.136843Uncertain0.6360.3200.000-10.502Likely Pathogenic0.742Likely PathogenicLikely Benign-0.01Likely Benign0.7-0.01Likely Benign-0.01Likely Benign-0.10Likely Benign0.239Likely Benign-2.58Deleterious0.981Probably Damaging0.483Possibly Damaging3.47Benign0.15Tolerated0.17510.7241220.0-0.98
c.2039A>C
E680A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E680A missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Those that predict a pathogenic impact are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools give uncertain results: Rosetta and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as likely pathogenic, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a benign effect. AlphaMissense‑Optimized remains inconclusive. Overall, the majority of predictions lean toward pathogenicity, but the conflicting high‑accuracy results leave the classification uncertain. The variant is most likely pathogenic based on the prevailing evidence, and this assessment does not contradict the ClinVar status, which currently has no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.209395Structured0.136843Uncertain0.6360.3200.000-11.338Likely Pathogenic0.819Likely PathogenicAmbiguous0.34Likely Benign0.20.59Ambiguous0.47Likely Benign0.30Likely Benign0.444Likely Benign-5.22Deleterious0.935Possibly Damaging0.490Possibly Damaging3.47Benign0.09Tolerated0.39310.69890-15.3-58.04
c.2039A>G
E680G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E680G is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools lean toward a pathogenic effect, with high‑accuracy methods split but tipping toward pathogenicity. The variant’s status in ClinVar is unknown, so there is no contradiction between the predictions and existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.209395Structured0.136843Uncertain0.6360.3200.000-11.396Likely Pathogenic0.743Likely PathogenicLikely Benign0.67Ambiguous0.20.11Likely Benign0.39Likely Benign0.44Likely Benign0.411Likely Benign-5.48Deleterious0.998Probably Damaging0.739Possibly Damaging3.47Benign0.01Affected0.27080.62280-23.1-72.06
c.2039A>T
E680V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E680V missense change is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, premPS, and Foldetta. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and Rosetta is inconclusive. High‑accuracy methods give mixed results: AlphaMissense‑Optimized is uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, more tools (seven) predict pathogenicity than benign (five), and the high‑accuracy consensus leans toward pathogenic. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.209395Structured0.136843Uncertain0.6360.3200.000-12.051Likely Pathogenic0.936Likely PathogenicAmbiguous0.46Likely Benign0.3-1.08Ambiguous-0.31Likely Benign0.18Likely Benign0.454Likely Benign-6.21Deleterious0.988Probably Damaging0.606Possibly Damaging3.47Benign0.01Affected0.10910.7518-2-27.7-29.98
c.2064G>C
E688D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E688D is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM. Tools that predict a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy methods specifically give AlphaMissense‑Optimized a pathogenic prediction, SGM‑Consensus a pathogenic prediction, and Foldetta an uncertain result. Overall, the majority of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.061840Structured0.211124Uncertain0.9470.2230.000-11.890Likely Pathogenic0.987Likely PathogenicLikely Pathogenic1.79Ambiguous0.50.53Ambiguous1.16Ambiguous0.91Ambiguous0.302Likely Benign-2.89Deleterious0.995Probably Damaging0.960Probably Damaging3.47Benign0.08Tolerated0.17220.3492320.0-14.03
c.2064G>T
E688D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E688D is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM. Tools that predict a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy methods specifically give: AlphaMissense‑Optimized – pathogenic; SGM‑Consensus – pathogenic; Foldetta – uncertain. Taken together, the majority of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.061840Structured0.211124Uncertain0.9470.2230.000-11.890Likely Pathogenic0.987Likely PathogenicLikely Pathogenic1.79Ambiguous0.50.53Ambiguous1.16Ambiguous0.91Ambiguous0.302Likely Benign-2.89Deleterious0.995Probably Damaging0.960Probably Damaging3.47Benign0.08Tolerated0.17220.3492320.0-14.03
c.2126T>C
L709P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L709P is not reported in ClinVar and is absent from gnomAD. Benign predictions come from REVEL, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from FoldX, Rosetta, Foldetta, polyPhen2_HumDiv, polyPhen2_HumVar, and AlphaMissense‑Default. High‑accuracy tools give mixed results: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, FATHMM, PROVEAN) also predicts benign; Foldetta predicts pathogenic. Because the majority of standard predictors and the SGM Consensus favor benign, the variant is most likely benign, and this is consistent with the lack of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.243554Structured0.365830Uncertain0.9340.3790.000-7.517In-Between0.767Likely PathogenicLikely Benign2.81Destabilizing0.05.65Destabilizing4.23Destabilizing0.31Likely Benign0.167Likely Benign-1.93Neutral1.000Probably Damaging0.975Probably Damaging3.47Benign0.37Tolerated0.30040.0825-3-3-5.4-16.04
c.326G>T
S109I
2D
AIThe SynGAP1 missense variant S109I is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized remains uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is a 2‑vs‑2 tie, and Foldetta data are unavailable. Overall, the majority of evidence (five benign vs. three pathogenic predictions) points toward a benign impact. This conclusion does not contradict ClinVar, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.622677Disordered0.669335Binding0.3280.8640.750-5.195Likely Benign0.927Likely PathogenicAmbiguous0.200Likely Benign-2.56Deleterious0.267Benign0.039Benign3.47Benign0.00Affected0.09100.4930-1-25.326.08
c.406C>G
R136G
2D
AIThe SynGAP1 missense variant R136G is not reported in ClinVar and is absent from gnomAD. Consensus from standard in‑silico predictors shows a split: benign calls come from REVEL, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic calls arise from PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.433034Structured0.657394Binding0.3510.8940.250-10.641Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.246Likely Benign-3.46Deleterious0.487Possibly Damaging0.211Benign3.47Benign0.00Affected0.35810.3585-3-24.1-99.14
c.407G>C
R136P
2D
AIThe SynGAP1 missense variant R136P is listed in ClinVar (ID 579340.0) with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.433034Structured0.657394Binding0.3510.8940.250Uncertain 1-11.952Likely Pathogenic0.981Likely PathogenicLikely Pathogenic0.277Likely Benign-3.72Deleterious0.910Possibly Damaging0.578Possibly Damaging3.47Benign0.00Affected3.6150.20630.44260-22.9-59.07
c.425A>C
K142T
2D
AIThe SynGAP1 missense variant K142T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect comprise PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as Likely Pathogenic; Foldetta results are unavailable. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.461924Structured0.558796Binding0.3740.8590.500-12.013Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.251Likely Benign-3.77Deleterious0.247Benign0.166Benign3.47Benign0.00Affected0.20340.27080-13.2-27.07
c.426A>C
K142N
2D
AIThe SynGAP1 missense variant K142N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas those that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus also indicates Likely Pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of computational evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.461924Structured0.558796Binding0.3740.8590.500-12.169Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.097Likely Benign-3.13Deleterious0.700Possibly Damaging0.383Benign3.47Benign0.00Affected0.35860.1437100.4-14.07
c.426A>T
K142N
2D
AIThe SynGAP1 missense variant K142N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas those that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus also indicates Likely Pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of computational evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.461924Structured0.558796Binding0.3740.8590.500-12.169Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.096Likely Benign-3.13Deleterious0.700Possibly Damaging0.383Benign3.47Benign0.00Affected0.35860.1437100.4-14.07
c.550G>C
E184Q
2D
AIThe SynGAP1 missense variant E184Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available, so it does not influence the overall assessment. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.557691Disordered0.431514Uncertain0.3480.6220.625-11.927Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.210Likely Benign-2.55Deleterious0.990Probably Damaging0.815Possibly Damaging3.47Benign0.00Affected0.16880.7914220.0-0.98
c.67G>C
D23H
2D
AIThe SynGAP1 D23H missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain” and the SGM‑Consensus as “Likely Benign”; Foldetta results are unavailable. Overall, the majority of evidence points toward a benign impact, and this conclusion does not contradict any ClinVar annotation (none exists). Thus, the variant is most likely benign based on current predictive data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.557691Disordered0.440341Uncertain0.3690.8920.375-3.801Likely Benign0.867Likely PathogenicAmbiguous0.103Likely Benign-2.46Neutral0.972Probably Damaging0.861Possibly Damaging3.47Benign0.00Affected0.26440.90171-10.322.05
c.1282T>A
Y428N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y428N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are limited to FATHMM, which classifies the change as benign. All other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic or likely pathogenic impact. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized reports pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.000-12.164Likely Pathogenic0.976Likely PathogenicLikely Pathogenic2.34Destabilizing0.03.81Destabilizing3.08Destabilizing1.85Destabilizing0.533Likely Pathogenic-8.59Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.03Affected0.26070.0971-2-2-2.2-49.07
c.1289T>C
M430T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430T is reported in gnomAD (6‑33438194‑T‑C) and has no ClinVar entry. Consensus from multiple in‑silico predictors indicates a benign effect: REVEL, FoldX (uncertain), Rosetta, Foldetta (uncertain), premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify it as benign or likely benign. No tool predicts pathogenicity. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is benign, the SGM Consensus is likely benign, and Foldetta is uncertain. Overall, the computational evidence strongly supports a benign classification, and this is consistent with the absence of a ClinVar pathogenic report. Thus, the variant is most likely benign, and this is not contradictory to ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.071867Structured0.385298Uncertain0.9520.3060.0006-33438194-T-C16.19e-7-3.430Likely Benign0.107Likely BenignLikely Benign1.89Ambiguous0.10.01Likely Benign0.95Ambiguous0.43Likely Benign0.103Likely Benign-1.48Neutral0.016Benign0.010Benign3.48Benign0.40Tolerated3.37290.20020.3184-1-1-2.6-30.09
c.1289T>G
M430R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and ESM1b. The remaining tools—FoldX, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of consensus tools lean toward a benign classification, while a subset of high‑accuracy methods suggest pathogenicity, leaving the variant’s impact ambiguous. Based on the aggregate predictions, the variant is most likely benign, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.071867Structured0.385298Uncertain0.9520.3060.000-10.636Likely Pathogenic0.558AmbiguousLikely Benign0.98Ambiguous0.10.47Likely Benign0.73Ambiguous0.83Ambiguous0.153Likely Benign-2.87Deleterious0.620Possibly Damaging0.046Benign3.48Benign0.38Tolerated0.17750.16520-1-6.424.99
c.1319A>C
N440T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N440T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly favor a benign effect: AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, REVEL, premPS, Rosetta, Foldetta, and the SGM‑Consensus (majority vote) all predict benign or likely benign. No tool predicts pathogenicity; the only inconclusive result is from FoldX, which is listed as uncertain. High‑accuracy methods corroborate the benign assessment: AlphaMissense‑Optimized is benign, the SGM‑Consensus is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Therefore, based on the available predictions, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.191378Structured0.267204Uncertain0.9290.2450.000-5.371Likely Benign0.143Likely BenignLikely Benign0.58Ambiguous0.00.16Likely Benign0.37Likely Benign0.11Likely Benign0.079Likely Benign-1.27Neutral0.007Benign0.005Benign3.48Benign0.14Tolerated0.09690.3341002.8-13.00
c.1357C>A
H453N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant H453N is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. A third set of methods (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) yield uncertain or inconclusive results. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized remains uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also uncertain. Overall, the majority of evidence points toward a pathogenic effect for H453N. This conclusion is not contradicted by ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-8.416Likely Pathogenic0.789Likely PathogenicAmbiguous0.93Ambiguous0.10.97Ambiguous0.95Ambiguous0.78Ambiguous0.347Likely Benign-6.92Deleterious1.000Probably Damaging0.999Probably Damaging3.48Benign0.09Tolerated0.14350.254821-0.3-23.04
c.1357C>G
H453D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H453D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are made by FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus methods reinforce a pathogenic interpretation: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenicity. premPS remains uncertain. Overall, the majority of evidence points to a pathogenic effect for H453D, and this conclusion is not contradicted by ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-15.256Likely Pathogenic0.980Likely PathogenicLikely Pathogenic3.33Destabilizing0.02.68Destabilizing3.01Destabilizing0.97Ambiguous0.443Likely Benign-8.89Deleterious1.000Probably Damaging0.999Probably Damaging3.48Benign0.09Tolerated0.22250.18151-1-0.3-22.05
c.1372A>T
T458S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T458S missense variant has no ClinVar entry and is not present in gnomAD. Functional prediction tools cluster into two groups: benign calls from REVEL, FoldX, Rosetta, SIFT, and FATHMM; pathogenic calls from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments further split the signal: AlphaMissense‑Optimized remains uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Because the majority of standard predictors are evenly divided and the high‑accuracy methods disagree, the variant’s effect cannot be confidently classified as benign or pathogenic. Thus, the variant is of uncertain significance, and this uncertainty does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.185198Structured0.294848Uncertain0.9150.1440.000-8.465Likely Pathogenic0.915Likely PathogenicAmbiguous0.44Likely Benign0.10.35Likely Benign0.40Likely Benign0.55Ambiguous0.260Likely Benign-3.49Deleterious0.998Probably Damaging0.994Probably Damaging3.48Benign0.13Tolerated0.35250.434911-0.1-14.03
c.1441C>G
H481D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant H481D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two consensus groups: benign predictions come from REVEL, FoldX, SIFT, and FATHMM, whereas pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments further support a pathogenic signal: the SGM‑Consensus majority vote (AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, AlphaMissense‑Optimized is uncertain, and Foldetta (combining FoldX‑MD and Rosetta) predicts benign stability. Uncertain results from AlphaMissense‑Optimized, Foldetta, premPS, and Rosetta are treated as unavailable. Overall, the preponderance of evidence points to a pathogenic effect for H481D, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-11.822Likely Pathogenic0.812Likely PathogenicAmbiguous-0.09Likely Benign0.10.54Ambiguous0.23Likely Benign0.70Ambiguous0.273Likely Benign-5.41Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.50Tolerated0.21090.10581-1-0.3-22.05
c.1552T>A
Y518N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 Y518N missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools (SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and Foldetta) uniformly predict a pathogenic impact. Two tools give uncertain results: AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments show that AlphaMissense‑Optimized is inconclusive, the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta also predicts pathogenicity. Taken together, the overwhelming majority of evidence indicates a pathogenic effect. This conclusion is not contradicted by ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.139895Structured0.126970Uncertain0.8970.3210.000-12.036Likely Pathogenic0.949Likely PathogenicAmbiguous2.99Destabilizing0.81.50Ambiguous2.25Destabilizing1.29Destabilizing0.506Likely Pathogenic-8.45Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.04Affected0.17910.0212-2-2-2.2-49.07
c.1675T>C
C559R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C559R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, Rosetta, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain or inconclusive results come from FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools (six pathogenic vs five benign) lean toward a pathogenic interpretation, and this does not contradict any ClinVar status because the variant is not yet classified in ClinVar. Thus, the variant is most likely pathogenic based on current predictive evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.016021Structured0.010460Uncertain0.8420.2040.000-9.509Likely Pathogenic0.779Likely PathogenicLikely Benign-1.03Ambiguous0.1-0.38Likely Benign-0.71Ambiguous0.79Ambiguous0.498Likely Benign-8.58Deleterious0.999Probably Damaging0.996Probably Damaging3.48Benign0.46Tolerated0.24980.1720-4-3-7.053.05
c.1689G>C
R563S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 R563S missense change is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, ESM1b, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Five tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) return uncertain or inconclusive results. High‑accuracy assessments are likewise ambiguous: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is a 2‑to‑2 tie and therefore unavailable; Foldetta also reports an uncertain stability change. Consequently, the evidence does not strongly support either benign or pathogenic status. The variant’s classification is therefore inconclusive and does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.039760Structured0.031987Uncertain0.8760.2090.000-6.503Likely Benign0.949Likely PathogenicAmbiguous1.16Ambiguous0.11.46Ambiguous1.31Ambiguous0.69Ambiguous0.251Likely Benign-4.49Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.23Tolerated0.30310.25340-13.7-69.11
c.1689G>T
R563S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R563S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, ESM1b, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The remaining tools—FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized—yield uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments are likewise inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is a 2‑to‑2 tie, and Foldetta is uncertain. Consequently, the evidence does not strongly favor either outcome. Based on the current predictions, the variant is most likely benign, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.039760Structured0.031987Uncertain0.8760.2090.000-6.503Likely Benign0.949Likely PathogenicAmbiguous1.16Ambiguous0.11.46Ambiguous1.31Ambiguous0.69Ambiguous0.251Likely Benign-4.49Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.23Tolerated0.30310.25340-13.7-69.11
c.1700A>T
E567V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E567V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, FoldX, premPS, SIFT, FATHMM) and pathogenic predictions (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default). High‑accuracy assessments further support a pathogenic bias: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, while Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts benign. Rosetta alone is inconclusive and treated as unavailable. Overall, the majority of evidence points to a pathogenic effect for E567V, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.021816Structured0.051008Uncertain0.9160.2340.000-15.638Likely Pathogenic0.965Likely PathogenicLikely Pathogenic0.27Likely Benign0.10.59Ambiguous0.43Likely Benign0.38Likely Benign0.440Likely Benign-6.77Deleterious0.999Probably Damaging0.996Probably Damaging3.48Benign0.06Tolerated0.05730.6175-2-27.7-29.98
c.1771G>A
A591T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A591T is listed in ClinVar with an uncertain significance designation and is observed in gnomAD (variant ID 6‑33440823‑G‑A). Functional prediction tools cluster into two groups: benign predictions come from REVEL, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic outcome. High‑accuracy assessments further show AlphaMissense‑Optimized as benign, SGM Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No other folding‑stability metrics are available. Overall, the balance of evidence favors a pathogenic interpretation, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018787Structured0.093848Uncertain0.8820.1850.000Conflicting 36-33440823-G-A181.12e-5-9.572Likely Pathogenic0.704Likely PathogenicLikely Benign1.61Ambiguous0.21.00Ambiguous1.31Ambiguous1.19Destabilizing0.270Likely Benign-3.40Deleterious0.955Possibly Damaging0.209Benign3.48Benign0.01Affected3.37350.12250.415510-2.530.03202.9-43.40.20.00.70.1XPotentially BenignThe methyl group of the Ala591 side chain, located in the middle of an α helix (res. Glu582-Met603), packs against hydrophobic residues (e.g., Ile483, Phe484) of an opposing partially helical loop (res. Phe476-Asn487).In the variant simulations, the hydroxyl group of Thr591 can form hydrogen bonds with the backbone carbonyl of Ile843 in the opposing loop or the backbone carbonyl group of Arg587. These interactions could either reinforce the tertiary assembly or weaken the α helix unity. Additionally, the Thr591 side chain can hydrogen bond with the guanidinium group of the Arg587 side chain, potentially strengthening the α helix unity.Overall, the residue swap does not seem to cause any major negative effects on the protein structure.
c.1841A>C
Y614S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y614S is not reported in ClinVar and is present in gnomAD (ID 6‑33440893‑A‑C). Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas the majority of algorithms—AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 (HumDiv and HumVar), premPS, Rosetta, Foldetta, and the SGM Consensus—indicate pathogenicity; FoldX remains uncertain. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labels it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Overall, the preponderance of evidence points to a pathogenic classification, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.182134Uncertain0.8520.2540.0006-33440893-A-C16.20e-7-12.709Likely Pathogenic0.990Likely PathogenicLikely Pathogenic1.74Ambiguous0.43.25Destabilizing2.50Destabilizing2.05Destabilizing0.482Likely Benign-8.83Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.09Tolerated3.37350.41550.1220-2-30.5-76.10
c.1939G>A
G647S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G647S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from Rosetta and premPS, which are treated as unavailable. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the evidence strongly favors a benign classification, and this is consistent with its absence from ClinVar. The variant is most likely benign, and this is consistent with its absence from ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.048328Structured0.325524Uncertain0.9360.3560.000-2.175Likely Benign0.082Likely BenignLikely Benign0.05Likely Benign0.1-0.75Ambiguous-0.35Likely Benign-0.56Ambiguous0.037Likely Benign0.65Neutral0.002Benign0.004Benign3.48Benign0.89Tolerated0.24090.395910-0.430.03
c.1943T>C
F648S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F648S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: benign calls are limited to SIFT and FATHMM, whereas the remaining 12 predictors—including REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, both polyPhen‑2 versions, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the substitution as pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports a likely pathogenic outcome, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also indicates a pathogenic effect. No prediction is inconclusive or missing. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.346782Uncertain0.9430.3390.000-10.356Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.36Destabilizing0.03.23Destabilizing3.30Destabilizing1.35Destabilizing0.604Likely Pathogenic-7.98Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.06Tolerated0.36800.0200-3-2-3.6-60.10
c.1953G>C
E651D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E651D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen2_HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only polyPhen2_HumDiv predicts a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores the variant as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign effect; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign prediction. No prediction tool or stability analysis is inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.088832Structured0.365409Uncertain0.9550.3400.000-3.220Likely Benign0.231Likely BenignLikely Benign0.16Likely Benign0.10.33Likely Benign0.25Likely Benign-0.29Likely Benign0.153Likely Benign-0.13Neutral0.906Possibly Damaging0.429Benign3.48Benign0.53Tolerated0.18130.3762320.0-14.03
c.1953G>T
E651D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E651D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen2_HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. Only polyPhen2_HumDiv predicts a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores the variant as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign effect; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign prediction. No prediction tool or stability analysis is inconclusive or missing. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.088832Structured0.365409Uncertain0.9550.3400.000-3.220Likely Benign0.231Likely BenignLikely Benign0.16Likely Benign0.10.33Likely Benign0.25Likely Benign-0.29Likely Benign0.153Likely Benign-0.13Neutral0.906Possibly Damaging0.429Benign3.48Benign0.53Tolerated0.18130.3762320.0-14.03
c.1969T>A
W657R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W657R is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign calls come from REVEL, SIFT, and FATHMM, whereas pathogenic calls are made by premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus score, which is labeled Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, and the Foldetta stability analysis is inconclusive. Overall, the majority of evidence points to a pathogenic impact for W657R, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.030611Structured0.208729Uncertain0.9410.2450.000-13.391Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.56Ambiguous0.21.64Ambiguous1.60Ambiguous1.29Destabilizing0.461Likely Benign-11.96Deleterious0.999Probably Damaging0.964Probably Damaging3.48Benign0.07Tolerated0.46840.00002-3-3.6-30.03
c.1969T>C
W657R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W657R is not reported in ClinVar and has no entry in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, while pathogenic predictions are made by premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority of the four high‑accuracy tools) is pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive. FoldX and Rosetta individually report uncertain effects on protein stability. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.030611Structured0.208729Uncertain0.9410.2450.000-13.391Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.56Ambiguous0.21.64Ambiguous1.60Ambiguous1.29Destabilizing0.461Likely Benign-11.96Deleterious0.999Probably Damaging0.964Probably Damaging3.48Benign0.07Tolerated0.46840.00002-3-3.6-30.03
c.1985A>G
Q662R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q662R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess sequence conservation, structural impact, or functional effect all converge on a benign outcome: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, FATHMM, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, premPS, FoldX, and Rosetta all predict benign. No tool in the dataset indicates pathogenicity. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Thus, based on the available predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.046336Structured0.103446Uncertain0.9320.3230.000-6.678Likely Benign0.300Likely BenignLikely Benign-0.41Likely Benign0.00.10Likely Benign-0.16Likely Benign-0.42Likely Benign0.159Likely Benign0.49Neutral0.428Benign0.095Benign3.48Benign1.00Tolerated0.20230.139111-1.028.06
c.2072C>G
T691R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T691R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions are made by premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as Benign, SGM Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Uncertain. Overall, the preponderance of evidence from standard and high‑accuracy predictors points to a pathogenic effect. Based on the aggregate predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which has no entry for it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.060549Structured0.271308Uncertain0.9410.2320.000-12.228Likely Pathogenic0.621Likely PathogenicLikely Benign-1.27Ambiguous0.3-0.94Ambiguous-1.11Ambiguous1.35Destabilizing0.180Likely Benign-3.66Deleterious0.993Probably Damaging0.566Possibly Damaging3.48Benign0.02Affected0.07290.2478-1-1-3.855.08
c.2081C>A
A694D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A694D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, FATHMM, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Consequently, the variant’s functional impact remains ambiguous. The predictions do not contradict ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.127496Structured0.352199Uncertain0.9380.2690.000-9.542Likely Pathogenic0.841Likely PathogenicAmbiguous0.35Likely Benign0.11.04Ambiguous0.70Ambiguous1.01Destabilizing0.163Likely Benign-2.47Neutral0.918Possibly Damaging0.375Benign3.48Benign0.05Affected0.20850.22160-2-5.344.01
c.2091G>C
W697C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 W697C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, ESM1b, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The remaining tools—FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized—return uncertain or inconclusive results. High‑accuracy assessments are likewise ambiguous: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Consequently, the evidence does not favor either outcome; the variant’s impact remains indeterminate. This lack of consensus does not contradict ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.175930Structured0.400169Uncertain0.9450.2970.000-5.683Likely Benign0.811Likely PathogenicAmbiguous1.84Ambiguous0.11.01Ambiguous1.43Ambiguous0.98Ambiguous0.318Likely Benign-8.65Deleterious1.000Probably Damaging0.999Probably Damaging3.48Benign0.10Tolerated0.35750.1015-8-23.4-83.07
c.2091G>T
W697C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 W697C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, ESM1b, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Five tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) yield uncertain or missing results. High‑accuracy assessments are likewise inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is a 2‑vs‑2 tie; and Foldetta is uncertain. Consequently, the evidence does not strongly favor either outcome. The variant is therefore best classified as of uncertain significance; this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.175930Structured0.400169Uncertain0.9450.2970.000-5.683Likely Benign0.811Likely PathogenicAmbiguous1.84Ambiguous0.11.01Ambiguous1.43Ambiguous0.98Ambiguous0.318Likely Benign-8.65Deleterious1.000Probably Damaging0.999Probably Damaging3.48Benign0.10Tolerated0.35750.1015-8-23.4-83.07
c.2095G>C
V699L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V699L has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Only ESM1b predicts a pathogenic outcome, while FoldX, premPS, and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority; and Foldetta also predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the variant is most likely benign based on the preponderance of evidence, and this assessment does not contradict any ClinVar status, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.069024Structured0.432975Uncertain0.9350.3150.000-8.301Likely Pathogenic0.558AmbiguousLikely Benign-0.58Ambiguous0.1-0.36Likely Benign-0.47Likely Benign0.69Ambiguous0.150Likely Benign-2.14Neutral0.448Benign0.153Benign3.48Benign0.10Tolerated0.09000.328921-0.414.03
c.2095G>T
V699L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V699L has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Only ESM1b predicts a pathogenic outcome, while FoldX, premPS, and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority; and Foldetta also predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the variant is most likely benign based on the consensus of the available tools, and this benign prediction does not contradict any ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.069024Structured0.432975Uncertain0.9350.3150.000-8.301Likely Pathogenic0.558AmbiguousLikely Benign-0.58Ambiguous0.1-0.36Likely Benign-0.47Likely Benign0.69Ambiguous0.150Likely Benign-2.14Neutral0.448Benign0.153Benign3.48Benign0.10Tolerated0.09000.328921-0.414.03
c.2101C>T
P701S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P701S (ClinVar ID 2995856.0) is listed as “Uncertain” in ClinVar and is present in gnomAD (ID 6‑33441360‑C‑T). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). No tool in the dataset predicts a pathogenic outcome; all remaining predictions are either benign or uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Uncertain. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which remains uncertain.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.074921Structured0.404318Uncertain0.9180.3450.000Uncertain 16-33441360-C-T31.86e-6-4.375Likely Benign0.221Likely BenignLikely Benign1.33Ambiguous0.00.12Likely Benign0.73Ambiguous-0.36Likely Benign0.132Likely Benign0.78Neutral0.044Benign0.025Benign3.48Benign1.00Tolerated3.47100.31490.3782-110.8-10.0410.1016/j.ajhg.2020.11.011
c.2188A>G
I730V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730V is reported as “Likely Benign” in ClinVar and is not present in gnomAD. All available in‑silico predictors classify the change as benign: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-3.960Likely Benign0.091Likely BenignLikely Benign0.25Likely Benign0.10.04Likely Benign0.15Likely Benign0.03Likely Benign0.028Likely Benign-0.14Neutral0.112Benign0.033Benign3.48Benign0.39Tolerated0.10100.230343-0.3-14.03
c.325A>C
S109R
2D
AIThe SynGAP1 missense variant S109R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM, whereas pathogenic calls come from SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments highlight that AlphaMissense‑Optimized predicts pathogenicity, whereas the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts benign impact; Foldetta data are unavailable. Overall, the balance of evidence leans toward a benign effect for S109R, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.622677Disordered0.669335Binding0.3280.8640.750-4.830Likely Benign0.993Likely PathogenicLikely Pathogenic0.225Likely Benign-1.80Neutral0.002Benign0.001Benign3.48Benign0.00Affected0.08840.27000-1-3.769.11
c.327T>A
S109R
2D
AIThe SynGAP1 missense variant S109R has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) remains benign; Foldetta stability analysis is unavailable. Overall, the majority of predictions lean toward a benign impact, and this is not contradicted by any ClinVar status. Thus, the variant is most likely benign based on the current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.622677Disordered0.669335Binding0.3280.8640.750-4.830Likely Benign0.993Likely PathogenicLikely Pathogenic0.198Likely Benign-1.80Neutral0.002Benign0.001Benign3.48Benign0.00Affected0.08840.27000-1-3.769.11
c.327T>G
S109R
2D
AIThe SynGAP1 missense variant S109R has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify it as benign include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Tools that predict pathogenicity are SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give mixed results: AlphaMissense‑Optimized reports a pathogenic effect, whereas the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome; Foldetta stability analysis is unavailable. Overall, the majority of predictions lean toward a benign impact, with one high‑accuracy tool suggesting pathogenicity, and there is no ClinVar status to contradict these findings.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.622677Disordered0.669335Binding0.3280.8640.750-4.830Likely Benign0.993Likely PathogenicLikely Pathogenic0.198Likely Benign-1.80Neutral0.002Benign0.001Benign3.48Benign0.00Affected0.08840.27000-1-3.769.11
c.407G>T
R136L
2D
AIThe SynGAP1 missense variant R136L is catalogued in gnomAD (ID 6‑33432704‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; pathogenic predictions arise from PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, and the SGM‑Consensus (majority vote) also indicates Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of computational evidence points to a pathogenic impact, and this assessment does not conflict with ClinVar, which currently has no classification for R136L.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.433034Structured0.657394Binding0.3510.8940.2506-33432704-G-T17.05e-7-11.512Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.347Likely Benign-4.19Deleterious0.190Benign0.037Benign3.48Benign0.01Affected3.6150.17180.4475-2-38.3-43.03
c.419C>A
S140Y
2D
AIThe SynGAP1 missense variant S140Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default—predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the S140Y variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.476583Structured0.587898Binding0.3210.8960.625-13.071Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.252Likely Benign-3.88Deleterious0.995Probably Damaging0.986Probably Damaging3.48Benign0.00Affected0.05970.5849-3-2-0.576.10
c.419C>T
S140F
2D
AIThe SynGAP1 missense variant S140F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic or likely pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports “Likely Pathogenic.” High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote) also indicates likely pathogenic. Foldetta results are unavailable. Overall, the consensus of the available predictions points to a pathogenic effect for S140F, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.476583Structured0.587898Binding0.3210.8960.625-10.824Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.246Likely Benign-3.83Deleterious0.995Probably Damaging0.986Probably Damaging3.48Benign0.00Affected0.05650.5988-3-23.660.10
c.551A>C
E184A
2D
AIThe SynGAP1 missense variant E184A has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas those that predict a pathogenic impact are PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as Likely Pathogenic; the Foldetta protein‑folding stability analysis is unavailable. Overall, the majority of computational evidence supports a pathogenic effect for E184A. This prediction is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.557691Disordered0.431514Uncertain0.3480.6220.625-11.486Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.338Likely Benign-4.98Deleterious0.868Possibly Damaging0.344Benign3.48Benign0.00Affected0.44190.73810-15.3-58.04
c.68A>T
D23V
2D
AIThe SynGAP1 D23V missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie and thus unavailable; Foldetta predictions are not provided. Overall, more tools (five) predict pathogenicity than benign (three), and no ClinVar evidence contradicts this assessment. Therefore, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.557691Disordered0.440341Uncertain0.3690.8920.375-3.244Likely Benign0.842Likely PathogenicAmbiguous0.137Likely Benign-2.72Deleterious0.972Probably Damaging0.804Possibly Damaging3.48Benign0.00Affected0.15150.8367-2-37.7-15.96
c.1309C>T
P437S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P437S is not reported in ClinVar (ClinVar ID: None) but is present in gnomAD (ID 6‑33438214‑C‑T). Prediction tools that agree on a benign effect include REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized, whereas PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b all predict a pathogenic outcome; the remaining methods (FoldX, Foldetta, premPS, AlphaMissense‑Default) are uncertain and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the balance of evidence favors a pathogenic interpretation. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.175930Structured0.306196Uncertain0.9210.2980.0006-33438214-C-T21.24e-6-11.964Likely Pathogenic0.518AmbiguousLikely Benign1.14Ambiguous0.0-3.31Stabilizing-1.09Ambiguous0.60Ambiguous0.226Likely Benign-6.60Deleterious1.000Probably Damaging0.996Probably Damaging3.49Benign0.01Affected3.38260.35480.4843-110.8-10.04
c.1367A>T
Q456L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q456L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Tools with uncertain or inconclusive results are FoldX, Foldetta, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of predictions (six benign vs. four pathogenic) lean toward a benign interpretation, with no evidence of contradiction with the ClinVar status. Thus, the variant is most likely benign based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.170161Structured0.302348Uncertain0.9390.1640.000-10.272Likely Pathogenic0.492AmbiguousLikely Benign-0.88Ambiguous0.1-0.30Likely Benign-0.59Ambiguous0.28Likely Benign0.347Likely Benign-6.65Deleterious0.987Probably Damaging0.914Probably Damaging3.49Benign0.36Tolerated0.05540.4317-2-27.3-14.97
c.1384A>G
K462E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K462E is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Tools that agree on a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Rosetta and Foldetta are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta is uncertain. Overall, the majority of predictions (7 pathogenic vs. 5 benign) and the high‑accuracy tools support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-14.696Likely Pathogenic0.967Likely PathogenicLikely Pathogenic0.34Likely Benign0.01.56Ambiguous0.95Ambiguous0.33Likely Benign0.433Likely Benign-3.88Deleterious0.998Probably Damaging0.991Probably Damaging3.49Benign0.15Tolerated0.41450.1022010.40.94
c.1426T>G
F476V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F476V variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM. Those that agree on a pathogenic effect are FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and Foldetta. Tools with uncertain or mixed outputs are Rosetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta predicts a pathogenic impact. Overall, the majority of evidence points toward a pathogenic effect. The variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-12.329Likely Pathogenic0.918Likely PathogenicAmbiguous3.01Destabilizing0.21.90Ambiguous2.46Destabilizing0.64Ambiguous0.353Likely Benign-1.63Neutral0.996Probably Damaging0.993Probably Damaging3.49Benign0.53Tolerated0.14780.2251-1-11.4-48.04
c.1432G>A
E478K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478K is not reported in ClinVar (ClinVar ID: None) and has no entries in gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SGM‑Consensus (Likely Pathogenic), PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta as benign. Overall, the majority of evidence (eight benign versus five pathogenic predictions) points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.414660Uncertain0.7870.2490.000-12.654Likely Pathogenic0.899Likely PathogenicAmbiguous0.23Likely Benign0.00.12Likely Benign0.18Likely Benign-0.02Likely Benign0.309Likely Benign-3.45Deleterious0.320Benign0.117Benign3.49Benign0.05Affected0.20660.619201-0.4-0.94
c.1660G>C
V554L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V554L has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Only AlphaMissense‑Default predicts a pathogenic outcome, while FoldX, premPS, and ESM1b are uncertain. High‑accuracy assessments reinforce the benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign consensus; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. No prediction or stability result is missing or inconclusive. Overall, the variant is most likely benign based on the available computational evidence, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.020522Structured0.007349Uncertain0.9550.2260.000-7.884In-Between0.645Likely PathogenicLikely Benign-1.14Ambiguous0.00.29Likely Benign-0.43Likely Benign0.56Ambiguous0.162Likely Benign-1.54Neutral0.204Benign0.053Benign3.49Benign0.08Tolerated0.09910.299821-0.414.03
c.1660G>T
V554L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V554L has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Only AlphaMissense‑Default predicts a pathogenic outcome, while FoldX, premPS, and ESM1b are uncertain. High‑accuracy assessments reinforce the benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign consensus; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. No prediction or stability result is missing or inconclusive. Overall, the variant is most likely benign based on the available computational evidence, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.020522Structured0.007349Uncertain0.9550.2260.000-7.884In-Between0.645Likely PathogenicLikely Benign-1.14Ambiguous0.00.29Likely Benign-0.43Likely Benign0.56Ambiguous0.162Likely Benign-1.54Neutral0.204Benign0.053Benign3.49Benign0.08Tolerated0.09910.299821-0.414.03
c.1688G>C
R563T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 R563T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, and FATHMM, while those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The remaining tools—FoldX, Rosetta, ESM1b, AlphaMissense‑Optimized, and Foldetta—give uncertain or inconclusive results. High‑accuracy methods provide the following: AlphaMissense‑Optimized is unavailable; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic; Foldetta is unavailable. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which has no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.039760Structured0.031987Uncertain0.8760.2090.000-7.088In-Between0.913Likely PathogenicAmbiguous1.13Ambiguous0.10.77Ambiguous0.95Ambiguous0.18Likely Benign0.307Likely Benign-4.77Deleterious1.000Probably Damaging0.997Probably Damaging3.49Benign0.23Tolerated0.21150.3148-1-13.8-55.08
c.1931A>T
D644V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D644V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑to‑2 split. Overall, the majority of evidence points to a benign impact. Thus, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.066181Structured0.248888Uncertain0.8830.3200.000-6.230Likely Benign0.636Likely PathogenicLikely Benign0.50Ambiguous0.0-0.35Likely Benign0.08Likely Benign-0.03Likely Benign0.347Likely Benign-4.96Deleterious0.198Benign0.052Benign3.49Benign0.11Tolerated0.09510.6267-2-37.7-15.96
c.1939G>C
G647R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G647R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, polyPhen‑2 HumVar, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate benign or likely benign. In contrast, AlphaMissense‑Default and polyPhen‑2 HumDiv predict pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus as likely benign, and Foldetta (combining FoldX‑MD and Rosetta) is inconclusive. No evidence from FoldX or Rosetta alone is available. Overall, the preponderance of evidence supports a benign classification, and this is consistent with the lack of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.048328Structured0.325524Uncertain0.9360.3560.000-6.590Likely Benign0.636Likely PathogenicLikely Benign-0.51Ambiguous0.1-0.97Ambiguous-0.74Ambiguous0.29Likely Benign0.097Likely Benign-1.81Neutral0.787Possibly Damaging0.349Benign3.49Benign0.17Tolerated0.10200.3712-3-2-4.199.14
c.1942T>G
F648V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F648V is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include SIFT and FATHMM, whereas the remaining tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and the SGM‑Consensus—predict it to be pathogenic. High‑accuracy methods give consistent results: AlphaMissense‑Optimized indicates pathogenicity; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a destabilizing, pathogenic effect. No prediction is missing or inconclusive. Overall, the evidence overwhelmingly supports a pathogenic classification, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.346782Uncertain0.9430.3390.000-11.574Likely Pathogenic0.991Likely PathogenicLikely Pathogenic3.11Destabilizing0.12.80Destabilizing2.96Destabilizing1.14Destabilizing0.514Likely Pathogenic-6.98Deleterious0.998Probably Damaging0.993Probably Damaging3.49Benign0.06Tolerated0.18480.1983-1-11.4-48.04
c.1982A>T
Q661L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q661L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain, so it is not used as evidence. Overall, the majority of predictions support a pathogenic impact, and this is consistent with the lack of ClinVar annotation. Therefore, the variant is most likely pathogenic, with no contradiction from ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.117089Uncertain0.9240.3090.000-9.003Likely Pathogenic0.613Likely PathogenicLikely Benign-0.19Likely Benign0.1-1.12Ambiguous-0.66Ambiguous0.36Likely Benign0.391Likely Benign-5.11Deleterious0.976Probably Damaging0.567Possibly Damaging3.49Benign0.02Affected0.08340.4675-2-27.3-14.97
c.1984C>A
Q662K
2D
AIThe SynGAP1 missense variant Q662K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign, while only ESM1b predicts pathogenicity. When high‑accuracy methods are considered separately, AlphaMissense‑Optimized remains benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a Likely Benign verdict, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a benign effect. No conflicting evidence is present. Therefore, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.046336Structured0.103446Uncertain0.9320.3230.000-8.892Likely Pathogenic0.309Likely BenignLikely Benign-0.02Likely Benign0.20.03Likely Benign0.01Likely Benign-0.04Likely Benign0.108Likely Benign-0.80Neutral0.321Benign0.030Benign3.49Benign0.37Tolerated0.23910.319811-0.40.04
c.2024A>C
N675T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N675T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b. Uncertain results come from Rosetta and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. No evidence contradicts the ClinVar status. Overall, the balance of evidence, especially from the high‑accuracy tools, indicates that the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.111024Uncertain0.5130.3330.000-10.636Likely Pathogenic0.208Likely BenignLikely Benign0.36Likely Benign0.3-0.67Ambiguous-0.16Likely Benign0.56Ambiguous0.258Likely Benign-4.63Deleterious0.991Probably Damaging0.710Possibly Damaging3.49Benign0.05Affected0.12830.7910002.8-13.00
c.2038G>A
E680K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E680K missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are SIFT, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. With a majority of individual tools and the SGM‑Consensus indicating pathogenicity, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.209395Structured0.136843Uncertain0.6360.3200.000-12.728Likely Pathogenic0.901Likely PathogenicAmbiguous-0.10Likely Benign0.4-0.15Likely Benign-0.13Likely Benign0.33Likely Benign0.417Likely Benign-3.54Deleterious0.959Probably Damaging0.411Benign3.49Benign0.02Affected0.30480.755301-0.4-0.94
c.2071A>G
T691A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T691A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate benign or tolerated. Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while premPS and ESM1b are uncertain. The SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) classifies the variant as Likely Benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign, SGM‑Consensus is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. No prediction contradicts the ClinVar status, which is currently unreported. Based on the preponderance of evidence, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.060549Structured0.271308Uncertain0.9410.2320.000-7.840In-Between0.086Likely BenignLikely Benign-0.11Likely Benign0.00.22Likely Benign0.06Likely Benign0.69Ambiguous0.063Likely Benign-1.84Neutral0.751Possibly Damaging0.131Benign3.49Benign0.33Tolerated0.28190.3251102.5-30.03
c.2071A>T
T691S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T691S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall consensus of the available predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.060549Structured0.271308Uncertain0.9410.2320.000-9.274Likely Pathogenic0.123Likely BenignLikely Benign0.44Likely Benign0.10.23Likely Benign0.34Likely Benign0.88Ambiguous0.041Likely Benign-1.67Neutral0.860Possibly Damaging0.584Possibly Damaging3.49Benign0.61Tolerated0.22130.334311-0.1-14.03
c.2072C>T
T691I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T691I is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (gnomAD ID: 6‑33441331‑C‑T). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from FoldX, Foldetta, and premPS. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign, while Foldetta remains uncertain. Overall, the evidence overwhelmingly indicates that T691I is most likely benign, and this conclusion does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.060549Structured0.271308Uncertain0.9410.2320.0006-33441331-C-T16.20e-7-5.857Likely Benign0.202Likely BenignLikely Benign-1.08Ambiguous0.1-2.12Stabilizing-1.60Ambiguous-0.61Ambiguous0.052Likely Benign-1.19Neutral0.040Benign0.003Benign3.49Benign0.34Tolerated3.43140.06440.5397-105.212.05
c.2111G>T
S704I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S704I lies in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM, whereas the majority of other in silico predictors (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) report a pathogenic or likely pathogenic outcome. FoldX, Rosetta, and Foldetta provide uncertain results. High‑accuracy methods specifically give AlphaMissense‑Optimized as pathogenic, the SGM Consensus as likely pathogenic, and Foldetta as uncertain. Based on the overall consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.096677Structured0.383620Uncertain0.9280.3630.000-14.222Likely Pathogenic0.978Likely PathogenicLikely Pathogenic1.63Ambiguous0.11.32Ambiguous1.48Ambiguous0.29Likely Benign0.232Likely Benign-4.05Deleterious0.997Probably Damaging0.758Possibly Damaging3.49Benign0.02Affected0.07270.4798-1-25.326.08
c.2167A>C
T723P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T723P is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FATHMM, and AlphaMissense‑Optimized. Tools that predict pathogenicity are SGM Consensus, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic; Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. premPS is uncertain and does not influence the overall assessment. Overall, the majority of tools and the high‑accuracy methods support a pathogenic effect. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.476583Structured0.458243Uncertain0.9450.4470.375-9.231Likely Pathogenic0.741Likely PathogenicLikely Benign3.98Destabilizing0.16.10Destabilizing5.04Destabilizing0.54Ambiguous0.085Likely Benign-2.51Deleterious0.995Probably Damaging0.929Probably Damaging3.49Benign0.04Affected0.18260.44060-1-0.9-3.99
c.2189T>C
I730T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant I730T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive are premPS and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores the variant as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign classification, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a benign effect. Overall, the consensus of both general and high‑accuracy predictors points to a benign impact, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-5.641Likely Benign0.404AmbiguousLikely Benign0.18Likely Benign0.20.12Likely Benign0.15Likely Benign0.54Ambiguous0.103Likely Benign-0.83Neutral0.995Probably Damaging0.934Probably Damaging3.49Benign0.08Tolerated0.10740.08850-1-5.2-12.05
c.326G>A
S109N
2D
AIThe SynGAP1 missense variant S109N is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign calls come from REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, and FATHMM, while pathogenic calls come from polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves to a likely benign verdict. High‑accuracy assessments further support this: AlphaMissense‑Optimized is uncertain, and Foldetta data are unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.622677Disordered0.669335Binding0.3280.8640.750-5.509Likely Benign0.863Likely PathogenicAmbiguous0.116Likely Benign-1.45Neutral0.596Possibly Damaging0.074Benign3.49Benign0.00Affected0.13500.371711-2.727.03
c.4000A>T
N1334Y
2D
AIThe SynGAP1 missense variant N1334Y is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—yields a tie and is therefore inconclusive; Foldetta results are unavailable. Overall, the majority of conventional tools predict a pathogenic impact, but the single high‑accuracy benign prediction and the inconclusive consensus suggest uncertainty. Consequently, the variant is most likely pathogenic based on the prevailing evidence, and this assessment does not contradict any ClinVar annotation because the variant has not yet been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.915074Disordered0.960403Binding0.4060.7340.875-5.916Likely Benign0.770Likely PathogenicLikely Benign0.249Likely Benign-4.62Deleterious0.985Probably Damaging0.852Possibly Damaging3.49Benign0.00Affected0.07160.5447-2-22.249.07
c.419C>G
S140C
2D
AIThe SynGAP1 missense variant S140C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default—predict a pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the S140C variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.476583Structured0.587898Binding0.3210.8960.625-10.103Likely Pathogenic0.977Likely PathogenicLikely Pathogenic0.170Likely Benign-3.11Deleterious0.999Probably Damaging0.990Probably Damaging3.49Benign0.01Affected0.08110.57090-13.316.06
c.424A>G
K142E
2D
AIThe SynGAP1 missense variant K142E is not reported in ClinVar (no ClinVar entry) and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. In contrast, tools that predict a pathogenic effect are PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts Pathogenic, and the SGM‑Consensus (majority vote) also indicates Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions point to a pathogenic effect, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.461924Structured0.558796Binding0.3740.8590.500-14.450Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.249Likely Benign-2.59Deleterious0.247Benign0.125Benign3.49Benign0.00Affected0.36440.0952010.40.94
c.428G>C
R143P
2D
AIThe SynGAP1 missense variant R143P is listed in ClinVar with an “Uncertain” status (ClinVar ID 4632511) and is present in gnomAD (6‑33432725‑G‑C). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect comprise PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as Likely Pathogenic; Foldetta results are unavailable. Overall, the majority of computational evidence points to a pathogenic impact, and this is not in conflict with the ClinVar “Uncertain” classification. Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.575842Disordered0.538584Binding0.3380.8380.625Uncertain 16-33432725-G-C21.35e-6-14.564Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.292Likely Benign-3.74Deleterious0.001Benign0.000Benign3.49Benign0.00Affected3.6150.20630.4457-202.9-59.07
c.1262C>T
A421V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A421V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, FoldX, Foldetta, premPS, polyPhen‑2 HumVar, SIFT, and FATHMM, while pathogenic predictions are reported by PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote) also predicts pathogenic, whereas Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta, predicts benign. Rosetta alone is uncertain and is treated as unavailable. Overall, the majority of high‑confidence tools favor a pathogenic effect, so A421V is most likely pathogenic, with no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-8.167Likely Pathogenic0.984Likely PathogenicLikely Pathogenic-0.05Likely Benign0.1-0.82Ambiguous-0.44Likely Benign-0.06Likely Benign0.111Likely Benign-3.15Deleterious0.538Possibly Damaging0.113Benign3.50Benign0.14Tolerated0.10550.3738002.428.05
c.1270G>A
V424I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V424I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as tolerated or benign. The only inconclusive results come from FoldX (uncertain) and Foldetta (uncertain). When high‑accuracy methods are considered separately, AlphaMissense‑Optimized predicts benign, the SGM Consensus—derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also predicts benign, while Foldetta remains uncertain. No tool predicts pathogenicity. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.050641Structured0.411431Uncertain0.9730.2480.000-3.814Likely Benign0.095Likely BenignLikely Benign-1.04Ambiguous0.1-0.48Likely Benign-0.76Ambiguous0.02Likely Benign0.084Likely Benign-0.15Neutral0.013Benign0.006Benign3.50Benign0.63Tolerated0.08740.2609430.314.03
c.1282T>G
Y428D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y428D is not reported in ClinVar and is absent from gnomAD. Across a broad panel of in silico predictors, 15 tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) uniformly predict a deleterious effect, whereas only FATHMM classifies it as benign. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote) is likely pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a pathogenic effect. No prediction or stability result is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.389652Uncertain0.9650.2920.000-13.473Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.24Destabilizing0.04.19Destabilizing3.72Destabilizing1.64Destabilizing0.554Likely Pathogenic-9.55Deleterious1.000Probably Damaging1.000Probably Damaging3.50Benign0.01Affected0.44580.1003-4-3-2.2-48.09
c.1320T>A
N440K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N440K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Tools that predict a pathogenic effect are ESM1b and AlphaMissense‑Default. The remaining methods—FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized—yield uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments are likewise inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Based on the overall distribution of predictions, the variant is most likely benign, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.191378Structured0.267204Uncertain0.9290.2450.000-10.114Likely Pathogenic0.895Likely PathogenicAmbiguous0.92Ambiguous0.11.04Ambiguous0.98Ambiguous0.40Likely Benign0.058Likely Benign-1.97Neutral0.206Benign0.021Benign3.50Benign0.19Tolerated0.16600.255010-0.414.07
c.1320T>G
N440K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N440K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Tools that predict a pathogenic effect are ESM1b and AlphaMissense‑Default. The remaining methods—FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized—yield uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments are likewise inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Based on the overall distribution of predictions, the variant is most likely benign, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.191378Structured0.267204Uncertain0.9290.2450.000-10.114Likely Pathogenic0.895Likely PathogenicAmbiguous0.92Ambiguous0.11.04Ambiguous0.98Ambiguous0.40Likely Benign0.057Likely Benign-1.97Neutral0.206Benign0.021Benign3.50Benign0.19Tolerated0.16600.255010-0.414.07
c.1426T>A
F476I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F476I has no ClinVar entry and is not reported in gnomAD. Functional prediction tools fall into two groups: benign predictions come from REVEL, premPS, PROVEAN, SIFT, and FATHMM; pathogenic predictions come from FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—remains inconclusive and is treated as unavailable. With seven tools indicating pathogenicity versus five indicating benign, and two high‑accuracy tools supporting pathogenicity, the evidence points to a likely pathogenic effect. This conclusion is not contradicted by ClinVar, which contains no record for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-12.617Likely Pathogenic0.962Likely PathogenicLikely Pathogenic3.90Destabilizing0.13.09Destabilizing3.50Destabilizing0.39Likely Benign0.239Likely Benign-1.23Neutral0.997Probably Damaging0.989Probably Damaging3.50Benign0.37Tolerated0.13830.2202101.7-34.02
c.1553A>T
Y518F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 Y518F missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, AlphaMissense‑Optimized, and Foldetta. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Two tools are uncertain: Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of individual predictors (seven benign vs. four pathogenic) support a benign classification, and this does not contradict the ClinVar status, which has no entry for this variant. Thus, based on the available predictions, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.139895Structured0.126970Uncertain0.8970.3210.000-10.617Likely Pathogenic0.466AmbiguousLikely Benign0.34Likely Benign0.1-0.61Ambiguous-0.14Likely Benign0.41Likely Benign0.318Likely Benign-3.68Deleterious0.999Probably Damaging0.996Probably Damaging3.50Benign0.22Tolerated0.21070.2230734.1-16.00
c.1675T>G
C559G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 C559G is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX, Foldetta, SIFT, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions are made by SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain calls from Rosetta and premPS are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta as benign. Overall, the majority of predictions (seven pathogenic vs five benign) and the high‑accuracy consensus lean toward a pathogenic effect. This conclusion does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.016021Structured0.010460Uncertain0.8420.2040.000-12.342Likely Pathogenic0.581Likely PathogenicLikely Benign0.12Likely Benign0.10.53Ambiguous0.33Likely Benign0.76Ambiguous0.547Likely Pathogenic-8.96Deleterious1.000Probably Damaging1.000Probably Damaging3.50Benign0.37Tolerated0.24540.2001-3-3-2.9-46.09
c.1912A>G
K638E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K638E is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are uncertain or unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain. Overall, the balance of evidence favors a pathogenic classification; this conclusion does not contradict ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.098064Uncertain0.9370.2600.000-13.390Likely Pathogenic0.927Likely PathogenicAmbiguous0.57Ambiguous0.01.00Ambiguous0.79Ambiguous0.32Likely Benign0.363Likely Benign-3.70Deleterious0.995Probably Damaging0.947Probably Damaging3.50Benign0.12Tolerated0.30360.0790010.40.94
c.1964T>G
L655R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L655R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools uniformly indicate a benign effect: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, premPS, FoldX, and the majority of consensus methods (AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all score the variant as benign. The only inconclusive result comes from Rosetta, which is treated as unavailable. High‑accuracy assessments reinforce this benign prediction: AlphaMissense‑Optimized reports benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Thus, based on the available predictions, the variant is most likely benign, with no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.015344Structured0.268808Uncertain0.9610.2740.000-4.848Likely Benign0.284Likely BenignLikely Benign-0.40Likely Benign0.00.54Ambiguous0.07Likely Benign-0.09Likely Benign0.160Likely Benign0.46Neutral0.006Benign0.001Benign3.50Benign0.60Tolerated0.15890.0615-3-2-8.343.03
c.1975T>G
S659A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S659A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign, while ESM1b remains uncertain. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized is benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports a benign effect. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.067594Structured0.154597Uncertain0.9540.2830.000-7.066In-Between0.117Likely BenignLikely Benign-0.31Likely Benign0.00.02Likely Benign-0.15Likely Benign0.14Likely Benign0.088Likely Benign-2.22Neutral0.097Benign0.114Benign3.50Benign0.64Tolerated0.48420.3813112.6-16.00
c.1993T>A
Y665N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 Y665N variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) give uncertain results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of conventional predictors lean toward a benign impact, and this assessment does not contradict ClinVar status (none). Thus, the variant is most likely benign based on the prevailing predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.098513Structured0.086641Uncertain0.9220.3610.000-11.189Likely Pathogenic0.470AmbiguousLikely Benign1.11Ambiguous0.11.43Ambiguous1.27Ambiguous0.50Likely Benign0.219Likely Benign-3.03Deleterious1.000Probably Damaging0.996Probably Damaging3.50Benign0.88Tolerated0.19290.0573-2-2-2.2-49.07
c.2005A>G
N669D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N669D has no ClinVar entry and is not reported in gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, Foldetta, SIFT, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions are reported by premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, leans toward pathogenicity (3/4 votes). High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote) predicts pathogenic, and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts benign. Overall, the majority of high‑confidence tools (AlphaMissense‑Optimized, Foldetta, and the SGM‑Consensus majority) suggest a pathogenic effect, but the presence of several benign predictions introduces uncertainty. Based on the current computational evidence, the variant is most likely pathogenic, which does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.142424Structured0.086615Uncertain0.8720.3800.000-10.384Likely Pathogenic0.674Likely PathogenicLikely Benign0.53Ambiguous0.20.00Likely Benign0.27Likely Benign1.00Destabilizing0.336Likely Benign-4.45Deleterious0.999Probably Damaging0.990Probably Damaging3.50Benign0.07Tolerated0.21820.2827210.00.98
c.2006A>C
N669T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N669T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. FoldX, Rosetta, and Foldetta give uncertain results. High‑accuracy methods give a split verdict: AlphaMissense‑Optimized classifies the variant as benign, whereas the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts it to be pathogenic; Foldetta remains inconclusive. Overall, the majority of tools favor a pathogenic interpretation, and this assessment does not contradict the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.142424Structured0.086615Uncertain0.8720.3800.000-9.875Likely Pathogenic0.565Likely PathogenicLikely Benign0.74Ambiguous0.10.68Ambiguous0.71Ambiguous0.49Likely Benign0.292Likely Benign-5.25Deleterious0.991Probably Damaging0.962Probably Damaging3.50Benign0.17Tolerated0.15040.4803002.8-13.00
c.2020A>C
T674P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T674P missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The high‑accuracy AlphaMissense‑Optimized predicts benign, while Foldetta predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑to‑2 split. No other high‑accuracy tool provides a definitive call. Consequently, the evidence is evenly split between benign and pathogenic, leaving the variant’s clinical significance uncertain. This uncertainty does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.109297Uncertain0.5210.3490.000-8.661Likely Pathogenic0.109Likely BenignLikely Benign0.91Ambiguous0.64.12Destabilizing2.52Destabilizing0.12Likely Benign0.143Likely Benign-2.69Deleterious0.995Probably Damaging0.891Possibly Damaging3.50Benign0.16Tolerated0.20390.61030-1-0.9-3.99
c.2024A>G
N675S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N675S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, FATHMM, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. Two tools (premPS and ESM1b) return uncertain results. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a benign consensus; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts benign. Taken together, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.129801Structured0.111024Uncertain0.5130.3330.000-7.871In-Between0.081Likely BenignLikely Benign0.37Likely Benign0.0-0.43Likely Benign-0.03Likely Benign0.61Ambiguous0.157Likely Benign-3.78Deleterious0.993Probably Damaging0.606Possibly Damaging3.50Benign0.11Tolerated0.34620.7587112.7-27.03
c.2035T>G
F679V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F679V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and FATHMM, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments further support a deleterious effect: the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as Likely Pathogenic, while AlphaMissense‑Optimized and Foldetta provide inconclusive results and are treated as unavailable. Overall, the balance of evidence favors a pathogenic classification, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.222385Structured0.129316Uncertain0.7000.3200.000-11.868Likely Pathogenic0.900Likely PathogenicAmbiguous1.92Ambiguous0.50.29Likely Benign1.11Ambiguous0.89Ambiguous0.497Likely Benign-6.86Deleterious0.993Probably Damaging0.968Probably Damaging3.50Benign0.01Affected0.18300.2349-1-11.4-48.04
c.2036T>C
F679S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F679S is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: benign predictions are limited to FATHMM, while the remaining 12 tools (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all classify the variant as pathogenic. FoldX reports an uncertain outcome and is therefore not counted as evidence. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. Based on the preponderance of pathogenic predictions and the absence of any benign consensus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.222385Structured0.129316Uncertain0.7000.3200.000-12.159Likely Pathogenic0.963Likely PathogenicLikely Pathogenic1.86Ambiguous0.42.20Destabilizing2.03Destabilizing1.28Destabilizing0.575Likely Pathogenic-7.86Deleterious0.998Probably Damaging0.986Probably Damaging3.50Benign0.04Affected0.42760.0200-3-2-3.6-60.10
c.2081C>G
A694G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A694G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact. The variant’s predicted benign status does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.127496Structured0.352199Uncertain0.9380.2690.000-3.420Likely Benign0.144Likely BenignLikely Benign0.86Ambiguous0.01.16Ambiguous1.01Ambiguous0.86Ambiguous0.093Likely Benign-1.90Neutral0.866Possibly Damaging0.171Benign3.50Benign0.05Affected0.20150.338710-2.2-14.03
c.2101C>G
P701A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P701A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; all of these classify the substitution as benign. No tool predicts a pathogenic outcome. Predictions that are inconclusive are FoldX (uncertain) and Foldetta (uncertain). High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign, while Foldetta remains uncertain. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.074921Structured0.404318Uncertain0.9180.3450.000-6.836Likely Benign0.217Likely BenignLikely Benign1.35Ambiguous0.00.23Likely Benign0.79Ambiguous-0.16Likely Benign0.058Likely Benign-0.55Neutral0.002Benign0.011Benign3.50Benign0.82Tolerated0.31430.37651-13.4-26.04
c.2102C>T
P701L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P701L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Foldetta, premPS, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and ESM1b. The remaining tools (FoldX, Rosetta, AlphaMissense‑Default) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of predictions (7 benign vs. 3 pathogenic) and the two high‑accuracy benign calls suggest that the variant is most likely benign. This conclusion does not contradict any ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.074921Structured0.404318Uncertain0.9180.3450.000-10.185Likely Pathogenic0.515AmbiguousLikely Benign1.15Ambiguous0.0-0.68Ambiguous0.24Likely Benign0.12Likely Benign0.116Likely Benign-3.04Deleterious0.642Possibly Damaging0.087Benign3.50Benign0.09Tolerated0.20180.5546-3-35.416.04
c.2126T>G
L709R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L709R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv and ESM1b. Tools with uncertain or inconclusive results are Rosetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign consensus; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Overall, the majority of evidence indicates a benign impact for the variant, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.243554Structured0.365830Uncertain0.9340.3790.000-8.636Likely Pathogenic0.482AmbiguousLikely Benign0.22Likely Benign0.00.68Ambiguous0.45Likely Benign0.62Ambiguous0.061Likely Benign-1.56Neutral0.906Possibly Damaging0.314Benign3.50Benign0.44Tolerated0.11270.0488-3-2-8.343.03
c.4000A>C
N1334H
2D
AIThe SynGAP1 missense variant N1334H is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of reliable tools and the high‑accuracy consensus predict a benign impact. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.915074Disordered0.960403Binding0.4060.7340.875-4.954Likely Benign0.496AmbiguousLikely Benign0.164Likely Benign-2.99Deleterious0.985Probably Damaging0.927Probably Damaging3.50Benign0.00Affected0.19630.6246210.323.04
c.4001A>T
N1334I
2D
AIThe SynGAP1 missense variant N1334I is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign), and Foldetta results are unavailable. Overall, the balance of evidence (seven pathogenic vs. three benign predictions) indicates that the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, as the variant has no existing ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.915074Disordered0.960403Binding0.4060.7340.875-5.880Likely Benign0.962Likely PathogenicLikely Pathogenic0.193Likely Benign-5.06Deleterious0.985Probably Damaging0.721Possibly Damaging3.50Benign0.00Affected0.08610.5491-2-38.0-0.94
c.424A>C
K142Q
2D
AIThe SynGAP1 missense variant K142Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas those that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus also indicates Likely Pathogenic. No Foldetta stability analysis is available for this variant. Overall, the preponderance of computational evidence points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.461924Structured0.558796Binding0.3740.8590.500-11.295Likely Pathogenic0.979Likely PathogenicLikely Pathogenic0.191Likely Benign-2.50Deleterious0.700Possibly Damaging0.383Benign3.50Benign0.00Affected0.42320.1132110.4-0.04
c.550G>A
E184K
2D
AIThe SynGAP1 missense variant E184K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the majority of computational evidence indicates that E184K is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.557691Disordered0.431514Uncertain0.3480.6220.625-14.037Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.289Likely Benign-3.31Deleterious0.970Probably Damaging0.681Possibly Damaging3.50Benign0.00Affected0.28900.822701-0.4-0.94
c.556T>A
L186M
2D
AIThe SynGAP1 missense variant L186M is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool rates the variant as uncertain, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions (5 pathogenic vs. 3 benign) suggest a pathogenic impact. This conclusion is not contradicted by ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.458154Structured0.428613Uncertain0.3970.6170.500-11.783Likely Pathogenic0.933Likely PathogenicAmbiguous0.146Likely Benign-1.58Neutral0.952Possibly Damaging0.694Possibly Damaging3.50Benign0.00Affected0.06710.339642-1.918.03
c.558G>C
L186F
2D
AIThe SynGAP1 missense variant L186F is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), and FATHMM. In contrast, tools that predict a pathogenic effect are PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Pathogenic.” High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (majority vote) also indicates likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of computational evidence points to a pathogenic effect, which does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.458154Structured0.428613Uncertain0.3970.6170.500Uncertain 1-11.861Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.132Likely Benign-3.03Deleterious0.009Benign0.012Benign3.50Benign0.00Affected0.05240.317720-1.034.02
c.558G>T
L186F
2D
AIThe SynGAP1 missense variant L186F has no ClinVar entry (ClinVar status: not reported) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of computational evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.458154Structured0.428613Uncertain0.3970.6170.500-11.861Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.132Likely Benign-3.03Deleterious0.009Benign0.012Benign3.50Benign0.00Affected0.05240.317720-1.034.02
c.68A>G
D23G
2D
AIThe SynGAP1 missense variant D23G is listed in ClinVar (ID 3644551.0) with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of computational evidence points to a benign impact, which does not contradict the ClinVar “Uncertain” classification but leans toward a benign interpretation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.557691Disordered0.440341Uncertain0.3690.8920.375Uncertain 1-2.622Likely Benign0.684Likely PathogenicLikely Benign0.100Likely Benign-2.45Neutral0.805Possibly Damaging0.539Possibly Damaging3.50Benign0.00Affected0.46820.76321-13.1-58.04
c.1280A>C
H427P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H427P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. Two tools are uncertain: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as inconclusive, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both indicate a pathogenic effect. Overall, the preponderance of evidence points to a pathogenic classification for H427P, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.081712Structured0.394261Uncertain0.9620.2870.000-11.098Likely Pathogenic0.950Likely PathogenicAmbiguous4.74Destabilizing0.17.61Destabilizing6.18Destabilizing0.68Ambiguous0.324Likely Benign-4.22Deleterious0.993Probably Damaging0.819Possibly Damaging3.51Benign0.01Affected0.20610.34420-21.6-40.02
c.1280A>G
H427R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H427R is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438185‑A‑G). Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN and SIFT, while premPS and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign stability change. No predictions or folding results are missing or inconclusive. Overall, the majority of evidence indicates the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.081712Structured0.394261Uncertain0.9620.2870.0006-33438185-A-G-3.259Likely Benign0.439AmbiguousLikely Benign-0.04Likely Benign0.10.48Likely Benign0.22Likely Benign0.72Ambiguous0.168Likely Benign-2.61Deleterious0.174Benign0.018Benign3.51Benign0.03Affected3.38250.21080.212102-1.319.05
c.1309C>G
P437A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P437A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, Rosetta, FATHMM, AlphaMissense‑Optimized, and premPS. Those that predict pathogenicity are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Tools with uncertain or inconclusive results are AlphaMissense‑Default, FoldX, and Foldetta. High‑accuracy assessments give AlphaMissense‑Optimized a benign prediction. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default (uncertain), ESM1b (pathogenic), FATHMM (benign), and PROVEAN (pathogenic), yields a pathogenic consensus. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain. Overall, the balance of evidence leans toward a pathogenic effect for P437A, and this conclusion does not contradict the current ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.175930Structured0.306196Uncertain0.9210.2980.000-12.059Likely Pathogenic0.392AmbiguousLikely Benign1.23Ambiguous0.0-3.14Stabilizing-0.96Ambiguous0.50Likely Benign0.266Likely Benign-6.53Deleterious0.999Probably Damaging0.998Probably Damaging3.51Benign0.03Affected0.34890.47751-13.4-26.04
c.1310C>G
P437R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P437R is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, and FATHMM, whereas pathogenic predictions are made by SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. With the majority of tools indicating pathogenicity and the high‑accuracy consensus leaning toward pathogenic, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.306196Uncertain0.9210.2980.000-13.094Likely Pathogenic0.879Likely PathogenicAmbiguous0.34Likely Benign0.1-3.52Stabilizing-1.59Ambiguous0.61Ambiguous0.461Likely Benign-7.72Deleterious1.000Probably Damaging0.996Probably Damaging3.51Benign0.03Affected0.14480.28460-2-2.959.07
c.1327G>A
G443S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G443S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree that the substitution is benign: REVEL, FoldX, PROVEAN, polyPhen‑2 (both HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as benign. Only Rosetta and premPS yield uncertain results, which are treated as unavailable. Grouping by consensus, the benign‑predicting tools outnumber any pathogenic calls (none). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports benign. Therefore, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.250310Structured0.258623Uncertain0.9350.2060.000-1.258Likely Benign0.086Likely BenignLikely Benign0.25Likely Benign0.1-0.72Ambiguous-0.24Likely Benign-0.65Ambiguous0.087Likely Benign0.40Neutral0.000Benign0.001Benign3.51Benign0.34Tolerated0.24090.341610-0.430.03
c.1360A>C
I454L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I454L is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default predict a pathogenic impact. The remaining tools—FoldX, Rosetta, Foldetta, premPS, ESM1b, and AlphaMissense‑Optimized—yield uncertain or inconclusive results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) leaning toward benign, and Foldetta also uncertain. Overall, the majority of reliable predictors and the SGM Consensus favor a benign classification. Thus, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.254060Structured0.312811Uncertain0.9650.1820.000-7.852In-Between0.786Likely PathogenicAmbiguous0.57Ambiguous0.11.36Ambiguous0.97Ambiguous0.80Ambiguous0.246Likely Benign-1.98Neutral0.908Possibly Damaging0.943Probably Damaging3.51Benign0.26Tolerated0.06530.285722-0.70.00
c.1501A>C
I501L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I501L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, Rosetta, Foldetta, PROVEAN, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions come from polyPhen‑2 (HumDiv and HumVar) and SIFT. Uncertain or inconclusive results are reported for FoldX, premPS, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta as Benign, all supporting a non‑deleterious effect. Based on the preponderance of benign predictions and the concordant high‑accuracy tools, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.079919Structured0.366596Uncertain0.8860.1530.000-7.348In-Between0.282Likely BenignLikely Benign0.78Ambiguous0.2-0.34Likely Benign0.22Likely Benign0.86Ambiguous0.219Likely Benign-1.92Neutral0.930Possibly Damaging0.985Probably Damaging3.51Benign0.05Affected0.08170.226122-0.70.00
c.1644G>C
E548D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E548D variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, premPS, SIFT, and FATHMM, whereas a separate group predicts pathogenicity: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. Predictions that are uncertain or unavailable are FoldX, Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a pathogenic verdict (2 pathogenic, 1 benign, 1 uncertain). Foldetta’s stability prediction is unavailable. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.054297Structured0.008632Uncertain0.9650.2880.000-7.359In-Between0.992Likely PathogenicLikely Pathogenic0.74Ambiguous0.11.29Ambiguous1.02Ambiguous0.32Likely Benign0.254Likely Benign-2.85Deleterious0.998Probably Damaging0.989Probably Damaging3.51Benign0.09Tolerated0.13740.2524320.0-14.03
c.1644G>T
E548D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E548D variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, premPS, SIFT, and FATHMM, whereas a separate group predicts a pathogenic effect: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. Predictions that are uncertain or unavailable are FoldX, Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a pathogenic verdict (2 pathogenic, 1 benign, 1 uncertain). Foldetta’s stability prediction is unavailable. Overall, the majority of evidence points to a pathogenic impact for E548D, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.054297Structured0.008632Uncertain0.9650.2880.000-7.359In-Between0.992Likely PathogenicLikely Pathogenic0.74Ambiguous0.11.29Ambiguous1.02Ambiguous0.32Likely Benign0.254Likely Benign-2.85Deleterious0.998Probably Damaging0.989Probably Damaging3.51Benign0.09Tolerated0.13740.2524320.0-14.03
c.1918A>G
T640A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T640A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN, REVEL, FoldX, premPS, polyPhen‑2 (HumDiv and HumVar), and SIFT all score the substitution as benign. No tool predicts pathogenicity; only Rosetta yields an uncertain result. High‑accuracy assessments corroborate this benign trend: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled likely benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) remains uncertain. Taken together, the evidence overwhelmingly supports a benign classification for T640A, and this conclusion does not contradict any ClinVar annotation (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.066181Structured0.137043Uncertain0.8930.2840.000-3.068Likely Benign0.074Likely BenignLikely Benign0.14Likely Benign0.10.93Ambiguous0.54Ambiguous-0.17Likely Benign0.078Likely Benign0.51Neutral0.009Benign0.001Benign3.51Benign0.42Tolerated0.38340.3202102.5-30.03
c.1931A>C
D644A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D644A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, Foldetta, and premPS. Only PROVEAN predicts it as pathogenic, while Rosetta and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign; and Foldetta also predicts benign stability. Based on the aggregate evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.066181Structured0.248888Uncertain0.8830.3200.000-3.358Likely Benign0.502AmbiguousLikely Benign-0.14Likely Benign0.1-0.83Ambiguous-0.49Likely Benign-0.18Likely Benign0.274Likely Benign-3.90Deleterious0.311Benign0.032Benign3.51Benign0.39Tolerated0.38830.54810-25.3-44.01
c.2167A>G
T723A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T723A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess sequence conservation, structural impact, or functional effect all converge on a benign outcome: SIFT, PolyPhen‑2 (HumDiv and HumVar), PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, REVEL, and the protein‑stability predictors FoldX, Rosetta, premPS, and Foldetta all indicate a benign effect. No tool predicts pathogenicity. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. Based on the uniform predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.476583Structured0.458243Uncertain0.9450.4470.375-4.572Likely Benign0.064Likely BenignLikely Benign-0.47Likely Benign0.00.16Likely Benign-0.16Likely Benign0.25Likely Benign0.053Likely Benign-0.91Neutral0.161Benign0.045Benign3.51Benign0.06Tolerated0.39020.3639102.5-30.03
c.2168C>G
T723R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T723R has no ClinVar entry and is not reported in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all classify it as benign. Two tools (polyPhen‑2 HumDiv and HumVar) predict it to be pathogenic, while FoldX, Foldetta, and AlphaMissense‑Default are uncertain. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as likely benign. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as likely benign, and Foldetta as uncertain. Overall, the preponderance of evidence points to a benign impact for T723R, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.476583Structured0.458243Uncertain0.9450.4470.375-3.654Likely Benign0.408AmbiguousLikely Benign-0.90Ambiguous0.1-0.13Likely Benign-0.52Ambiguous0.44Likely Benign0.146Likely Benign-1.50Neutral0.931Possibly Damaging0.458Possibly Damaging3.51Benign0.29Tolerated0.07940.2437-1-1-3.855.08
c.2187C>A
N729K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N729K has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus call (Likely Benign). Only AlphaMissense‑Default predicts a pathogenic outcome. Tools with uncertain or mixed results are Foldetta (protein‑folding stability) and Rosetta. High‑accuracy assessments: AlphaMissense‑Optimized reports a benign effect; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely benign; Foldetta’s stability prediction is inconclusive. Overall, the majority of evidence points to a benign impact for the variant, and this conclusion does not contradict the current ClinVar status, which contains no report for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.426547Uncertain0.6510.5830.625-5.101Likely Benign0.648Likely PathogenicLikely Benign-0.03Likely Benign0.11.92Ambiguous0.95Ambiguous0.12Likely Benign0.036Likely Benign-1.39Neutral0.109Benign0.033Benign3.51Benign0.47Tolerated0.19480.361210-0.414.07
c.2187C>G
N729K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N729K has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus call (Likely Benign). Only AlphaMissense‑Default predicts a pathogenic outcome. Tools with uncertain or mixed results are Foldetta (protein‑folding stability) and Rosetta. High‑accuracy assessments: AlphaMissense‑Optimized reports a benign effect; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely benign; Foldetta’s stability prediction is inconclusive. Overall, the majority of evidence points to a benign impact for the variant, and this conclusion does not contradict the current ClinVar status, which contains no report for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.426547Uncertain0.6510.5830.625-5.101Likely Benign0.648Likely PathogenicLikely Benign-0.03Likely Benign0.11.92Ambiguous0.95Ambiguous0.12Likely Benign0.036Likely Benign-1.39Neutral0.109Benign0.033Benign3.51Benign0.47Tolerated0.19480.361210-0.414.07
c.325A>G
S109G
2D
AIThe SynGAP1 missense variant S109G is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (majority of the four high‑accuracy tools) also indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.622677Disordered0.669335Binding0.3280.8640.750-3.918Likely Benign0.549AmbiguousLikely Benign0.132Likely Benign-1.95Neutral0.378Benign0.067Benign3.51Benign0.00Affected0.26860.3779100.4-30.03
c.427C>G
R143G
2D
AIThe SynGAP1 missense variant R143G is not reported in ClinVar and is absent from gnomAD. In silico predictors that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), and FATHMM. Predictors that agree on a pathogenic effect include PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (majority vote) also indicates pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the preponderance of evidence from multiple independent tools points to a pathogenic effect. This conclusion is not contradicted by ClinVar status, as no ClinVar annotation exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.575842Disordered0.538584Binding0.3380.8380.625-12.686Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.151Likely Benign-3.86Deleterious0.319Benign0.124Benign3.51Benign0.00Affected0.35020.3547-3-24.1-99.14
c.557T>C
L186S
2D
AIThe SynGAP1 missense variant L186S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a deleterious effect, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels the variant as Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.458154Structured0.428613Uncertain0.3970.6170.500-13.906Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.250Likely Benign-4.73Deleterious0.952Possibly Damaging0.601Possibly Damaging3.51Benign0.00Affected0.32140.0808-3-2-4.6-26.08
c.1281T>A
H427Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H427Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv and SIFT. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign effect for H427Q. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.081712Structured0.394261Uncertain0.9620.2870.000-5.858Likely Benign0.367AmbiguousLikely Benign0.77Ambiguous0.10.62Ambiguous0.70Ambiguous0.73Ambiguous0.142Likely Benign-2.41Neutral0.864Possibly Damaging0.088Benign3.52Benign0.02Affected0.15560.338230-0.3-9.01
c.1281T>G
H427Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H427Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv and SIFT. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign effect for H427Q. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.081712Structured0.394261Uncertain0.9620.2870.000-5.858Likely Benign0.367AmbiguousLikely Benign0.77Ambiguous0.10.62Ambiguous0.70Ambiguous0.73Ambiguous0.142Likely Benign-2.41Neutral0.864Possibly Damaging0.088Benign3.52Benign0.02Affected0.15560.338230-0.3-9.01
c.1373C>G
T458R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T458R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, SIFT, and FATHMM, whereas a larger set—SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict pathogenicity. Uncertain results come from FoldX and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as benign. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.185198Structured0.294848Uncertain0.9150.1440.000-12.984Likely Pathogenic0.980Likely PathogenicLikely Pathogenic-0.81Ambiguous0.1-0.11Likely Benign-0.46Likely Benign0.61Ambiguous0.390Likely Benign-5.26Deleterious1.000Probably Damaging0.996Probably Damaging3.52Benign0.20Tolerated0.10160.3013-1-1-3.855.08
c.1501A>G
I501V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I501V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions from FoldX, Rosetta, and Foldetta are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact for I501V, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.079919Structured0.366596Uncertain0.8860.1530.000-2.326Likely Benign0.083Likely BenignLikely Benign0.94Ambiguous0.00.56Ambiguous0.75Ambiguous0.06Likely Benign0.200Likely Benign0.20Neutral0.951Possibly Damaging0.960Probably Damaging3.52Benign1.00Tolerated0.09850.249143-0.3-14.03
c.1771G>T
A591S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A591S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign effect, and the Foldetta stability analysis is inconclusive (unavailable). Consequently, the variant is most likely benign based on the available predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.018787Structured0.093848Uncertain0.8820.1850.000-7.535In-Between0.126Likely BenignLikely Benign0.58Ambiguous0.11.21Ambiguous0.90Ambiguous0.49Likely Benign0.083Likely Benign-2.11Neutral0.034Benign0.082Benign3.52Benign0.19Tolerated0.24050.330411-2.616.00
c.1876A>C
I626L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I626L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, and FATHMM, whereas polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default predict a pathogenic outcome. Three tools—Foldetta, premPS, and Rosetta—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta also yields an uncertain stability prediction. Overall, the balance of evidence leans toward a benign interpretation, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.109221Structured0.040732Uncertain0.9700.2230.000-10.696Likely Pathogenic0.622Likely PathogenicLikely Benign0.32Likely Benign0.11.00Ambiguous0.66Ambiguous0.83Ambiguous0.311Likely Benign-1.86Neutral0.955Possibly Damaging0.985Probably Damaging3.52Benign0.12Tolerated0.07410.246122-0.70.00
c.1913A>C
K638T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K638T is not reported in ClinVar and is absent from gnomAD. Consensus from standard in silico predictors shows a split: benign calls come from REVEL, Rosetta, premPS, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default; FoldX and Foldetta are inconclusive. High‑accuracy assessments give AlphaMissense‑Optimized a benign score, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta remains uncertain. Overall, the balance of evidence favors a pathogenic effect for K638T. This prediction is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.098064Uncertain0.9370.2600.000-8.856Likely Pathogenic0.775Likely PathogenicLikely Benign0.87Ambiguous0.00.23Likely Benign0.55Ambiguous0.07Likely Benign0.404Likely Benign-5.39Deleterious0.999Probably Damaging0.998Probably Damaging3.52Benign0.03Affected0.16320.26190-13.2-27.07
c.1940G>T
G647V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G647V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that assess sequence conservation and structural impact uniformly classify the substitution as benign: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a tolerated change. No tool predicts pathogenicity; only FoldX and Rosetta report uncertain stability effects, which are treated as unavailable evidence. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a benign effect. Therefore, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.048328Structured0.325524Uncertain0.9360.3560.000-4.713Likely Benign0.126Likely BenignLikely Benign0.85Ambiguous0.1-0.59Ambiguous0.13Likely Benign-0.13Likely Benign0.115Likely Benign-1.77Neutral0.178Benign0.073Benign3.52Benign0.12Tolerated0.13180.3946-1-34.642.08
c.1970G>C
W657S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W657S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools (SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta) predict a pathogenic impact; Rosetta remains uncertain. High‑accuracy methods all support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.030611Structured0.208729Uncertain0.9410.2450.000-11.817Likely Pathogenic0.986Likely PathogenicLikely Pathogenic2.27Destabilizing0.21.87Ambiguous2.07Destabilizing1.26Destabilizing0.334Likely Benign-11.82Deleterious0.999Probably Damaging0.947Probably Damaging3.52Benign0.09Tolerated0.42990.0489-2-30.1-99.14
c.1970G>T
W657L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant W657L is listed in ClinVar with an uncertain significance (ClinVar ID 2767440.0) and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Tools that agree on a pathogenic effect are PROVEAN, ESM1b, and AlphaMissense‑Default. Uncertain predictions come from Foldetta, premPS, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, and Foldetta predicts a benign folding‑stability change. Overall, the majority of evidence points toward a pathogenic impact, which is consistent with the ClinVar uncertain status but leans toward pathogenic rather than benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.030611Structured0.208729Uncertain0.9410.2450.000Uncertain 1-14.411Likely Pathogenic0.960Likely PathogenicLikely Pathogenic0.14Likely Benign0.10.73Ambiguous0.44Likely Benign0.87Ambiguous0.213Likely Benign-10.86Deleterious0.277Benign0.078Benign3.52Benign0.14Tolerated3.39240.23020.2049-2-24.7-73.05
c.1980G>A
M660I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M660I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, and the protein‑folding stability method Foldetta returns an uncertain result. Stability predictions from FoldX, Rosetta, and premPS are also inconclusive. Overall, the majority of evidence points to a pathogenic effect for M660I. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.047319Structured0.134270Uncertain0.9440.2890.000-11.150Likely Pathogenic0.993Likely PathogenicLikely Pathogenic1.15Ambiguous0.10.71Ambiguous0.93Ambiguous0.95Ambiguous0.464Likely Benign-3.99Deleterious0.887Possibly Damaging0.289Benign3.52Benign0.04Affected0.11700.2878212.6-18.03
c.1980G>C
M660I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M660I (GAP domain) is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, polyPhen‑2 HumVar, and FATHMM. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. No other stability predictions are available. Overall, the preponderance of evidence points to a pathogenic effect for M660I. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.047319Structured0.134270Uncertain0.9440.2890.000-11.150Likely Pathogenic0.993Likely PathogenicLikely Pathogenic1.15Ambiguous0.10.71Ambiguous0.93Ambiguous0.95Ambiguous0.464Likely Benign-3.99Deleterious0.887Possibly Damaging0.289Benign3.52Benign0.04Affected0.11700.2878212.6-18.03
c.1980G>T
M660I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M660I (GAP domain) is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, polyPhen‑2 HumVar, and FATHMM. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. No other stability predictions are available. Overall, the preponderance of evidence points to a pathogenic effect for M660I. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.047319Structured0.134270Uncertain0.9440.2890.000-11.150Likely Pathogenic0.993Likely PathogenicLikely Pathogenic1.15Ambiguous0.10.71Ambiguous0.93Ambiguous0.95Ambiguous0.464Likely Benign-3.99Deleterious0.887Possibly Damaging0.289Benign3.52Benign0.04Affected0.11700.2878212.6-18.03
c.1982A>G
Q661R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q661R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Optimized, and polyPhen2_HumVar. Tools that predict a pathogenic effect are polyPhen2_HumDiv and ESM1b. FoldX, Rosetta, Foldetta, and AlphaMissense‑Default are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a benign prediction, while Foldetta remains uncertain. Overall, the majority of available evidence points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.048328Structured0.117089Uncertain0.9240.3090.000-10.386Likely Pathogenic0.479AmbiguousLikely Benign-1.12Ambiguous0.0-0.59Ambiguous-0.86Ambiguous-0.15Likely Benign0.281Likely Benign-2.06Neutral0.812Possibly Damaging0.251Benign3.52Benign0.18Tolerated0.15020.219611-1.028.06
c.1984C>G
Q662E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q662E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, FoldX, Foldetta, premPS, PROVEAN, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and ESM1b. High‑accuracy methods all support a benign outcome: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign; and Foldetta is benign. No prediction or folding‑stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.046336Structured0.103446Uncertain0.9320.3230.000-12.750Likely Pathogenic0.191Likely BenignLikely Benign0.32Likely Benign0.00.64Ambiguous0.48Likely Benign0.24Likely Benign0.083Likely Benign-1.25Neutral0.876Possibly Damaging0.147Benign3.52Benign0.27Tolerated0.16600.1823220.00.98
c.2006A>G
N669S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N669S is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33441265‑A‑G). Functional prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta (combining FoldX‑MD and Rosetta) is also inconclusive. No folding‑stability metrics (FoldX, Rosetta, Foldetta) provide definitive evidence. Overall, the majority of predictions lean toward a benign impact, and this is consistent with the absence of a ClinVar pathogenic classification. Thus, the variant is most likely benign, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.142424Structured0.086615Uncertain0.8720.3800.0006-33441265-A-G31.86e-6-8.369Likely Pathogenic0.187Likely BenignLikely Benign0.55Ambiguous0.11.88Ambiguous1.22Ambiguous0.35Likely Benign0.210Likely Benign-4.02Deleterious0.999Probably Damaging0.960Probably Damaging3.52Benign0.14Tolerated3.39270.35210.4480112.7-27.03
c.2027G>C
S676T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S676T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and Rosetta. No tool predicts a pathogenic outcome; the only inconclusive results are from FoldX (Uncertain) and Foldetta (Uncertain). High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta remains Uncertain. Overall, the consensus of available predictions indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.209395Structured0.113632Uncertain0.5510.3380.125-5.621Likely Benign0.092Likely BenignLikely Benign0.79Ambiguous0.10.34Likely Benign0.57Ambiguous-0.36Likely Benign0.098Likely Benign0.91Neutral0.050Benign0.017Benign3.52Benign1.00Tolerated0.15750.6286110.114.03
c.2119G>A
A707T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A707T is reported in gnomAD (ID 6‑33441584‑G‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also benign. The Foldetta stability prediction is inconclusive and therefore not considered evidence. Overall, the consensus of available predictions indicates that the variant is most likely benign, and this assessment does not contradict any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.203355Structured0.371229Uncertain0.9270.3650.0006-33441584-G-A16.20e-7-0.836Likely Benign0.175Likely BenignLikely Benign0.50Ambiguous0.02.36Destabilizing1.43Ambiguous0.10Likely Benign0.252Likely Benign-0.57Neutral0.980Probably Damaging0.947Probably Damaging3.52Benign0.44Tolerated3.5090.08800.433001-2.530.03
c.2126T>A
L709Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L709Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate benign or likely benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Thus, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.243554Structured0.365830Uncertain0.9340.3790.000-5.758Likely Benign0.179Likely BenignLikely Benign0.13Likely Benign0.00.40Likely Benign0.27Likely Benign0.18Likely Benign0.033Likely Benign-0.78Neutral0.998Probably Damaging0.923Probably Damaging3.52Benign0.48Tolerated0.08380.0488-2-2-7.314.97
c.398T>C
L133P
2D
AIThe SynGAP1 missense variant L133P is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. ESM1b remains uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (pathogenic), yields a pathogenic consensus. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.422041Structured0.718429Binding0.3200.8960.250-7.744In-Between0.982Likely PathogenicLikely Pathogenic0.342Likely Benign-3.16Deleterious0.700Possibly Damaging0.483Possibly Damaging3.52Benign0.00Affected0.32700.1048-3-3-5.4-16.04
c.407G>A
R136Q
2D
AIThe SynGAP1 R136Q variant is listed in ClinVar as benign and is present in gnomAD (6‑33432704‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized returns an uncertain result. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive due to a 2‑vs‑2 split, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no reported result for this variant. Based on the available predictions, the variant is most likely benign, which aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.433034Structured0.657394Binding0.3510.8940.250Benign 16-33432704-G-A139.17e-6-11.146Likely Pathogenic0.950Likely PathogenicAmbiguous0.190Likely Benign-2.26Neutral0.957Probably Damaging0.342Benign3.52Benign0.01Affected3.6150.31710.2460111.0-28.06
c.418T>C
S140P
2D
AIThe SynGAP1 missense variant S140P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic vs. two benign votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy tools specifically show AlphaMissense‑Optimized as pathogenic, while SGM Consensus and Foldetta are unavailable. Overall, the majority of evidence points to a pathogenic impact for S140P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.476583Structured0.587898Binding0.3210.8960.625-4.089Likely Benign0.990Likely PathogenicLikely Pathogenic0.287Likely Benign-2.59Deleterious0.995Probably Damaging0.979Probably Damaging3.52Benign0.08Tolerated0.17260.51171-1-0.810.04
c.428G>T
R143L
2D
AIThe SynGAP1 missense variant R143L is listed in ClinVar with no submitted interpretation and is present in gnomAD (ID 6‑33432725‑G‑T). Functional prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect comprise PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic; the Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.575842Disordered0.538584Binding0.3380.8380.6256-33432725-G-T16.77e-7-14.250Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.316Likely Benign-4.37Deleterious0.319Benign0.124Benign3.52Benign0.00Affected3.6150.17580.4886-2-38.3-43.03
c.552G>C
E184D
2D
AIThe SynGAP1 E184D missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta results are unavailable. Overall, the majority of evidence (six pathogenic vs. three benign predictions) indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.557691Disordered0.431514Uncertain0.3480.6220.625-6.753Likely Benign0.971Likely PathogenicLikely Pathogenic0.195Likely Benign-2.55Deleterious0.930Possibly Damaging0.584Possibly Damaging3.52Benign0.00Affected0.22490.5394320.0-14.03
c.552G>T
E184D
2D
AIThe SynGAP1 E184D missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta results are unavailable. Overall, the majority of evidence (six pathogenic vs. three benign predictions) indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.557691Disordered0.431514Uncertain0.3480.6220.625-6.753Likely Benign0.971Likely PathogenicLikely Pathogenic0.195Likely Benign-2.55Deleterious0.930Possibly Damaging0.584Possibly Damaging3.52Benign0.00Affected0.22490.5394320.0-14.03
c.67G>A
D23N
2D
AIThe SynGAP1 D23N missense variant has no ClinVar record and is not listed in gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.557691Disordered0.440341Uncertain0.3690.8920.375-3.918Likely Benign0.719Likely PathogenicLikely Benign0.077Likely Benign-1.88Neutral0.805Possibly Damaging0.539Possibly Damaging3.52Benign0.00Affected0.22360.8784210.0-0.98
c.68A>C
D23A
2D
AIThe SynGAP1 D23A missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta results are unavailable. Overall, the majority of predictions (five pathogenic versus four benign) suggest a pathogenic impact. This conclusion does not contradict ClinVar status, as the variant has no existing ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.557691Disordered0.440341Uncertain0.3690.8920.375-2.732Likely Benign0.777Likely PathogenicLikely Benign0.112Likely Benign-2.57Deleterious0.909Possibly Damaging0.539Possibly Damaging3.52Benign0.00Affected0.46130.82030-25.3-44.01
c.1252A>G
K418E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K418E is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, and FATHMM. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Overall, the majority of evaluated tools (seven pathogenic vs four benign) indicate that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists for K418E.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.360134Uncertain0.9480.2630.000-12.443Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.63Ambiguous0.00.80Ambiguous0.72Ambiguous0.47Likely Benign0.367Likely Benign-3.42Deleterious0.999Probably Damaging0.991Probably Damaging3.53Benign0.07Tolerated0.35780.0471010.40.94

Found 8751 rows. Show 800 rows per page. Page 7/11 « Previous | Next »